data_2cpn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cpn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.637 0.732 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -49.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.721 2.281 . . . . 0.0 112.333 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.3 t -47.03 -36.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.22 -18.76 62.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.64 -53.67 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.3 tp -50.61 -28.86 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -30.07 67.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -81.8 -43.09 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.473 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -62.52 -54.06 45.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.8 m -41.97 -54.23 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.0 t -52.62 -36.86 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -72.81 -31.48 64.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.561 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 40.7 mttm -85.83 -20.69 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.47 36.27 7.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.561 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 43.9 m0 -114.31 172.82 6.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -101.47 162.53 12.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 24.9 mt -41.21 144.86 0.64 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 152.52 69.56 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.718 2.278 . . . . 0.0 112.383 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -97.81 127.84 44.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.553 ' CZ ' ' CG ' ' A' ' 214' ' ' LYS . 40.8 m-85 -113.65 117.38 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.951 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.2 m -145.37 135.77 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.143 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.7 t -77.53 122.24 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.0 p -92.58 -60.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.415 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 18.4 tt0 -119.08 160.41 22.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.415 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 3.7 mp0 -144.57 114.04 7.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -134.61 167.74 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.46 149.26 9.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.563 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.1 Cg_endo -69.72 -169.22 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.6 16.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.563 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 15.6 p-80 -59.94 -35.15 74.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -134.47 91.79 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -87.12 146.69 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -138.7 123.92 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -108.29 135.34 49.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 37.7 m -99.24 97.83 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.0 ttm -100.2 138.93 36.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 17.6 m -116.2 136.88 52.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 53.2 t -93.2 115.22 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.841 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -98.53 102.7 14.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 32.4 t -95.78 157.31 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -34.38 -65.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 5.9 ptm180 -122.92 31.06 6.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 23.6 m-85 -146.74 155.49 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.4 mt -150.01 141.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -153.17 122.8 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 59.8 mt -84.99 140.29 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.183 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -140.01 165.59 25.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 62.4 m -143.38 150.86 39.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.52 140.5 6.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 76.3 p -38.07 -44.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.823 0.344 . . . . 0.0 111.216 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.9 m -120.24 164.81 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -61.04 -50.8 71.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -52.1 -45.03 64.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 30.9 mt -65.93 -51.93 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.4 -57.51 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.553 ' CG ' ' CZ ' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -40.28 -50.31 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -62.8 -48.52 78.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -48.72 -41.66 32.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.55 -52.7 11.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.27 -59.65 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.42 -59.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -52.31 -43.95 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 14.3 tpp -53.68 -43.05 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -40.41 -58.26 1.59 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.64 -47.52 75.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -45.79 -55.17 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.545 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 30.1 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.614 0.721 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -50.75 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 80.2 t -47.26 -45.42 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.95 -12.84 84.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.527 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.23 -50.25 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.0 tp -57.45 -38.06 73.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.435 ' OE1' ' CD2' ' A' ' 175' ' ' LEU . 6.2 tp60 -58.8 -27.95 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.83 -46.98 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 167' ' ' LEU . 4.5 mt -58.67 -54.02 51.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.1 m -40.36 -51.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.4 -34.08 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.119 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 167' ' ' LEU . 51.6 mt-30 -76.07 -33.43 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.555 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 15.3 mtpp -84.65 -15.14 46.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.21 41.91 7.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.488 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.9 m0 -118.74 174.3 6.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -102.21 163.64 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.435 ' CD2' ' OE1' ' A' ' 165' ' ' GLN . 38.9 mt -37.77 143.21 0.4 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 143.44 51.15 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.308 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -97.04 134.51 40.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.552 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.5 m-85 -132.32 115.21 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.406 ' C ' ' HG3' ' A' ' 194' ' ' MET . 9.7 m -139.69 131.3 27.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.54 112.86 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.419 ' CG2' ' OG1' ' A' ' 195' ' ' THR . 1.6 t -89.27 -33.63 16.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -150.89 156.74 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.465 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 75.5 mt-10 -140.35 110.99 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.6 t -126.74 171.05 11.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.69 162.75 12.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.498 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.3 Cg_endo -69.78 -179.34 2.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.0 112.39 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.89 28.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 18.5 p-80 -57.79 -41.34 81.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -127.49 88.87 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -83.47 125.05 31.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 129.63 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.465 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 10.6 m-85 -110.41 118.16 35.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.0 m -93.04 104.11 16.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.406 ' HG3' ' C ' ' A' ' 179' ' ' THR . 5.1 ttp -106.49 141.26 38.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.419 ' OG1' ' CG2' ' A' ' 181' ' ' THR . 3.4 m -108.33 135.41 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.147 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . 0.441 ' SG ' ' CE1' ' A' ' 178' ' ' TYR . 46.6 t -93.58 109.98 21.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -93.85 108.89 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -103.79 157.39 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 43.7 mm-40 -34.01 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.474 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 61.7 mtt180 -118.64 32.23 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 21.3 m-85 -147.64 154.66 40.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.6 mt -149.96 136.53 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -146.35 147.45 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 46.4 mt -104.83 126.65 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.32 168.27 18.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.2 m -143.52 160.15 41.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.909 0.385 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -178.3 140.6 4.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -42.42 -43.65 3.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 111.148 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 210' ' ' LYS . 55.8 p -125.64 140.85 52.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 209' ' ' SER . 85.9 mttt -36.54 -46.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -50.75 -51.76 47.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.38 -47.16 71.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -42.6 -46.5 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.552 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.2 OUTLIER -54.1 -46.28 72.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.81 -48.8 80.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -55.13 -44.33 74.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.9 -52.68 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.078 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.84 -64.06 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -38.18 -63.36 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -46.26 -47.61 18.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 6.2 tpp -54.34 -43.15 71.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 64.7 mt -45.26 -60.0 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.09 -44.14 87.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -54.67 -62.76 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 19.0 m . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -50.53 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.35 -41.29 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -78.67 -11.97 84.71 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.504 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.69 -48.52 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.087 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.1 tp -52.35 -33.87 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -60.45 -31.26 70.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.79 -42.37 34.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 167' ' ' LEU . 4.5 mt -64.08 -60.42 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 167' ' ' LEU . 5.4 m -36.34 -49.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 48.0 t -59.76 -42.53 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 167' ' ' LEU . 78.2 mt-30 -64.87 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.525 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 40.1 mttm -99.96 -13.09 19.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.57 40.83 9.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.525 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 48.5 m0 -115.83 173.7 6.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.766 0.317 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -101.01 173.17 6.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 61.3 mt -49.36 143.58 9.68 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.903 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.39 69.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.37 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -98.7 131.04 45.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.541 ' CD2' ' HE3' ' A' ' 214' ' ' LYS . 70.3 m-85 -121.36 112.86 19.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.7 m -147.04 144.57 29.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 91.7 t -79.62 130.07 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.02 -40.87 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.419 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 31.3 tp60 -140.94 159.52 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.477 ' OE1' ' CE2' ' A' ' 192' ' ' PHE . 25.6 mt-10 -149.61 109.02 3.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.7 t -118.32 172.15 7.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.68 145.9 18.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.469 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.73 -168.42 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.88 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 2.3 p-80 -64.77 -41.53 95.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -117.32 89.85 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -88.24 131.3 34.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -130.51 114.86 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.477 ' CE2' ' OE1' ' A' ' 183' ' ' GLU . 32.1 m-85 -103.91 124.92 49.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -97.71 98.29 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 52.8 ttm -100.67 140.81 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 20.3 m -115.39 138.56 50.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 221' ' ' MET . 7.0 t -95.28 117.22 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -98.95 122.92 42.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.2 t -119.65 157.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.489 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 75.2 mm-40 -34.05 -68.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 199' ' ' GLU . 13.4 mmp_? -120.76 32.33 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 28.6 m-85 -146.59 150.44 35.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -150.03 139.05 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.64 142.6 21.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 205' ' ' GLY . 74.7 mt -100.87 141.11 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 204' ' ' ILE . . . -130.15 173.12 20.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 60.6 p -142.95 146.62 34.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.408 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 208' ' ' THR . . . -168.46 126.62 1.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 207' ' ' GLY . 43.7 p -36.02 -44.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.1 t -118.18 144.53 45.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -44.26 -47.72 9.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -52.85 -46.6 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.2 -46.33 74.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -47.82 -44.46 28.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.541 ' HE3' ' CD2' ' A' ' 178' ' ' TYR . 51.8 tttt -55.49 -44.71 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -69.85 -41.22 75.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -61.83 -42.14 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.12 -54.92 16.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.65 -50.39 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.59 -62.11 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.084 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -51.99 -44.82 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' MET . . . . . 0.426 ' CE ' ' CG2' ' A' ' 198' ' ' VAL . 1.3 ttt -49.93 -40.69 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 71.5 mt -43.4 -52.35 6.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.3 mt -72.28 -48.74 40.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -45.49 -44.13 12.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.562 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 10.6 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.425 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 11.8 t30 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.638 0.733 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.74 -47.41 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 0.0 112.349 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.6 t -50.28 -37.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.81 -11.81 78.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.451 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.91 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -55.29 -34.48 64.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.81 -34.13 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -77.37 -49.85 14.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -55.72 -58.41 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.6 m -37.84 -46.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 79.8 t -53.56 -46.48 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.17 -37.95 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.527 ' HD2' ' CH2' ' A' ' 173' ' ' TRP . 22.7 mtmm -74.39 -23.59 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.05 35.42 6.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.479 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.527 ' CH2' ' HD2' ' A' ' 171' ' ' LYS . 39.6 m0 -118.44 171.49 8.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -101.85 172.9 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.1 mt -43.54 144.08 1.4 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 0.0 110.944 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 155.35 66.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.331 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -93.54 135.5 34.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.553 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 42.7 m-85 -129.24 112.03 13.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.4 m -145.55 142.58 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.435 HG13 ' CG ' ' A' ' 183' ' ' GLU . 99.2 t -77.89 121.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 20.1 p -89.82 -45.8 9.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.409 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 28.4 tt0 -135.86 162.28 33.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.435 ' CG ' HG13 ' A' ' 180' ' ' VAL . 31.8 mt-10 -151.19 113.5 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -136.34 171.65 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.05 146.21 20.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.635 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.75 -164.24 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.705 2.27 . . . . 0.0 112.358 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.21 -38.96 55.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.635 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 44.3 p-80 -75.26 -21.85 58.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 188' ' ' HIS . 22.6 mtp180 -131.81 58.18 1.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -68.44 134.95 50.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -137.69 114.68 10.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -107.77 131.66 54.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.0 m -104.05 97.72 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.9 ttm -101.38 135.29 43.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.409 HG23 ' CG1' ' A' ' 204' ' ' ILE . 33.4 m -114.42 136.7 52.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 5.1 t -92.56 113.98 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -96.83 104.78 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.4 t -99.99 157.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.4 mm-40 -34.01 -72.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.0 29.8 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 38.8 m-85 -144.92 151.18 38.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 69.4 mt -149.98 137.27 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -151.27 133.68 15.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.409 ' CG1' HG23 ' A' ' 195' ' ' THR . 57.9 mt -93.57 136.31 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.56 175.29 16.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 51.7 p -152.44 139.0 18.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.881 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -163.18 143.41 8.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.4 p -42.51 -39.45 2.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 111.155 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.8 m -129.67 148.47 51.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -47.51 -40.1 17.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -56.18 -48.02 77.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.6 mt -70.57 -47.01 62.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -44.88 -52.7 8.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.141 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.553 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 12.9 ttmt -44.89 -46.99 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 46.1 mtt85 -62.17 -47.75 83.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -52.38 -46.14 66.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.8 -50.71 47.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -60.85 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 222' ' ' LEU . . . -45.67 -55.79 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -49.79 -41.27 44.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' MET . . . . . 0.403 ' O ' ' C ' ' A' ' 222' ' ' LEU . 5.2 tpp -61.99 -45.21 94.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 219' ' ' ALA . 73.8 mt -37.07 -47.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.1 mt -77.9 -47.0 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -46.75 -57.36 4.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.46 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 16.8 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.084 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.63 0.729 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -50.74 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 94.7 t -49.37 -32.31 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -88.49 -22.69 39.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.42 -54.08 6.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.7 tp -49.1 -38.43 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.494 ' NE2' ' CD2' ' A' ' 175' ' ' LEU . 4.9 tp-100 -60.88 -31.51 70.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -77.3 -35.85 54.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -71.11 -55.89 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.0 m -41.44 -52.57 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.27 -36.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.106 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -75.32 -37.25 60.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.556 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 27.5 mttt -78.79 -14.87 59.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 39.03 7.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.556 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 36.4 m0 -120.69 171.58 8.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.773 0.321 . . . . 0.0 110.945 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -101.71 168.5 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.494 ' CD2' ' NE2' ' A' ' 165' ' ' GLN . 26.1 mt -43.65 142.88 1.74 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.56 68.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.329 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.87 127.1 48.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.541 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 75.5 m-85 -122.32 114.72 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.1 m -136.51 130.76 32.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.68 111.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.176 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -86.03 -59.09 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -117.18 158.07 24.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -145.62 113.37 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.3 t -133.03 169.89 16.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.86 145.47 19.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.56 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.74 -174.77 0.96 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.704 2.269 . . . . 0.0 112.36 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.06 85.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 19.2 p-80 -67.34 -39.89 85.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -113.34 51.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -58.28 129.49 42.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.908 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -133.66 116.64 16.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -107.05 128.23 54.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 m -101.96 100.72 11.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.073 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 4.9 ttp -106.37 139.56 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.438 HG21 ' CG1' ' A' ' 204' ' ' ILE . 5.8 m -110.43 140.13 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.56 117.73 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 16.5 ttp85 -99.97 101.58 12.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 37.3 t -96.05 157.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.491 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 11.0 mm-40 -33.75 -69.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.456 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 6.0 ptm180 -119.55 31.87 6.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.543 ' CD2' HG12 ' A' ' 225' ' ' VAL . 22.3 m-85 -147.41 151.91 37.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 203' ' ' GLU . 74.0 mt -149.98 135.89 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.448 ' N ' HG22 ' A' ' 202' ' ' ILE . 6.9 tp10 -150.85 134.92 16.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.438 ' CG1' HG21 ' A' ' 195' ' ' THR . 56.5 mt -86.63 135.82 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.34 169.23 15.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 78.4 p -144.21 143.47 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.87 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.66 132.32 2.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.9 p -38.34 -40.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.153 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 57.9 m -126.15 145.79 50.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -39.37 -45.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -56.05 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 22.6 mt -58.92 -43.71 91.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -53.54 -49.16 68.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.541 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 52.5 tttt -50.08 -37.95 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 216' ' ' ASN . 2.4 mtp-105 -68.83 -66.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 215' ' ' ARG . 0.7 OUTLIER -37.12 -50.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.53 -49.19 77.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.38 -55.82 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 222' ' ' LEU . . . -45.72 -62.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -46.14 -45.99 16.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' MET . . . . . 0.419 ' HE3' ' N ' ' A' ' 203' ' ' GLU . 4.7 tpp -52.73 -43.58 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 219' ' ' ALA . 31.9 mt -43.31 -55.79 3.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.06 -39.03 92.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -55.45 -63.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.543 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.9 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.42 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 3.9 t30 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.624 0.726 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.1 Cg_endo -69.71 -50.41 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.689 2.259 . . . . 0.0 112.374 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.11 -35.16 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.51 -19.51 60.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.74 -55.99 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.2 tp -49.09 -28.52 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -67.74 -32.38 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -78.88 -38.16 38.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.478 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.06 -50.25 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.5 m -49.38 -44.1 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.05 -32.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -80.1 -32.29 39.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.562 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 16.2 mtpp -82.95 -17.54 43.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.06 42.37 7.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.562 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.4 m0 -119.43 175.3 5.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.783 0.325 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -103.68 162.72 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.2 mt -38.77 143.29 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.625 0.726 . . . . 0.0 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 155.18 66.47 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.656 2.237 . . . . 0.0 112.382 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.91 141.34 30.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.551 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 65.9 m-85 -134.2 113.33 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 m -148.82 137.44 21.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.17 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.54 129.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.47 -35.55 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 2.9 tp-100 -137.33 154.39 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.458 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 2.2 mp0 -143.12 106.64 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -127.63 170.27 12.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 113.26 150.09 10.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.78 -165.55 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.17 -47.33 14.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.5 p-80 -58.19 -37.88 75.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -135.04 96.76 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -87.12 125.03 33.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.93 130.23 53.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -119.7 128.67 54.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 64.0 m -103.57 101.12 10.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 50.3 ttm -100.78 141.24 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.6 m -113.53 141.99 46.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.39 112.23 24.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -95.46 108.67 20.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -100.93 158.19 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.6 mm-40 -33.2 -64.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 3.4 ptm180 -126.67 33.29 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.546 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 21.4 m-85 -147.93 158.09 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.0 mt -150.03 139.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.46 128.69 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 38.0 mt -87.21 135.45 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -135.3 166.11 24.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 29.9 t -146.93 166.75 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.879 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 178.12 142.73 4.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.7 p -46.07 -32.66 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 111.126 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.7 m -130.86 154.98 47.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -50.82 -54.85 20.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -46.23 -38.37 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 213' ' ' ALA . 64.0 mt -72.78 -65.16 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.8 -39.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.551 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 74.8 tttt -61.22 -56.61 18.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -62.11 -28.02 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 -46.37 70.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.94 -42.48 89.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.23 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.77 -56.08 13.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -59.14 -35.22 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 5.0 tpp -59.58 -41.42 90.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 37.4 mt -43.98 -42.55 6.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.59 -43.62 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.959 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -49.48 -54.44 17.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.546 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 13.4 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.421 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 14.2 t30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.73 -43.02 2.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.672 2.248 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -51.12 -51.97 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.9 -10.57 80.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.62 -47.15 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 111.079 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 29.8 tp -57.55 -26.41 61.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.457 ' NE2' HD22 ' A' ' 175' ' ' LEU . 5.7 tp-100 -69.75 -25.25 63.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.07 -29.74 34.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 167' ' ' LEU . 4.5 mt -75.89 -55.91 5.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.5 m -42.36 -50.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 51.2 t -57.36 -38.45 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -72.19 -34.53 68.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.554 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 34.1 mttt -82.38 -18.21 42.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.61 40.12 6.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.554 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 42.6 m0 -118.78 176.96 5.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -103.46 173.07 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.839 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.457 HD22 ' NE2' ' A' ' 165' ' ' GLN . 32.3 mt -51.07 143.39 16.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.934 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.15 68.03 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.92 122.26 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.497 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 93.8 m-85 -113.76 114.98 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.417 ' C ' ' HG3' ' A' ' 194' ' ' MET . 4.4 m -140.17 132.05 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.53 119.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.1 t -97.49 -37.51 9.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 10.8 tp60 -138.3 154.86 49.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.459 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 4.7 mp0 -144.25 108.98 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -125.02 172.13 9.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.26 145.15 16.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.49 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.8 -169.32 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.678 2.252 . . . . 0.0 112.356 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.84 -48.58 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.1 p-80 -59.55 -41.75 90.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -122.62 80.74 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -76.96 140.56 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.22 118.05 15.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -110.63 124.5 52.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.0 m -102.61 104.63 15.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.417 ' HG3' ' C ' ' A' ' 179' ' ' THR . 4.0 ttp -103.09 145.78 29.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.2 m -115.46 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.173 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -95.68 116.58 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -96.63 105.73 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 44.8 t -96.71 157.44 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 78.8 mm-40 -33.88 -69.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 78.8 mtt180 -119.32 30.94 6.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.514 ' CD2' HG12 ' A' ' 225' ' ' VAL . 21.7 m-85 -147.3 155.47 42.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.1 mt -149.84 139.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -151.58 140.73 21.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.8 mt -103.87 134.02 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.3 168.52 18.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.7 p -133.87 151.31 51.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -172.21 136.77 3.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.5 p -45.61 -42.07 10.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 212' ' ' LEU . 1.9 t -125.99 141.23 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -38.73 -48.91 1.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.82 -41.87 45.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 209' ' ' SER . 25.3 mt -75.33 -50.64 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.75 -41.32 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.497 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.1 ttpm? -54.33 -56.82 14.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -57.03 -40.11 76.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -45.33 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.29 -51.51 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -47.29 -63.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -39.44 -66.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -41.97 -47.38 4.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 16.7 tpp -56.69 -43.39 80.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 84.6 mt -44.89 -59.16 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.63 -46.81 87.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -48.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.514 HG12 ' CD2' ' A' ' 201' ' ' PHE . 27.9 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.466 ' ND2' ' HD2' ' A' ' 160' ' ' PRO . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.645 0.736 . . . . 0.0 110.852 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.466 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.75 -50.23 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.683 2.255 . . . . 0.0 112.338 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.14 -41.2 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.59 86.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -96.4 -55.29 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.7 tp -50.1 -30.06 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -64.78 -34.7 78.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -77.57 -46.11 23.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.0 mt -58.87 -57.43 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.7 m -40.21 -42.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.26 -40.98 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 44.4 mt-30 -70.69 -31.2 68.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.568 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 28.2 mttp -85.02 -15.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.83 8.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.568 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 39.2 m0 -120.85 172.61 7.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -100.5 172.24 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.7 mt -46.95 142.6 4.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 145.87 58.69 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.19 146.24 24.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.403 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 91.1 m-85 -138.0 117.94 13.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.979 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.401 ' C ' ' HG3' ' A' ' 194' ' ' MET . 35.1 m -140.25 128.42 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.158 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.92 113.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.5 p -88.51 -56.2 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.43 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 8.7 tp60 -119.88 154.72 33.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.43 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 2.7 mp0 -144.58 114.47 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.1 t -136.51 170.72 15.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.43 145.92 11.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.421 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.79 -173.13 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.71 62.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.0 p-80 -62.57 -38.71 91.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -123.28 83.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -82.19 126.46 32.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.21 124.39 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.18 132.31 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.4 m -107.19 102.71 12.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.401 ' HG3' ' C ' ' A' ' 179' ' ' THR . 8.6 ttp -107.49 139.67 41.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 31.1 m -108.04 136.79 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.5 t -93.38 115.1 27.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -94.67 105.5 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.464 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.2 t -97.04 156.59 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.464 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 12.0 mm-40 -34.15 -70.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -117.27 29.93 7.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 30.1 m-85 -145.99 155.65 42.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.832 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -149.23 137.76 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.442 ' O ' ' CG2' ' A' ' 195' ' ' THR . 4.5 tp10 -150.43 145.44 26.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.18 131.33 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.31 173.75 17.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.7 t -152.14 155.34 37.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.845 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.92 144.09 8.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.1 p -49.38 -26.26 3.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 81.8 p -140.03 145.29 37.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -42.61 -54.42 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -44.82 -39.45 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 215' ' ' ARG . 75.2 mt -76.99 -58.11 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.24 -37.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.403 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 36.7 tttt -64.48 -49.28 72.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 212' ' ' LEU . 12.0 ptt180 -68.9 -30.55 69.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -45.77 84.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.52 81.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.078 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.22 66.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.54 -61.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -48.87 -43.26 38.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 8.1 tpp -55.2 -43.8 74.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 80.4 mt -38.43 -53.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 24.9 mt -72.89 -38.95 66.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -52.07 -56.62 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.564 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 11.1 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -44.74 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.96 -48.85 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.99 -11.98 78.99 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.58 -55.38 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.1 tp -39.81 -35.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.468 ' NE2' HD21 ' A' ' 175' ' ' LEU . 6.6 tp-100 -55.81 -46.77 77.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.457 ' CG ' HD23 ' A' ' 167' ' ' LEU . 3.9 pt-20 -55.33 -33.99 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.457 HD23 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -70.27 -68.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.9 m -40.1 -45.54 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.1 t -52.31 -53.88 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -64.51 -38.95 92.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -71.25 -24.14 62.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.27 26.85 22.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.463 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -103.09 174.15 5.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 175' ' ' LEU . 35.7 ptt180 -103.58 159.78 15.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.468 HD21 ' NE2' ' A' ' 165' ' ' GLN . 21.1 mt -34.25 142.05 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.562 0.696 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 156.99 62.0 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -97.42 130.34 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.512 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 54.1 m-85 -124.07 112.79 17.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.3 m -145.34 150.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -82.96 133.04 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 -42.62 5.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 3.3 tp-100 -140.12 150.2 43.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 1.9 mp0 -137.27 107.05 6.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 t -124.33 169.91 11.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.92 144.41 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.417 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.77 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.34 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.05 -48.13 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -59.66 -37.47 78.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -125.46 81.69 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -81.44 136.33 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -136.89 114.47 11.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -110.25 130.11 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.3 m -99.79 106.64 18.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 36.2 ttm -108.46 138.87 44.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 28.8 m -115.97 137.62 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 52.6 t -94.13 118.04 30.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -101.31 103.16 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.9 t -99.74 158.29 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.51 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 7.6 mm-40 -34.14 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 56.2 mtp180 -113.65 31.67 6.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.567 ' CD2' HG11 ' A' ' 225' ' ' VAL . 23.3 m-85 -146.98 148.92 32.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.6 mt -150.02 139.39 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -155.77 139.69 16.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 21.7 mt -98.33 142.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.16 179.07 18.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' A' ' 216' ' ' ASN . 1.9 m -150.98 161.74 42.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.87 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -175.54 139.59 4.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.7 p -41.78 -40.37 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 31.3 m -126.73 144.02 51.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.847 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -39.91 -49.83 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -52.53 -53.49 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 32.3 mt -57.19 -45.67 83.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 214' ' ' LYS . . . -49.24 -57.91 5.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.512 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.4 ttpm? -35.94 -46.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -68.15 -56.57 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 206' ' ' SER . 16.8 m-80 -38.09 -45.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.12 -46.73 49.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.05 -60.02 4.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.27 -55.0 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -57.56 -42.67 83.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' MET . . . . . 0.4 ' CE ' HG22 ' A' ' 198' ' ' VAL . 1.7 tpp -53.2 -45.47 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 35.6 mt -42.13 -42.79 3.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.7 mt -78.46 -36.66 45.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -57.67 -60.5 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.567 HG11 ' CD2' ' A' ' 201' ' ' PHE . 30.6 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.597 0.713 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.19 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.64 2.226 . . . . 0.0 112.392 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -45.96 -40.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.55 71.34 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.458 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.04 -50.78 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -49.8 -38.39 34.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -52.43 -27.77 17.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.16 -43.66 41.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 167' ' ' LEU . 4.5 mt -62.17 -48.2 81.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.401 HG21 ' N ' ' A' ' 169' ' ' VAL . 17.4 m -60.91 -50.14 81.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.401 ' N ' HG21 ' A' ' 168' ' ' VAL . 26.0 t -56.32 -54.35 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 13.5 pt20 -62.02 -43.19 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.556 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 21.6 mmmt -67.47 -28.38 67.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.96 47.07 3.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.454 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.556 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 41.6 m0 -120.17 178.16 4.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 175' ' ' LEU . 12.3 ptt180 -99.29 148.87 23.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 174' ' ' ARG . 39.7 mt -34.03 142.35 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.596 0.712 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 143.18 49.91 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 0.0 112.349 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -104.11 128.82 51.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.42 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 89.8 m-85 -122.25 115.71 22.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.411 ' C ' ' HG3' ' A' ' 194' ' ' MET . 99.3 m -131.29 131.13 43.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.458 ' CG1' ' HG3' ' A' ' 183' ' ' GLU . 87.3 t -67.88 107.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.7 p -81.95 -59.07 2.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -115.26 151.74 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.458 ' HG3' ' CG1' ' A' ' 180' ' ' VAL . 3.6 mp0 -143.87 113.98 7.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.5 t -133.49 172.34 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.27 145.32 18.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.504 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.3 Cg_endo -69.79 -164.76 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.667 2.245 . . . . 0.0 112.325 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.75 -30.5 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.504 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 4.8 p-80 -80.61 -24.37 39.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -130.37 52.82 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -55.27 126.24 24.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.64 114.63 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.884 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.08 131.79 54.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.3 m -105.74 102.65 12.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.129 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.411 ' HG3' ' C ' ' A' ' 179' ' ' THR . 8.0 ttp -105.85 139.61 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 29.2 m -112.16 138.63 48.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.31 122.79 38.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -104.9 103.6 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 17.7 t -96.97 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.532 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.9 mm-40 -33.51 -68.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -121.47 33.03 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -146.85 152.07 38.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.465 ' CA ' ' HE2' ' A' ' 221' ' ' MET . 98.8 mt -149.23 141.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -156.48 139.06 15.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.56 134.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -124.3 165.01 17.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.5 p -134.91 138.24 43.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 0.0 110.828 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -158.46 134.64 3.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 12.2 p -43.13 -34.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 0.0 111.144 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 210' ' ' LYS . 28.6 t -132.43 141.84 49.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 209' ' ' SER . 22.9 mtmt -37.6 -57.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -46.01 -42.22 12.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 215' ' ' ARG . 54.1 mt -73.14 -57.03 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -39.71 -31.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.42 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 44.5 tttt -66.1 -45.25 81.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.2 ptt85 -66.39 -40.55 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.15 -50.91 71.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.64 -50.04 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -49.81 64.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.57 -62.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -50.52 -49.02 56.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' MET . . . . . 0.465 ' HE2' ' CA ' ' A' ' 202' ' ' ILE . 2.4 tpp -48.62 -46.26 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.1 mt -38.74 -57.69 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.2 mt -63.68 -48.35 77.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -47.74 -63.26 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.621 0.724 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.362 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.0 t -49.26 -40.04 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.63 -15.51 81.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.51 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.85 -56.85 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 36.3 tp -49.75 -30.21 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -33.84 76.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -76.71 -41.56 44.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.484 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -64.6 -61.31 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 167' ' ' LEU . 3.3 m -37.19 -53.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 76.3 t -54.96 -44.1 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -64.81 -34.52 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.549 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 17.7 mtpp -83.34 -12.53 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.17 11.16 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.437 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.549 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 48.8 m0 -116.06 174.38 6.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.753 0.311 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -106.04 164.63 11.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.6 mt -42.52 142.27 1.35 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 110.884 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 143.57 50.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.5 128.77 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.513 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 90.9 m-85 -118.73 115.9 25.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.415 ' C ' ' HG3' ' A' ' 194' ' ' MET . 98.9 m -138.52 128.63 25.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 88.0 t -64.24 115.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.7 p -89.08 -58.9 2.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.438 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 9.0 tp60 -117.7 154.11 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.438 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 3.4 mp0 -144.85 114.74 7.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.5 t -136.03 172.42 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.67 144.75 13.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.544 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.75 -174.13 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 0.0 112.352 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.69 -42.69 73.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -66.78 -37.91 85.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -123.83 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -83.29 133.8 34.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -136.37 114.55 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -105.34 140.08 39.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 35.5 m -114.07 98.65 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.415 ' HG3' ' C ' ' A' ' 179' ' ' THR . 6.5 ttp -100.59 141.12 33.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.0 m -110.43 133.91 52.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 8.5 t -91.65 114.35 26.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -95.94 109.5 21.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 36.9 t -102.17 156.69 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.473 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -33.54 -67.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 45.0 mtp180 -122.47 31.32 6.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 25.7 m-85 -147.34 156.34 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.8 mt -150.0 139.41 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.162 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.454 ' CG ' ' HG3' ' A' ' 224' ' ' ARG . 5.8 mm-40 -150.64 133.73 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 205' ' ' GLY . 35.0 mt -90.68 136.99 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.412 ' N ' HG22 ' A' ' 204' ' ' ILE . . . -126.65 155.5 19.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.497 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 p -137.52 145.71 43.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.97 159.81 33.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.8 p -65.94 -12.61 56.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 111.129 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 64.8 p -150.92 154.9 38.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.813 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -49.57 -58.17 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -42.85 -44.66 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 214' ' ' LYS . 44.3 mt -67.57 -65.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.99 -31.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.513 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 73.0 tttt -67.33 -52.59 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.917 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -65.11 -39.21 92.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -57.68 -50.25 73.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.55 74.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.081 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.55 -51.0 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.85 -62.19 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -51.97 -39.87 59.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' MET . . . . . 0.423 ' HE1' ' N ' ' A' ' 203' ' ' GLU . 7.7 tpp -55.05 -41.98 72.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 18.7 mt -44.06 -62.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.7 -42.32 92.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.454 ' HG3' ' CG ' ' A' ' 203' ' ' GLU . 12.4 mmt180 -51.78 -56.12 15.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.547 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 21.5 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.615 0.721 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -50.36 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.667 2.245 . . . . 0.0 112.359 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.42 -42.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.74 -18.77 78.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.39 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.5 tp -47.91 -39.02 17.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -57.6 -31.06 65.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.956 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -80.39 -46.45 15.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.464 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -57.72 -46.94 83.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.3 m -56.38 -52.48 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.1 t -54.54 -58.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 15.2 pt20 -54.3 -44.9 72.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.561 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 12.1 mtpp -69.5 -25.94 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.4 48.97 3.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.461 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.561 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 45.7 m0 -123.13 178.13 5.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.893 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -99.83 157.21 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.7 mt -39.7 143.99 0.53 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 146.76 61.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.99 141.3 30.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 69.5 m-85 -133.77 118.43 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 180' ' ' VAL . 98.5 m -147.72 135.16 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.126 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.447 HG12 ' CG ' ' A' ' 183' ' ' GLU . 87.9 t -75.47 118.11 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 57.4 p -88.34 -43.96 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.417 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 12.9 tm0? -135.33 161.3 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.447 ' CG ' HG12 ' A' ' 180' ' ' VAL . 29.1 mt-10 -151.72 113.85 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.1 t -134.39 172.1 13.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.44 145.68 11.67 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.567 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.76 -172.23 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.391 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.4 63.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.567 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.5 p-80 -80.55 -31.62 36.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -127.01 83.54 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -83.2 135.72 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -140.44 119.13 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -109.82 134.88 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 10.1 m -99.52 96.52 7.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 45.3 ttm -100.01 134.52 42.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 30.6 m -111.63 137.41 49.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.5 t -93.34 119.02 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -103.11 100.01 9.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.9 t -97.0 159.84 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.538 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 29.8 mm-40 -34.3 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.473 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 14.5 mmt85 -113.34 33.07 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.473 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 20.0 m-85 -147.34 147.12 30.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.421 ' O ' ' CD ' ' A' ' 203' ' ' GLU . 77.5 mt -149.99 135.51 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 195' ' ' THR . 6.6 mp0 -153.94 146.54 24.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 32.3 mt -101.31 136.61 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.43 -179.37 15.75 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 87.9 p -152.11 144.12 23.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -161.23 134.5 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 22.4 p -40.72 -39.54 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.121 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 45.6 m -128.78 141.9 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.823 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -38.55 -53.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -48.96 -45.12 41.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.9 mt -66.31 -51.65 55.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.62 -56.75 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.538 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 3.2 ttpm? -41.77 -47.13 4.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -67.85 -43.1 80.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.58 -48.31 79.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.86 -50.64 65.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.28 -56.24 23.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.42 -57.04 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -54.92 -42.87 72.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 51.3 tpp -53.6 -40.95 66.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 32.0 mt -48.13 -47.72 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.71 -43.39 76.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -56.95 -58.38 8.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.939 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.418 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 8.8 t30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.73 -49.92 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.327 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.8 t -45.91 -32.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.163 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -93.57 -16.03 47.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.47 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.39 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.21 -40.21 73.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.431 ' NE2' HD21 ' A' ' 175' ' ' LEU . 4.9 tp-100 -57.26 -24.88 57.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.76 -42.19 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 167' ' ' LEU . 4.5 mt -67.89 -57.57 6.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.0 m -39.42 -45.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.2 t -57.44 -40.86 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 9.6 mm100 -76.41 -36.85 57.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.559 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.98 -23.89 58.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.6 39.42 5.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.559 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 12.1 m0 -121.33 168.37 11.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.91 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -98.92 170.41 8.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.431 HD21 ' NE2' ' A' ' 165' ' ' GLN . 37.1 mt -41.22 141.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 0.0 110.891 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 148.48 65.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -101.35 131.83 47.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.505 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 88.2 m-85 -123.97 120.01 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.932 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.413 ' C ' ' HG3' ' A' ' 194' ' ' MET . 48.6 m -140.14 129.93 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.26 113.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 68.4 p -82.09 -51.44 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.56 158.73 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -137.58 109.82 7.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.0 t -118.78 170.7 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 100.03 143.69 14.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.436 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.76 -168.18 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.63 2.22 . . . . 0.0 112.347 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.91 43.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.436 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -58.61 -41.2 85.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 189' ' ' ARG . 14.3 mtp-105 -120.92 91.73 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.9 137.97 31.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -138.57 119.27 14.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.54 126.2 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.8 m -99.41 97.28 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.413 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.9 ttp -101.72 139.32 37.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.868 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 31.4 m -111.88 138.18 48.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.21 118.75 30.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.7 ttp85 -100.46 101.57 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 24.9 t -98.48 157.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 61.9 mm-40 -34.1 -72.56 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.21 31.52 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 29.4 m-85 -146.92 150.3 34.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 203' ' ' GLU . 74.6 mt -149.68 138.29 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.121 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.467 ' O ' ' CG2' ' A' ' 195' ' ' THR . 4.5 tm-20 -153.14 146.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.1 136.48 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.64 171.25 17.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 77.8 p -144.22 142.25 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.23 134.6 3.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 30.9 p -40.84 -34.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.18 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.1 m -134.61 150.17 50.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -42.71 -55.75 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -44.05 -37.08 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.4 mt -78.87 -63.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.55 -34.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 43.5 tttt -66.31 -51.96 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.73 -50.77 65.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.9 86.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.15 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -48.29 -56.54 7.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -56.11 -46.5 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 7.9 tpp -51.08 -41.26 59.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.42 -53.33 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.88 -37.07 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -54.74 -45.49 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.55 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 18.4 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -50.67 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.378 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.6 t -45.56 -43.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -80.84 -17.35 72.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.544 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.56 6.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.061 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 16.4 tp -45.28 -43.42 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.62 -36.83 37.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -67.71 -44.54 77.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.49 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -60.09 -60.29 4.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.1 m -43.9 -39.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.06 -38.39 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -77.96 -39.3 43.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.558 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.3 mmpt? -72.55 -25.51 61.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.81 43.63 5.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.501 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.558 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 11.0 m0 -121.58 175.35 6.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.32 . . . . 0.0 110.886 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -102.1 164.36 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 mt -38.35 143.28 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 151.55 68.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.645 2.23 . . . . 0.0 112.363 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -92.07 120.18 32.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.563 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 37.6 m-85 -112.25 113.29 25.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.5 m -149.71 146.15 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.82 132.67 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.07 -39.25 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -132.32 149.86 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -143.22 111.68 6.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.5 t -128.24 172.25 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.23 145.64 15.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.52 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.76 -168.83 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.724 2.282 . . . . 0.0 112.345 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.33 -52.11 15.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.52 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 30.2 p-80 -57.47 -32.48 67.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -133.68 92.44 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -86.52 135.67 33.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -125.99 114.73 18.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -106.99 139.44 41.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 20.1 m -116.85 102.79 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -102.26 148.25 25.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.8 m -121.75 144.87 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 6.6 t -101.55 110.61 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -96.93 100.05 11.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 31.1 t -95.73 159.19 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 21.7 mm-40 -33.33 -66.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.465 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 66.9 mtt85 -123.92 33.6 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 225' ' ' VAL . 23.9 m-85 -148.04 154.16 39.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -150.12 139.8 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -150.48 124.48 9.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 58.2 mt -90.38 137.28 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -128.26 174.46 18.81 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 158.63 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 179.36 152.93 11.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.1 p -65.51 -23.19 66.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 0.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 150.33 50.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -49.15 -57.02 7.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.58 -40.36 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 213' ' ' ALA . 35.9 mt -70.85 -61.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.17 -44.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -58.23 -61.66 2.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.2 -26.43 60.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.31 -42.51 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.34 63.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.077 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -66.8 -53.8 29.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -42.14 -58.4 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -58.46 -44.9 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 13.0 tpp -50.45 -37.2 36.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 47.4 mt -48.63 -58.21 5.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.37 -44.15 97.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -48.22 -54.74 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.558 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.664 0.745 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -50.77 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.269 . . . . 0.0 112.392 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.9 t -47.45 -37.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.53 -19.83 61.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.39 -52.11 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.101 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.9 tp -47.99 -28.24 2.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 7.3 tp-100 -61.01 -56.17 24.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CG ' HD22 ' A' ' 167' ' ' LEU . 5.0 pt-20 -48.58 -32.86 8.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.462 HD22 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -68.81 -68.37 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 3.3 m -40.21 -38.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -57.96 -47.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -71.9 -39.28 69.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.567 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.0 mmpt? -70.4 -27.13 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.12 45.06 4.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.492 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.567 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 10.6 m0 -123.89 174.7 7.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.758 0.313 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.72 166.4 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.53 140.65 0.98 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.608 0.718 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 159.31 53.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.329 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -95.53 138.42 33.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.518 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 70.6 m-85 -130.34 107.93 9.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.6 m -144.7 150.7 37.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.465 ' CG1' ' HG3' ' A' ' 183' ' ' GLU . 25.3 t -85.87 122.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 1.5 t -96.65 -32.35 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.152 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.43 145.67 50.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.465 ' HG3' ' CG1' ' A' ' 180' ' ' VAL . 1.9 mp0 -144.86 107.02 4.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -135.45 166.1 23.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.12 142.69 10.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.445 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.8 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.256 . . . . 0.0 112.308 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.13 -33.58 65.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.8 p-80 -77.8 -28.9 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -131.04 80.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.74 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -138.62 114.45 9.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -105.83 142.38 35.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -114.55 101.12 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.2 ttm -103.03 143.76 32.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 89.1 m -124.05 136.01 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 11.0 t -91.38 111.88 23.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -96.09 110.13 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.0 t -103.64 159.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.53 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.3 mm-40 -34.17 -72.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.11 32.06 6.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.555 ' CD2' HG13 ' A' ' 225' ' ' VAL . 25.4 m-85 -146.63 153.01 39.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.467 ' CA ' ' HE1' ' A' ' 221' ' ' MET . 90.4 mt -150.04 137.23 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.478 ' O ' ' CG2' ' A' ' 195' ' ' THR . 29.0 tp10 -148.94 138.0 21.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 46.1 mt -99.46 142.29 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -133.87 -179.27 16.24 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 65.7 p -151.52 153.57 34.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.401 . . . . 0.0 110.834 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -171.71 150.46 13.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.5 p -59.5 -34.2 72.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 6.1 m -131.59 144.91 51.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -41.63 -56.67 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -38.1 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.0 mt -75.37 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -39.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.518 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 11.0 tttm -61.14 -55.09 36.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.3 ptt85 -63.17 -30.64 71.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.68 -47.21 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.38 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.22 69.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -44.83 -58.91 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -56.47 -44.97 81.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' MET . . . . . 0.467 ' HE1' ' CA ' ' A' ' 202' ' ' ILE . 2.9 tpp -51.3 -44.78 62.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 26.3 mt -38.65 -56.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -44.38 -57.71 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.555 HG13 ' CD2' ' A' ' 201' ' ' PHE . 27.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 59.3 t30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.647 0.736 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 -44.75 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.412 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.9 t -48.31 -37.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -86.84 -16.44 61.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.66 -51.76 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.044 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.03 -42.54 13.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -51.83 -34.95 42.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -69.68 -41.19 75.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.23 -59.22 3.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.9 m -41.11 -51.42 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 88.2 t -54.12 -41.77 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -64.52 -45.43 87.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -75.19 -21.52 58.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.62 43.5 4.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.497 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -116.19 172.35 7.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.745 0.307 . . . . 0.0 110.922 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 175' ' ' LEU . 22.5 ptt-85 -101.55 164.22 11.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 174' ' ' ARG . 48.9 mt -36.4 142.34 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.573 0.701 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 146.8 61.1 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.631 2.221 . . . . 0.0 112.335 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.43 137.88 33.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.56 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 94.5 m-85 -127.83 122.15 31.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -149.28 139.6 22.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.148 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.1 t -76.33 126.64 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 67.2 p -94.04 -41.53 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -150.58 164.17 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.81 120.12 12.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.0 t -132.02 166.04 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 146.58 21.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.535 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.4 Cg_endo -69.77 -175.09 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.78 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.535 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.7 p-80 -61.44 -41.77 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -120.06 58.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -64.45 150.94 45.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.9 116.9 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -107.78 127.98 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 22.8 m -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 58.7 ttm -101.7 144.9 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 18.0 m -122.65 139.06 54.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.7 t -96.67 120.54 37.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -102.51 119.56 39.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.2 t -115.51 157.44 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.492 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.2 mt-10 -33.82 -68.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -120.24 32.37 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.546 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 31.8 m-85 -146.43 152.05 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.0 mt -149.99 142.56 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.451 ' O ' ' CG2' ' A' ' 195' ' ' THR . 9.4 tm-20 -155.64 146.1 21.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.88 147.03 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -141.63 170.06 24.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.6 p -142.69 139.82 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.837 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.5 136.27 5.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 p -46.11 -23.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.9 m -142.74 148.75 37.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -42.42 -56.14 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -44.66 -44.26 8.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.3 mt -70.01 -60.84 2.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.21 -37.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.56 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 8.1 tttp -66.84 -53.94 27.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -64.56 -28.97 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -66.52 -49.03 67.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.08 -52.02 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -50.88 -44.49 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.5 -64.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -53.43 -33.32 53.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' MET . . . . . 0.467 ' HE2' ' CG2' ' A' ' 198' ' ' VAL . 0.6 OUTLIER -62.15 -36.94 83.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 67.9 mt -49.73 -38.03 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.5 -36.59 20.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -59.18 -50.2 74.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.546 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 28.8 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.421 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 13.1 t30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.654 0.74 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.6 Cg_endo -69.73 -48.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.331 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.6 t -49.29 -48.67 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -70.92 -9.57 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.68 -47.94 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.098 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.8 tp -60.76 -26.55 67.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -65.19 -31.5 72.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.12 -42.56 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -61.97 -54.04 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.0 m -45.21 -52.53 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 69.4 t -52.06 -52.23 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -60.74 -29.4 69.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.508 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 27.1 mttm -85.63 -16.43 39.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.07 36.98 9.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.509 ' CG ' ' HG3' ' A' ' 199' ' ' GLU . 38.6 m0 -118.74 176.57 5.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.321 . . . . 0.0 110.88 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -109.05 164.11 12.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.4 mt -38.05 142.48 0.45 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.576 0.703 . . . . 0.0 110.951 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 149.71 67.3 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.357 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.19 139.8 30.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.555 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.4 m-85 -133.43 112.51 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.42 ' C ' ' HG3' ' A' ' 194' ' ' MET . 5.1 m -139.14 128.45 24.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.77 119.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.434 ' CG2' ' OG1' ' A' ' 195' ' ' THR . 1.5 t -96.32 -32.06 12.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -141.59 149.89 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.9 106.98 6.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.4 t -136.13 171.28 14.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.58 148.38 12.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.413 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.539 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.8 -173.1 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.33 -44.66 51.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.8 p-80 -61.17 -41.1 96.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -129.81 88.63 2.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -80.6 130.8 35.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -112.39 120.28 41.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -112.33 116.31 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 m -100.34 98.54 9.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.42 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.8 ttp -102.91 143.68 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.434 ' OG1' ' CG2' ' A' ' 181' ' ' THR . 2.4 m -109.67 140.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 36.1 t -101.61 119.76 39.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -101.08 103.95 15.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.6 t -96.17 159.45 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 50.6 mm-40 -32.96 -69.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -120.44 32.88 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 32.8 m-85 -146.23 154.19 41.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.6 mt -149.82 136.01 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.476 ' C ' ' CD ' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -151.0 153.08 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 36.8 mt -109.31 130.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -116.76 176.66 16.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.8 p -149.23 144.77 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.64 141.54 7.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.503 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.9 p -54.08 -16.03 1.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 210' ' ' LYS . 3.1 m -149.7 143.84 25.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' SER . 76.0 mttt -37.5 -58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -41.81 -47.11 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 215' ' ' ARG . 35.7 mt -69.65 -59.05 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.25 -35.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.555 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -67.0 -48.68 67.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.6 ptt180 -65.4 -44.5 87.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 215' ' ' ARG . 22.2 t-20 -56.21 -42.67 77.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.405 ' CB ' ' OE2' ' A' ' 203' ' ' GLU . . . -68.83 -48.61 63.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.61 -46.43 87.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.56 -64.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -52.38 -43.88 64.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 222' ' ' LEU . 8.0 tpp -50.95 -47.03 61.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.844 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 221' ' ' MET . 46.6 mt -36.76 -51.59 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.951 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.13 -43.91 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -45.54 -56.72 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.53 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.471 ' ND2' ' HD2' ' A' ' 160' ' ' PRO . 1.3 t30 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.471 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.76 -50.33 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.9 t -45.49 -41.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.141 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.08 -23.82 54.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.42 -58.42 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 111.1 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.43 -40.37 12.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.484 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 6.6 tp60 -56.47 -35.37 67.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.23 -37.06 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -66.44 -49.97 64.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 7.2 m -46.72 -36.18 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.52 -37.68 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -71.72 -40.58 69.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -78.59 -27.95 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.936 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.73 46.36 4.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.408 ' HB3' ' CG ' ' A' ' 199' ' ' GLU . 30.5 m0 -115.92 175.52 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 110.93 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 175' ' ' LEU . 55.0 mtt180 -100.57 155.13 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 174' ' ' ARG . 30.2 mt -34.39 141.55 0.25 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 152.91 69.35 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.716 2.278 . . . . 0.0 112.336 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -97.16 130.93 44.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.566 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 62.0 m-85 -123.04 109.77 14.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 m -144.54 148.57 34.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.5 t -87.27 122.46 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.0 t -96.62 -28.47 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.421 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 44.2 mt-30 -146.59 163.19 36.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.565 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 41.0 mt-10 -151.88 105.87 3.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.8 t -119.11 172.37 7.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.25 145.08 14.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.548 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.75 -175.33 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.548 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -71.5 -40.77 69.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -117.36 83.97 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -83.31 137.44 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -137.47 126.08 23.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.565 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 4.4 m-85 -117.01 128.5 55.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.2 m -94.39 105.33 17.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.425 ' CB ' ' HB1' ' A' ' 213' ' ' ALA . 40.5 ttm -105.74 141.79 36.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.5 m -118.91 134.71 55.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -92.63 108.25 19.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -92.07 102.51 15.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 38.9 t -97.26 157.72 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.486 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 59.6 mm-40 -33.71 -73.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -114.2 30.34 7.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 36.1 m-85 -145.66 153.74 41.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 57.6 mt -149.78 135.49 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -146.24 143.24 29.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 65.3 mt -108.39 136.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.87 -179.33 16.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.487 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 73.8 p -149.6 144.23 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.832 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -160.61 143.91 9.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.2 p -48.54 -29.38 4.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -141.69 148.37 38.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' LYS . 70.3 mttt -40.55 -67.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -35.35 -43.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.93 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.8 mt -72.52 -55.16 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 194' ' ' MET . . . -41.84 -39.05 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.566 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 5.4 ttmt -57.61 -55.48 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 216' ' ' ASN . 5.0 ptm180 -60.77 -37.39 81.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.43 ' N ' ' HG2' ' A' ' 215' ' ' ARG . 5.1 m120 -56.91 -49.55 75.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.96 -46.75 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.118 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -49.83 -56.24 11.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -39.47 80.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.938 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 4.9 tpp -55.73 -45.73 77.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 54.4 mt -38.35 -51.73 1.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.7 mt -72.69 -48.49 38.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 224' ' ' ARG . 12.1 mmp_? -39.19 -50.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.564 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.598 0.713 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -50.52 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.23 -38.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.7 -19.94 62.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.5 -54.85 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.4 tp -44.67 -42.95 7.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.419 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 15.5 tp60 -49.99 -35.89 26.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -69.61 -44.47 70.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.48 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -60.74 -58.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 5.3 m -42.05 -41.84 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.2 -37.44 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 167' ' ' LEU . 16.4 mm100 -72.49 -38.79 68.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -80.24 -20.05 45.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.57 44.26 6.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -115.49 178.22 4.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.744 0.307 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.409 ' CD ' ' O ' ' A' ' 175' ' ' LEU . 0.5 OUTLIER -107.3 166.67 10.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.409 ' O ' ' CD ' ' A' ' 174' ' ' ARG . 44.3 mt -45.52 136.16 5.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.581 0.705 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 158.13 58.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 0.0 112.348 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -95.77 148.49 22.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.566 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 80.7 m-85 -135.37 112.48 10.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.418 HG21 ' N ' ' A' ' 180' ' ' VAL . 19.2 m -144.76 143.82 30.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.418 ' N ' HG21 ' A' ' 179' ' ' THR . 91.7 t -78.76 127.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.9 p -101.65 -40.74 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -135.75 163.29 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.547 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 73.6 mt-10 -150.82 107.01 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.7 t -123.19 172.19 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.32 145.91 16.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.644 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 53.1 Cg_endo -69.84 -164.47 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.614 2.209 . . . . 0.0 112.326 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.07 -42.93 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.644 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 46.0 p-80 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.561 ' HG3' ' CD2' ' A' ' 188' ' ' HIS . 34.3 mtm180 -133.21 49.11 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.05 136.89 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.96 123.4 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.547 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 3.4 m-85 -116.58 129.71 56.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.1 m -94.79 97.8 10.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 47.1 ttm -98.88 136.21 39.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.446 HG23 ' CG1' ' A' ' 204' ' ' ILE . 19.1 m -112.29 134.66 53.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 5.7 t -93.63 117.59 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.4 128.29 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.7 t -122.58 157.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.471 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.6 mm-40 -33.87 -66.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.469 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 20.6 mmm180 -123.21 32.84 5.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 22.1 m-85 -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.6 mt -150.0 139.8 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -152.29 137.69 17.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.446 ' CG1' HG23 ' A' ' 195' ' ' THR . 61.4 mt -97.68 137.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.57 174.78 18.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.512 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.8 p -149.76 138.58 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.37 134.12 3.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.514 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.0 p -40.31 -35.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.9 t -132.01 146.17 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -41.46 -57.56 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -43.4 -40.55 3.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 213' ' ' ALA . 24.4 mt -75.09 -60.24 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.3 -41.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.566 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 79.0 tttt -58.35 -57.41 13.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -61.13 -32.62 72.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -64.35 -46.37 83.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.71 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.01 92.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.13 -63.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -52.5 -40.29 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' MET . . . . . 0.461 ' HE1' ' CG2' ' A' ' 198' ' ' VAL . 0.8 OUTLIER -57.25 -34.92 69.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 75.2 mt -47.88 -46.91 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.09 -44.89 36.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 -47.21 -56.59 6.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.541 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 29.6 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.624 0.726 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -50.34 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.345 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -48.89 -40.31 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.56 61.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.88 -58.88 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.401 ' CD1' HD23 ' A' ' 222' ' ' LEU . 27.3 tp -41.32 -45.54 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -52.01 -39.4 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.27 -31.62 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -75.3 -62.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.8 m -39.08 -46.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.02 -37.37 77.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 167' ' ' LEU . 32.3 mt-30 -72.22 -35.18 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.564 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 24.0 mmmt -82.96 -22.36 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.83 36.49 7.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.564 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 32.7 m0 -106.78 177.98 4.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 175' ' ' LEU . 83.7 mtt180 -102.28 155.41 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 174' ' ' ARG . 64.9 mt -36.91 142.8 0.35 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.26 50.25 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.429 ' OE1' ' C ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -94.57 128.81 41.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.527 ' CE1' ' HG3' ' A' ' 214' ' ' LYS . 87.9 m-85 -118.39 123.99 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 88.4 m -143.89 142.87 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.01 119.02 33.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.3 p -90.05 -62.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.415 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 26.4 tp60 -116.65 154.18 30.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 182' ' ' GLN . 28.3 mt-10 -150.61 108.36 3.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.94 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 t -134.49 172.08 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 111.0 146.14 10.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.551 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.77 177.69 5.34 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.97 99.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.551 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 24.4 p-80 -68.34 -41.21 81.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -120.67 78.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -78.02 141.82 38.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -138.05 122.13 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.439 ' CD2' ' HG3' ' A' ' 210' ' ' LYS . 8.7 m-85 -114.45 141.23 47.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 8.7 m -112.84 98.56 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 54.6 ttm -105.67 138.08 42.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 9.1 m -114.1 135.14 54.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 10.7 t -93.39 117.5 30.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -98.66 126.42 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 17.8 t -122.23 157.78 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 16.1 mm-40 -32.73 -67.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.89 32.02 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -144.91 152.09 39.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.7 mt -149.84 139.7 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -151.04 134.46 16.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 14.0 mt -94.9 132.98 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -128.34 168.67 20.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -149.83 170.43 18.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 176.94 171.87 40.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 52.6 p -71.94 -17.96 62.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.4 m -150.54 142.1 23.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.439 ' HG3' ' CD2' ' A' ' 192' ' ' PHE . 8.3 mtmp? -40.49 -50.5 2.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -48.26 -39.97 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.7 mt -74.25 -63.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -38.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.527 ' HG3' ' CE1' ' A' ' 178' ' ' TYR . 12.1 tttm -61.4 -54.07 48.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -34.35 76.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -47.1 80.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.28 91.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.98 78.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.36 -61.69 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.2 -40.74 71.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' MET . . . . . 0.409 ' SD ' ' CG2' ' A' ' 198' ' ' VAL . 0.5 OUTLIER -57.14 -32.78 66.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.401 HD23 ' CD1' ' A' ' 164' ' ' LEU . 59.5 mt -52.04 -49.62 63.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.4 mt -73.04 -44.0 61.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.42 ' NH1' ' HB3' ' A' ' 224' ' ' ARG . 2.9 mmm180 -45.91 -53.13 10.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.9 m -162.54 153.73 17.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.842 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.4 m -134.41 142.84 47.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.66 133.21 8.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t -166.94 131.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 110.886 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.7 t -99.91 -48.31 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.86 149.61 24.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.474 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 111.77 2.91 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.658 2.239 . . . . 0.0 112.307 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.58 130.24 74.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -54.65 144.12 46.09 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.684 0.754 . . . . 0.0 110.855 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 103.26 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.261 . . . . 0.0 112.368 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -72.54 106.41 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -68.87 109.48 3.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 66.8 m -142.13 148.11 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -42.18 161.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 10.1 m -91.33 136.1 33.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -161.59 144.01 8.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.637 0.732 . . . . 0.0 110.83 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -49.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.721 2.281 . . . . 0.0 112.333 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.3 t -47.03 -36.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.22 -18.76 62.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.64 -53.67 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.3 tp -50.61 -28.86 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -30.07 67.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -81.8 -43.09 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.473 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -62.52 -54.06 45.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.8 m -41.97 -54.23 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.0 t -52.62 -36.86 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -72.81 -31.48 64.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.561 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 40.7 mttm -85.83 -20.69 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.47 36.27 7.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.561 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 43.9 m0 -114.31 172.82 6.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -101.47 162.53 12.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 24.9 mt -41.21 144.86 0.64 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 152.52 69.56 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.718 2.278 . . . . 0.0 112.383 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -97.81 127.84 44.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.553 ' CZ ' ' CG ' ' A' ' 214' ' ' LYS . 40.8 m-85 -113.65 117.38 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.951 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.2 m -145.37 135.77 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.143 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.7 t -77.53 122.24 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.0 p -92.58 -60.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.415 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 18.4 tt0 -119.08 160.41 22.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.415 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 3.7 mp0 -144.57 114.04 7.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -134.61 167.74 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.46 149.26 9.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.563 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.1 Cg_endo -69.72 -169.22 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.6 16.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.563 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 15.6 p-80 -59.94 -35.15 74.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -134.47 91.79 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -87.12 146.69 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -138.7 123.92 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -108.29 135.34 49.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 37.7 m -99.24 97.83 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.0 ttm -100.2 138.93 36.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 17.6 m -116.2 136.88 52.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 53.2 t -93.2 115.22 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.841 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -98.53 102.7 14.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 32.4 t -95.78 157.31 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -34.38 -65.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 5.9 ptm180 -122.92 31.06 6.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 23.6 m-85 -146.74 155.49 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.4 mt -150.01 141.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -153.17 122.8 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 59.8 mt -84.99 140.29 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.183 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -140.01 165.59 25.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 62.4 m -143.38 150.86 39.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.52 140.5 6.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 76.3 p -38.07 -44.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.823 0.344 . . . . 0.0 111.216 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.9 m -120.24 164.81 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -61.04 -50.8 71.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -52.1 -45.03 64.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 30.9 mt -65.93 -51.93 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.4 -57.51 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.553 ' CG ' ' CZ ' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -40.28 -50.31 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -62.8 -48.52 78.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -48.72 -41.66 32.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.55 -52.7 11.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.27 -59.65 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.42 -59.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -52.31 -43.95 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 14.3 tpp -53.68 -43.05 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -40.41 -58.26 1.59 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.64 -47.52 75.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -45.79 -55.17 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.545 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 30.1 m -72.51 -34.99 49.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.3 t -54.08 -65.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 173.24 -80.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 134.21 27.5 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.745 2.297 . . . . 0.0 112.38 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.4 t -119.08 96.73 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.7 t -78.08 108.81 11.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.885 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.1 t -163.44 129.1 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.864 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.5 t -160.47 150.38 17.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.803 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 105.22 138.53 9.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 t -160.1 146.91 16.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.859 0.362 . . . . 0.0 110.862 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 21.4 m -76.46 122.35 24.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.844 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -157.86 68.06 0.28 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 136.2 32.47 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.669 2.246 . . . . 0.0 112.384 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.18 117.99 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.129 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.1 t -115.45 80.07 7.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.663 0.744 . . . . 0.0 110.859 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 157.32 60.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.693 2.262 . . . . 0.0 112.323 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -167.68 145.56 4.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -121.11 169.67 10.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 46.2 p -112.43 40.47 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -83.17 -57.57 3.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 69.4 m -54.1 137.28 40.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.34 143.72 0.79 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 110.912 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -50.75 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 80.2 t -47.26 -45.42 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.95 -12.84 84.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.527 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.23 -50.25 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.0 tp -57.45 -38.06 73.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.435 ' OE1' ' CD2' ' A' ' 175' ' ' LEU . 6.2 tp60 -58.8 -27.95 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.83 -46.98 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 167' ' ' LEU . 4.5 mt -58.67 -54.02 51.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.1 m -40.36 -51.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.4 -34.08 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.119 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 167' ' ' LEU . 51.6 mt-30 -76.07 -33.43 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.555 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 15.3 mtpp -84.65 -15.14 46.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.21 41.91 7.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.488 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.9 m0 -118.74 174.3 6.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -102.21 163.64 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.435 ' CD2' ' OE1' ' A' ' 165' ' ' GLN . 38.9 mt -37.77 143.21 0.4 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 143.44 51.15 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.308 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -97.04 134.51 40.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.552 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.5 m-85 -132.32 115.21 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.406 ' C ' ' HG3' ' A' ' 194' ' ' MET . 9.7 m -139.69 131.3 27.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.54 112.86 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.419 ' CG2' ' OG1' ' A' ' 195' ' ' THR . 1.6 t -89.27 -33.63 16.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -150.89 156.74 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.465 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 75.5 mt-10 -140.35 110.99 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.6 t -126.74 171.05 11.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.69 162.75 12.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.498 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.3 Cg_endo -69.78 -179.34 2.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.0 112.39 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.89 28.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 18.5 p-80 -57.79 -41.34 81.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -127.49 88.87 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -83.47 125.05 31.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 129.63 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.465 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 10.6 m-85 -110.41 118.16 35.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.0 m -93.04 104.11 16.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.406 ' HG3' ' C ' ' A' ' 179' ' ' THR . 5.1 ttp -106.49 141.26 38.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.419 ' OG1' ' CG2' ' A' ' 181' ' ' THR . 3.4 m -108.33 135.41 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.147 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . 0.441 ' SG ' ' CE1' ' A' ' 178' ' ' TYR . 46.6 t -93.58 109.98 21.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -93.85 108.89 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -103.79 157.39 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 43.7 mm-40 -34.01 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.474 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 61.7 mtt180 -118.64 32.23 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 21.3 m-85 -147.64 154.66 40.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.6 mt -149.96 136.53 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -146.35 147.45 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 46.4 mt -104.83 126.65 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.32 168.27 18.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.2 m -143.52 160.15 41.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.909 0.385 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -178.3 140.6 4.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -42.42 -43.65 3.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 111.148 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 210' ' ' LYS . 55.8 p -125.64 140.85 52.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 209' ' ' SER . 85.9 mttt -36.54 -46.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -50.75 -51.76 47.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.38 -47.16 71.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -42.6 -46.5 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.552 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.2 OUTLIER -54.1 -46.28 72.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.81 -48.8 80.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -55.13 -44.33 74.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.9 -52.68 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.078 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.84 -64.06 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -38.18 -63.36 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -46.26 -47.61 18.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 6.2 tpp -54.34 -43.15 71.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 64.7 mt -45.26 -60.0 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.09 -44.14 87.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -54.67 -62.76 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 19.0 m -61.57 -37.42 77.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -75.92 165.79 24.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -58.78 151.73 32.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -25.05 29.19 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.66 2.24 . . . . 0.0 112.34 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 m -51.29 121.43 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 68.5 p -108.83 157.75 18.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.861 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.459 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 91.5 p -111.58 -45.99 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.1 t 49.4 42.84 22.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.836 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.73 138.28 12.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.6 m -136.22 166.26 23.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.8 m -150.61 159.63 44.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -173.69 146.25 8.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 141.16 44.37 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 p -134.73 141.34 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.123 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.4 p -138.95 144.21 40.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.669 0.747 . . . . 0.0 110.817 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 158.88 55.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.654 2.236 . . . . 0.0 112.345 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -86.24 -55.43 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -74.98 145.32 42.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 57.4 m -101.32 105.17 16.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -161.83 160.82 28.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.9 t -107.81 138.38 44.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.92 144.05 1.75 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -50.53 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.35 -41.29 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -78.67 -11.97 84.71 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.504 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.69 -48.52 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.087 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.1 tp -52.35 -33.87 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -60.45 -31.26 70.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.79 -42.37 34.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 167' ' ' LEU . 4.5 mt -64.08 -60.42 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 167' ' ' LEU . 5.4 m -36.34 -49.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 48.0 t -59.76 -42.53 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 167' ' ' LEU . 78.2 mt-30 -64.87 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.525 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 40.1 mttm -99.96 -13.09 19.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.57 40.83 9.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.525 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 48.5 m0 -115.83 173.7 6.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.766 0.317 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -101.01 173.17 6.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 61.3 mt -49.36 143.58 9.68 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.903 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.39 69.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.37 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -98.7 131.04 45.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.541 ' CD2' ' HE3' ' A' ' 214' ' ' LYS . 70.3 m-85 -121.36 112.86 19.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.7 m -147.04 144.57 29.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 91.7 t -79.62 130.07 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.02 -40.87 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.419 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 31.3 tp60 -140.94 159.52 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.477 ' OE1' ' CE2' ' A' ' 192' ' ' PHE . 25.6 mt-10 -149.61 109.02 3.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.7 t -118.32 172.15 7.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.68 145.9 18.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.469 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.73 -168.42 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.88 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 2.3 p-80 -64.77 -41.53 95.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -117.32 89.85 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -88.24 131.3 34.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -130.51 114.86 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.477 ' CE2' ' OE1' ' A' ' 183' ' ' GLU . 32.1 m-85 -103.91 124.92 49.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -97.71 98.29 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 52.8 ttm -100.67 140.81 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 20.3 m -115.39 138.56 50.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 221' ' ' MET . 7.0 t -95.28 117.22 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -98.95 122.92 42.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.2 t -119.65 157.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.489 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 75.2 mm-40 -34.05 -68.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 199' ' ' GLU . 13.4 mmp_? -120.76 32.33 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 28.6 m-85 -146.59 150.44 35.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -150.03 139.05 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.64 142.6 21.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 205' ' ' GLY . 74.7 mt -100.87 141.11 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 204' ' ' ILE . . . -130.15 173.12 20.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 60.6 p -142.95 146.62 34.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.408 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 208' ' ' THR . . . -168.46 126.62 1.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 207' ' ' GLY . 43.7 p -36.02 -44.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.1 t -118.18 144.53 45.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -44.26 -47.72 9.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -52.85 -46.6 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.2 -46.33 74.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -47.82 -44.46 28.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.541 ' HE3' ' CD2' ' A' ' 178' ' ' TYR . 51.8 tttt -55.49 -44.71 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -69.85 -41.22 75.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -61.83 -42.14 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.12 -54.92 16.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.65 -50.39 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.59 -62.11 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.084 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -51.99 -44.82 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.426 ' CE ' ' CG2' ' A' ' 198' ' ' VAL . 1.3 ttt -49.93 -40.69 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 71.5 mt -43.4 -52.35 6.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.3 mt -72.28 -48.74 40.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -45.49 -44.13 12.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.562 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 10.6 m -82.87 -34.6 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.454 ' N ' HG23 ' A' ' 225' ' ' VAL . 20.1 t -69.38 111.33 5.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.65 157.21 45.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 141.52 45.32 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.323 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.4 t -98.22 -61.46 1.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.7 m -113.84 -61.3 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.542 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.0 p -67.14 136.51 55.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 110.877 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.9 t -142.85 139.22 30.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.16 -50.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.552 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 52.2 p -61.94 -47.88 82.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.0 110.864 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.9 m -72.48 103.1 3.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.95 156.55 15.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.62 12.3 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.664 2.243 . . . . 0.0 112.34 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.8 p -161.99 124.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 61.5 p -122.04 144.12 40.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.907 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 135.8 31.42 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -83.6 151.62 25.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 156' ' ' SER . 38.0 mt-30 -127.77 108.44 10.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 155' ' ' GLN . 6.2 m -35.44 -40.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.07 100.54 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.915 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 32.0 p -70.99 143.16 50.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.425 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 11.8 t30 -171.25 141.2 1.33 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.638 0.733 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.74 -47.41 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 0.0 112.349 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.6 t -50.28 -37.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.81 -11.81 78.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.451 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.91 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -55.29 -34.48 64.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.81 -34.13 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -77.37 -49.85 14.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -55.72 -58.41 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.6 m -37.84 -46.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 79.8 t -53.56 -46.48 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.17 -37.95 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.527 ' HD2' ' CH2' ' A' ' 173' ' ' TRP . 22.7 mtmm -74.39 -23.59 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.05 35.42 6.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.479 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.527 ' CH2' ' HD2' ' A' ' 171' ' ' LYS . 39.6 m0 -118.44 171.49 8.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -101.85 172.9 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.1 mt -43.54 144.08 1.4 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 0.0 110.944 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 155.35 66.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.331 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -93.54 135.5 34.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.553 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 42.7 m-85 -129.24 112.03 13.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.4 m -145.55 142.58 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.435 HG13 ' CG ' ' A' ' 183' ' ' GLU . 99.2 t -77.89 121.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 20.1 p -89.82 -45.8 9.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.409 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 28.4 tt0 -135.86 162.28 33.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.435 ' CG ' HG13 ' A' ' 180' ' ' VAL . 31.8 mt-10 -151.19 113.5 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -136.34 171.65 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.05 146.21 20.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.635 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.75 -164.24 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.705 2.27 . . . . 0.0 112.358 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.21 -38.96 55.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.635 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 44.3 p-80 -75.26 -21.85 58.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 188' ' ' HIS . 22.6 mtp180 -131.81 58.18 1.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -68.44 134.95 50.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -137.69 114.68 10.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -107.77 131.66 54.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.0 m -104.05 97.72 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.9 ttm -101.38 135.29 43.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.409 HG23 ' CG1' ' A' ' 204' ' ' ILE . 33.4 m -114.42 136.7 52.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 5.1 t -92.56 113.98 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -96.83 104.78 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.4 t -99.99 157.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.4 mm-40 -34.01 -72.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.0 29.8 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 38.8 m-85 -144.92 151.18 38.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 69.4 mt -149.98 137.27 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -151.27 133.68 15.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.409 ' CG1' HG23 ' A' ' 195' ' ' THR . 57.9 mt -93.57 136.31 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.56 175.29 16.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 51.7 p -152.44 139.0 18.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.881 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -163.18 143.41 8.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.4 p -42.51 -39.45 2.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 111.155 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.8 m -129.67 148.47 51.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -47.51 -40.1 17.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -56.18 -48.02 77.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.6 mt -70.57 -47.01 62.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -44.88 -52.7 8.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.141 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.553 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 12.9 ttmt -44.89 -46.99 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 46.1 mtt85 -62.17 -47.75 83.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -52.38 -46.14 66.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.8 -50.71 47.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -60.85 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 222' ' ' LEU . . . -45.67 -55.79 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -49.79 -41.27 44.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.403 ' O ' ' C ' ' A' ' 222' ' ' LEU . 5.2 tpp -61.99 -45.21 94.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 219' ' ' ALA . 73.8 mt -37.07 -47.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.1 mt -77.9 -47.0 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -46.75 -57.36 4.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.46 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 16.8 m -67.47 -25.77 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.084 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 m -85.26 89.5 7.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -51.52 -94.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 123.06 9.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.3 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 140.16 47.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 54.6 m -90.87 54.93 2.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.435 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.0 t -145.14 139.39 27.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.815 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.6 p -92.41 41.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.84 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.17 127.71 0.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 t -94.37 143.39 26.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.826 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 t -125.4 108.72 11.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.99 146.22 16.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.55 14.32 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.338 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.1 m -91.85 124.64 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.8 m -67.38 144.09 97.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.896 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 128.98 16.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.671 2.247 . . . . 0.0 112.373 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -124.08 89.05 3.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -108.9 144.5 36.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.9 p -108.23 47.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -95.79 -53.38 3.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 25.0 p -51.54 154.92 1.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -67.66 142.98 96.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.63 0.729 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -50.74 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 94.7 t -49.37 -32.31 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -88.49 -22.69 39.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.42 -54.08 6.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.7 tp -49.1 -38.43 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.494 ' NE2' ' CD2' ' A' ' 175' ' ' LEU . 4.9 tp-100 -60.88 -31.51 70.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -77.3 -35.85 54.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -71.11 -55.89 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.0 m -41.44 -52.57 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.27 -36.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.106 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -75.32 -37.25 60.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.556 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 27.5 mttt -78.79 -14.87 59.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 39.03 7.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.556 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 36.4 m0 -120.69 171.58 8.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.773 0.321 . . . . 0.0 110.945 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -101.71 168.5 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.494 ' CD2' ' NE2' ' A' ' 165' ' ' GLN . 26.1 mt -43.65 142.88 1.74 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.56 68.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.329 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.87 127.1 48.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.541 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 75.5 m-85 -122.32 114.72 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.1 m -136.51 130.76 32.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.68 111.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.176 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -86.03 -59.09 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -117.18 158.07 24.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -145.62 113.37 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.3 t -133.03 169.89 16.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.86 145.47 19.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.56 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.74 -174.77 0.96 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.704 2.269 . . . . 0.0 112.36 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.06 85.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 19.2 p-80 -67.34 -39.89 85.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -113.34 51.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -58.28 129.49 42.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.908 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -133.66 116.64 16.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -107.05 128.23 54.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 m -101.96 100.72 11.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.073 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 4.9 ttp -106.37 139.56 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.438 HG21 ' CG1' ' A' ' 204' ' ' ILE . 5.8 m -110.43 140.13 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.56 117.73 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 16.5 ttp85 -99.97 101.58 12.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 37.3 t -96.05 157.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.491 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 11.0 mm-40 -33.75 -69.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.456 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 6.0 ptm180 -119.55 31.87 6.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.543 ' CD2' HG12 ' A' ' 225' ' ' VAL . 22.3 m-85 -147.41 151.91 37.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 203' ' ' GLU . 74.0 mt -149.98 135.89 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.448 ' N ' HG22 ' A' ' 202' ' ' ILE . 6.9 tp10 -150.85 134.92 16.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.438 ' CG1' HG21 ' A' ' 195' ' ' THR . 56.5 mt -86.63 135.82 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.34 169.23 15.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 78.4 p -144.21 143.47 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.87 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.66 132.32 2.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.9 p -38.34 -40.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.153 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 57.9 m -126.15 145.79 50.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -39.37 -45.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -56.05 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 22.6 mt -58.92 -43.71 91.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -53.54 -49.16 68.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.541 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 52.5 tttt -50.08 -37.95 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 216' ' ' ASN . 2.4 mtp-105 -68.83 -66.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 215' ' ' ARG . 0.7 OUTLIER -37.12 -50.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.53 -49.19 77.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.38 -55.82 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 222' ' ' LEU . . . -45.72 -62.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -46.14 -45.99 16.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.419 ' HE3' ' N ' ' A' ' 203' ' ' GLU . 4.7 tpp -52.73 -43.58 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 219' ' ' ALA . 31.9 mt -43.31 -55.79 3.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.06 -39.03 92.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -55.45 -63.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.543 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.9 m -66.3 -32.37 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t -49.87 165.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -151.08 83.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.496 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -4.21 13.61 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 97.3 p -49.74 126.68 14.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.8 m -105.74 154.47 20.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.5 t -113.04 85.32 2.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 0.0 110.879 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t 67.34 47.45 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.52 111.05 0.45 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -57.25 134.81 56.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 149' ' ' GLY . 15.4 m 57.44 43.35 23.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 148' ' ' SER . . . 34.0 -96.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.53 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.431 ' N ' ' O ' ' A' ' 148' ' ' SER . 53.7 Cg_endo -69.74 108.57 2.1 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.665 2.243 . . . . 0.0 112.382 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.32 156.55 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.0 m -50.58 144.54 12.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.675 0.75 . . . . 0.0 110.855 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -22.55 31.79 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.318 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -56.9 126.8 28.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 156' ' ' SER . 19.4 mt-30 -134.26 137.2 44.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 155' ' ' GLN . 1.1 t -34.7 -58.54 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.816 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -148.56 154.04 39.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -89.73 136.33 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.42 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 3.9 t30 -162.64 141.19 6.7 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.624 0.726 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.1 Cg_endo -69.71 -50.41 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.689 2.259 . . . . 0.0 112.374 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.11 -35.16 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.51 -19.51 60.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.74 -55.99 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.2 tp -49.09 -28.52 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -67.74 -32.38 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -78.88 -38.16 38.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.478 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.06 -50.25 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.5 m -49.38 -44.1 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.05 -32.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -80.1 -32.29 39.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.562 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 16.2 mtpp -82.95 -17.54 43.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.06 42.37 7.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.562 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.4 m0 -119.43 175.3 5.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.783 0.325 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -103.68 162.72 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.2 mt -38.77 143.29 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.625 0.726 . . . . 0.0 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 155.18 66.47 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.656 2.237 . . . . 0.0 112.382 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.91 141.34 30.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.551 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 65.9 m-85 -134.2 113.33 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 m -148.82 137.44 21.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.17 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.54 129.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.47 -35.55 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 2.9 tp-100 -137.33 154.39 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.458 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 2.2 mp0 -143.12 106.64 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -127.63 170.27 12.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 113.26 150.09 10.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.78 -165.55 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.17 -47.33 14.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.5 p-80 -58.19 -37.88 75.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -135.04 96.76 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -87.12 125.03 33.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.93 130.23 53.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -119.7 128.67 54.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 64.0 m -103.57 101.12 10.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 50.3 ttm -100.78 141.24 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.6 m -113.53 141.99 46.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.39 112.23 24.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -95.46 108.67 20.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -100.93 158.19 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.6 mm-40 -33.2 -64.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 3.4 ptm180 -126.67 33.29 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.546 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 21.4 m-85 -147.93 158.09 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.0 mt -150.03 139.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.46 128.69 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 38.0 mt -87.21 135.45 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -135.3 166.11 24.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 29.9 t -146.93 166.75 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.879 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 178.12 142.73 4.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.7 p -46.07 -32.66 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 111.126 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.7 m -130.86 154.98 47.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -50.82 -54.85 20.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -46.23 -38.37 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 213' ' ' ALA . 64.0 mt -72.78 -65.16 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.8 -39.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.551 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 74.8 tttt -61.22 -56.61 18.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -62.11 -28.02 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 -46.37 70.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.94 -42.48 89.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.23 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.77 -56.08 13.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -59.14 -35.22 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 5.0 tpp -59.58 -41.42 90.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 37.4 mt -43.98 -42.55 6.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.59 -43.62 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.959 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -49.48 -54.44 17.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.546 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 13.4 m -64.47 -35.4 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.458 ' N ' HG21 ' A' ' 225' ' ' VAL . 3.6 p -72.9 121.91 20.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.23 84.35 0.77 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.465 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 154.34 67.88 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.73 2.287 . . . . 0.0 112.344 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 27.7 m -54.32 -51.25 65.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.822 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.1 t -129.38 -62.3 0.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 25.4 p -128.95 -49.88 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.1 p -55.72 105.9 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.07 114.19 3.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 t -99.36 101.94 13.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 110.837 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.2 p -113.46 154.5 26.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -137.02 66.1 0.55 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 174.95 8.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.56 122.73 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -156.97 149.06 17.58 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.656 0.741 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 106.7 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.348 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -101.58 117.63 35.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 53.43 46.91 25.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.6 m -91.23 -44.2 9.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -58.51 -51.68 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 20.7 p -62.24 144.77 55.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.421 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 14.2 t30 -70.14 140.34 88.12 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.73 -43.02 2.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.672 2.248 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -51.12 -51.97 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.9 -10.57 80.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.62 -47.15 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 111.079 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 29.8 tp -57.55 -26.41 61.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.457 ' NE2' HD22 ' A' ' 175' ' ' LEU . 5.7 tp-100 -69.75 -25.25 63.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.07 -29.74 34.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 167' ' ' LEU . 4.5 mt -75.89 -55.91 5.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.5 m -42.36 -50.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 51.2 t -57.36 -38.45 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -72.19 -34.53 68.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.554 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 34.1 mttt -82.38 -18.21 42.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.61 40.12 6.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.554 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 42.6 m0 -118.78 176.96 5.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -103.46 173.07 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.839 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.457 HD22 ' NE2' ' A' ' 165' ' ' GLN . 32.3 mt -51.07 143.39 16.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.934 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.15 68.03 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.92 122.26 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.497 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 93.8 m-85 -113.76 114.98 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.417 ' C ' ' HG3' ' A' ' 194' ' ' MET . 4.4 m -140.17 132.05 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.53 119.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.1 t -97.49 -37.51 9.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 10.8 tp60 -138.3 154.86 49.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.459 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 4.7 mp0 -144.25 108.98 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -125.02 172.13 9.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.26 145.15 16.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.49 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.8 -169.32 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.678 2.252 . . . . 0.0 112.356 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.84 -48.58 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.1 p-80 -59.55 -41.75 90.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -122.62 80.74 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -76.96 140.56 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.22 118.05 15.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -110.63 124.5 52.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.0 m -102.61 104.63 15.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.417 ' HG3' ' C ' ' A' ' 179' ' ' THR . 4.0 ttp -103.09 145.78 29.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.2 m -115.46 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.173 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -95.68 116.58 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -96.63 105.73 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 44.8 t -96.71 157.44 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 78.8 mm-40 -33.88 -69.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 78.8 mtt180 -119.32 30.94 6.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.514 ' CD2' HG12 ' A' ' 225' ' ' VAL . 21.7 m-85 -147.3 155.47 42.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.1 mt -149.84 139.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -151.58 140.73 21.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.8 mt -103.87 134.02 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.3 168.52 18.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.7 p -133.87 151.31 51.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -172.21 136.77 3.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.5 p -45.61 -42.07 10.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 212' ' ' LEU . 1.9 t -125.99 141.23 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -38.73 -48.91 1.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.82 -41.87 45.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 209' ' ' SER . 25.3 mt -75.33 -50.64 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.75 -41.32 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.497 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.1 ttpm? -54.33 -56.82 14.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -57.03 -40.11 76.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -45.33 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.29 -51.51 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -47.29 -63.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -39.44 -66.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -41.97 -47.38 4.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 16.7 tpp -56.69 -43.39 80.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.459 ' O ' ' CB ' ' A' ' 226' ' ' SER . 84.6 mt -44.89 -59.16 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.63 -46.81 87.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -48.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.514 HG12 ' CD2' ' A' ' 201' ' ' PHE . 27.9 m -65.75 -31.49 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 222' ' ' LEU . 21.3 t -81.86 103.99 11.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.59 75.67 0.42 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.475 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -25.44 28.49 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.642 2.228 . . . . 0.0 112.344 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.1 t -114.09 152.35 31.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 66.4 m -87.96 176.28 7.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.2 p -124.13 141.35 52.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.0 m -148.39 148.0 29.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.77 -178.29 46.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.8 m -64.67 84.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.858 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.6 m -173.55 170.22 4.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 175.48 146.55 5.89 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 161.81 44.49 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.692 2.262 . . . . 0.0 112.347 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -166.51 132.71 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.159 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.2 p -110.88 145.0 31.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.658 0.742 . . . . 0.0 110.876 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 143.87 52.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -104.62 145.61 30.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.09 -67.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 69.5 m -80.97 136.1 35.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -48.44 -43.03 34.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.4 m -68.07 121.19 15.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.466 ' ND2' ' HD2' ' A' ' 160' ' ' PRO . 1.0 OUTLIER -171.05 139.85 1.27 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.645 0.736 . . . . 0.0 110.852 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.466 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.75 -50.23 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.683 2.255 . . . . 0.0 112.338 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.14 -41.2 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.59 86.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -96.4 -55.29 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.7 tp -50.1 -30.06 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -64.78 -34.7 78.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -77.57 -46.11 23.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.0 mt -58.87 -57.43 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.7 m -40.21 -42.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.26 -40.98 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 44.4 mt-30 -70.69 -31.2 68.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.568 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 28.2 mttp -85.02 -15.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.83 8.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.568 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 39.2 m0 -120.85 172.61 7.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -100.5 172.24 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.7 mt -46.95 142.6 4.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 145.87 58.69 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.19 146.24 24.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.403 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 91.1 m-85 -138.0 117.94 13.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.979 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.401 ' C ' ' HG3' ' A' ' 194' ' ' MET . 35.1 m -140.25 128.42 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.158 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.92 113.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.5 p -88.51 -56.2 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.43 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 8.7 tp60 -119.88 154.72 33.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.43 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 2.7 mp0 -144.58 114.47 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.1 t -136.51 170.72 15.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.43 145.92 11.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.421 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.79 -173.13 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.71 62.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.0 p-80 -62.57 -38.71 91.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -123.28 83.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -82.19 126.46 32.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.21 124.39 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.18 132.31 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.4 m -107.19 102.71 12.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.401 ' HG3' ' C ' ' A' ' 179' ' ' THR . 8.6 ttp -107.49 139.67 41.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 31.1 m -108.04 136.79 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.5 t -93.38 115.1 27.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -94.67 105.5 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.464 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.2 t -97.04 156.59 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.464 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 12.0 mm-40 -34.15 -70.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -117.27 29.93 7.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 30.1 m-85 -145.99 155.65 42.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.832 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -149.23 137.76 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.442 ' O ' ' CG2' ' A' ' 195' ' ' THR . 4.5 tp10 -150.43 145.44 26.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.18 131.33 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.31 173.75 17.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.7 t -152.14 155.34 37.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.845 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.92 144.09 8.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.1 p -49.38 -26.26 3.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 81.8 p -140.03 145.29 37.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -42.61 -54.42 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -44.82 -39.45 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 215' ' ' ARG . 75.2 mt -76.99 -58.11 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.24 -37.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.403 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 36.7 tttt -64.48 -49.28 72.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 212' ' ' LEU . 12.0 ptt180 -68.9 -30.55 69.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -45.77 84.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.52 81.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.078 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.22 66.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.54 -61.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -48.87 -43.26 38.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 8.1 tpp -55.2 -43.8 74.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 80.4 mt -38.43 -53.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 24.9 mt -72.89 -38.95 66.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -52.07 -56.62 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.564 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 11.1 m -71.34 -31.32 43.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 26.1 t -71.75 154.45 41.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.823 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -102.44 -78.86 1.34 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.508 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 124.36 11.02 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.697 2.265 . . . . 0.0 112.332 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 59.9 p -151.05 123.54 8.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 88.4 p -115.53 170.36 8.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.5 p -39.91 127.9 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -157.45 118.66 3.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -139.43 -157.3 7.24 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.526 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 79.7 p -103.44 125.41 50.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.2 p -104.19 -0.66 28.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.64 83.87 1.76 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 170.68 16.03 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.372 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 78.9 t -124.31 128.08 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.133 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.3 t -168.54 142.44 2.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.651 0.739 . . . . 0.0 110.851 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.47 34.39 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.708 2.272 . . . . 0.0 112.346 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -60.78 -48.53 81.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -85.13 110.74 19.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 t -75.88 82.09 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.846 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -39.3 -50.81 2.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.832 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 19.3 t -60.44 123.57 17.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.841 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -40.09 155.21 0.18 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -44.74 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.96 -48.85 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.99 -11.98 78.99 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.58 -55.38 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.1 tp -39.81 -35.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.468 ' NE2' HD21 ' A' ' 175' ' ' LEU . 6.6 tp-100 -55.81 -46.77 77.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.457 ' CG ' HD23 ' A' ' 167' ' ' LEU . 3.9 pt-20 -55.33 -33.99 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.457 HD23 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -70.27 -68.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.9 m -40.1 -45.54 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.1 t -52.31 -53.88 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -64.51 -38.95 92.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -71.25 -24.14 62.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.27 26.85 22.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.463 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -103.09 174.15 5.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 175' ' ' LEU . 35.7 ptt180 -103.58 159.78 15.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.468 HD21 ' NE2' ' A' ' 165' ' ' GLN . 21.1 mt -34.25 142.05 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.562 0.696 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 156.99 62.0 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -97.42 130.34 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.512 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 54.1 m-85 -124.07 112.79 17.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.3 m -145.34 150.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -82.96 133.04 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 -42.62 5.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 3.3 tp-100 -140.12 150.2 43.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 1.9 mp0 -137.27 107.05 6.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 t -124.33 169.91 11.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.92 144.41 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.417 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.77 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.34 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.05 -48.13 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -59.66 -37.47 78.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -125.46 81.69 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -81.44 136.33 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -136.89 114.47 11.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -110.25 130.11 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.3 m -99.79 106.64 18.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 36.2 ttm -108.46 138.87 44.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 28.8 m -115.97 137.62 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 52.6 t -94.13 118.04 30.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -101.31 103.16 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.9 t -99.74 158.29 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.51 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 7.6 mm-40 -34.14 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 56.2 mtp180 -113.65 31.67 6.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.567 ' CD2' HG11 ' A' ' 225' ' ' VAL . 23.3 m-85 -146.98 148.92 32.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.6 mt -150.02 139.39 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -155.77 139.69 16.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 21.7 mt -98.33 142.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.16 179.07 18.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' A' ' 216' ' ' ASN . 1.9 m -150.98 161.74 42.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.87 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -175.54 139.59 4.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.7 p -41.78 -40.37 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 31.3 m -126.73 144.02 51.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.847 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -39.91 -49.83 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -52.53 -53.49 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 32.3 mt -57.19 -45.67 83.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 214' ' ' LYS . . . -49.24 -57.91 5.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.512 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.4 ttpm? -35.94 -46.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -68.15 -56.57 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 206' ' ' SER . 16.8 m-80 -38.09 -45.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.12 -46.73 49.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.05 -60.02 4.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.27 -55.0 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -57.56 -42.67 83.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.4 ' CE ' HG22 ' A' ' 198' ' ' VAL . 1.7 tpp -53.2 -45.47 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 35.6 mt -42.13 -42.79 3.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.7 mt -78.46 -36.66 45.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -57.67 -60.5 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.567 HG11 ' CD2' ' A' ' 201' ' ' PHE . 30.6 m -72.35 -37.61 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.0 t -126.14 96.64 4.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.63 83.81 0.36 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 114.87 3.85 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.353 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 10.5 t -139.54 146.67 40.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.826 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.5 m -81.54 93.83 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.843 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.4 p -134.59 145.62 48.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.904 0.383 . . . . 0.0 110.837 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -56.48 147.57 21.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.2 65.86 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.7 t -153.4 176.85 11.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.85 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.0 p -79.87 2.87 21.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 138.98 145.49 4.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 100.82 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.335 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.4 p -38.65 117.97 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.12 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.8 m -107.5 81.5 1.1 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.605 0.717 . . . . 0.0 110.837 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 120.16 6.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.624 2.216 . . . . 0.0 112.369 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -115.93 132.59 56.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -85.93 141.33 29.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.3 m -132.47 -55.03 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.08 -36.07 67.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 46.8 t -59.4 133.62 56.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.83 143.01 8.66 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 0.0 110.93 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.19 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.64 2.226 . . . . 0.0 112.392 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -45.96 -40.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.55 71.34 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.458 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.04 -50.78 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -49.8 -38.39 34.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -52.43 -27.77 17.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.16 -43.66 41.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 167' ' ' LEU . 4.5 mt -62.17 -48.2 81.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.401 HG21 ' N ' ' A' ' 169' ' ' VAL . 17.4 m -60.91 -50.14 81.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.401 ' N ' HG21 ' A' ' 168' ' ' VAL . 26.0 t -56.32 -54.35 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 13.5 pt20 -62.02 -43.19 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.556 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 21.6 mmmt -67.47 -28.38 67.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.96 47.07 3.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.454 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.556 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 41.6 m0 -120.17 178.16 4.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 175' ' ' LEU . 12.3 ptt180 -99.29 148.87 23.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 174' ' ' ARG . 39.7 mt -34.03 142.35 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.596 0.712 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 143.18 49.91 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 0.0 112.349 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -104.11 128.82 51.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.42 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 89.8 m-85 -122.25 115.71 22.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.411 ' C ' ' HG3' ' A' ' 194' ' ' MET . 99.3 m -131.29 131.13 43.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.458 ' CG1' ' HG3' ' A' ' 183' ' ' GLU . 87.3 t -67.88 107.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.7 p -81.95 -59.07 2.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -115.26 151.74 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.458 ' HG3' ' CG1' ' A' ' 180' ' ' VAL . 3.6 mp0 -143.87 113.98 7.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.5 t -133.49 172.34 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.27 145.32 18.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.504 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.3 Cg_endo -69.79 -164.76 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.667 2.245 . . . . 0.0 112.325 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.75 -30.5 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.504 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 4.8 p-80 -80.61 -24.37 39.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -130.37 52.82 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -55.27 126.24 24.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.64 114.63 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.884 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.08 131.79 54.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.3 m -105.74 102.65 12.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.129 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.411 ' HG3' ' C ' ' A' ' 179' ' ' THR . 8.0 ttp -105.85 139.61 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 29.2 m -112.16 138.63 48.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.31 122.79 38.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -104.9 103.6 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 17.7 t -96.97 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.532 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.9 mm-40 -33.51 -68.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -121.47 33.03 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -146.85 152.07 38.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.465 ' CA ' ' HE2' ' A' ' 221' ' ' MET . 98.8 mt -149.23 141.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -156.48 139.06 15.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.56 134.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -124.3 165.01 17.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.5 p -134.91 138.24 43.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 0.0 110.828 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -158.46 134.64 3.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 12.2 p -43.13 -34.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 0.0 111.144 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 210' ' ' LYS . 28.6 t -132.43 141.84 49.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 209' ' ' SER . 22.9 mtmt -37.6 -57.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -46.01 -42.22 12.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 215' ' ' ARG . 54.1 mt -73.14 -57.03 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -39.71 -31.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.42 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 44.5 tttt -66.1 -45.25 81.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.2 ptt85 -66.39 -40.55 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.15 -50.91 71.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.64 -50.04 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -49.81 64.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.57 -62.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -50.52 -49.02 56.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.465 ' HE2' ' CA ' ' A' ' 202' ' ' ILE . 2.4 tpp -48.62 -46.26 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.1 mt -38.74 -57.69 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.2 mt -63.68 -48.35 77.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -47.74 -63.26 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.1 m -63.63 -27.83 43.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.3 t -42.75 126.87 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -124.89 -160.19 10.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -174.69 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.669 2.246 . . . . 0.0 112.375 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.2 t -62.05 103.53 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.0 m 53.42 44.4 30.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.528 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.2 p -109.31 -43.54 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.872 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.3 t -117.28 137.28 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.83 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.45 -156.21 15.76 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.534 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -122.07 -59.36 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 53.8 m -115.04 142.03 47.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.823 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -151.07 -91.8 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.468 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 136.25 32.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.672 2.248 . . . . 0.0 112.342 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.67 141.09 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.112 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.3 m -142.92 143.77 26.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.697 0.76 . . . . 0.0 110.878 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 138.74 38.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.368 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -60.26 144.1 51.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -105.07 170.61 7.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 t -82.32 -57.0 3.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.82 141.67 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 60.6 m -103.44 136.82 42.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -133.48 144.2 51.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.362 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.0 t -49.26 -40.04 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.63 -15.51 81.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.51 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.85 -56.85 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 36.3 tp -49.75 -30.21 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -33.84 76.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -76.71 -41.56 44.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.484 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -64.6 -61.31 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 167' ' ' LEU . 3.3 m -37.19 -53.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 76.3 t -54.96 -44.1 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -64.81 -34.52 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.549 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 17.7 mtpp -83.34 -12.53 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.17 11.16 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.437 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.549 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 48.8 m0 -116.06 174.38 6.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.753 0.311 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -106.04 164.63 11.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.6 mt -42.52 142.27 1.35 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 110.884 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 143.57 50.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.5 128.77 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.513 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 90.9 m-85 -118.73 115.9 25.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.415 ' C ' ' HG3' ' A' ' 194' ' ' MET . 98.9 m -138.52 128.63 25.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 88.0 t -64.24 115.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.7 p -89.08 -58.9 2.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.438 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 9.0 tp60 -117.7 154.11 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.438 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 3.4 mp0 -144.85 114.74 7.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.5 t -136.03 172.42 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.67 144.75 13.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.544 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.75 -174.13 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 0.0 112.352 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.69 -42.69 73.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -66.78 -37.91 85.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -123.83 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -83.29 133.8 34.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -136.37 114.55 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -105.34 140.08 39.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 35.5 m -114.07 98.65 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.415 ' HG3' ' C ' ' A' ' 179' ' ' THR . 6.5 ttp -100.59 141.12 33.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.0 m -110.43 133.91 52.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 8.5 t -91.65 114.35 26.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -95.94 109.5 21.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 36.9 t -102.17 156.69 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.473 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -33.54 -67.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 45.0 mtp180 -122.47 31.32 6.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 25.7 m-85 -147.34 156.34 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.8 mt -150.0 139.41 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.162 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.454 ' CG ' ' HG3' ' A' ' 224' ' ' ARG . 5.8 mm-40 -150.64 133.73 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 205' ' ' GLY . 35.0 mt -90.68 136.99 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.412 ' N ' HG22 ' A' ' 204' ' ' ILE . . . -126.65 155.5 19.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.497 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 p -137.52 145.71 43.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.97 159.81 33.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.8 p -65.94 -12.61 56.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 111.129 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 64.8 p -150.92 154.9 38.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.813 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -49.57 -58.17 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -42.85 -44.66 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 214' ' ' LYS . 44.3 mt -67.57 -65.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.99 -31.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.513 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 73.0 tttt -67.33 -52.59 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.917 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -65.11 -39.21 92.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -57.68 -50.25 73.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.55 74.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.081 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.55 -51.0 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.85 -62.19 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -51.97 -39.87 59.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.423 ' HE1' ' N ' ' A' ' 203' ' ' GLU . 7.7 tpp -55.05 -41.98 72.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 18.7 mt -44.06 -62.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.7 -42.32 92.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.454 ' HG3' ' CG ' ' A' ' 203' ' ' GLU . 12.4 mmt180 -51.78 -56.12 15.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.547 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 21.5 m -69.55 -36.31 70.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 225' ' ' VAL . 7.4 p -60.81 172.48 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.97 -94.94 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -25.99 27.99 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.343 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 31.9 t -50.71 134.99 24.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.806 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.5 m -48.37 155.27 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.877 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.499 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.4 t -48.34 145.16 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.837 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 m -77.36 155.87 31.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.856 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -95.93 71.05 0.92 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.504 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 146' ' ' GLY . 35.5 p 34.69 44.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 95.1 p -137.87 108.95 6.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -125.42 145.88 15.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.48 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 115.06 3.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.683 2.256 . . . . 0.0 112.373 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 86.1 t -95.44 121.89 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.5 p -71.92 148.2 91.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 122.54 9.21 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.346 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -59.0 -42.8 90.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -145.01 111.38 5.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 t -88.25 97.72 11.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -82.07 45.78 0.96 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.2 p -104.03 172.77 6.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -91.83 144.81 29.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.615 0.721 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -50.36 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.667 2.245 . . . . 0.0 112.359 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.42 -42.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.74 -18.77 78.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.39 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.5 tp -47.91 -39.02 17.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -57.6 -31.06 65.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.956 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -80.39 -46.45 15.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.464 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -57.72 -46.94 83.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.3 m -56.38 -52.48 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.1 t -54.54 -58.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 15.2 pt20 -54.3 -44.9 72.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.561 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 12.1 mtpp -69.5 -25.94 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.4 48.97 3.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.461 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.561 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 45.7 m0 -123.13 178.13 5.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.893 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -99.83 157.21 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.7 mt -39.7 143.99 0.53 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 146.76 61.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.99 141.3 30.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 69.5 m-85 -133.77 118.43 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 180' ' ' VAL . 98.5 m -147.72 135.16 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.126 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.447 HG12 ' CG ' ' A' ' 183' ' ' GLU . 87.9 t -75.47 118.11 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 57.4 p -88.34 -43.96 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.417 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 12.9 tm0? -135.33 161.3 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.447 ' CG ' HG12 ' A' ' 180' ' ' VAL . 29.1 mt-10 -151.72 113.85 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.1 t -134.39 172.1 13.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.44 145.68 11.67 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.567 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.76 -172.23 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.391 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.4 63.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.567 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.5 p-80 -80.55 -31.62 36.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -127.01 83.54 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -83.2 135.72 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -140.44 119.13 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -109.82 134.88 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 10.1 m -99.52 96.52 7.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 45.3 ttm -100.01 134.52 42.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 30.6 m -111.63 137.41 49.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.5 t -93.34 119.02 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -103.11 100.01 9.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.9 t -97.0 159.84 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.538 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 29.8 mm-40 -34.3 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.473 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 14.5 mmt85 -113.34 33.07 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.473 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 20.0 m-85 -147.34 147.12 30.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.421 ' O ' ' CD ' ' A' ' 203' ' ' GLU . 77.5 mt -149.99 135.51 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 195' ' ' THR . 6.6 mp0 -153.94 146.54 24.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 32.3 mt -101.31 136.61 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.43 -179.37 15.75 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 87.9 p -152.11 144.12 23.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -161.23 134.5 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 22.4 p -40.72 -39.54 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.121 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 45.6 m -128.78 141.9 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.823 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -38.55 -53.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -48.96 -45.12 41.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.9 mt -66.31 -51.65 55.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.62 -56.75 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.538 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 3.2 ttpm? -41.77 -47.13 4.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -67.85 -43.1 80.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.58 -48.31 79.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.86 -50.64 65.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.28 -56.24 23.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.42 -57.04 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -54.92 -42.87 72.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 51.3 tpp -53.6 -40.95 66.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 32.0 mt -48.13 -47.72 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.71 -43.39 76.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -56.95 -58.38 8.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.455 HG21 ' N ' ' A' ' 226' ' ' SER . 27.3 m -62.98 -29.07 46.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.455 ' N ' HG21 ' A' ' 225' ' ' VAL . 95.4 p -157.06 117.65 3.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 171.63 -93.37 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 90.21 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.727 2.285 . . . . 0.0 112.316 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 21.6 t -113.16 -61.27 1.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 28.8 t -130.98 96.63 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.875 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.461 180.0 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 21.2 t -54.57 151.09 8.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.867 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 p -132.81 -55.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.888 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.58 -163.56 12.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.427 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.0 p -161.23 139.23 9.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.827 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.4 t -153.23 157.29 40.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.75 145.74 23.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.465 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 105.07 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 0.0 112.336 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.6 p -90.87 122.44 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.141 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.9 p -71.18 144.05 89.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.681 0.753 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 154' ' ' GLN . 53.3 Cg_endo -69.77 -1.04 7.8 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 0.0 112.315 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 153' ' ' PRO . 77.9 mm-40 -35.38 108.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.401 ' C ' ' OE1' ' A' ' 155' ' ' GLN . 2.5 tm0? -165.79 140.82 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.6 p -171.05 148.56 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 50.22 32.69 6.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 2.8 t -101.68 148.26 25.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.418 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 8.8 t30 -68.73 140.42 91.82 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.73 -49.92 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.327 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.8 t -45.91 -32.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.163 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -93.57 -16.03 47.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.47 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.39 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.21 -40.21 73.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.431 ' NE2' HD21 ' A' ' 175' ' ' LEU . 4.9 tp-100 -57.26 -24.88 57.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.76 -42.19 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.89 -57.57 6.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.0 m -39.42 -45.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.2 t -57.44 -40.86 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 9.6 mm100 -76.41 -36.85 57.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.559 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.98 -23.89 58.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.6 39.42 5.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.559 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 12.1 m0 -121.33 168.37 11.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.91 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -98.92 170.41 8.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.431 HD21 ' NE2' ' A' ' 165' ' ' GLN . 37.1 mt -41.22 141.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 0.0 110.891 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 148.48 65.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -101.35 131.83 47.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.505 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 88.2 m-85 -123.97 120.01 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.932 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.413 ' C ' ' HG3' ' A' ' 194' ' ' MET . 48.6 m -140.14 129.93 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.26 113.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 68.4 p -82.09 -51.44 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.56 158.73 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -137.58 109.82 7.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.0 t -118.78 170.7 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 100.03 143.69 14.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.436 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.76 -168.18 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.63 2.22 . . . . 0.0 112.347 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.91 43.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.436 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -58.61 -41.2 85.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 189' ' ' ARG . 14.3 mtp-105 -120.92 91.73 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.9 137.97 31.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -138.57 119.27 14.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.54 126.2 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.8 m -99.41 97.28 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.413 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.9 ttp -101.72 139.32 37.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.868 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 31.4 m -111.88 138.18 48.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.21 118.75 30.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.7 ttp85 -100.46 101.57 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 24.9 t -98.48 157.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 61.9 mm-40 -34.1 -72.56 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.21 31.52 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 29.4 m-85 -146.92 150.3 34.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 203' ' ' GLU . 74.6 mt -149.68 138.29 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.121 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.467 ' O ' ' CG2' ' A' ' 195' ' ' THR . 4.5 tm-20 -153.14 146.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.1 136.48 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.64 171.25 17.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 77.8 p -144.22 142.25 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.23 134.6 3.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 30.9 p -40.84 -34.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.18 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.1 m -134.61 150.17 50.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -42.71 -55.75 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -44.05 -37.08 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.4 mt -78.87 -63.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.55 -34.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 43.5 tttt -66.31 -51.96 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.73 -50.77 65.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.9 86.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.15 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -48.29 -56.54 7.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -56.11 -46.5 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 7.9 tpp -51.08 -41.26 59.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.42 -53.33 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.88 -37.07 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -54.74 -45.49 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.55 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 18.4 m -80.25 -34.36 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.466 ' N ' HG23 ' A' ' 225' ' ' VAL . 3.4 m -89.1 80.45 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 76.59 164.4 18.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 155.9 64.8 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 44.9 t -43.09 -49.7 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 50.6 m -93.62 133.36 37.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.844 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.465 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.7 t 61.51 44.43 9.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.2 t -79.75 -43.83 21.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.52 86.67 0.25 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.522 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -88.87 -55.95 3.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 110.883 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.5 t 55.07 25.04 6.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -120.45 -79.91 0.59 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 126.05 12.85 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.36 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.8 t -118.2 138.58 48.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 m -136.55 144.04 45.64 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.644 0.735 . . . . 0.0 110.877 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 133.76 26.49 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 0.0 112.322 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.28 166.27 18.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.936 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -118.5 -17.92 9.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.4 m -79.01 152.94 30.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.69 157.02 28.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.87 132.81 33.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -65.98 140.56 97.15 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -50.67 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.378 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.6 t -45.56 -43.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -80.84 -17.35 72.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.544 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.56 6.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.061 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 16.4 tp -45.28 -43.42 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.62 -36.83 37.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -67.71 -44.54 77.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.49 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -60.09 -60.29 4.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.1 m -43.9 -39.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.06 -38.39 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -77.96 -39.3 43.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.558 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.3 mmpt? -72.55 -25.51 61.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.81 43.63 5.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.501 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.558 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 11.0 m0 -121.58 175.35 6.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.32 . . . . 0.0 110.886 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -102.1 164.36 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 mt -38.35 143.28 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 151.55 68.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.645 2.23 . . . . 0.0 112.363 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -92.07 120.18 32.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.563 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 37.6 m-85 -112.25 113.29 25.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.5 m -149.71 146.15 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.82 132.67 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.07 -39.25 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -132.32 149.86 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -143.22 111.68 6.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.5 t -128.24 172.25 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.23 145.64 15.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.52 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.76 -168.83 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.724 2.282 . . . . 0.0 112.345 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.33 -52.11 15.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.52 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 30.2 p-80 -57.47 -32.48 67.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -133.68 92.44 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -86.52 135.67 33.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -125.99 114.73 18.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -106.99 139.44 41.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 20.1 m -116.85 102.79 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -102.26 148.25 25.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.8 m -121.75 144.87 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 6.6 t -101.55 110.61 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -96.93 100.05 11.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 31.1 t -95.73 159.19 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 21.7 mm-40 -33.33 -66.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.465 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 66.9 mtt85 -123.92 33.6 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 225' ' ' VAL . 23.9 m-85 -148.04 154.16 39.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -150.12 139.8 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -150.48 124.48 9.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 58.2 mt -90.38 137.28 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -128.26 174.46 18.81 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 158.63 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 179.36 152.93 11.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.1 p -65.51 -23.19 66.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 0.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 150.33 50.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -49.15 -57.02 7.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.58 -40.36 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 213' ' ' ALA . 35.9 mt -70.85 -61.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.17 -44.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -58.23 -61.66 2.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.2 -26.43 60.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.31 -42.51 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.34 63.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.077 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -66.8 -53.8 29.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -42.14 -58.4 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -58.46 -44.9 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 13.0 tpp -50.45 -37.2 36.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 47.4 mt -48.63 -58.21 5.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.37 -44.15 97.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -48.22 -54.74 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.558 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.1 m -74.78 -34.01 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.3 t -42.23 -57.22 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 168.74 162.32 20.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.503 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 229' ' ' SER . 53.5 Cg_endo -69.76 -22.58 31.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.696 2.264 . . . . 0.0 112.309 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 228' ' ' PRO . 98.8 p -37.62 -59.57 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.7 m -52.3 -61.53 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.482 179.996 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.9 t -118.76 131.22 56.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.37 . . . . 0.0 110.874 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.1 t -64.17 83.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.87 40.49 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.455 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.0 m -143.83 173.98 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 0.0 110.842 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 89.0 p -170.04 163.2 9.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.836 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 131.95 146.23 5.68 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 -176.38 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.713 2.275 . . . . 0.0 112.365 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.435 HG23 ' N ' ' A' ' 152' ' ' SER . 12.6 p -173.81 144.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.435 ' N ' HG23 ' A' ' 151' ' ' VAL . 1.8 m -164.42 144.17 6.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.872 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 137.46 35.47 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.691 2.261 . . . . 0.0 112.353 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -94.79 81.51 3.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -160.79 140.1 10.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 19.1 m -63.25 -63.17 1.27 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.33 151.19 5.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 63.9 m -58.5 161.5 4.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.37 143.05 47.67 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.664 0.745 . . . . 0.0 110.894 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -50.77 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.269 . . . . 0.0 112.392 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.9 t -47.45 -37.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.53 -19.83 61.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.39 -52.11 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.101 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.9 tp -47.99 -28.24 2.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 7.3 tp-100 -61.01 -56.17 24.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CG ' HD22 ' A' ' 167' ' ' LEU . 5.0 pt-20 -48.58 -32.86 8.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.462 HD22 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -68.81 -68.37 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 3.3 m -40.21 -38.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -57.96 -47.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -71.9 -39.28 69.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.567 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.0 mmpt? -70.4 -27.13 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.12 45.06 4.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.492 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.567 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 10.6 m0 -123.89 174.7 7.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.758 0.313 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.72 166.4 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.53 140.65 0.98 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.608 0.718 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 159.31 53.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.329 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -95.53 138.42 33.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.518 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 70.6 m-85 -130.34 107.93 9.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.6 m -144.7 150.7 37.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.465 ' CG1' ' HG3' ' A' ' 183' ' ' GLU . 25.3 t -85.87 122.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 1.5 t -96.65 -32.35 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.152 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.43 145.67 50.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.465 ' HG3' ' CG1' ' A' ' 180' ' ' VAL . 1.9 mp0 -144.86 107.02 4.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -135.45 166.1 23.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.12 142.69 10.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.445 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.8 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.256 . . . . 0.0 112.308 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.13 -33.58 65.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.8 p-80 -77.8 -28.9 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -131.04 80.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.74 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -138.62 114.45 9.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -105.83 142.38 35.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -114.55 101.12 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.2 ttm -103.03 143.76 32.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 89.1 m -124.05 136.01 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 11.0 t -91.38 111.88 23.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -96.09 110.13 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.0 t -103.64 159.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.53 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.3 mm-40 -34.17 -72.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.11 32.06 6.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.555 ' CD2' HG13 ' A' ' 225' ' ' VAL . 25.4 m-85 -146.63 153.01 39.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.467 ' CA ' ' HE1' ' A' ' 221' ' ' MET . 90.4 mt -150.04 137.23 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.478 ' O ' ' CG2' ' A' ' 195' ' ' THR . 29.0 tp10 -148.94 138.0 21.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 46.1 mt -99.46 142.29 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -133.87 -179.27 16.24 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 65.7 p -151.52 153.57 34.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.401 . . . . 0.0 110.834 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -171.71 150.46 13.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.5 p -59.5 -34.2 72.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 6.1 m -131.59 144.91 51.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -41.63 -56.67 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -38.1 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.0 mt -75.37 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -39.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.518 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 11.0 tttm -61.14 -55.09 36.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.3 ptt85 -63.17 -30.64 71.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.68 -47.21 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.38 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.22 69.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -44.83 -58.91 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -56.47 -44.97 81.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.467 ' HE1' ' CA ' ' A' ' 202' ' ' ILE . 2.9 tpp -51.3 -44.78 62.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 26.3 mt -38.65 -56.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -44.38 -57.71 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.555 HG13 ' CD2' ' A' ' 201' ' ' PHE . 27.0 m -74.66 -34.62 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.2 t -42.58 159.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.11 84.04 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 102.64 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 m -85.8 -53.28 5.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 11.8 t -54.94 91.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.7 m -124.54 94.32 4.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 110.869 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.1 t -142.93 127.37 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.94 -120.34 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -59.36 106.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 110.874 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.5 m -137.29 116.3 12.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 171.27 146.46 5.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 138.56 38.18 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.711 2.274 . . . . 0.0 112.316 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.01 88.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.152 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.5 m -109.61 83.24 2.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.631 0.729 . . . . 0.0 110.889 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -18.4 36.82 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -118.24 123.41 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -43.66 159.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.5 t -166.56 134.46 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -52.1 145.37 10.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.1 p -90.96 129.58 36.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -107.54 85.08 2.1 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.736 . . . . 0.0 110.905 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 -44.75 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.412 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.9 t -48.31 -37.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -86.84 -16.44 61.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.66 -51.76 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.044 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.03 -42.54 13.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -51.83 -34.95 42.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -69.68 -41.19 75.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.23 -59.22 3.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.9 m -41.11 -51.42 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 88.2 t -54.12 -41.77 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -64.52 -45.43 87.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -75.19 -21.52 58.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.62 43.5 4.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.497 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -116.19 172.35 7.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.745 0.307 . . . . 0.0 110.922 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 175' ' ' LEU . 22.5 ptt-85 -101.55 164.22 11.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 174' ' ' ARG . 48.9 mt -36.4 142.34 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.573 0.701 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 146.8 61.1 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.631 2.221 . . . . 0.0 112.335 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.43 137.88 33.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.56 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 94.5 m-85 -127.83 122.15 31.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -149.28 139.6 22.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.148 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.1 t -76.33 126.64 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 67.2 p -94.04 -41.53 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -150.58 164.17 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.81 120.12 12.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.0 t -132.02 166.04 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 146.58 21.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.535 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.4 Cg_endo -69.77 -175.09 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.78 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.535 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.7 p-80 -61.44 -41.77 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -120.06 58.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -64.45 150.94 45.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.9 116.9 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -107.78 127.98 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 22.8 m -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 58.7 ttm -101.7 144.9 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 18.0 m -122.65 139.06 54.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.7 t -96.67 120.54 37.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -102.51 119.56 39.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.2 t -115.51 157.44 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.492 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.2 mt-10 -33.82 -68.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -120.24 32.37 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.546 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 31.8 m-85 -146.43 152.05 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.0 mt -149.99 142.56 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.451 ' O ' ' CG2' ' A' ' 195' ' ' THR . 9.4 tm-20 -155.64 146.1 21.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.88 147.03 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -141.63 170.06 24.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.6 p -142.69 139.82 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.837 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.5 136.27 5.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 p -46.11 -23.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.9 m -142.74 148.75 37.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -42.42 -56.14 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -44.66 -44.26 8.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.3 mt -70.01 -60.84 2.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.21 -37.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.56 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 8.1 tttp -66.84 -53.94 27.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -64.56 -28.97 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -66.52 -49.03 67.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.08 -52.02 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -50.88 -44.49 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.5 -64.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -53.43 -33.32 53.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.467 ' HE2' ' CG2' ' A' ' 198' ' ' VAL . 0.6 OUTLIER -62.15 -36.94 83.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 67.9 mt -49.73 -38.03 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.5 -36.59 20.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -59.18 -50.2 74.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.546 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 28.8 m -69.12 -26.41 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.6 p -87.64 139.26 30.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -70.04 -88.97 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.33 53.8 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.7 2.267 . . . . 0.0 112.32 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.1 m -108.07 138.9 43.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 52.0 p -52.26 -58.39 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.3 m -60.24 149.35 33.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.854 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.3 t -90.04 91.64 8.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.45 112.33 1.16 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.4 p -74.69 163.88 27.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.877 0.37 . . . . 0.0 110.911 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.3 m -147.64 135.01 20.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 60.65 157.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 175.81 7.63 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 30.2 m -120.13 113.79 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.9 t -95.99 142.96 25.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.623 0.725 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -39.37 6.72 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.709 2.273 . . . . 0.0 112.387 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 47.5 38.22 7.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -139.4 126.2 20.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 56.1 m -46.59 173.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.792 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 158' ' ' CYS . 0.9 OUTLIER -86.04 -33.28 21.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.94 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.406 ' N ' ' HG2' ' A' ' 157' ' ' GLU . 67.2 m -109.74 120.78 43.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.421 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 13.1 t30 -147.25 140.47 14.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 0.0 110.849 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.6 Cg_endo -69.73 -48.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.331 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.6 t -49.29 -48.67 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -70.92 -9.57 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.68 -47.94 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.098 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.8 tp -60.76 -26.55 67.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -65.19 -31.5 72.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.12 -42.56 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -61.97 -54.04 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.0 m -45.21 -52.53 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 69.4 t -52.06 -52.23 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -60.74 -29.4 69.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.508 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 27.1 mttm -85.63 -16.43 39.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.07 36.98 9.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.509 ' CG ' ' HG3' ' A' ' 199' ' ' GLU . 38.6 m0 -118.74 176.57 5.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.321 . . . . 0.0 110.88 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -109.05 164.11 12.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.4 mt -38.05 142.48 0.45 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.576 0.703 . . . . 0.0 110.951 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 149.71 67.3 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.357 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.19 139.8 30.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.555 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.4 m-85 -133.43 112.51 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.42 ' C ' ' HG3' ' A' ' 194' ' ' MET . 5.1 m -139.14 128.45 24.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.77 119.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.434 ' CG2' ' OG1' ' A' ' 195' ' ' THR . 1.5 t -96.32 -32.06 12.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -141.59 149.89 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.9 106.98 6.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.4 t -136.13 171.28 14.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.58 148.38 12.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.413 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.539 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.8 -173.1 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.33 -44.66 51.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.8 p-80 -61.17 -41.1 96.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -129.81 88.63 2.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -80.6 130.8 35.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -112.39 120.28 41.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -112.33 116.31 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 m -100.34 98.54 9.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.42 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.8 ttp -102.91 143.68 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.434 ' OG1' ' CG2' ' A' ' 181' ' ' THR . 2.4 m -109.67 140.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 36.1 t -101.61 119.76 39.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -101.08 103.95 15.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.6 t -96.17 159.45 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 50.6 mm-40 -32.96 -69.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -120.44 32.88 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 32.8 m-85 -146.23 154.19 41.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.6 mt -149.82 136.01 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.476 ' C ' ' CD ' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -151.0 153.08 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 36.8 mt -109.31 130.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -116.76 176.66 16.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.8 p -149.23 144.77 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.64 141.54 7.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.503 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.9 p -54.08 -16.03 1.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 210' ' ' LYS . 3.1 m -149.7 143.84 25.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' SER . 76.0 mttt -37.5 -58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -41.81 -47.11 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 215' ' ' ARG . 35.7 mt -69.65 -59.05 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.25 -35.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.555 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -67.0 -48.68 67.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.6 ptt180 -65.4 -44.5 87.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 215' ' ' ARG . 22.2 t-20 -56.21 -42.67 77.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.405 ' CB ' ' OE2' ' A' ' 203' ' ' GLU . . . -68.83 -48.61 63.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.61 -46.43 87.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.56 -64.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -52.38 -43.88 64.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 222' ' ' LEU . 8.0 tpp -50.95 -47.03 61.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.844 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 221' ' ' MET . 46.6 mt -36.76 -51.59 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.951 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.13 -43.91 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -45.54 -56.72 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.53 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m -68.95 -37.95 77.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.409 ' N ' HG23 ' A' ' 225' ' ' VAL . 18.6 t -63.77 134.48 55.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.13 -158.71 7.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.529 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -18.64 36.69 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.725 2.283 . . . . 0.0 112.342 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 p 71.85 29.38 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 44.5 t -77.07 -177.45 4.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.3 m 42.66 41.38 2.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.4 m -64.13 -55.32 22.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.864 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.06 161.37 10.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 96.7 p -138.19 112.44 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.861 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 149' ' ' GLY . 39.6 m -77.89 96.97 5.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.814 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 148' ' ' SER . . . 36.93 82.64 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.482 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 178.36 4.61 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.745 2.296 . . . . 0.0 112.346 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.9 m -73.39 129.43 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.139 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.5 p -117.89 143.14 32.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.701 0.762 . . . . 0.0 110.835 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 150.56 68.6 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.731 2.287 . . . . 0.0 112.317 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -80.66 107.39 13.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -71.15 83.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 62.0 p -50.04 -44.99 51.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -130.71 118.18 20.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.9 t -75.61 138.04 41.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.471 ' ND2' ' HD2' ' A' ' 160' ' ' PRO . 1.3 t30 -153.63 139.18 11.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.471 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.76 -50.33 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.9 t -45.49 -41.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.141 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.08 -23.82 54.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.42 -58.42 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 111.1 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.43 -40.37 12.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.484 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 6.6 tp60 -56.47 -35.37 67.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.23 -37.06 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -66.44 -49.97 64.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 7.2 m -46.72 -36.18 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.52 -37.68 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -71.72 -40.58 69.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -78.59 -27.95 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.936 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.73 46.36 4.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.408 ' HB3' ' CG ' ' A' ' 199' ' ' GLU . 30.5 m0 -115.92 175.52 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 110.93 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 175' ' ' LEU . 55.0 mtt180 -100.57 155.13 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 174' ' ' ARG . 30.2 mt -34.39 141.55 0.25 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 152.91 69.35 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.716 2.278 . . . . 0.0 112.336 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -97.16 130.93 44.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.566 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 62.0 m-85 -123.04 109.77 14.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 m -144.54 148.57 34.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.5 t -87.27 122.46 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.0 t -96.62 -28.47 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.421 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 44.2 mt-30 -146.59 163.19 36.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.565 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 41.0 mt-10 -151.88 105.87 3.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.8 t -119.11 172.37 7.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.25 145.08 14.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.548 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.75 -175.33 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.548 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -71.5 -40.77 69.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -117.36 83.97 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -83.31 137.44 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -137.47 126.08 23.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.565 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 4.4 m-85 -117.01 128.5 55.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.2 m -94.39 105.33 17.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.425 ' CB ' ' HB1' ' A' ' 213' ' ' ALA . 40.5 ttm -105.74 141.79 36.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.5 m -118.91 134.71 55.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -92.63 108.25 19.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -92.07 102.51 15.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 38.9 t -97.26 157.72 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.486 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 59.6 mm-40 -33.71 -73.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -114.2 30.34 7.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 36.1 m-85 -145.66 153.74 41.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 57.6 mt -149.78 135.49 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -146.24 143.24 29.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 65.3 mt -108.39 136.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.87 -179.33 16.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.487 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 73.8 p -149.6 144.23 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.832 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -160.61 143.91 9.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.2 p -48.54 -29.38 4.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -141.69 148.37 38.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' LYS . 70.3 mttt -40.55 -67.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -35.35 -43.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.93 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.8 mt -72.52 -55.16 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 194' ' ' MET . . . -41.84 -39.05 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.566 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 5.4 ttmt -57.61 -55.48 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 216' ' ' ASN . 5.0 ptm180 -60.77 -37.39 81.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.43 ' N ' ' HG2' ' A' ' 215' ' ' ARG . 5.1 m120 -56.91 -49.55 75.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.96 -46.75 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.118 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -49.83 -56.24 11.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -39.47 80.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.938 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 4.9 tpp -55.73 -45.73 77.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 54.4 mt -38.35 -51.73 1.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.7 mt -72.69 -48.49 38.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 224' ' ' ARG . 12.1 mmp_? -39.19 -50.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.564 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m -76.03 -35.15 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.7 t -123.14 93.94 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -75.09 -158.09 6.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 126.07 12.87 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 85.5 p -67.42 165.48 16.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 18.2 t -54.62 -43.45 72.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.855 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.448 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.1 p -150.38 162.68 40.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.804 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -88.22 133.37 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.64 109.78 3.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.497 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.1 m -93.44 42.99 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 110.817 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 54.5 p -57.05 -44.34 82.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.65 86.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.461 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 122.18 8.86 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.674 2.249 . . . . 0.0 112.33 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.12 175.77 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.164 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.8 m -86.37 150.51 51.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.671 0.748 . . . . 0.0 110.87 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -41.02 4.59 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -163.89 141.99 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -111.97 47.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.6 m 41.28 39.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -144.64 168.38 20.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 26.6 p -88.52 125.85 34.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -162.81 144.82 8.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.598 0.713 . . . . 0.0 110.927 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -50.52 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.23 -38.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.7 -19.94 62.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.5 -54.85 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.4 tp -44.67 -42.95 7.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.419 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 15.5 tp60 -49.99 -35.89 26.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -69.61 -44.47 70.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.48 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -60.74 -58.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 5.3 m -42.05 -41.84 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.2 -37.44 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 167' ' ' LEU . 16.4 mm100 -72.49 -38.79 68.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -80.24 -20.05 45.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.57 44.26 6.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -115.49 178.22 4.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.744 0.307 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.409 ' CD ' ' O ' ' A' ' 175' ' ' LEU . 0.5 OUTLIER -107.3 166.67 10.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.409 ' O ' ' CD ' ' A' ' 174' ' ' ARG . 44.3 mt -45.52 136.16 5.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.581 0.705 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 158.13 58.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 0.0 112.348 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -95.77 148.49 22.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.566 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 80.7 m-85 -135.37 112.48 10.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.418 HG21 ' N ' ' A' ' 180' ' ' VAL . 19.2 m -144.76 143.82 30.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.418 ' N ' HG21 ' A' ' 179' ' ' THR . 91.7 t -78.76 127.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.9 p -101.65 -40.74 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -135.75 163.29 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.547 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 73.6 mt-10 -150.82 107.01 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.7 t -123.19 172.19 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.32 145.91 16.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.644 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 53.1 Cg_endo -69.84 -164.47 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.614 2.209 . . . . 0.0 112.326 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.07 -42.93 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.644 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 46.0 p-80 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.561 ' HG3' ' CD2' ' A' ' 188' ' ' HIS . 34.3 mtm180 -133.21 49.11 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.05 136.89 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.96 123.4 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.547 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 3.4 m-85 -116.58 129.71 56.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.1 m -94.79 97.8 10.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 47.1 ttm -98.88 136.21 39.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.446 HG23 ' CG1' ' A' ' 204' ' ' ILE . 19.1 m -112.29 134.66 53.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 5.7 t -93.63 117.59 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.4 128.29 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.7 t -122.58 157.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.471 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.6 mm-40 -33.87 -66.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.469 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 20.6 mmm180 -123.21 32.84 5.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 22.1 m-85 -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.6 mt -150.0 139.8 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -152.29 137.69 17.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.446 ' CG1' HG23 ' A' ' 195' ' ' THR . 61.4 mt -97.68 137.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.57 174.78 18.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.512 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.8 p -149.76 138.58 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.37 134.12 3.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.514 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.0 p -40.31 -35.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.9 t -132.01 146.17 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -41.46 -57.56 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -43.4 -40.55 3.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 213' ' ' ALA . 24.4 mt -75.09 -60.24 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.3 -41.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.566 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 79.0 tttt -58.35 -57.41 13.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -61.13 -32.62 72.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -64.35 -46.37 83.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.71 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.01 92.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.13 -63.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -52.5 -40.29 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.461 ' HE1' ' CG2' ' A' ' 198' ' ' VAL . 0.8 OUTLIER -57.25 -34.92 69.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 75.2 mt -47.88 -46.91 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.09 -44.89 36.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 -47.21 -56.59 6.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.541 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 29.6 m -68.27 -32.59 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 13.7 m -79.4 83.59 5.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -40.35 146.5 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 160.13 50.84 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.616 2.211 . . . . 0.0 112.36 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 75.2 m -159.58 129.22 5.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.1 t -83.49 106.67 15.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.874 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.8 t -138.53 138.89 38.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 m -38.35 125.26 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.819 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.16 -110.09 3.92 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.483 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.1 t -157.93 142.49 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.816 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.9 t -134.82 110.07 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -128.62 67.68 0.55 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -174.34 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 0.0 112.371 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.4 m -119.96 159.18 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 65.6 p -67.1 144.08 98.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.668 0.747 . . . . 0.0 110.842 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 166.17 28.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 0.0 112.331 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -94.42 136.87 34.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -103.95 141.6 35.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 17.7 m -92.62 -48.91 6.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -130.07 165.17 22.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 28.1 p -75.64 146.81 40.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -158.66 142.41 11.09 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 110.894 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -50.34 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.345 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -48.89 -40.31 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.56 61.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.88 -58.88 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.401 ' CD1' HD23 ' A' ' 222' ' ' LEU . 27.3 tp -41.32 -45.54 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -52.01 -39.4 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.27 -31.62 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -75.3 -62.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.8 m -39.08 -46.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.02 -37.37 77.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 167' ' ' LEU . 32.3 mt-30 -72.22 -35.18 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.564 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 24.0 mmmt -82.96 -22.36 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.83 36.49 7.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.564 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 32.7 m0 -106.78 177.98 4.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 175' ' ' LEU . 83.7 mtt180 -102.28 155.41 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 174' ' ' ARG . 64.9 mt -36.91 142.8 0.35 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.26 50.25 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.429 ' OE1' ' C ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -94.57 128.81 41.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.527 ' CE1' ' HG3' ' A' ' 214' ' ' LYS . 87.9 m-85 -118.39 123.99 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 88.4 m -143.89 142.87 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.01 119.02 33.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.3 p -90.05 -62.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.415 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 26.4 tp60 -116.65 154.18 30.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 182' ' ' GLN . 28.3 mt-10 -150.61 108.36 3.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.94 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 t -134.49 172.08 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 111.0 146.14 10.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.551 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.77 177.69 5.34 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.97 99.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.551 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 24.4 p-80 -68.34 -41.21 81.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -120.67 78.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -78.02 141.82 38.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -138.05 122.13 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.439 ' CD2' ' HG3' ' A' ' 210' ' ' LYS . 8.7 m-85 -114.45 141.23 47.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 8.7 m -112.84 98.56 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 54.6 ttm -105.67 138.08 42.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 9.1 m -114.1 135.14 54.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 10.7 t -93.39 117.5 30.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -98.66 126.42 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 17.8 t -122.23 157.78 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 16.1 mm-40 -32.73 -67.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.89 32.02 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -144.91 152.09 39.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.7 mt -149.84 139.7 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -151.04 134.46 16.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 14.0 mt -94.9 132.98 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -128.34 168.67 20.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -149.83 170.43 18.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 176.94 171.87 40.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 52.6 p -71.94 -17.96 62.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.4 m -150.54 142.1 23.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.439 ' HG3' ' CD2' ' A' ' 192' ' ' PHE . 8.3 mtmp? -40.49 -50.5 2.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -48.26 -39.97 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.7 mt -74.25 -63.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -38.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.527 ' HG3' ' CE1' ' A' ' 178' ' ' TYR . 12.1 tttm -61.4 -54.07 48.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -34.35 76.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -47.1 80.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.28 91.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.98 78.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.36 -61.69 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.2 -40.74 71.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.409 ' SD ' ' CG2' ' A' ' 198' ' ' VAL . 0.5 OUTLIER -57.14 -32.78 66.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.401 HD23 ' CD1' ' A' ' 164' ' ' LEU . 59.5 mt -52.04 -49.62 63.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.4 mt -73.04 -44.0 61.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.42 ' NH1' ' HB3' ' A' ' 224' ' ' ARG . 2.9 mmm180 -45.91 -53.13 10.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.63 -26.8 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.9 t -78.26 137.66 38.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -134.53 175.74 20.31 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.514 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 113.19 3.29 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.3 m -91.07 116.93 29.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.9 m -76.33 97.09 4.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.637 0.732 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -49.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.721 2.281 . . . . 0.0 112.333 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' HG2' ' A' ' 215' ' ' ARG . 85.3 t -47.03 -36.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.22 -18.76 62.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.64 -53.67 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.717 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.3 tp -50.61 -28.86 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.422 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -70.05 -30.07 67.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -81.8 -43.09 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -62.52 -54.06 45.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.8 m -41.97 -54.23 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.55 ' H ' HG23 ' A' ' 168' ' ' VAL . 60.0 t -52.62 -36.86 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -72.81 -31.48 64.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.584 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 40.7 mttm -85.83 -20.69 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.47 36.27 7.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.584 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 43.9 m0 -114.31 172.82 6.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -101.47 162.53 12.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 24.9 mt -41.21 144.86 0.64 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.428 ' HG3' HD23 ' A' ' 164' ' ' LEU . 54.4 Cg_endo -69.71 152.52 69.56 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.718 2.278 . . . . 0.0 112.383 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -97.81 127.84 44.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 214' ' ' LYS . 40.8 m-85 -113.65 117.38 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.951 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.2 m -145.37 135.77 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.143 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.7 t -77.53 122.24 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.0 p -92.58 -60.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.415 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 18.4 tt0 -119.08 160.41 22.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.415 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 3.7 mp0 -144.57 114.04 7.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -134.61 167.74 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.46 149.26 9.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.593 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.1 Cg_endo -69.72 -169.22 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.6 16.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.593 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 15.6 p-80 -59.94 -35.15 74.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -134.47 91.79 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -87.12 146.69 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -138.7 123.92 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -108.29 135.34 49.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 37.7 m -99.24 97.83 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.0 ttm -100.2 138.93 36.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 204' ' ' ILE . 17.6 m -116.2 136.88 52.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 53.2 t -93.2 115.22 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.841 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -98.53 102.7 14.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 32.4 t -95.78 157.31 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -34.38 -65.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 5.9 ptm180 -122.92 31.06 6.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.559 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 23.6 m-85 -146.74 155.49 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.4 mt -150.01 141.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -153.17 122.8 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.575 ' HA ' HG23 ' A' ' 195' ' ' THR . 59.8 mt -84.99 140.29 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.183 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -140.01 165.59 25.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 62.4 m -143.38 150.86 39.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.52 140.5 6.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 76.3 p -38.07 -44.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.823 0.344 . . . . 0.0 111.216 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.9 m -120.24 164.81 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -61.04 -50.8 71.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -52.1 -45.03 64.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 30.9 mt -65.93 -51.93 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.4 -57.51 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.561 ' HG3' ' CE1' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -40.28 -50.31 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.452 ' HG2' HG23 ' A' ' 161' ' ' VAL . 64.7 mtt180 -62.8 -48.52 78.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -48.72 -41.66 32.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.55 -52.7 11.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.27 -59.65 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.42 -59.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -52.31 -43.95 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 14.3 tpp -53.68 -43.05 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -40.41 -58.26 1.59 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.64 -47.52 75.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -45.79 -55.17 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.559 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 30.1 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.614 0.721 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -50.75 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 80.2 t -47.26 -45.42 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.95 -12.84 84.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.527 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.23 -50.25 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 168' ' ' VAL . 20.0 tp -57.45 -38.06 73.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.474 HE22 HD23 ' A' ' 175' ' ' LEU . 6.2 tp60 -58.8 -27.95 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.83 -46.98 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -58.67 -54.02 51.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 164' ' ' LEU . 5.1 m -40.36 -51.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.465 ' N ' HG23 ' A' ' 168' ' ' VAL . 73.9 t -57.4 -34.08 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.119 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 167' ' ' LEU . 51.6 mt-30 -76.07 -33.43 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.567 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 15.3 mtpp -84.65 -15.14 46.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.21 41.91 7.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.488 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.567 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.9 m0 -118.74 174.3 6.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -102.21 163.64 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.474 HD23 HE22 ' A' ' 165' ' ' GLN . 38.9 mt -37.77 143.21 0.4 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 143.44 51.15 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.308 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -97.04 134.51 40.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.561 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.5 m-85 -132.32 115.21 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 194' ' ' MET . 9.7 m -139.69 131.3 27.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.444 HG11 ' OE2' ' A' ' 183' ' ' GLU . 72.6 t -63.54 112.86 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.531 HG21 ' OG1' ' A' ' 195' ' ' THR . 1.6 t -89.27 -33.63 16.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -150.89 156.74 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.463 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 75.5 mt-10 -140.35 110.99 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.6 t -126.74 171.05 11.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.69 162.75 12.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.53 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.3 Cg_endo -69.78 -179.34 2.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.0 112.39 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.89 28.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.53 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 18.5 p-80 -57.79 -41.34 81.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -127.49 88.87 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -83.47 125.05 31.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 129.63 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.463 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 10.6 m-85 -110.41 118.16 35.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.0 m -93.04 104.11 16.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.408 ' HG3' ' C ' ' A' ' 179' ' ' THR . 5.1 ttp -106.49 141.26 38.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.531 ' OG1' HG21 ' A' ' 181' ' ' THR . 3.4 m -108.33 135.41 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.147 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' CYS . . . . . 0.429 ' SG ' ' CE1' ' A' ' 178' ' ' TYR . 46.6 t -93.58 109.98 21.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -93.85 108.89 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -103.79 157.39 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 43.7 mm-40 -34.01 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.474 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 61.7 mtt180 -118.64 32.23 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.593 ' CD2' HG12 ' A' ' 225' ' ' VAL . 21.3 m-85 -147.64 154.66 40.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.43 ' C ' ' HE1' ' A' ' 221' ' ' MET . 97.6 mt -149.96 136.53 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -146.35 147.45 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 46.4 mt -104.83 126.65 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.32 168.27 18.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.2 m -143.52 160.15 41.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.909 0.385 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -178.3 140.6 4.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -42.42 -43.65 3.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 111.148 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 210' ' ' LYS . 55.8 p -125.64 140.85 52.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 209' ' ' SER . 85.9 mttt -36.54 -46.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -50.75 -51.76 47.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.38 -47.16 71.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -42.6 -46.5 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.2 OUTLIER -54.1 -46.28 72.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.81 -48.8 80.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -55.13 -44.33 74.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -66.9 -52.68 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.078 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.84 -64.06 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -38.18 -63.36 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -46.26 -47.61 18.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.43 ' HE1' ' C ' ' A' ' 202' ' ' ILE . 6.2 tpp -54.34 -43.15 71.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.473 HD23 HD13 ' A' ' 164' ' ' LEU . 64.7 mt -45.26 -60.0 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.09 -44.14 87.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -54.67 -62.76 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 201' ' ' PHE . 19.0 m . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -50.53 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.35 -41.29 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -78.67 -11.97 84.71 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.504 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.69 -48.52 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.087 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.658 ' O ' HG22 ' A' ' 168' ' ' VAL . 17.1 tp -52.35 -33.87 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.435 ' OE1' HD21 ' A' ' 175' ' ' LEU . 15.0 tp60 -60.45 -31.26 70.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.79 -42.37 34.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -64.08 -60.42 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 164' ' ' LEU . 5.4 m -36.34 -49.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.44 ' N ' HG23 ' A' ' 168' ' ' VAL . 48.0 t -59.76 -42.53 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 167' ' ' LEU . 78.2 mt-30 -64.87 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.549 ' HD2' ' CH2' ' A' ' 173' ' ' TRP . 40.1 mttm -99.96 -13.09 19.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.57 40.83 9.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.549 ' CH2' ' HD2' ' A' ' 171' ' ' LYS . 48.5 m0 -115.83 173.7 6.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.766 0.317 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -101.01 173.17 6.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.435 HD21 ' OE1' ' A' ' 165' ' ' GLN . 61.3 mt -49.36 143.58 9.68 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.903 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.39 69.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.37 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -98.7 131.04 45.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.565 ' CD2' ' HE3' ' A' ' 214' ' ' LYS . 70.3 m-85 -121.36 112.86 19.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.7 m -147.04 144.57 29.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 91.7 t -79.62 130.07 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.02 -40.87 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.427 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 31.3 tp60 -140.94 159.52 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.477 ' OE1' ' CE2' ' A' ' 192' ' ' PHE . 25.6 mt-10 -149.61 109.02 3.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.7 t -118.32 172.15 7.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.68 145.9 18.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.498 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.73 -168.42 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.88 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 2.3 p-80 -64.77 -41.53 95.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -117.32 89.85 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -88.24 131.3 34.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -130.51 114.86 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.477 ' CE2' ' OE1' ' A' ' 183' ' ' GLU . 32.1 m-85 -103.91 124.92 49.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -97.71 98.29 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 52.8 ttm -100.67 140.81 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 203' ' ' GLU . 20.3 m -115.39 138.56 50.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 221' ' ' MET . 7.0 t -95.28 117.22 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -98.95 122.92 42.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.2 t -119.65 157.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.489 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 75.2 mm-40 -34.05 -68.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 199' ' ' GLU . 13.4 mmp_? -120.76 32.33 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.579 ' CD2' HG12 ' A' ' 225' ' ' VAL . 28.6 m-85 -146.59 150.44 35.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -150.03 139.05 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 195' ' ' THR . 0.3 OUTLIER -153.64 142.6 21.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.485 ' HA ' HG23 ' A' ' 195' ' ' THR . 74.7 mt -100.87 141.11 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -130.15 173.12 20.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 60.6 p -142.95 146.62 34.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.408 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 208' ' ' THR . . . -168.46 126.62 1.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 207' ' ' GLY . 43.7 p -36.02 -44.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.1 t -118.18 144.53 45.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -44.26 -47.72 9.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -52.85 -46.6 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.2 -46.33 74.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -47.82 -44.46 28.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.565 ' HE3' ' CD2' ' A' ' 178' ' ' TYR . 51.8 tttt -55.49 -44.71 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -69.85 -41.22 75.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -61.83 -42.14 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.512 ' HB1' ' OE2' ' A' ' 203' ' ' GLU . . . -67.12 -54.92 16.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.65 -50.39 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.59 -62.11 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.084 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -51.99 -44.82 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.477 ' CE ' HG23 ' A' ' 198' ' ' VAL . 1.3 ttt -49.93 -40.69 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 71.5 mt -43.4 -52.35 6.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.3 mt -72.28 -48.74 40.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -45.49 -44.13 12.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.579 HG12 ' CD2' ' A' ' 201' ' ' PHE . 10.6 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.432 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 11.8 t30 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.638 0.733 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.74 -47.41 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 0.0 112.349 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.443 HG23 ' HG2' ' A' ' 215' ' ' ARG . 61.6 t -50.28 -37.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.81 -11.81 78.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.451 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.91 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.794 ' O ' HG22 ' A' ' 168' ' ' VAL . 15.2 tp -55.29 -34.48 64.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.536 ' OE1' HD21 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -60.81 -34.13 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -77.37 -49.85 14.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -55.72 -58.41 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.6 m -37.84 -46.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 165' ' ' GLN . 79.8 t -53.56 -46.48 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.17 -37.95 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.543 ' HD2' ' CH2' ' A' ' 173' ' ' TRP . 22.7 mtmm -74.39 -23.59 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.05 35.42 6.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.479 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.543 ' CH2' ' HD2' ' A' ' 171' ' ' LYS . 39.6 m0 -118.44 171.49 8.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -101.85 172.9 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.536 HD21 ' OE1' ' A' ' 165' ' ' GLN . 25.1 mt -43.54 144.08 1.4 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 0.0 110.944 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 155.35 66.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.331 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -93.54 135.5 34.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.572 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 42.7 m-85 -129.24 112.03 13.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.4 m -145.55 142.58 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.421 HG11 ' CG ' ' A' ' 183' ' ' GLU . 99.2 t -77.89 121.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 20.1 p -89.82 -45.8 9.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.419 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 28.4 tt0 -135.86 162.28 33.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.421 ' CG ' HG11 ' A' ' 180' ' ' VAL . 31.8 mt-10 -151.19 113.5 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -136.34 171.65 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.05 146.21 20.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.435 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.75 -164.24 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.705 2.27 . . . . 0.0 112.358 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.21 -38.96 55.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.557 ' CD2' ' H ' ' A' ' 188' ' ' HIS . 9.7 p80 -75.26 -21.85 58.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -131.81 58.18 1.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -68.44 134.95 50.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -137.69 114.68 10.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -107.77 131.66 54.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.0 m -104.05 97.72 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.9 ttm -101.38 135.29 43.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.546 HG23 ' HA ' ' A' ' 204' ' ' ILE . 33.4 m -114.42 136.7 52.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' CYS . . . . . 0.44 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 5.1 t -92.56 113.98 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -96.83 104.78 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.4 t -99.99 157.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.4 mm-40 -34.01 -72.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.0 29.8 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.486 ' CG ' HG12 ' A' ' 225' ' ' VAL . 38.8 m-85 -144.92 151.18 38.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 69.4 mt -149.98 137.27 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 195' ' ' THR . 18.2 tp10 -151.27 133.68 15.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.546 ' HA ' HG23 ' A' ' 195' ' ' THR . 57.9 mt -93.57 136.31 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.56 175.29 16.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 51.7 p -152.44 139.0 18.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.881 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -163.18 143.41 8.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.4 p -42.51 -39.45 2.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 111.155 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.8 m -129.67 148.47 51.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.4 ' HD3' HG21 ' A' ' 180' ' ' VAL . 43.5 mtmt -47.51 -40.1 17.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -56.18 -48.02 77.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.6 mt -70.57 -47.01 62.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -44.88 -52.7 8.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.141 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.572 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 12.9 ttmt -44.89 -46.99 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.443 ' HG2' HG23 ' A' ' 161' ' ' VAL . 46.1 mtt85 -62.17 -47.75 83.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -52.38 -46.14 66.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -68.8 -50.71 47.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -60.85 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 222' ' ' LEU . . . -45.67 -55.79 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -49.79 -41.27 44.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.604 ' O ' HG22 ' A' ' 225' ' ' VAL . 5.2 tpp -61.99 -45.21 94.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 219' ' ' ALA . 73.8 mt -37.07 -47.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.1 mt -77.9 -47.0 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -46.75 -57.36 4.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 221' ' ' MET . 16.8 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.084 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.754 ' N ' HD21 ' A' ' 159' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.63 0.729 . . . . 0.0 110.898 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -50.74 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 94.7 t -49.37 -32.31 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -88.49 -22.69 39.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.42 -54.08 6.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.7 tp -49.1 -38.43 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.561 ' OE1' HD23 ' A' ' 175' ' ' LEU . 35.5 tp60 -60.88 -31.51 70.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -77.3 -35.85 54.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -71.11 -55.89 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 164' ' ' LEU . 7.0 m -41.44 -52.57 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.51 ' H ' HG23 ' A' ' 168' ' ' VAL . 55.7 t -54.27 -36.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -75.32 -37.25 60.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.581 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 27.5 mttt -78.79 -14.87 59.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 39.03 7.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.581 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 36.4 m0 -120.69 171.58 8.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.773 0.321 . . . . 0.0 110.945 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -101.71 168.5 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.561 HD23 ' OE1' ' A' ' 165' ' ' GLN . 26.1 mt -43.65 142.88 1.74 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.56 68.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.329 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.87 127.1 48.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.542 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 75.5 m-85 -122.32 114.72 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.1 m -136.51 130.76 32.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.612 HG21 ' HE2' ' A' ' 210' ' ' LYS . 57.5 t -65.68 111.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.176 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -86.03 -59.09 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -117.18 158.07 24.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -145.62 113.37 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.3 t -133.03 169.89 16.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.86 145.47 19.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.59 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.74 -174.77 0.96 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.704 2.269 . . . . 0.0 112.36 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.06 85.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.59 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 19.2 p-80 -67.34 -39.89 85.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -113.34 51.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -58.28 129.49 42.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.908 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -133.66 116.64 16.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -107.05 128.23 54.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 m -101.96 100.72 11.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.073 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 4.9 ttp -106.37 139.56 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.665 HG23 ' HA ' ' A' ' 204' ' ' ILE . 5.8 m -110.43 140.13 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.56 117.73 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 16.5 ttp85 -99.97 101.58 12.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 37.3 t -96.05 157.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.491 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 11.0 mm-40 -33.75 -69.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.456 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 6.0 ptm180 -119.55 31.87 6.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.608 ' CD2' HG12 ' A' ' 225' ' ' VAL . 22.3 m-85 -147.41 151.91 37.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.0 mt -149.98 135.89 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.43 ' N ' ' HE1' ' A' ' 221' ' ' MET . 6.9 tp10 -150.85 134.92 16.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.665 ' HA ' HG23 ' A' ' 195' ' ' THR . 56.5 mt -86.63 135.82 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.769 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -123.34 169.23 15.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 78.4 p -144.21 143.47 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.87 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.66 132.32 2.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.9 p -38.34 -40.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.153 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 57.9 m -126.15 145.79 50.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.612 ' HE2' HG21 ' A' ' 180' ' ' VAL . 86.5 mttt -39.37 -45.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -56.05 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 22.6 mt -58.92 -43.71 91.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -53.54 -49.16 68.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.542 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 52.5 tttt -50.08 -37.95 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 216' ' ' ASN . 2.4 mtp-105 -68.83 -66.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 215' ' ' ARG . 16.1 t-20 -37.12 -50.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.769 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -61.53 -49.19 77.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.38 -55.82 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.453 ' HA ' HD12 ' A' ' 222' ' ' LEU . . . -45.72 -62.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -46.14 -45.99 16.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.43 ' HE1' ' N ' ' A' ' 203' ' ' GLU . 4.7 tpp -52.73 -43.58 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 219' ' ' ALA . 31.9 mt -43.31 -55.79 3.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.06 -39.03 92.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -55.45 -63.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.608 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.9 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.429 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 3.9 t30 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.624 0.726 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.1 Cg_endo -69.71 -50.41 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.689 2.259 . . . . 0.0 112.374 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.11 -35.16 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.51 -19.51 60.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.74 -55.99 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 168' ' ' VAL . 20.2 tp -49.09 -28.52 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -67.74 -32.38 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -78.88 -38.16 38.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.06 -50.25 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 164' ' ' LEU . 12.5 m -49.38 -44.1 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.402 ' N ' HG23 ' A' ' 168' ' ' VAL . 55.6 t -62.05 -32.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -80.1 -32.29 39.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.572 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 16.2 mtpp -82.95 -17.54 43.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.06 42.37 7.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.572 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.4 m0 -119.43 175.3 5.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.783 0.325 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -103.68 162.72 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.2 mt -38.77 143.29 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.625 0.726 . . . . 0.0 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 155.18 66.47 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.656 2.237 . . . . 0.0 112.382 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.91 141.34 30.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.568 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 65.9 m-85 -134.2 113.33 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 m -148.82 137.44 21.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.17 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.512 HG21 ' HE2' ' A' ' 210' ' ' LYS . 69.0 t -75.54 129.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.412 HG21 ' OG1' ' A' ' 195' ' ' THR . 0.1 OUTLIER -105.47 -35.55 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.444 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 2.9 tp-100 -137.33 154.39 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 2.2 mp0 -143.12 106.64 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -127.63 170.27 12.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 113.26 150.09 10.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.541 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.78 -165.55 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.17 -47.33 14.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.5 p-80 -58.19 -37.88 75.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -135.04 96.76 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -87.12 125.03 33.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.93 130.23 53.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -119.7 128.67 54.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 64.0 m -103.57 101.12 10.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 50.3 ttm -100.78 141.24 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 204' ' ' ILE . 1.6 m -113.53 141.99 46.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' CYS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 7.1 t -102.39 112.23 24.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -95.46 108.67 20.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -100.93 158.19 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.6 mm-40 -33.2 -64.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 3.4 ptm180 -126.67 33.29 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 21.4 m-85 -147.93 158.09 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.0 mt -150.03 139.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.46 128.69 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.564 ' HA ' HG23 ' A' ' 195' ' ' THR . 38.0 mt -87.21 135.45 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -135.3 166.11 24.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 29.9 t -146.93 166.75 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.879 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 178.12 142.73 4.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.7 p -46.07 -32.66 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 111.126 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.7 m -130.86 154.98 47.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.512 ' HE2' HG21 ' A' ' 180' ' ' VAL . 70.6 mttt -50.82 -54.85 20.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -46.23 -38.37 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 213' ' ' ALA . 64.0 mt -72.78 -65.16 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.8 -39.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.568 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 74.8 tttt -61.22 -56.61 18.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -62.11 -28.02 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 -46.37 70.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -65.94 -42.48 89.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.23 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.77 -56.08 13.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -59.14 -35.22 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.42 ' HE2' HG23 ' A' ' 198' ' ' VAL . 5.0 tpp -59.58 -41.42 90.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.452 HD23 HD13 ' A' ' 164' ' ' LEU . 37.4 mt -43.98 -42.55 6.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.59 -43.62 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.959 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -49.48 -54.44 17.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 13.4 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.423 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 14.2 t30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.73 -43.02 2.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.672 2.248 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -51.12 -51.97 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.9 -10.57 80.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.62 -47.15 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 111.079 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 168' ' ' VAL . 29.8 tp -57.55 -26.41 61.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.536 ' OE1' HD23 ' A' ' 175' ' ' LEU . 36.1 tp60 -69.75 -25.25 63.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.07 -29.74 34.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -75.89 -55.91 5.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.5 m -42.36 -50.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 168' ' ' VAL . 51.2 t -57.36 -38.45 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -72.19 -34.53 68.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.577 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 34.1 mttt -82.38 -18.21 42.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.61 40.12 6.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.577 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 42.6 m0 -118.78 176.96 5.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -103.46 173.07 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.839 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.536 HD23 ' OE1' ' A' ' 165' ' ' GLN . 32.3 mt -51.07 143.39 16.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.934 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.15 68.03 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.92 122.26 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.509 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 93.8 m-85 -113.76 114.98 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.416 ' C ' ' HG3' ' A' ' 194' ' ' MET . 4.4 m -140.17 132.05 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.53 119.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.467 HG21 ' OG1' ' A' ' 195' ' ' THR . 2.1 t -97.49 -37.51 9.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 10.8 tp60 -138.3 154.86 49.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.448 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 4.7 mp0 -144.25 108.98 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -125.02 172.13 9.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.26 145.15 16.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.521 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.8 -169.32 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.678 2.252 . . . . 0.0 112.356 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.84 -48.58 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.1 p-80 -59.55 -41.75 90.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -122.62 80.74 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -76.96 140.56 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.22 118.05 15.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -110.63 124.5 52.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 205' ' ' GLY . 88.0 m -102.61 104.63 15.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.416 ' HG3' ' C ' ' A' ' 179' ' ' THR . 4.0 ttp -103.09 145.78 29.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.467 ' OG1' HG21 ' A' ' 181' ' ' THR . 18.2 m -115.46 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.173 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -95.68 116.58 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -96.63 105.73 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 44.8 t -96.71 157.44 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 78.8 mm-40 -33.88 -69.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 78.8 mtt180 -119.32 30.94 6.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 21.7 m-85 -147.3 155.47 42.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.1 mt -149.84 139.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 195' ' ' THR . 45.6 mm-40 -151.58 140.73 21.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.8 mt -103.87 134.02 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 193' ' ' THR . . . -126.3 168.52 18.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.7 p -133.87 151.31 51.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -172.21 136.77 3.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.5 p -45.61 -42.07 10.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 212' ' ' LEU . 1.9 t -125.99 141.23 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -38.73 -48.91 1.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.82 -41.87 45.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 209' ' ' SER . 25.3 mt -75.33 -50.64 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.75 -41.32 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.509 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.1 ttpm? -54.33 -56.82 14.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -57.03 -40.11 76.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -57.66 -45.33 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.29 -51.51 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -47.29 -63.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -39.44 -66.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -41.97 -47.38 4.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.4 ' HE2' HG23 ' A' ' 198' ' ' VAL . 16.7 tpp -56.69 -43.39 80.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 84.6 mt -44.89 -59.16 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.63 -46.81 87.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -48.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.402 HG12 ' CD2' ' A' ' 201' ' ' PHE . 27.9 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.413 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 11.1 t-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.645 0.736 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.75 -50.23 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.683 2.255 . . . . 0.0 112.338 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.14 -41.2 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.59 86.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -96.4 -55.29 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.793 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.7 tp -50.1 -30.06 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.524 ' OE1' HD21 ' A' ' 175' ' ' LEU . 2.8 tp60 -64.78 -34.7 78.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -77.57 -46.11 23.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.0 mt -58.87 -57.43 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.7 m -40.21 -42.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.26 -40.98 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 44.4 mt-30 -70.69 -31.2 68.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.594 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 28.2 mttp -85.02 -15.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.83 8.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.594 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 39.2 m0 -120.85 172.61 7.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -100.5 172.24 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.524 HD21 ' OE1' ' A' ' 165' ' ' GLN . 27.7 mt -46.95 142.6 4.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.527 ' HG3' HD23 ' A' ' 164' ' ' LEU . 54.0 Cg_endo -69.72 145.87 58.69 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.19 146.24 24.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 91.1 m-85 -138.0 117.94 13.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.979 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.1 m -140.25 128.42 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.158 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.92 113.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.5 p -88.51 -56.2 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.43 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 8.7 tp60 -119.88 154.72 33.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.43 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 2.7 mp0 -144.58 114.47 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.1 t -136.51 170.72 15.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.43 145.92 11.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.79 -173.13 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.71 62.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.451 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.0 p-80 -62.57 -38.71 91.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -123.28 83.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -82.19 126.46 32.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.21 124.39 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.18 132.31 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.4 m -107.19 102.71 12.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 8.6 ttp -107.49 139.67 41.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 203' ' ' GLU . 31.1 m -108.04 136.79 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.5 t -93.38 115.1 27.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -94.67 105.5 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.464 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.2 t -97.04 156.59 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.464 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 12.0 mm-40 -34.15 -70.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -117.27 29.93 7.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 30.1 m-85 -145.99 155.65 42.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.832 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -149.23 137.76 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 195' ' ' THR . 4.5 tp10 -150.43 145.44 26.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.18 131.33 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.31 173.75 17.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.7 t -152.14 155.34 37.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.845 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.92 144.09 8.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.1 p -49.38 -26.26 3.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 81.8 p -140.03 145.29 37.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -42.61 -54.42 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -44.82 -39.45 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 215' ' ' ARG . 75.2 mt -76.99 -58.11 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.24 -37.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.411 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 36.7 tttt -64.48 -49.28 72.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 212' ' ' LEU . 12.0 ptt180 -68.9 -30.55 69.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -64.84 -45.77 84.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.52 81.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.078 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.22 66.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.54 -61.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -48.87 -43.26 38.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.497 ' O ' HG22 ' A' ' 225' ' ' VAL . 8.1 tpp -55.2 -43.8 74.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 80.4 mt -38.43 -53.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 24.9 mt -72.89 -38.95 66.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -52.07 -56.62 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.581 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 11.1 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.411 ' HA ' HD11 ' A' ' 222' ' ' LEU . 53.6 Cg_endo -69.79 -44.74 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.96 -48.85 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.99 -11.98 78.99 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.58 -55.38 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.55 HD23 ' HG3' ' A' ' 176' ' ' PRO . 17.1 tp -39.81 -35.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 6.6 tp-100 -55.81 -46.77 77.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.722 ' CG ' HD23 ' A' ' 167' ' ' LEU . 3.9 pt-20 -55.33 -33.99 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.722 HD23 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -70.27 -68.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.9 m -40.1 -45.54 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.1 t -52.31 -53.88 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -64.51 -38.95 92.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -71.25 -24.14 62.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.27 26.85 22.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.463 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -103.09 174.15 5.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 175' ' ' LEU . 35.7 ptt180 -103.58 159.78 15.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 174' ' ' ARG . 21.1 mt -34.25 142.05 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.562 0.696 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.55 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.4 Cg_endo -69.72 156.99 62.0 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -97.42 130.34 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.533 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 54.1 m-85 -124.07 112.79 17.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.3 m -145.34 150.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -82.96 133.04 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 -42.62 5.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 3.3 tp-100 -140.12 150.2 43.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 1.9 mp0 -137.27 107.05 6.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 t -124.33 169.91 11.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.92 144.41 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.77 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.34 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.05 -48.13 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -59.66 -37.47 78.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -125.46 81.69 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -81.44 136.33 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -136.89 114.47 11.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -110.25 130.11 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.3 m -99.79 106.64 18.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 36.2 ttm -108.46 138.87 44.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 203' ' ' GLU . 28.8 m -115.97 137.62 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 52.6 t -94.13 118.04 30.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -101.31 103.16 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.9 t -99.74 158.29 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.51 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 7.6 mm-40 -34.14 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 56.2 mtp180 -113.65 31.67 6.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.476 ' CG ' HG12 ' A' ' 225' ' ' VAL . 23.3 m-85 -146.98 148.92 32.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.6 mt -150.02 139.39 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 195' ' ' THR . 15.7 tt0 -155.77 139.69 16.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.514 ' HA ' HG23 ' A' ' 195' ' ' THR . 21.7 mt -98.33 142.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.16 179.07 18.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' A' ' 216' ' ' ASN . 1.9 m -150.98 161.74 42.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.87 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -175.54 139.59 4.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.7 p -41.78 -40.37 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 31.3 m -126.73 144.02 51.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.847 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -39.91 -49.83 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -52.53 -53.49 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 32.3 mt -57.19 -45.67 83.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 214' ' ' LYS . . . -49.24 -57.91 5.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.533 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.4 ttpm? -35.94 -46.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -68.15 -56.57 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 206' ' ' SER . 16.8 m-80 -38.09 -45.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.12 -46.73 49.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.05 -60.02 4.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.27 -55.0 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -57.56 -42.67 83.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.465 ' HE2' HG23 ' A' ' 198' ' ' VAL . 1.7 tpp -53.2 -45.47 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 160' ' ' PRO . 35.6 mt -42.13 -42.79 3.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.7 mt -78.46 -36.66 45.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -57.67 -60.5 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.476 HG12 ' CG ' ' A' ' 201' ' ' PHE . 30.6 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.597 0.713 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.19 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.64 2.226 . . . . 0.0 112.392 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -45.96 -40.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.55 71.34 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.458 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.04 -50.78 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -49.8 -38.39 34.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.428 ' O ' HG23 ' A' ' 169' ' ' VAL . 5.9 tp60 -52.43 -27.77 17.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.16 -43.66 41.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -62.17 -48.2 81.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 169' ' ' VAL . 17.4 m -60.91 -50.14 81.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.54 ' N ' HG23 ' A' ' 168' ' ' VAL . 26.0 t -56.32 -54.35 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 13.5 pt20 -62.02 -43.19 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.574 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 21.6 mmmt -67.47 -28.38 67.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.96 47.07 3.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.454 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.574 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 41.6 m0 -120.17 178.16 4.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 175' ' ' LEU . 12.3 ptt180 -99.29 148.87 23.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 174' ' ' ARG . 39.7 mt -34.03 142.35 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.596 0.712 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 143.18 49.91 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 0.0 112.349 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -104.11 128.82 51.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.414 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 89.8 m-85 -122.25 115.71 22.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 99.3 m -131.29 131.13 43.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.475 ' CG1' ' HG3' ' A' ' 183' ' ' GLU . 87.3 t -67.88 107.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.7 p -81.95 -59.07 2.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -115.26 151.74 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.475 ' HG3' ' CG1' ' A' ' 180' ' ' VAL . 3.6 mp0 -143.87 113.98 7.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.5 t -133.49 172.34 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.27 145.32 18.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.3 Cg_endo -69.79 -164.76 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.667 2.245 . . . . 0.0 112.325 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.75 -30.5 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 4.8 p-80 -80.61 -24.37 39.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -130.37 52.82 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -55.27 126.24 24.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.64 114.63 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.884 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.08 131.79 54.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.3 m -105.74 102.65 12.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.129 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 8.0 ttp -105.85 139.61 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 203' ' ' GLU . 29.2 m -112.16 138.63 48.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.31 122.79 38.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -104.9 103.6 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 17.7 t -96.97 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.532 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.9 mm-40 -33.51 -68.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -121.47 33.03 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -146.85 152.07 38.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 98.8 mt -149.23 141.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 195' ' ' THR . 13.2 mm-40 -156.48 139.06 15.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.56 134.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -124.3 165.01 17.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.5 p -134.91 138.24 43.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 0.0 110.828 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -158.46 134.64 3.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 208' ' ' THR . 12.2 p -43.13 -34.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 0.0 111.144 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 210' ' ' LYS . 28.6 t -132.43 141.84 49.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.426 ' HG2' HG21 ' A' ' 180' ' ' VAL . 22.9 mtmt -37.6 -57.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -46.01 -42.22 12.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 215' ' ' ARG . 54.1 mt -73.14 -57.03 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -39.71 -31.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.414 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 44.5 tttt -66.1 -45.25 81.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.2 ptt85 -66.39 -40.55 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.15 -50.91 71.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.428 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -59.64 -50.04 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -49.81 64.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.57 -62.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -50.52 -49.02 56.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.465 ' O ' HG22 ' A' ' 225' ' ' VAL . 2.4 tpp -48.62 -46.26 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.1 mt -38.74 -57.69 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.2 mt -63.68 -48.35 77.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -47.74 -63.26 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 221' ' ' MET . 31.1 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.621 0.724 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.362 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.0 t -49.26 -40.04 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.63 -15.51 81.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.51 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.85 -56.85 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.846 ' O ' HG22 ' A' ' 168' ' ' VAL . 36.3 tp -49.75 -30.21 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.5 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -63.39 -33.84 76.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -76.71 -41.56 44.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -64.6 -61.31 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.3 m -37.19 -53.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 165' ' ' GLN . 76.3 t -54.96 -44.1 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -64.81 -34.52 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.561 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 17.7 mtpp -83.34 -12.53 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.17 11.16 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.437 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.561 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 48.8 m0 -116.06 174.38 6.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.753 0.311 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -106.04 164.63 11.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.6 mt -42.52 142.27 1.35 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 110.884 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.83 143.57 50.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.5 128.77 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.556 ' OH ' ' HB2' ' A' ' 218' ' ' ALA . 90.9 m-85 -118.73 115.9 25.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 98.9 m -138.52 128.63 25.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.451 HG12 ' OE2' ' A' ' 183' ' ' GLU . 88.0 t -64.24 115.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.7 p -89.08 -58.9 2.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.438 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 9.0 tp60 -117.7 154.11 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.451 ' OE2' HG12 ' A' ' 180' ' ' VAL . 3.4 mp0 -144.85 114.74 7.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.5 t -136.03 172.42 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.67 144.75 13.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.575 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.75 -174.13 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 0.0 112.352 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.69 -42.69 73.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -66.78 -37.91 85.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -123.83 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -83.29 133.8 34.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -136.37 114.55 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -105.34 140.08 39.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 35.5 m -114.07 98.65 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 6.5 ttp -100.59 141.12 33.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.494 HG23 ' HA ' ' A' ' 204' ' ' ILE . 3.0 m -110.43 133.91 52.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 8.5 t -91.65 114.35 26.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -95.94 109.5 21.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.544 HG23 ' HE2' ' A' ' 221' ' ' MET . 36.9 t -102.17 156.69 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.473 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -33.54 -67.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 45.0 mtp180 -122.47 31.32 6.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 25.7 m-85 -147.34 156.34 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.8 mt -150.0 139.41 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.162 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.475 ' CG ' ' HG3' ' A' ' 224' ' ' ARG . 5.8 mm-40 -150.64 133.73 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.494 ' HA ' HG23 ' A' ' 195' ' ' THR . 35.0 mt -90.68 136.99 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -126.65 155.5 19.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.497 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 p -137.52 145.71 43.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.97 159.81 33.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.8 p -65.94 -12.61 56.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 111.129 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 64.8 p -150.92 154.9 38.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.813 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -49.57 -58.17 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -42.85 -44.66 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 214' ' ' LYS . 44.3 mt -67.57 -65.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.99 -31.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.525 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 73.0 tttt -67.33 -52.59 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.917 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -65.11 -39.21 92.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -57.68 -50.25 73.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.486 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -62.76 -49.55 74.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.081 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.556 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -55.55 -51.0 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.85 -62.19 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -51.97 -39.87 59.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.544 ' HE2' HG23 ' A' ' 198' ' ' VAL . 7.7 tpp -55.05 -41.98 72.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 18.7 mt -44.06 -62.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.7 -42.32 92.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.475 ' HG3' ' CG ' ' A' ' 203' ' ' GLU . 12.4 mmt180 -51.78 -56.12 15.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 21.5 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.75 ' N ' HD21 ' A' ' 159' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.615 0.721 . . . . 0.0 110.859 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -50.36 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.667 2.245 . . . . 0.0 112.359 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.42 -42.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.74 -18.77 78.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.39 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.5 tp -47.91 -39.02 17.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -57.6 -31.06 65.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.956 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -80.39 -46.45 15.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -57.72 -46.94 83.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 164' ' ' LEU . 15.3 m -56.38 -52.48 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.545 ' N ' HG23 ' A' ' 168' ' ' VAL . 43.1 t -54.54 -58.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 15.2 pt20 -54.3 -44.9 72.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 12.1 mtpp -69.5 -25.94 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.4 48.97 3.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.461 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.576 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 45.7 m0 -123.13 178.13 5.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.893 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -99.83 157.21 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.7 mt -39.7 143.99 0.53 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 146.76 61.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.99 141.3 30.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.558 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 69.5 m-85 -133.77 118.43 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 98.5 m -147.72 135.16 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.467 HG11 ' CG ' ' A' ' 183' ' ' GLU . 87.9 t -75.47 118.11 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 57.4 p -88.34 -43.96 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.429 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 12.9 tm0? -135.33 161.3 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.467 ' CG ' HG11 ' A' ' 180' ' ' VAL . 29.1 mt-10 -151.72 113.85 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.1 t -134.39 172.1 13.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.44 145.68 11.67 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.598 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.76 -172.23 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.391 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.4 63.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.5 p-80 -80.55 -31.62 36.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -127.01 83.54 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -83.2 135.72 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -140.44 119.13 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -109.82 134.88 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 10.1 m -99.52 96.52 7.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 45.3 ttm -100.01 134.52 42.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 203' ' ' GLU . 30.6 m -111.63 137.41 49.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.5 t -93.34 119.02 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -103.11 100.01 9.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.9 t -97.0 159.84 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.538 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 29.8 mm-40 -34.3 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.473 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 14.5 mmt85 -113.34 33.07 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.473 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 20.0 m-85 -147.34 147.12 30.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.421 ' O ' ' CD ' ' A' ' 203' ' ' GLU . 77.5 mt -149.99 135.51 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 195' ' ' THR . 6.6 mp0 -153.94 146.54 24.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.445 ' HA ' HG23 ' A' ' 195' ' ' THR . 32.3 mt -101.31 136.61 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.43 -179.37 15.75 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 87.9 p -152.11 144.12 23.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -161.23 134.5 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 22.4 p -40.72 -39.54 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.121 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 45.6 m -128.78 141.9 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.823 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -38.55 -53.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -48.96 -45.12 41.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.9 mt -66.31 -51.65 55.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.62 -56.75 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.558 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 3.2 ttpm? -41.77 -47.13 4.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -67.85 -43.1 80.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.58 -48.31 79.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.86 -50.64 65.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.28 -56.24 23.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.42 -57.04 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -54.92 -42.87 72.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.595 ' O ' HG22 ' A' ' 225' ' ' VAL . 51.3 tpp -53.6 -40.95 66.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 32.0 mt -48.13 -47.72 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.71 -43.39 76.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -56.95 -58.38 8.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 221' ' ' MET . 27.3 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.426 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 8.8 t30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.73 -49.92 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.327 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.8 t -45.91 -32.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.163 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -93.57 -16.03 47.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.47 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.39 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.418 ' O ' HG22 ' A' ' 168' ' ' VAL . 13.7 tp -56.21 -40.21 73.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -57.26 -24.88 57.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.76 -42.19 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.89 -57.57 6.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 169' ' ' VAL . 16.0 m -39.42 -45.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.45 ' N ' HG23 ' A' ' 168' ' ' VAL . 20.2 t -57.44 -40.86 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 9.6 mm100 -76.41 -36.85 57.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.573 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.98 -23.89 58.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.6 39.42 5.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.573 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 12.1 m0 -121.33 168.37 11.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.91 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -98.92 170.41 8.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 37.1 mt -41.22 141.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 148.48 65.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -101.35 131.83 47.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.505 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 88.2 m-85 -123.97 120.01 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.932 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 48.6 m -140.14 129.93 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.26 113.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 68.4 p -82.09 -51.44 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.56 158.73 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -137.58 109.82 7.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.0 t -118.78 170.7 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 100.03 143.69 14.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.465 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.76 -168.18 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.63 2.22 . . . . 0.0 112.347 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.91 43.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -58.61 -41.2 85.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 189' ' ' ARG . 14.3 mtp-105 -120.92 91.73 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.9 137.97 31.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -138.57 119.27 14.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.54 126.2 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.8 m -99.41 97.28 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.9 ttp -101.72 139.32 37.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.868 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 203' ' ' GLU . 31.4 m -111.88 138.18 48.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.21 118.75 30.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.7 ttp85 -100.46 101.57 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 24.9 t -98.48 157.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 61.9 mm-40 -34.1 -72.56 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.21 31.52 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 29.4 m-85 -146.92 150.3 34.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.6 mt -149.68 138.29 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.121 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 195' ' ' THR . 4.5 tm-20 -153.14 146.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.1 136.48 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.64 171.25 17.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 77.8 p -144.22 142.25 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.23 134.6 3.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 30.9 p -40.84 -34.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.18 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.1 m -134.61 150.17 50.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -42.71 -55.75 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -44.05 -37.08 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.4 mt -78.87 -63.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.55 -34.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 43.5 tttt -66.31 -51.96 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.73 -50.77 65.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.9 86.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.15 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -48.29 -56.54 7.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -56.11 -46.5 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.416 ' HE3' ' HB ' ' A' ' 198' ' ' VAL . 7.9 tpp -51.08 -41.26 59.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.42 -53.33 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.88 -37.07 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -54.74 -45.49 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 18.4 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.56 ' N ' HD21 ' A' ' 159' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -50.67 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.378 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.6 t -45.56 -43.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -80.84 -17.35 72.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.544 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.56 6.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.061 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.51 HD23 ' HG3' ' A' ' 176' ' ' PRO . 16.4 tp -45.28 -43.42 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.858 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -50.62 -36.83 37.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -67.71 -44.54 77.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -60.09 -60.29 4.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.1 m -43.9 -39.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 165' ' ' GLN . 92.2 t -59.06 -38.39 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -77.96 -39.3 43.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.566 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.3 mmpt? -72.55 -25.51 61.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.81 43.63 5.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.501 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.566 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 11.0 m0 -121.58 175.35 6.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.32 . . . . 0.0 110.886 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -102.1 164.36 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 mt -38.35 143.28 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.51 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.78 151.55 68.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.645 2.23 . . . . 0.0 112.363 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -92.07 120.18 32.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.583 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 37.6 m-85 -112.25 113.29 25.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.5 m -149.71 146.15 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.557 HG12 ' OE2' ' A' ' 183' ' ' GLU . 62.0 t -81.82 132.67 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.07 -39.25 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -132.32 149.86 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.557 ' OE2' HG12 ' A' ' 180' ' ' VAL . 4.3 mp0 -143.22 111.68 6.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.5 t -128.24 172.25 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.23 145.64 15.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.52 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.76 -168.83 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.724 2.282 . . . . 0.0 112.345 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.33 -52.11 15.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.52 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 30.2 p-80 -57.47 -32.48 67.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -133.68 92.44 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -86.52 135.67 33.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -125.99 114.73 18.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -106.99 139.44 41.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 205' ' ' GLY . 20.1 m -116.85 102.79 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -102.26 148.25 25.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 204' ' ' ILE . 6.8 m -121.75 144.87 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 6.6 t -101.55 110.61 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -96.93 100.05 11.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 31.1 t -95.73 159.19 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 21.7 mm-40 -33.33 -66.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.465 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 66.9 mtt85 -123.92 33.6 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 23.9 m-85 -148.04 154.16 39.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -150.12 139.8 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -150.48 124.48 9.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.485 ' HA ' HG23 ' A' ' 195' ' ' THR . 58.2 mt -90.38 137.28 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 193' ' ' THR . . . -128.26 174.46 18.81 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 158.63 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 179.36 152.93 11.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.1 p -65.51 -23.19 66.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 0.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 150.33 50.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -49.15 -57.02 7.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.58 -40.36 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 213' ' ' ALA . 35.9 mt -70.85 -61.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.17 -44.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.583 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -58.23 -61.66 2.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.2 -26.43 60.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.31 -42.51 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.34 63.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.077 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.473 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -66.8 -53.8 29.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -42.14 -58.4 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -58.46 -44.9 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 13.0 tpp -50.45 -37.2 36.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 47.4 mt -48.63 -58.21 5.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.37 -44.15 97.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -48.22 -54.74 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.414 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.664 0.745 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -50.77 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.269 . . . . 0.0 112.392 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.9 t -47.45 -37.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.53 -19.83 61.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.39 -52.11 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.101 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.5 HD23 ' HG3' ' A' ' 176' ' ' PRO . 34.9 tp -47.99 -28.24 2.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 45.0 tp60 -61.01 -56.17 24.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.707 ' CG ' HD23 ' A' ' 167' ' ' LEU . 5.0 pt-20 -48.58 -32.86 8.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.707 HD23 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -68.81 -68.37 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 3.3 m -40.21 -38.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -57.96 -47.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -71.9 -39.28 69.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.0 mmpt? -70.4 -27.13 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.12 45.06 4.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.492 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.576 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 10.6 m0 -123.89 174.7 7.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.758 0.313 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.72 166.4 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.53 140.65 0.98 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.608 0.718 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.5 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.74 159.31 53.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.329 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -95.53 138.42 33.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.516 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 70.6 m-85 -130.34 107.93 9.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.6 m -144.7 150.7 37.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.52 HG11 ' HG3' ' A' ' 183' ' ' GLU . 25.3 t -85.87 122.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 1.5 t -96.65 -32.35 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.152 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.43 145.67 50.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.52 ' HG3' HG11 ' A' ' 180' ' ' VAL . 1.9 mp0 -144.86 107.02 4.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -135.45 166.1 23.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.12 142.69 10.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.473 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.8 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.256 . . . . 0.0 112.308 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.13 -33.58 65.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.8 p-80 -77.8 -28.9 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -131.04 80.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.74 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -138.62 114.45 9.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -105.83 142.38 35.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -114.55 101.12 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.2 ttm -103.03 143.76 32.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.801 HG23 ' O ' ' A' ' 203' ' ' GLU . 89.1 m -124.05 136.01 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 11.0 t -91.38 111.88 23.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -96.09 110.13 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.0 t -103.64 159.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.53 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.3 mm-40 -34.17 -72.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.11 32.06 6.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -146.63 153.01 39.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.4 mt -150.04 137.23 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.109 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.801 ' O ' HG23 ' A' ' 195' ' ' THR . 29.0 tp10 -148.94 138.0 21.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.417 ' HA ' HG23 ' A' ' 195' ' ' THR . 46.1 mt -99.46 142.29 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -133.87 -179.27 16.24 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 65.7 p -151.52 153.57 34.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.401 . . . . 0.0 110.834 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -171.71 150.46 13.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.5 p -59.5 -34.2 72.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 6.1 m -131.59 144.91 51.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -41.63 -56.67 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -38.1 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.0 mt -75.37 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -39.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.516 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 11.0 tttm -61.14 -55.09 36.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.3 ptt85 -63.17 -30.64 71.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.68 -47.21 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.38 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.22 69.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 222' ' ' LEU . . . -44.83 -58.91 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -56.47 -44.97 81.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 2.9 tpp -51.3 -44.78 62.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 219' ' ' ALA . 26.3 mt -38.65 -56.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -44.38 -57.71 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 59.3 t30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.647 0.736 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 -44.75 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.412 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.455 HG21 ' HD3' ' A' ' 214' ' ' LYS . 64.9 t -48.31 -37.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -86.84 -16.44 61.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.66 -51.76 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.044 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.429 HD13 HD23 ' A' ' 222' ' ' LEU . 15.5 tp -46.03 -42.54 13.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.653 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.0 tp60 -51.83 -34.95 42.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -69.68 -41.19 75.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.23 -59.22 3.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 169' ' ' VAL . 12.9 m -41.11 -51.42 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 165' ' ' GLN . 88.2 t -54.12 -41.77 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -64.52 -45.43 87.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -75.19 -21.52 58.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.62 43.5 4.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.497 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -116.19 172.35 7.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.745 0.307 . . . . 0.0 110.922 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 175' ' ' LEU . 22.5 ptt-85 -101.55 164.22 11.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 174' ' ' ARG . 48.9 mt -36.4 142.34 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.573 0.701 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 146.8 61.1 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.631 2.221 . . . . 0.0 112.335 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.43 137.88 33.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.559 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 94.5 m-85 -127.83 122.15 31.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -149.28 139.6 22.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.148 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.1 t -76.33 126.64 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 67.2 p -94.04 -41.53 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -150.58 164.17 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.81 120.12 12.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.0 t -132.02 166.04 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 146.58 21.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.564 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.4 Cg_endo -69.77 -175.09 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.78 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.564 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.7 p-80 -61.44 -41.77 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -120.06 58.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -64.45 150.94 45.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.9 116.9 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -107.78 127.98 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 22.8 m -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.498 ' HB3' ' HB1' ' A' ' 213' ' ' ALA . 58.7 ttm -101.7 144.9 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 203' ' ' GLU . 18.0 m -122.65 139.06 54.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.7 t -96.67 120.54 37.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -102.51 119.56 39.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.2 t -115.51 157.44 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.492 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.2 mt-10 -33.82 -68.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -120.24 32.37 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 31.8 m-85 -146.43 152.05 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.0 mt -149.99 142.56 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 195' ' ' THR . 9.4 tm-20 -155.64 146.1 21.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.439 ' HA ' HG23 ' A' ' 195' ' ' THR . 53.5 mt -107.88 147.03 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -141.63 170.06 24.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.6 p -142.69 139.82 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.837 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.5 136.27 5.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 p -46.11 -23.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.9 m -142.74 148.75 37.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -42.42 -56.14 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -44.66 -44.26 8.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.3 mt -70.01 -60.84 2.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 194' ' ' MET . . . -35.21 -37.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.559 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 8.1 tttp -66.84 -53.94 27.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -64.56 -28.97 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -66.52 -49.03 67.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.08 -52.02 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -50.88 -44.49 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.5 -64.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -53.43 -33.32 53.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.569 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.6 OUTLIER -62.15 -36.94 83.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.429 HD23 HD13 ' A' ' 164' ' ' LEU . 67.9 mt -49.73 -38.03 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.5 -36.59 20.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -59.18 -50.2 74.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 221' ' ' MET . 28.8 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.429 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 13.1 t30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.654 0.74 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.6 Cg_endo -69.73 -48.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.331 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.6 t -49.29 -48.67 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -70.92 -9.57 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.68 -47.94 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.098 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.749 ' O ' HG22 ' A' ' 168' ' ' VAL . 17.8 tp -60.76 -26.55 67.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.478 ' OE1' HD21 ' A' ' 175' ' ' LEU . 1.2 tp60 -65.19 -31.5 72.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.12 -42.56 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -61.97 -54.04 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.0 m -45.21 -52.53 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.481 ' H ' HG23 ' A' ' 168' ' ' VAL . 69.4 t -52.06 -52.23 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -60.74 -29.4 69.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.531 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 27.1 mttm -85.63 -16.43 39.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.07 36.98 9.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.531 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 38.6 m0 -118.74 176.57 5.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.321 . . . . 0.0 110.88 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -109.05 164.11 12.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.478 HD21 ' OE1' ' A' ' 165' ' ' GLN . 21.4 mt -38.05 142.48 0.45 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.576 0.703 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.625 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.5 Cg_endo -69.75 149.71 67.3 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.357 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.19 139.8 30.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.569 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.4 m-85 -133.43 112.51 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.419 ' C ' ' HG3' ' A' ' 194' ' ' MET . 5.1 m -139.14 128.45 24.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.77 119.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.519 HG21 ' OG1' ' A' ' 195' ' ' THR . 1.5 t -96.32 -32.06 12.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -141.59 149.89 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.9 106.98 6.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.4 t -136.13 171.28 14.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.58 148.38 12.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.413 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.571 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.8 -173.1 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.33 -44.66 51.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.571 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.8 p-80 -61.17 -41.1 96.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -129.81 88.63 2.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -80.6 130.8 35.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -112.39 120.28 41.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -112.33 116.31 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 m -100.34 98.54 9.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.419 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.8 ttp -102.91 143.68 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.519 ' OG1' HG21 ' A' ' 181' ' ' THR . 2.4 m -109.67 140.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 36.1 t -101.61 119.76 39.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -101.08 103.95 15.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.6 t -96.17 159.45 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 50.6 mm-40 -32.96 -69.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -120.44 32.88 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 32.8 m-85 -146.23 154.19 41.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.6 mt -149.82 136.01 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.562 ' OE2' ' HB1' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -151.0 153.08 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 36.8 mt -109.31 130.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -116.76 176.66 16.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.8 p -149.23 144.77 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.64 141.54 7.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.503 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.9 p -54.08 -16.03 1.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 210' ' ' LYS . 3.1 m -149.7 143.84 25.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' SER . 76.0 mttt -37.5 -58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -41.81 -47.11 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 215' ' ' ARG . 35.7 mt -69.65 -59.05 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.25 -35.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.569 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -67.0 -48.68 67.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.6 ptt180 -65.4 -44.5 87.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 215' ' ' ARG . 22.2 t-20 -56.21 -42.67 77.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.562 ' HB1' ' OE2' ' A' ' 203' ' ' GLU . . . -68.83 -48.61 63.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.453 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -58.61 -46.43 87.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.56 -64.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -52.38 -43.88 64.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 222' ' ' LEU . 8.0 tpp -50.95 -47.03 61.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.844 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.503 HD23 HD13 ' A' ' 164' ' ' LEU . 46.6 mt -36.76 -51.59 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.951 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.13 -43.91 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -45.54 -56.72 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.549 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -50.33 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.9 t -45.49 -41.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.141 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.08 -23.82 54.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.42 -58.42 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 111.1 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.43 -40.37 12.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.484 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 6.6 tp60 -56.47 -35.37 67.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.23 -37.06 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -66.44 -49.97 64.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 7.2 m -46.72 -36.18 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.52 -37.68 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -71.72 -40.58 69.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -78.59 -27.95 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.936 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.73 46.36 4.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 30.5 m0 -115.92 175.52 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 175' ' ' LEU . 55.0 mtt180 -100.57 155.13 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 174' ' ' ARG . 30.2 mt -34.39 141.55 0.25 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 152.91 69.35 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.716 2.278 . . . . 0.0 112.336 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -97.16 130.93 44.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.585 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 62.0 m-85 -123.04 109.77 14.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 m -144.54 148.57 34.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.5 t -87.27 122.46 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.0 t -96.62 -28.47 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.432 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 44.2 mt-30 -146.59 163.19 36.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.565 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 41.0 mt-10 -151.88 105.87 3.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.8 t -119.11 172.37 7.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.25 145.08 14.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.577 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.75 -175.33 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.577 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -71.5 -40.77 69.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -117.36 83.97 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -83.31 137.44 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -137.47 126.08 23.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.565 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 4.4 m-85 -117.01 128.5 55.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.2 m -94.39 105.33 17.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 40.5 ttm -105.74 141.79 36.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 203' ' ' GLU . 7.5 m -118.91 134.71 55.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -92.63 108.25 19.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -92.07 102.51 15.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 38.9 t -97.26 157.72 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.486 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 59.6 mm-40 -33.71 -73.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -114.2 30.34 7.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 36.1 m-85 -145.66 153.74 41.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 57.6 mt -149.78 135.49 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 195' ' ' THR . 4.2 tp10 -146.24 143.24 29.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 65.3 mt -108.39 136.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.87 -179.33 16.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.487 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 73.8 p -149.6 144.23 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.832 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -160.61 143.91 9.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.2 p -48.54 -29.38 4.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -141.69 148.37 38.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' LYS . 70.3 mttt -40.55 -67.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.438 ' H ' ' CD ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -35.35 -43.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.93 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.8 mt -72.52 -55.16 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.84 -39.05 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.585 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 5.4 ttmt -57.61 -55.48 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 216' ' ' ASN . 5.0 ptm180 -60.77 -37.39 81.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.448 ' N ' ' HG2' ' A' ' 215' ' ' ARG . 6.3 m-80 -56.91 -49.55 75.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.96 -46.75 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.118 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -49.83 -56.24 11.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -39.47 80.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.938 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 4.9 tpp -55.73 -45.73 77.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 54.4 mt -38.35 -51.73 1.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.7 mt -72.69 -48.49 38.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 224' ' ' ARG . 12.1 mmp_? -39.19 -50.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.574 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.593 ' N ' HD21 ' A' ' 159' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.598 0.713 . . . . 0.0 110.927 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -50.52 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.23 -38.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.7 -19.94 62.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.5 -54.85 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.67 HD13 HD23 ' A' ' 222' ' ' LEU . 15.4 tp -44.67 -42.95 7.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.588 ' O ' HG23 ' A' ' 169' ' ' VAL . 15.5 tp60 -49.99 -35.89 26.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -69.61 -44.47 70.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -60.74 -58.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 5.3 m -42.05 -41.84 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 165' ' ' GLN . 89.7 t -62.2 -37.44 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 167' ' ' LEU . 16.4 mm100 -72.49 -38.79 68.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -80.24 -20.05 45.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.57 44.26 6.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -115.49 178.22 4.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.744 0.307 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.409 ' CD ' ' O ' ' A' ' 175' ' ' LEU . 0.5 OUTLIER -107.3 166.67 10.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.409 ' O ' ' CD ' ' A' ' 174' ' ' ARG . 44.3 mt -45.52 136.16 5.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.581 0.705 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.509 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.7 Cg_endo -69.72 158.13 58.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 0.0 112.348 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -95.77 148.49 22.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.581 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 80.7 m-85 -135.37 112.48 10.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -144.76 143.82 30.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 91.7 t -78.76 127.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.9 p -101.65 -40.74 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -135.75 163.29 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.547 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 73.6 mt-10 -150.82 107.01 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.7 t -123.19 172.19 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.32 145.91 16.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.445 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 53.1 Cg_endo -69.84 -164.47 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.614 2.209 . . . . 0.0 112.326 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.07 -42.93 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.506 ' CD2' ' H ' ' A' ' 188' ' ' HIS . 9.9 p80 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -133.21 49.11 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.05 136.89 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.96 123.4 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.547 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 3.4 m-85 -116.58 129.71 56.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.1 m -94.79 97.8 10.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 47.1 ttm -98.88 136.21 39.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.507 HG23 ' HA ' ' A' ' 204' ' ' ILE . 19.1 m -112.29 134.66 53.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 5.7 t -93.63 117.59 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.4 128.29 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.7 t -122.58 157.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.471 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.6 mm-40 -33.87 -66.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.469 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 20.6 mmm180 -123.21 32.84 5.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.556 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 22.1 m-85 -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.6 mt -150.0 139.8 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 195' ' ' THR . 14.8 tp10 -152.29 137.69 17.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.507 ' HA ' HG23 ' A' ' 195' ' ' THR . 61.4 mt -97.68 137.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.57 174.78 18.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.512 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.8 p -149.76 138.58 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.37 134.12 3.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.514 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.0 p -40.31 -35.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.9 t -132.01 146.17 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -41.46 -57.56 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -43.4 -40.55 3.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.507 HD23 ' HD3' ' A' ' 215' ' ' ARG . 24.4 mt -75.09 -60.24 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.3 -41.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.581 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 79.0 tttt -58.35 -57.41 13.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.507 ' HD3' HD23 ' A' ' 212' ' ' LEU . 5.1 ptm180 -61.13 -32.62 72.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -64.35 -46.37 83.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.71 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.01 92.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.13 -63.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -52.5 -40.29 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.577 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.8 OUTLIER -57.25 -34.92 69.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.67 HD23 HD13 ' A' ' 164' ' ' LEU . 75.2 mt -47.88 -46.91 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.09 -44.89 36.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 -47.21 -56.59 6.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 221' ' ' MET . 29.6 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.548 ' N ' HD21 ' A' ' 159' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.624 0.726 . . . . 0.0 110.894 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -50.34 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.345 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -48.89 -40.31 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.56 61.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.88 -58.88 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.477 HD13 HD23 ' A' ' 222' ' ' LEU . 27.3 tp -41.32 -45.54 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -52.01 -39.4 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.27 -31.62 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -75.3 -62.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.8 m -39.08 -46.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.02 -37.37 77.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 167' ' ' LEU . 32.3 mt-30 -72.22 -35.18 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.586 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 24.0 mmmt -82.96 -22.36 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.83 36.49 7.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.586 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 32.7 m0 -106.78 177.98 4.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 175' ' ' LEU . 83.7 mtt180 -102.28 155.41 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 174' ' ' ARG . 64.9 mt -36.91 142.8 0.35 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.26 50.25 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.429 ' C ' ' OE1' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -94.57 128.81 41.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CE1' ' HG3' ' A' ' 214' ' ' LYS . 87.9 m-85 -118.39 123.99 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 88.4 m -143.89 142.87 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.581 HG11 ' CD ' ' A' ' 183' ' ' GLU . 57.4 t -85.01 119.02 33.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.3 p -90.05 -62.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.424 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 26.4 tp60 -116.65 154.18 30.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.581 ' CD ' HG11 ' A' ' 180' ' ' VAL . 28.3 mt-10 -150.61 108.36 3.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.94 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 t -134.49 172.08 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 111.0 146.14 10.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.578 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.77 177.69 5.34 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.97 99.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 24.4 p-80 -68.34 -41.21 81.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -120.67 78.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -78.02 141.82 38.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -138.05 122.13 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.461 ' CD2' ' HG3' ' A' ' 210' ' ' LYS . 8.7 m-85 -114.45 141.23 47.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 8.7 m -112.84 98.56 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 54.6 ttm -105.67 138.08 42.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 204' ' ' ILE . 9.1 m -114.1 135.14 54.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 10.7 t -93.39 117.5 30.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -98.66 126.42 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.509 HG23 ' SD ' ' A' ' 221' ' ' MET . 17.8 t -122.23 157.78 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 16.1 mm-40 -32.73 -67.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.89 32.02 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.403 ' CD2' HG12 ' A' ' 225' ' ' VAL . 45.3 m-85 -144.91 152.09 39.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.7 mt -149.84 139.7 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -151.04 134.46 16.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.588 ' HA ' HG23 ' A' ' 195' ' ' THR . 14.0 mt -94.9 132.98 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -128.34 168.67 20.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -149.83 170.43 18.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 176.94 171.87 40.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 52.6 p -71.94 -17.96 62.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.4 m -150.54 142.1 23.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.461 ' HG3' ' CD2' ' A' ' 192' ' ' PHE . 8.3 mtmp? -40.49 -50.5 2.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -48.26 -39.97 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.7 mt -74.25 -63.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -38.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' A' ' 178' ' ' TYR . 12.1 tttm -61.4 -54.07 48.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -34.35 76.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.33 -47.1 80.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.28 91.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.448 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -61.62 -48.98 78.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.36 -61.69 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.2 -40.74 71.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' MET . . . . . 0.603 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -57.14 -32.78 66.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.477 HD23 HD13 ' A' ' 164' ' ' LEU . 59.5 mt -52.04 -49.62 63.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.4 mt -73.04 -44.0 61.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.414 ' HB3' ' NH1' ' A' ' 224' ' ' ARG . 2.9 mmm180 -45.91 -53.13 10.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 221' ' ' MET . 18.3 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.9 m -162.54 153.73 17.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.842 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.4 m -134.41 142.84 47.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.66 133.21 8.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t -166.94 131.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 110.886 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.7 t -99.91 -48.31 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.86 149.61 24.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.474 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 111.77 2.91 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.658 2.239 . . . . 0.0 112.307 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.58 130.24 74.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -54.65 144.12 46.09 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.684 0.754 . . . . 0.0 110.855 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 103.26 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.261 . . . . 0.0 112.368 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -72.54 106.41 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -68.87 109.48 3.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 66.8 m -142.13 148.11 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -42.18 161.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 10.1 m -91.33 136.1 33.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -161.59 144.01 8.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.637 0.732 . . . . 0.0 110.83 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -49.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.721 2.281 . . . . 0.0 112.333 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' HG2' ' A' ' 215' ' ' ARG . 85.3 t -47.03 -36.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.22 -18.76 62.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.64 -53.67 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.717 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.3 tp -50.61 -28.86 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.422 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -70.05 -30.07 67.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -81.8 -43.09 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -62.52 -54.06 45.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.8 m -41.97 -54.23 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.55 ' H ' HG23 ' A' ' 168' ' ' VAL . 60.0 t -52.62 -36.86 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -72.81 -31.48 64.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.584 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 40.7 mttm -85.83 -20.69 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.47 36.27 7.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.584 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 43.9 m0 -114.31 172.82 6.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -101.47 162.53 12.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 24.9 mt -41.21 144.86 0.64 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.428 ' HG3' HD23 ' A' ' 164' ' ' LEU . 54.4 Cg_endo -69.71 152.52 69.56 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.718 2.278 . . . . 0.0 112.383 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -97.81 127.84 44.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 214' ' ' LYS . 40.8 m-85 -113.65 117.38 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.951 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.2 m -145.37 135.77 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.143 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.7 t -77.53 122.24 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.0 p -92.58 -60.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.415 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 18.4 tt0 -119.08 160.41 22.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.415 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 3.7 mp0 -144.57 114.04 7.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -134.61 167.74 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.46 149.26 9.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.593 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.1 Cg_endo -69.72 -169.22 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.6 16.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.593 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 15.6 p-80 -59.94 -35.15 74.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -134.47 91.79 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -87.12 146.69 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -138.7 123.92 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -108.29 135.34 49.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 37.7 m -99.24 97.83 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.0 ttm -100.2 138.93 36.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 204' ' ' ILE . 17.6 m -116.2 136.88 52.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 53.2 t -93.2 115.22 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.841 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -98.53 102.7 14.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 32.4 t -95.78 157.31 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -34.38 -65.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 5.9 ptm180 -122.92 31.06 6.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.559 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 23.6 m-85 -146.74 155.49 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.4 mt -150.01 141.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -153.17 122.8 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.575 ' HA ' HG23 ' A' ' 195' ' ' THR . 59.8 mt -84.99 140.29 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.183 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -140.01 165.59 25.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 62.4 m -143.38 150.86 39.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.52 140.5 6.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 76.3 p -38.07 -44.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.823 0.344 . . . . 0.0 111.216 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.9 m -120.24 164.81 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -61.04 -50.8 71.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -52.1 -45.03 64.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 30.9 mt -65.93 -51.93 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.4 -57.51 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.561 ' HG3' ' CE1' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -40.28 -50.31 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.452 ' HG2' HG23 ' A' ' 161' ' ' VAL . 64.7 mtt180 -62.8 -48.52 78.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -48.72 -41.66 32.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.55 -52.7 11.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.27 -59.65 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.42 -59.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -52.31 -43.95 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 14.3 tpp -53.68 -43.05 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -40.41 -58.26 1.59 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.64 -47.52 75.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -45.79 -55.17 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.559 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 30.1 m -72.51 -34.99 49.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.3 t -54.08 -65.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 173.24 -80.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 134.21 27.5 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.745 2.297 . . . . 0.0 112.38 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.4 t -119.08 96.73 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.7 t -78.08 108.81 11.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.885 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.1 t -163.44 129.1 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.864 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.5 t -160.47 150.38 17.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.803 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 105.22 138.53 9.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 t -160.1 146.91 16.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.859 0.362 . . . . 0.0 110.862 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 21.4 m -76.46 122.35 24.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.844 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -157.86 68.06 0.28 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 136.2 32.47 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.669 2.246 . . . . 0.0 112.384 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.74 HG12 ' HD3' ' A' ' 153' ' ' PRO . 87.5 t -56.18 117.99 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.129 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.1 t -115.45 80.07 7.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.663 0.744 . . . . 0.0 110.859 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.74 ' HD3' HG12 ' A' ' 151' ' ' VAL . 53.5 Cg_endo -69.78 157.32 60.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.693 2.262 . . . . 0.0 112.323 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -167.68 145.56 4.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -121.11 169.67 10.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 46.2 p -112.43 40.47 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -83.17 -57.57 3.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 69.4 m -54.1 137.28 40.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.34 143.72 0.79 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 110.912 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -50.75 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 80.2 t -47.26 -45.42 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.95 -12.84 84.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.527 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.23 -50.25 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 168' ' ' VAL . 20.0 tp -57.45 -38.06 73.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.474 HE22 HD23 ' A' ' 175' ' ' LEU . 6.2 tp60 -58.8 -27.95 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.83 -46.98 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -58.67 -54.02 51.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 164' ' ' LEU . 5.1 m -40.36 -51.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.465 ' N ' HG23 ' A' ' 168' ' ' VAL . 73.9 t -57.4 -34.08 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.119 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 167' ' ' LEU . 51.6 mt-30 -76.07 -33.43 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.567 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 15.3 mtpp -84.65 -15.14 46.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.21 41.91 7.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.488 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.567 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.9 m0 -118.74 174.3 6.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -102.21 163.64 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.474 HD23 HE22 ' A' ' 165' ' ' GLN . 38.9 mt -37.77 143.21 0.4 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 143.44 51.15 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.308 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -97.04 134.51 40.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.561 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.5 m-85 -132.32 115.21 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 194' ' ' MET . 9.7 m -139.69 131.3 27.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.444 HG11 ' OE2' ' A' ' 183' ' ' GLU . 72.6 t -63.54 112.86 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.531 HG21 ' OG1' ' A' ' 195' ' ' THR . 1.6 t -89.27 -33.63 16.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -150.89 156.74 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.463 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 75.5 mt-10 -140.35 110.99 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.6 t -126.74 171.05 11.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.69 162.75 12.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.53 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.3 Cg_endo -69.78 -179.34 2.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.0 112.39 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.89 28.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.53 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 18.5 p-80 -57.79 -41.34 81.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -127.49 88.87 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -83.47 125.05 31.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 129.63 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.463 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 10.6 m-85 -110.41 118.16 35.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.0 m -93.04 104.11 16.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.408 ' HG3' ' C ' ' A' ' 179' ' ' THR . 5.1 ttp -106.49 141.26 38.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.531 ' OG1' HG21 ' A' ' 181' ' ' THR . 3.4 m -108.33 135.41 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.147 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' CYS . . . . . 0.429 ' SG ' ' CE1' ' A' ' 178' ' ' TYR . 46.6 t -93.58 109.98 21.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -93.85 108.89 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -103.79 157.39 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 43.7 mm-40 -34.01 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.474 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 61.7 mtt180 -118.64 32.23 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.593 ' CD2' HG12 ' A' ' 225' ' ' VAL . 21.3 m-85 -147.64 154.66 40.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.43 ' C ' ' HE1' ' A' ' 221' ' ' MET . 97.6 mt -149.96 136.53 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -146.35 147.45 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 46.4 mt -104.83 126.65 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.32 168.27 18.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.2 m -143.52 160.15 41.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.909 0.385 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -178.3 140.6 4.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -42.42 -43.65 3.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 111.148 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 210' ' ' LYS . 55.8 p -125.64 140.85 52.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 209' ' ' SER . 85.9 mttt -36.54 -46.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -50.75 -51.76 47.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.38 -47.16 71.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -42.6 -46.5 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.2 OUTLIER -54.1 -46.28 72.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.81 -48.8 80.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -55.13 -44.33 74.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -66.9 -52.68 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.078 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.84 -64.06 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -38.18 -63.36 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -46.26 -47.61 18.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.43 ' HE1' ' C ' ' A' ' 202' ' ' ILE . 6.2 tpp -54.34 -43.15 71.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.473 HD23 HD13 ' A' ' 164' ' ' LEU . 64.7 mt -45.26 -60.0 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.09 -44.14 87.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -54.67 -62.76 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 201' ' ' PHE . 19.0 m -61.57 -37.42 77.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -75.92 165.79 24.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -58.78 151.73 32.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -25.05 29.19 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.66 2.24 . . . . 0.0 112.34 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 m -51.29 121.43 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 68.5 p -108.83 157.75 18.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.861 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.459 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 91.5 p -111.58 -45.99 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.1 t 49.4 42.84 22.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.836 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.73 138.28 12.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.6 m -136.22 166.26 23.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.8 m -150.61 159.63 44.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -173.69 146.25 8.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 141.16 44.37 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 p -134.73 141.34 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.123 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.4 p -138.95 144.21 40.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.669 0.747 . . . . 0.0 110.817 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 158.88 55.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.654 2.236 . . . . 0.0 112.345 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -86.24 -55.43 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -74.98 145.32 42.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 57.4 m -101.32 105.17 16.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -161.83 160.82 28.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.9 t -107.81 138.38 44.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.92 144.05 1.75 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -50.53 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.35 -41.29 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -78.67 -11.97 84.71 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.504 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.69 -48.52 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.087 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.658 ' O ' HG22 ' A' ' 168' ' ' VAL . 17.1 tp -52.35 -33.87 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.435 ' OE1' HD21 ' A' ' 175' ' ' LEU . 15.0 tp60 -60.45 -31.26 70.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.79 -42.37 34.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -64.08 -60.42 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 164' ' ' LEU . 5.4 m -36.34 -49.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.44 ' N ' HG23 ' A' ' 168' ' ' VAL . 48.0 t -59.76 -42.53 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 167' ' ' LEU . 78.2 mt-30 -64.87 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.549 ' HD2' ' CH2' ' A' ' 173' ' ' TRP . 40.1 mttm -99.96 -13.09 19.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.57 40.83 9.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.549 ' CH2' ' HD2' ' A' ' 171' ' ' LYS . 48.5 m0 -115.83 173.7 6.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.766 0.317 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -101.01 173.17 6.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.435 HD21 ' OE1' ' A' ' 165' ' ' GLN . 61.3 mt -49.36 143.58 9.68 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.903 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.39 69.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.37 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -98.7 131.04 45.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.565 ' CD2' ' HE3' ' A' ' 214' ' ' LYS . 70.3 m-85 -121.36 112.86 19.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.7 m -147.04 144.57 29.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 91.7 t -79.62 130.07 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.02 -40.87 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.427 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 31.3 tp60 -140.94 159.52 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.477 ' OE1' ' CE2' ' A' ' 192' ' ' PHE . 25.6 mt-10 -149.61 109.02 3.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.7 t -118.32 172.15 7.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.68 145.9 18.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.498 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.73 -168.42 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.88 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 2.3 p-80 -64.77 -41.53 95.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -117.32 89.85 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -88.24 131.3 34.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -130.51 114.86 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.477 ' CE2' ' OE1' ' A' ' 183' ' ' GLU . 32.1 m-85 -103.91 124.92 49.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -97.71 98.29 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 52.8 ttm -100.67 140.81 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 203' ' ' GLU . 20.3 m -115.39 138.56 50.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 221' ' ' MET . 7.0 t -95.28 117.22 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -98.95 122.92 42.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.2 t -119.65 157.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.489 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 75.2 mm-40 -34.05 -68.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 199' ' ' GLU . 13.4 mmp_? -120.76 32.33 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.579 ' CD2' HG12 ' A' ' 225' ' ' VAL . 28.6 m-85 -146.59 150.44 35.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -150.03 139.05 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 195' ' ' THR . 0.3 OUTLIER -153.64 142.6 21.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.485 ' HA ' HG23 ' A' ' 195' ' ' THR . 74.7 mt -100.87 141.11 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -130.15 173.12 20.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 60.6 p -142.95 146.62 34.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.408 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 208' ' ' THR . . . -168.46 126.62 1.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 207' ' ' GLY . 43.7 p -36.02 -44.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.1 t -118.18 144.53 45.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -44.26 -47.72 9.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -52.85 -46.6 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.2 -46.33 74.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -47.82 -44.46 28.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.565 ' HE3' ' CD2' ' A' ' 178' ' ' TYR . 51.8 tttt -55.49 -44.71 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -69.85 -41.22 75.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -61.83 -42.14 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.512 ' HB1' ' OE2' ' A' ' 203' ' ' GLU . . . -67.12 -54.92 16.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.65 -50.39 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.59 -62.11 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.084 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -51.99 -44.82 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.477 ' CE ' HG23 ' A' ' 198' ' ' VAL . 1.3 ttt -49.93 -40.69 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 71.5 mt -43.4 -52.35 6.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.3 mt -72.28 -48.74 40.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -45.49 -44.13 12.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.579 HG12 ' CD2' ' A' ' 201' ' ' PHE . 10.6 m -82.87 -34.6 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 20.1 t -69.38 111.33 5.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.65 157.21 45.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 141.52 45.32 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.323 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.4 t -98.22 -61.46 1.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.7 m -113.84 -61.3 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.542 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.0 p -67.14 136.51 55.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 110.877 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.9 t -142.85 139.22 30.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.16 -50.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.552 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 52.2 p -61.94 -47.88 82.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.0 110.864 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.9 m -72.48 103.1 3.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.95 156.55 15.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.62 12.3 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.664 2.243 . . . . 0.0 112.34 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 151' ' ' VAL . 13.8 p -161.99 124.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 61.5 p -122.04 144.12 40.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.907 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 135.8 31.42 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -83.6 151.62 25.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 156' ' ' SER . 38.0 mt-30 -127.77 108.44 10.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 155' ' ' GLN . 6.2 m -35.44 -40.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.07 100.54 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.915 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 32.0 p -70.99 143.16 50.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.432 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 11.8 t30 -171.25 141.2 1.33 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.638 0.733 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.74 -47.41 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 0.0 112.349 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.443 HG23 ' HG2' ' A' ' 215' ' ' ARG . 61.6 t -50.28 -37.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.81 -11.81 78.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.451 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.91 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.794 ' O ' HG22 ' A' ' 168' ' ' VAL . 15.2 tp -55.29 -34.48 64.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.536 ' OE1' HD21 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -60.81 -34.13 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -77.37 -49.85 14.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -55.72 -58.41 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.6 m -37.84 -46.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 165' ' ' GLN . 79.8 t -53.56 -46.48 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.17 -37.95 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.543 ' HD2' ' CH2' ' A' ' 173' ' ' TRP . 22.7 mtmm -74.39 -23.59 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.05 35.42 6.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.479 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.543 ' CH2' ' HD2' ' A' ' 171' ' ' LYS . 39.6 m0 -118.44 171.49 8.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -101.85 172.9 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.536 HD21 ' OE1' ' A' ' 165' ' ' GLN . 25.1 mt -43.54 144.08 1.4 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 0.0 110.944 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 155.35 66.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.331 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -93.54 135.5 34.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.572 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 42.7 m-85 -129.24 112.03 13.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.4 m -145.55 142.58 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.421 HG11 ' CG ' ' A' ' 183' ' ' GLU . 99.2 t -77.89 121.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 20.1 p -89.82 -45.8 9.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.419 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 28.4 tt0 -135.86 162.28 33.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.421 ' CG ' HG11 ' A' ' 180' ' ' VAL . 31.8 mt-10 -151.19 113.5 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -136.34 171.65 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.05 146.21 20.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.435 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.75 -164.24 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.705 2.27 . . . . 0.0 112.358 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.21 -38.96 55.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.557 ' CD2' ' H ' ' A' ' 188' ' ' HIS . 9.7 p80 -75.26 -21.85 58.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -131.81 58.18 1.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -68.44 134.95 50.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -137.69 114.68 10.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -107.77 131.66 54.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.0 m -104.05 97.72 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.9 ttm -101.38 135.29 43.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.546 HG23 ' HA ' ' A' ' 204' ' ' ILE . 33.4 m -114.42 136.7 52.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' CYS . . . . . 0.44 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 5.1 t -92.56 113.98 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -96.83 104.78 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.4 t -99.99 157.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.4 mm-40 -34.01 -72.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.0 29.8 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.486 ' CG ' HG12 ' A' ' 225' ' ' VAL . 38.8 m-85 -144.92 151.18 38.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 69.4 mt -149.98 137.27 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 195' ' ' THR . 18.2 tp10 -151.27 133.68 15.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.546 ' HA ' HG23 ' A' ' 195' ' ' THR . 57.9 mt -93.57 136.31 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.56 175.29 16.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 51.7 p -152.44 139.0 18.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.881 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -163.18 143.41 8.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.4 p -42.51 -39.45 2.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 111.155 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.8 m -129.67 148.47 51.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.4 ' HD3' HG21 ' A' ' 180' ' ' VAL . 43.5 mtmt -47.51 -40.1 17.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -56.18 -48.02 77.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.6 mt -70.57 -47.01 62.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -44.88 -52.7 8.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.141 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.572 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 12.9 ttmt -44.89 -46.99 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.443 ' HG2' HG23 ' A' ' 161' ' ' VAL . 46.1 mtt85 -62.17 -47.75 83.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -52.38 -46.14 66.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -68.8 -50.71 47.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -60.85 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 222' ' ' LEU . . . -45.67 -55.79 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -49.79 -41.27 44.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.604 ' O ' HG22 ' A' ' 225' ' ' VAL . 5.2 tpp -61.99 -45.21 94.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 219' ' ' ALA . 73.8 mt -37.07 -47.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.1 mt -77.9 -47.0 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -46.75 -57.36 4.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 221' ' ' MET . 16.8 m -67.47 -25.77 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.084 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 m -85.26 89.5 7.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -51.52 -94.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 123.06 9.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.3 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 140.16 47.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 54.6 m -90.87 54.93 2.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.435 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.0 t -145.14 139.39 27.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.815 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.6 p -92.41 41.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.84 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.17 127.71 0.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 t -94.37 143.39 26.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.826 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 t -125.4 108.72 11.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.99 146.22 16.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.55 14.32 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.338 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 151' ' ' VAL . 21.1 m -91.85 124.64 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.8 m -67.38 144.09 97.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.896 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 128.98 16.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.671 2.247 . . . . 0.0 112.373 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -124.08 89.05 3.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -108.9 144.5 36.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.9 p -108.23 47.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -95.79 -53.38 3.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 25.0 p -51.54 154.92 1.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -67.66 142.98 96.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.63 0.729 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -50.74 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 94.7 t -49.37 -32.31 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -88.49 -22.69 39.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.42 -54.08 6.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.7 tp -49.1 -38.43 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.561 ' OE1' HD23 ' A' ' 175' ' ' LEU . 35.5 tp60 -60.88 -31.51 70.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -77.3 -35.85 54.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -71.11 -55.89 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 164' ' ' LEU . 7.0 m -41.44 -52.57 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.51 ' H ' HG23 ' A' ' 168' ' ' VAL . 55.7 t -54.27 -36.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -75.32 -37.25 60.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.581 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 27.5 mttt -78.79 -14.87 59.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 39.03 7.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.581 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 36.4 m0 -120.69 171.58 8.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.773 0.321 . . . . 0.0 110.945 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -101.71 168.5 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.561 HD23 ' OE1' ' A' ' 165' ' ' GLN . 26.1 mt -43.65 142.88 1.74 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.56 68.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.329 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.87 127.1 48.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.542 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 75.5 m-85 -122.32 114.72 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.1 m -136.51 130.76 32.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.612 HG21 ' HE2' ' A' ' 210' ' ' LYS . 57.5 t -65.68 111.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.176 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -86.03 -59.09 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -117.18 158.07 24.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -145.62 113.37 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.3 t -133.03 169.89 16.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.86 145.47 19.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.59 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.74 -174.77 0.96 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.704 2.269 . . . . 0.0 112.36 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.06 85.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.59 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 19.2 p-80 -67.34 -39.89 85.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -113.34 51.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -58.28 129.49 42.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.908 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -133.66 116.64 16.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -107.05 128.23 54.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 m -101.96 100.72 11.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.073 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 4.9 ttp -106.37 139.56 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.665 HG23 ' HA ' ' A' ' 204' ' ' ILE . 5.8 m -110.43 140.13 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.56 117.73 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 16.5 ttp85 -99.97 101.58 12.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 37.3 t -96.05 157.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.491 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 11.0 mm-40 -33.75 -69.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.456 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 6.0 ptm180 -119.55 31.87 6.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.608 ' CD2' HG12 ' A' ' 225' ' ' VAL . 22.3 m-85 -147.41 151.91 37.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.0 mt -149.98 135.89 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.43 ' N ' ' HE1' ' A' ' 221' ' ' MET . 6.9 tp10 -150.85 134.92 16.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.665 ' HA ' HG23 ' A' ' 195' ' ' THR . 56.5 mt -86.63 135.82 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.769 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -123.34 169.23 15.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 78.4 p -144.21 143.47 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.87 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.66 132.32 2.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.9 p -38.34 -40.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.153 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 57.9 m -126.15 145.79 50.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.612 ' HE2' HG21 ' A' ' 180' ' ' VAL . 86.5 mttt -39.37 -45.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -56.05 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 22.6 mt -58.92 -43.71 91.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -53.54 -49.16 68.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.542 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 52.5 tttt -50.08 -37.95 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 216' ' ' ASN . 2.4 mtp-105 -68.83 -66.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 215' ' ' ARG . 16.1 t-20 -37.12 -50.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.769 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -61.53 -49.19 77.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.38 -55.82 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.453 ' HA ' HD12 ' A' ' 222' ' ' LEU . . . -45.72 -62.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -46.14 -45.99 16.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.43 ' HE1' ' N ' ' A' ' 203' ' ' GLU . 4.7 tpp -52.73 -43.58 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 219' ' ' ALA . 31.9 mt -43.31 -55.79 3.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.06 -39.03 92.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -55.45 -63.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.608 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.9 m -66.3 -32.37 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t -49.87 165.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -151.08 83.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.496 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -4.21 13.61 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 97.3 p -49.74 126.68 14.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.8 m -105.74 154.47 20.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.5 t -113.04 85.32 2.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 0.0 110.879 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t 67.34 47.45 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.52 111.05 0.45 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -57.25 134.81 56.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 149' ' ' GLY . 15.4 m 57.44 43.35 23.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 148' ' ' SER . . . 34.0 -96.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.53 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.431 ' N ' ' O ' ' A' ' 148' ' ' SER . 53.7 Cg_endo -69.74 108.57 2.1 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.665 2.243 . . . . 0.0 112.382 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.32 156.55 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.0 m -50.58 144.54 12.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.675 0.75 . . . . 0.0 110.855 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -22.55 31.79 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.318 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -56.9 126.8 28.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 156' ' ' SER . 19.4 mt-30 -134.26 137.2 44.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 155' ' ' GLN . 1.1 t -34.7 -58.54 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.816 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -148.56 154.04 39.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -89.73 136.33 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.429 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 3.9 t30 -162.64 141.19 6.7 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.624 0.726 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.1 Cg_endo -69.71 -50.41 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.689 2.259 . . . . 0.0 112.374 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.11 -35.16 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.51 -19.51 60.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.74 -55.99 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 168' ' ' VAL . 20.2 tp -49.09 -28.52 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -67.74 -32.38 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -78.88 -38.16 38.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.06 -50.25 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 164' ' ' LEU . 12.5 m -49.38 -44.1 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.402 ' N ' HG23 ' A' ' 168' ' ' VAL . 55.6 t -62.05 -32.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -80.1 -32.29 39.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.572 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 16.2 mtpp -82.95 -17.54 43.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.06 42.37 7.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.572 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.4 m0 -119.43 175.3 5.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.783 0.325 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -103.68 162.72 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.2 mt -38.77 143.29 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.625 0.726 . . . . 0.0 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 155.18 66.47 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.656 2.237 . . . . 0.0 112.382 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.91 141.34 30.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.568 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 65.9 m-85 -134.2 113.33 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 m -148.82 137.44 21.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.17 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.512 HG21 ' HE2' ' A' ' 210' ' ' LYS . 69.0 t -75.54 129.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.412 HG21 ' OG1' ' A' ' 195' ' ' THR . 0.1 OUTLIER -105.47 -35.55 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.444 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 2.9 tp-100 -137.33 154.39 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 2.2 mp0 -143.12 106.64 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -127.63 170.27 12.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 113.26 150.09 10.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.541 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.78 -165.55 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.17 -47.33 14.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.5 p-80 -58.19 -37.88 75.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -135.04 96.76 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -87.12 125.03 33.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.93 130.23 53.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -119.7 128.67 54.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 64.0 m -103.57 101.12 10.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 50.3 ttm -100.78 141.24 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 204' ' ' ILE . 1.6 m -113.53 141.99 46.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' CYS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 7.1 t -102.39 112.23 24.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -95.46 108.67 20.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -100.93 158.19 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.6 mm-40 -33.2 -64.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 3.4 ptm180 -126.67 33.29 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 21.4 m-85 -147.93 158.09 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.0 mt -150.03 139.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.46 128.69 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.564 ' HA ' HG23 ' A' ' 195' ' ' THR . 38.0 mt -87.21 135.45 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -135.3 166.11 24.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 29.9 t -146.93 166.75 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.879 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 178.12 142.73 4.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.7 p -46.07 -32.66 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 111.126 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.7 m -130.86 154.98 47.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.512 ' HE2' HG21 ' A' ' 180' ' ' VAL . 70.6 mttt -50.82 -54.85 20.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -46.23 -38.37 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 213' ' ' ALA . 64.0 mt -72.78 -65.16 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.8 -39.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.568 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 74.8 tttt -61.22 -56.61 18.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -62.11 -28.02 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 -46.37 70.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -65.94 -42.48 89.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.23 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.77 -56.08 13.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -59.14 -35.22 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.42 ' HE2' HG23 ' A' ' 198' ' ' VAL . 5.0 tpp -59.58 -41.42 90.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.452 HD23 HD13 ' A' ' 164' ' ' LEU . 37.4 mt -43.98 -42.55 6.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.59 -43.62 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.959 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -49.48 -54.44 17.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 13.4 m -64.47 -35.4 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.6 p -72.9 121.91 20.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.23 84.35 0.77 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.465 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 154.34 67.88 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.73 2.287 . . . . 0.0 112.344 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 27.7 m -54.32 -51.25 65.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.822 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.1 t -129.38 -62.3 0.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 25.4 p -128.95 -49.88 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.1 p -55.72 105.9 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.07 114.19 3.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 t -99.36 101.94 13.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 110.837 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.2 p -113.46 154.5 26.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -137.02 66.1 0.55 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 174.95 8.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.56 122.73 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -156.97 149.06 17.58 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.656 0.741 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 106.7 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.348 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -101.58 117.63 35.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 53.43 46.91 25.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.6 m -91.23 -44.2 9.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -58.51 -51.68 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 20.7 p -62.24 144.77 55.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.423 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 14.2 t30 -70.14 140.34 88.12 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.73 -43.02 2.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.672 2.248 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -51.12 -51.97 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.9 -10.57 80.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.62 -47.15 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 111.079 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 168' ' ' VAL . 29.8 tp -57.55 -26.41 61.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.536 ' OE1' HD23 ' A' ' 175' ' ' LEU . 36.1 tp60 -69.75 -25.25 63.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.07 -29.74 34.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -75.89 -55.91 5.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.5 m -42.36 -50.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 168' ' ' VAL . 51.2 t -57.36 -38.45 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -72.19 -34.53 68.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.577 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 34.1 mttt -82.38 -18.21 42.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.61 40.12 6.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.577 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 42.6 m0 -118.78 176.96 5.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -103.46 173.07 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.839 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.536 HD23 ' OE1' ' A' ' 165' ' ' GLN . 32.3 mt -51.07 143.39 16.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.934 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.15 68.03 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.92 122.26 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.509 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 93.8 m-85 -113.76 114.98 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.416 ' C ' ' HG3' ' A' ' 194' ' ' MET . 4.4 m -140.17 132.05 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.53 119.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.467 HG21 ' OG1' ' A' ' 195' ' ' THR . 2.1 t -97.49 -37.51 9.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 10.8 tp60 -138.3 154.86 49.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.448 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 4.7 mp0 -144.25 108.98 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -125.02 172.13 9.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.26 145.15 16.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.521 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.8 -169.32 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.678 2.252 . . . . 0.0 112.356 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.84 -48.58 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.1 p-80 -59.55 -41.75 90.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -122.62 80.74 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -76.96 140.56 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.22 118.05 15.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -110.63 124.5 52.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 205' ' ' GLY . 88.0 m -102.61 104.63 15.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.416 ' HG3' ' C ' ' A' ' 179' ' ' THR . 4.0 ttp -103.09 145.78 29.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.467 ' OG1' HG21 ' A' ' 181' ' ' THR . 18.2 m -115.46 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.173 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -95.68 116.58 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -96.63 105.73 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 44.8 t -96.71 157.44 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 78.8 mm-40 -33.88 -69.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 78.8 mtt180 -119.32 30.94 6.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 21.7 m-85 -147.3 155.47 42.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.1 mt -149.84 139.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 195' ' ' THR . 45.6 mm-40 -151.58 140.73 21.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.8 mt -103.87 134.02 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 193' ' ' THR . . . -126.3 168.52 18.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.7 p -133.87 151.31 51.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -172.21 136.77 3.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.5 p -45.61 -42.07 10.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 212' ' ' LEU . 1.9 t -125.99 141.23 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -38.73 -48.91 1.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.82 -41.87 45.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 209' ' ' SER . 25.3 mt -75.33 -50.64 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.75 -41.32 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.509 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.1 ttpm? -54.33 -56.82 14.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -57.03 -40.11 76.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -57.66 -45.33 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.29 -51.51 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -47.29 -63.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -39.44 -66.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -41.97 -47.38 4.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.4 ' HE2' HG23 ' A' ' 198' ' ' VAL . 16.7 tpp -56.69 -43.39 80.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.459 ' O ' ' CB ' ' A' ' 226' ' ' SER . 84.6 mt -44.89 -59.16 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.63 -46.81 87.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -48.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.402 HG12 ' CD2' ' A' ' 201' ' ' PHE . 27.9 m -65.75 -31.49 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 222' ' ' LEU . 21.3 t -81.86 103.99 11.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.59 75.67 0.42 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.475 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -25.44 28.49 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.642 2.228 . . . . 0.0 112.344 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.1 t -114.09 152.35 31.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 66.4 m -87.96 176.28 7.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.2 p -124.13 141.35 52.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.0 m -148.39 148.0 29.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.77 -178.29 46.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.8 m -64.67 84.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.858 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.6 m -173.55 170.22 4.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 175.48 146.55 5.89 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 161.81 44.49 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.692 2.262 . . . . 0.0 112.347 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -166.51 132.71 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.159 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.2 p -110.88 145.0 31.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.658 0.742 . . . . 0.0 110.876 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 143.87 52.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -104.62 145.61 30.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.09 -67.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 69.5 m -80.97 136.1 35.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -48.44 -43.03 34.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.4 m -68.07 121.19 15.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.413 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 11.1 t-20 -171.05 139.85 1.27 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.645 0.736 . . . . 0.0 110.852 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.75 -50.23 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.683 2.255 . . . . 0.0 112.338 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.14 -41.2 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.59 86.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -96.4 -55.29 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.793 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.7 tp -50.1 -30.06 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.524 ' OE1' HD21 ' A' ' 175' ' ' LEU . 2.8 tp60 -64.78 -34.7 78.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -77.57 -46.11 23.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.0 mt -58.87 -57.43 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.7 m -40.21 -42.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.26 -40.98 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 44.4 mt-30 -70.69 -31.2 68.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.594 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 28.2 mttp -85.02 -15.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.83 8.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.594 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 39.2 m0 -120.85 172.61 7.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -100.5 172.24 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.524 HD21 ' OE1' ' A' ' 165' ' ' GLN . 27.7 mt -46.95 142.6 4.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.527 ' HG3' HD23 ' A' ' 164' ' ' LEU . 54.0 Cg_endo -69.72 145.87 58.69 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.19 146.24 24.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 91.1 m-85 -138.0 117.94 13.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.979 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.1 m -140.25 128.42 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.158 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.92 113.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.5 p -88.51 -56.2 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.43 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 8.7 tp60 -119.88 154.72 33.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.43 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 2.7 mp0 -144.58 114.47 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.1 t -136.51 170.72 15.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.43 145.92 11.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.79 -173.13 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.71 62.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.451 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.0 p-80 -62.57 -38.71 91.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -123.28 83.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -82.19 126.46 32.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.21 124.39 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.18 132.31 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.4 m -107.19 102.71 12.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 8.6 ttp -107.49 139.67 41.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 203' ' ' GLU . 31.1 m -108.04 136.79 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.5 t -93.38 115.1 27.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -94.67 105.5 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.464 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.2 t -97.04 156.59 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.464 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 12.0 mm-40 -34.15 -70.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -117.27 29.93 7.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 30.1 m-85 -145.99 155.65 42.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.832 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -149.23 137.76 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 195' ' ' THR . 4.5 tp10 -150.43 145.44 26.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.18 131.33 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.31 173.75 17.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.7 t -152.14 155.34 37.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.845 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.92 144.09 8.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.1 p -49.38 -26.26 3.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 81.8 p -140.03 145.29 37.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -42.61 -54.42 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -44.82 -39.45 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 215' ' ' ARG . 75.2 mt -76.99 -58.11 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.24 -37.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.411 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 36.7 tttt -64.48 -49.28 72.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 212' ' ' LEU . 12.0 ptt180 -68.9 -30.55 69.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -64.84 -45.77 84.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.52 81.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.078 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.22 66.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.54 -61.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -48.87 -43.26 38.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.497 ' O ' HG22 ' A' ' 225' ' ' VAL . 8.1 tpp -55.2 -43.8 74.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 80.4 mt -38.43 -53.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 24.9 mt -72.89 -38.95 66.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -52.07 -56.62 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.581 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 11.1 m -71.34 -31.32 43.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 26.1 t -71.75 154.45 41.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.823 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -102.44 -78.86 1.34 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.508 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 124.36 11.02 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.697 2.265 . . . . 0.0 112.332 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 59.9 p -151.05 123.54 8.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 88.4 p -115.53 170.36 8.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.5 p -39.91 127.9 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -157.45 118.66 3.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -139.43 -157.3 7.24 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.526 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 79.7 p -103.44 125.41 50.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.2 p -104.19 -0.66 28.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.64 83.87 1.76 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 170.68 16.03 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.372 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 78.9 t -124.31 128.08 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.133 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.3 t -168.54 142.44 2.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.651 0.739 . . . . 0.0 110.851 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.47 34.39 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.708 2.272 . . . . 0.0 112.346 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -60.78 -48.53 81.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -85.13 110.74 19.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 t -75.88 82.09 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.846 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -39.3 -50.81 2.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.832 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 19.3 t -60.44 123.57 17.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.841 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -40.09 155.21 0.18 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.411 ' HA ' HD11 ' A' ' 222' ' ' LEU . 53.6 Cg_endo -69.79 -44.74 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.96 -48.85 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.99 -11.98 78.99 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.58 -55.38 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.55 HD23 ' HG3' ' A' ' 176' ' ' PRO . 17.1 tp -39.81 -35.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 6.6 tp-100 -55.81 -46.77 77.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.722 ' CG ' HD23 ' A' ' 167' ' ' LEU . 3.9 pt-20 -55.33 -33.99 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.722 HD23 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -70.27 -68.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.9 m -40.1 -45.54 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.1 t -52.31 -53.88 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -64.51 -38.95 92.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -71.25 -24.14 62.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.27 26.85 22.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.463 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -103.09 174.15 5.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 175' ' ' LEU . 35.7 ptt180 -103.58 159.78 15.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 174' ' ' ARG . 21.1 mt -34.25 142.05 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.562 0.696 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.55 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.4 Cg_endo -69.72 156.99 62.0 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -97.42 130.34 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.533 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 54.1 m-85 -124.07 112.79 17.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.3 m -145.34 150.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -82.96 133.04 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 -42.62 5.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 3.3 tp-100 -140.12 150.2 43.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 1.9 mp0 -137.27 107.05 6.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 t -124.33 169.91 11.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.92 144.41 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.77 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.34 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.05 -48.13 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -59.66 -37.47 78.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -125.46 81.69 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -81.44 136.33 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -136.89 114.47 11.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -110.25 130.11 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.3 m -99.79 106.64 18.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 36.2 ttm -108.46 138.87 44.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 203' ' ' GLU . 28.8 m -115.97 137.62 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 52.6 t -94.13 118.04 30.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -101.31 103.16 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.9 t -99.74 158.29 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.51 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 7.6 mm-40 -34.14 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 56.2 mtp180 -113.65 31.67 6.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.476 ' CG ' HG12 ' A' ' 225' ' ' VAL . 23.3 m-85 -146.98 148.92 32.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.6 mt -150.02 139.39 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 195' ' ' THR . 15.7 tt0 -155.77 139.69 16.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.514 ' HA ' HG23 ' A' ' 195' ' ' THR . 21.7 mt -98.33 142.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.16 179.07 18.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' A' ' 216' ' ' ASN . 1.9 m -150.98 161.74 42.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.87 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -175.54 139.59 4.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.7 p -41.78 -40.37 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 31.3 m -126.73 144.02 51.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.847 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -39.91 -49.83 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -52.53 -53.49 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 32.3 mt -57.19 -45.67 83.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 214' ' ' LYS . . . -49.24 -57.91 5.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.533 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.4 ttpm? -35.94 -46.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -68.15 -56.57 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 206' ' ' SER . 16.8 m-80 -38.09 -45.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.12 -46.73 49.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.05 -60.02 4.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.27 -55.0 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -57.56 -42.67 83.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.465 ' HE2' HG23 ' A' ' 198' ' ' VAL . 1.7 tpp -53.2 -45.47 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 160' ' ' PRO . 35.6 mt -42.13 -42.79 3.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.7 mt -78.46 -36.66 45.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -57.67 -60.5 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.476 HG12 ' CG ' ' A' ' 201' ' ' PHE . 30.6 m -72.35 -37.61 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.402 ' O ' ' HD3' ' A' ' 228' ' ' PRO . 2.0 t -126.14 96.64 4.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.63 83.81 0.36 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 226' ' ' SER . 53.8 Cg_endo -69.79 114.87 3.85 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.353 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 10.5 t -139.54 146.67 40.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.826 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.5 m -81.54 93.83 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.843 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.4 p -134.59 145.62 48.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.904 0.383 . . . . 0.0 110.837 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -56.48 147.57 21.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.2 65.86 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.7 t -153.4 176.85 11.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.85 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.0 p -79.87 2.87 21.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 138.98 145.49 4.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 100.82 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.335 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 151' ' ' VAL . 7.4 p -38.65 117.97 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.8 m -107.5 81.5 1.1 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.605 0.717 . . . . 0.0 110.837 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.443 ' HD3' HG22 ' A' ' 151' ' ' VAL . 53.8 Cg_endo -69.8 120.16 6.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.624 2.216 . . . . 0.0 112.369 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -115.93 132.59 56.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -85.93 141.33 29.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.3 m -132.47 -55.03 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.08 -36.07 67.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 46.8 t -59.4 133.62 56.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.83 143.01 8.66 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 0.0 110.93 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.19 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.64 2.226 . . . . 0.0 112.392 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -45.96 -40.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.55 71.34 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.458 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.04 -50.78 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -49.8 -38.39 34.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.428 ' O ' HG23 ' A' ' 169' ' ' VAL . 5.9 tp60 -52.43 -27.77 17.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.16 -43.66 41.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -62.17 -48.2 81.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 169' ' ' VAL . 17.4 m -60.91 -50.14 81.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.54 ' N ' HG23 ' A' ' 168' ' ' VAL . 26.0 t -56.32 -54.35 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 13.5 pt20 -62.02 -43.19 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.574 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 21.6 mmmt -67.47 -28.38 67.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.96 47.07 3.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.454 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.574 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 41.6 m0 -120.17 178.16 4.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 175' ' ' LEU . 12.3 ptt180 -99.29 148.87 23.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 174' ' ' ARG . 39.7 mt -34.03 142.35 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.596 0.712 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 143.18 49.91 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 0.0 112.349 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -104.11 128.82 51.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.414 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 89.8 m-85 -122.25 115.71 22.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 99.3 m -131.29 131.13 43.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.475 ' CG1' ' HG3' ' A' ' 183' ' ' GLU . 87.3 t -67.88 107.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.7 p -81.95 -59.07 2.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -115.26 151.74 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.475 ' HG3' ' CG1' ' A' ' 180' ' ' VAL . 3.6 mp0 -143.87 113.98 7.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.5 t -133.49 172.34 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.27 145.32 18.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.3 Cg_endo -69.79 -164.76 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.667 2.245 . . . . 0.0 112.325 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.75 -30.5 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 4.8 p-80 -80.61 -24.37 39.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -130.37 52.82 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -55.27 126.24 24.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.64 114.63 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.884 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.08 131.79 54.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.3 m -105.74 102.65 12.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.129 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 8.0 ttp -105.85 139.61 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 203' ' ' GLU . 29.2 m -112.16 138.63 48.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.31 122.79 38.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -104.9 103.6 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 17.7 t -96.97 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.532 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.9 mm-40 -33.51 -68.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -121.47 33.03 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -146.85 152.07 38.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 98.8 mt -149.23 141.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 195' ' ' THR . 13.2 mm-40 -156.48 139.06 15.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.56 134.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -124.3 165.01 17.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.5 p -134.91 138.24 43.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 0.0 110.828 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -158.46 134.64 3.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 208' ' ' THR . 12.2 p -43.13 -34.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 0.0 111.144 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 210' ' ' LYS . 28.6 t -132.43 141.84 49.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.426 ' HG2' HG21 ' A' ' 180' ' ' VAL . 22.9 mtmt -37.6 -57.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -46.01 -42.22 12.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 215' ' ' ARG . 54.1 mt -73.14 -57.03 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -39.71 -31.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.414 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 44.5 tttt -66.1 -45.25 81.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.2 ptt85 -66.39 -40.55 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.15 -50.91 71.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.428 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -59.64 -50.04 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -49.81 64.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.57 -62.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -50.52 -49.02 56.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.465 ' O ' HG22 ' A' ' 225' ' ' VAL . 2.4 tpp -48.62 -46.26 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.1 mt -38.74 -57.69 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.2 mt -63.68 -48.35 77.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -47.74 -63.26 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 221' ' ' MET . 31.1 m -63.63 -27.83 43.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.3 t -42.75 126.87 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -124.89 -160.19 10.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -174.69 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.669 2.246 . . . . 0.0 112.375 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.2 t -62.05 103.53 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.0 m 53.42 44.4 30.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.528 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.2 p -109.31 -43.54 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.872 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.3 t -117.28 137.28 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.83 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.45 -156.21 15.76 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.534 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -122.07 -59.36 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 53.8 m -115.04 142.03 47.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.823 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -151.07 -91.8 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.468 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 136.25 32.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.672 2.248 . . . . 0.0 112.342 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.67 141.09 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.112 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.3 m -142.92 143.77 26.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.697 0.76 . . . . 0.0 110.878 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 138.74 38.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.368 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -60.26 144.1 51.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -105.07 170.61 7.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 t -82.32 -57.0 3.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.82 141.67 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 60.6 m -103.44 136.82 42.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -133.48 144.2 51.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.362 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.0 t -49.26 -40.04 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.63 -15.51 81.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.51 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.85 -56.85 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.846 ' O ' HG22 ' A' ' 168' ' ' VAL . 36.3 tp -49.75 -30.21 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.5 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -63.39 -33.84 76.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -76.71 -41.56 44.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -64.6 -61.31 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.3 m -37.19 -53.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 165' ' ' GLN . 76.3 t -54.96 -44.1 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -64.81 -34.52 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.561 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 17.7 mtpp -83.34 -12.53 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.17 11.16 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.437 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.561 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 48.8 m0 -116.06 174.38 6.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.753 0.311 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -106.04 164.63 11.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.6 mt -42.52 142.27 1.35 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 110.884 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.83 143.57 50.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.5 128.77 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.556 ' OH ' ' HB2' ' A' ' 218' ' ' ALA . 90.9 m-85 -118.73 115.9 25.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 98.9 m -138.52 128.63 25.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.451 HG12 ' OE2' ' A' ' 183' ' ' GLU . 88.0 t -64.24 115.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.7 p -89.08 -58.9 2.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.438 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 9.0 tp60 -117.7 154.11 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.451 ' OE2' HG12 ' A' ' 180' ' ' VAL . 3.4 mp0 -144.85 114.74 7.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.5 t -136.03 172.42 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.67 144.75 13.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.575 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.75 -174.13 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 0.0 112.352 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.69 -42.69 73.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -66.78 -37.91 85.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -123.83 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -83.29 133.8 34.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -136.37 114.55 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -105.34 140.08 39.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 35.5 m -114.07 98.65 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 6.5 ttp -100.59 141.12 33.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.494 HG23 ' HA ' ' A' ' 204' ' ' ILE . 3.0 m -110.43 133.91 52.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 8.5 t -91.65 114.35 26.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -95.94 109.5 21.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.544 HG23 ' HE2' ' A' ' 221' ' ' MET . 36.9 t -102.17 156.69 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.473 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -33.54 -67.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 45.0 mtp180 -122.47 31.32 6.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 25.7 m-85 -147.34 156.34 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.8 mt -150.0 139.41 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.162 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.475 ' CG ' ' HG3' ' A' ' 224' ' ' ARG . 5.8 mm-40 -150.64 133.73 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.494 ' HA ' HG23 ' A' ' 195' ' ' THR . 35.0 mt -90.68 136.99 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -126.65 155.5 19.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.497 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 p -137.52 145.71 43.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.97 159.81 33.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.8 p -65.94 -12.61 56.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 111.129 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 64.8 p -150.92 154.9 38.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.813 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -49.57 -58.17 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -42.85 -44.66 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 214' ' ' LYS . 44.3 mt -67.57 -65.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.99 -31.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.525 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 73.0 tttt -67.33 -52.59 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.917 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -65.11 -39.21 92.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -57.68 -50.25 73.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.486 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -62.76 -49.55 74.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.081 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.556 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -55.55 -51.0 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.85 -62.19 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -51.97 -39.87 59.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.544 ' HE2' HG23 ' A' ' 198' ' ' VAL . 7.7 tpp -55.05 -41.98 72.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 18.7 mt -44.06 -62.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.7 -42.32 92.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.475 ' HG3' ' CG ' ' A' ' 203' ' ' GLU . 12.4 mmt180 -51.78 -56.12 15.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 21.5 m -69.55 -36.31 70.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 7.4 p -60.81 172.48 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.97 -94.94 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -25.99 27.99 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.343 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 31.9 t -50.71 134.99 24.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.806 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.5 m -48.37 155.27 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.877 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.499 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.4 t -48.34 145.16 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.837 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 m -77.36 155.87 31.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.856 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -95.93 71.05 0.92 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.504 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 146' ' ' GLY . 35.5 p 34.69 44.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 95.1 p -137.87 108.95 6.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -125.42 145.88 15.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.48 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 115.06 3.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.683 2.256 . . . . 0.0 112.373 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 86.1 t -95.44 121.89 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.5 p -71.92 148.2 91.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 122.54 9.21 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.346 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -59.0 -42.8 90.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -145.01 111.38 5.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 t -88.25 97.72 11.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -82.07 45.78 0.96 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.2 p -104.03 172.77 6.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -91.83 144.81 29.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.615 0.721 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -50.36 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.667 2.245 . . . . 0.0 112.359 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.42 -42.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.74 -18.77 78.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.39 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.5 tp -47.91 -39.02 17.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -57.6 -31.06 65.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.956 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -80.39 -46.45 15.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -57.72 -46.94 83.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 164' ' ' LEU . 15.3 m -56.38 -52.48 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.545 ' N ' HG23 ' A' ' 168' ' ' VAL . 43.1 t -54.54 -58.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 15.2 pt20 -54.3 -44.9 72.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 12.1 mtpp -69.5 -25.94 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.4 48.97 3.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.461 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.576 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 45.7 m0 -123.13 178.13 5.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.893 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -99.83 157.21 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.7 mt -39.7 143.99 0.53 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 146.76 61.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.99 141.3 30.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.558 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 69.5 m-85 -133.77 118.43 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 98.5 m -147.72 135.16 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.467 HG11 ' CG ' ' A' ' 183' ' ' GLU . 87.9 t -75.47 118.11 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 57.4 p -88.34 -43.96 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.429 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 12.9 tm0? -135.33 161.3 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.467 ' CG ' HG11 ' A' ' 180' ' ' VAL . 29.1 mt-10 -151.72 113.85 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.1 t -134.39 172.1 13.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.44 145.68 11.67 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.598 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.76 -172.23 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.391 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.4 63.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.5 p-80 -80.55 -31.62 36.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -127.01 83.54 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -83.2 135.72 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -140.44 119.13 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -109.82 134.88 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 10.1 m -99.52 96.52 7.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 45.3 ttm -100.01 134.52 42.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 203' ' ' GLU . 30.6 m -111.63 137.41 49.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.5 t -93.34 119.02 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -103.11 100.01 9.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.9 t -97.0 159.84 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.538 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 29.8 mm-40 -34.3 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.473 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 14.5 mmt85 -113.34 33.07 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.473 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 20.0 m-85 -147.34 147.12 30.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.421 ' O ' ' CD ' ' A' ' 203' ' ' GLU . 77.5 mt -149.99 135.51 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 195' ' ' THR . 6.6 mp0 -153.94 146.54 24.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.445 ' HA ' HG23 ' A' ' 195' ' ' THR . 32.3 mt -101.31 136.61 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.43 -179.37 15.75 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 87.9 p -152.11 144.12 23.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -161.23 134.5 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 22.4 p -40.72 -39.54 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.121 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 45.6 m -128.78 141.9 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.823 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -38.55 -53.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -48.96 -45.12 41.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.9 mt -66.31 -51.65 55.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.62 -56.75 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.558 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 3.2 ttpm? -41.77 -47.13 4.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -67.85 -43.1 80.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.58 -48.31 79.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.86 -50.64 65.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.28 -56.24 23.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.42 -57.04 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -54.92 -42.87 72.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.595 ' O ' HG22 ' A' ' 225' ' ' VAL . 51.3 tpp -53.6 -40.95 66.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 32.0 mt -48.13 -47.72 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.71 -43.39 76.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -56.95 -58.38 8.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 221' ' ' MET . 27.3 m -62.98 -29.07 46.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 95.4 p -157.06 117.65 3.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 171.63 -93.37 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 90.21 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.727 2.285 . . . . 0.0 112.316 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 21.6 t -113.16 -61.27 1.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 28.8 t -130.98 96.63 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.875 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.461 180.0 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 21.2 t -54.57 151.09 8.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.867 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 p -132.81 -55.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.888 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.58 -163.56 12.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.427 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.0 p -161.23 139.23 9.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.827 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.4 t -153.23 157.29 40.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.75 145.74 23.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.465 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 105.07 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 0.0 112.336 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.6 p -90.87 122.44 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.141 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.9 p -71.18 144.05 89.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.681 0.753 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 154' ' ' GLN . 53.3 Cg_endo -69.77 -1.04 7.8 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 0.0 112.315 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 153' ' ' PRO . 77.9 mm-40 -35.38 108.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.401 ' C ' ' OE1' ' A' ' 155' ' ' GLN . 2.5 tm0? -165.79 140.82 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.6 p -171.05 148.56 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 50.22 32.69 6.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 2.8 t -101.68 148.26 25.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.426 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 8.8 t30 -68.73 140.42 91.82 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.73 -49.92 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.327 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.8 t -45.91 -32.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.163 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -93.57 -16.03 47.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.47 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.39 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.418 ' O ' HG22 ' A' ' 168' ' ' VAL . 13.7 tp -56.21 -40.21 73.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -57.26 -24.88 57.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.76 -42.19 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.89 -57.57 6.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 169' ' ' VAL . 16.0 m -39.42 -45.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.45 ' N ' HG23 ' A' ' 168' ' ' VAL . 20.2 t -57.44 -40.86 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 9.6 mm100 -76.41 -36.85 57.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.573 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.98 -23.89 58.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.6 39.42 5.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.573 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 12.1 m0 -121.33 168.37 11.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.91 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -98.92 170.41 8.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 37.1 mt -41.22 141.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 148.48 65.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -101.35 131.83 47.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.505 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 88.2 m-85 -123.97 120.01 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.932 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 48.6 m -140.14 129.93 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.26 113.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 68.4 p -82.09 -51.44 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.56 158.73 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -137.58 109.82 7.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.0 t -118.78 170.7 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 100.03 143.69 14.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.465 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.76 -168.18 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.63 2.22 . . . . 0.0 112.347 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.91 43.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -58.61 -41.2 85.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 189' ' ' ARG . 14.3 mtp-105 -120.92 91.73 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.9 137.97 31.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -138.57 119.27 14.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.54 126.2 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.8 m -99.41 97.28 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.9 ttp -101.72 139.32 37.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.868 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 203' ' ' GLU . 31.4 m -111.88 138.18 48.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.21 118.75 30.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.7 ttp85 -100.46 101.57 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 24.9 t -98.48 157.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 61.9 mm-40 -34.1 -72.56 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.21 31.52 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 29.4 m-85 -146.92 150.3 34.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.6 mt -149.68 138.29 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.121 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 195' ' ' THR . 4.5 tm-20 -153.14 146.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.1 136.48 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.64 171.25 17.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 77.8 p -144.22 142.25 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.23 134.6 3.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 30.9 p -40.84 -34.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.18 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.1 m -134.61 150.17 50.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -42.71 -55.75 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -44.05 -37.08 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.4 mt -78.87 -63.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.55 -34.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 43.5 tttt -66.31 -51.96 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.73 -50.77 65.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.9 86.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.15 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -48.29 -56.54 7.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -56.11 -46.5 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.416 ' HE3' ' HB ' ' A' ' 198' ' ' VAL . 7.9 tpp -51.08 -41.26 59.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.42 -53.33 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.88 -37.07 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -54.74 -45.49 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 18.4 m -80.25 -34.36 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.4 m -89.1 80.45 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 76.59 164.4 18.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 155.9 64.8 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 44.9 t -43.09 -49.7 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 50.6 m -93.62 133.36 37.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.844 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.465 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.7 t 61.51 44.43 9.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.2 t -79.75 -43.83 21.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.52 86.67 0.25 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.522 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -88.87 -55.95 3.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 110.883 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.5 t 55.07 25.04 6.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -120.45 -79.91 0.59 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 126.05 12.85 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.36 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.8 t -118.2 138.58 48.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 m -136.55 144.04 45.64 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.644 0.735 . . . . 0.0 110.877 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 133.76 26.49 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 0.0 112.322 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.28 166.27 18.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.936 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -118.5 -17.92 9.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.4 m -79.01 152.94 30.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.69 157.02 28.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.87 132.81 33.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -65.98 140.56 97.15 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -50.67 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.378 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.6 t -45.56 -43.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -80.84 -17.35 72.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.544 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.56 6.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.061 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.51 HD23 ' HG3' ' A' ' 176' ' ' PRO . 16.4 tp -45.28 -43.42 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.858 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -50.62 -36.83 37.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -67.71 -44.54 77.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -60.09 -60.29 4.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.1 m -43.9 -39.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 165' ' ' GLN . 92.2 t -59.06 -38.39 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -77.96 -39.3 43.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.566 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.3 mmpt? -72.55 -25.51 61.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.81 43.63 5.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.501 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.566 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 11.0 m0 -121.58 175.35 6.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.32 . . . . 0.0 110.886 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -102.1 164.36 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 mt -38.35 143.28 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.51 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.78 151.55 68.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.645 2.23 . . . . 0.0 112.363 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -92.07 120.18 32.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.583 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 37.6 m-85 -112.25 113.29 25.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.5 m -149.71 146.15 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.557 HG12 ' OE2' ' A' ' 183' ' ' GLU . 62.0 t -81.82 132.67 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.07 -39.25 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -132.32 149.86 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.557 ' OE2' HG12 ' A' ' 180' ' ' VAL . 4.3 mp0 -143.22 111.68 6.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.5 t -128.24 172.25 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.23 145.64 15.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.52 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.76 -168.83 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.724 2.282 . . . . 0.0 112.345 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.33 -52.11 15.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.52 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 30.2 p-80 -57.47 -32.48 67.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -133.68 92.44 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -86.52 135.67 33.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -125.99 114.73 18.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -106.99 139.44 41.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 205' ' ' GLY . 20.1 m -116.85 102.79 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -102.26 148.25 25.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 204' ' ' ILE . 6.8 m -121.75 144.87 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 6.6 t -101.55 110.61 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -96.93 100.05 11.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 31.1 t -95.73 159.19 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 21.7 mm-40 -33.33 -66.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.465 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 66.9 mtt85 -123.92 33.6 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 23.9 m-85 -148.04 154.16 39.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -150.12 139.8 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -150.48 124.48 9.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.485 ' HA ' HG23 ' A' ' 195' ' ' THR . 58.2 mt -90.38 137.28 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 193' ' ' THR . . . -128.26 174.46 18.81 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 158.63 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 179.36 152.93 11.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.1 p -65.51 -23.19 66.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 0.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 150.33 50.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -49.15 -57.02 7.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.58 -40.36 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 213' ' ' ALA . 35.9 mt -70.85 -61.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.17 -44.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.583 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -58.23 -61.66 2.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.2 -26.43 60.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.31 -42.51 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.34 63.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.077 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.473 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -66.8 -53.8 29.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -42.14 -58.4 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -58.46 -44.9 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 13.0 tpp -50.45 -37.2 36.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 47.4 mt -48.63 -58.21 5.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.37 -44.15 97.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -48.22 -54.74 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.414 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.1 m -74.78 -34.01 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.3 t -42.23 -57.22 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 168.74 162.32 20.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.503 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 229' ' ' SER . 53.5 Cg_endo -69.76 -22.58 31.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.696 2.264 . . . . 0.0 112.309 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 228' ' ' PRO . 98.8 p -37.62 -59.57 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.7 m -52.3 -61.53 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.482 179.996 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.9 t -118.76 131.22 56.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.37 . . . . 0.0 110.874 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.1 t -64.17 83.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.87 40.49 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.455 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.0 m -143.83 173.98 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 0.0 110.842 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 89.0 p -170.04 163.2 9.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.836 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 131.95 146.23 5.68 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 -176.38 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.713 2.275 . . . . 0.0 112.365 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.6 p -173.81 144.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.8 m -164.42 144.17 6.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 137.46 35.47 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.691 2.261 . . . . 0.0 112.353 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -94.79 81.51 3.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -160.79 140.1 10.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 19.1 m -63.25 -63.17 1.27 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.33 151.19 5.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 63.9 m -58.5 161.5 4.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.37 143.05 47.67 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.664 0.745 . . . . 0.0 110.894 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -50.77 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.269 . . . . 0.0 112.392 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.9 t -47.45 -37.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.53 -19.83 61.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.39 -52.11 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.101 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.5 HD23 ' HG3' ' A' ' 176' ' ' PRO . 34.9 tp -47.99 -28.24 2.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 45.0 tp60 -61.01 -56.17 24.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.707 ' CG ' HD23 ' A' ' 167' ' ' LEU . 5.0 pt-20 -48.58 -32.86 8.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.707 HD23 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -68.81 -68.37 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 3.3 m -40.21 -38.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -57.96 -47.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -71.9 -39.28 69.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.0 mmpt? -70.4 -27.13 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.12 45.06 4.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.492 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.576 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 10.6 m0 -123.89 174.7 7.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.758 0.313 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.72 166.4 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.53 140.65 0.98 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.608 0.718 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.5 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.74 159.31 53.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.329 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -95.53 138.42 33.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.516 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 70.6 m-85 -130.34 107.93 9.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.6 m -144.7 150.7 37.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.52 HG11 ' HG3' ' A' ' 183' ' ' GLU . 25.3 t -85.87 122.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 1.5 t -96.65 -32.35 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.152 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.43 145.67 50.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.52 ' HG3' HG11 ' A' ' 180' ' ' VAL . 1.9 mp0 -144.86 107.02 4.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -135.45 166.1 23.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.12 142.69 10.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.473 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.8 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.256 . . . . 0.0 112.308 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.13 -33.58 65.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.8 p-80 -77.8 -28.9 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -131.04 80.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.74 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -138.62 114.45 9.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -105.83 142.38 35.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -114.55 101.12 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.2 ttm -103.03 143.76 32.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.801 HG23 ' O ' ' A' ' 203' ' ' GLU . 89.1 m -124.05 136.01 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 11.0 t -91.38 111.88 23.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -96.09 110.13 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.0 t -103.64 159.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.53 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.3 mm-40 -34.17 -72.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.11 32.06 6.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -146.63 153.01 39.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.4 mt -150.04 137.23 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.109 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.801 ' O ' HG23 ' A' ' 195' ' ' THR . 29.0 tp10 -148.94 138.0 21.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.417 ' HA ' HG23 ' A' ' 195' ' ' THR . 46.1 mt -99.46 142.29 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -133.87 -179.27 16.24 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 65.7 p -151.52 153.57 34.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.401 . . . . 0.0 110.834 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -171.71 150.46 13.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.5 p -59.5 -34.2 72.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 6.1 m -131.59 144.91 51.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -41.63 -56.67 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -38.1 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.0 mt -75.37 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -39.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.516 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 11.0 tttm -61.14 -55.09 36.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.3 ptt85 -63.17 -30.64 71.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.68 -47.21 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.38 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.22 69.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 222' ' ' LEU . . . -44.83 -58.91 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -56.47 -44.97 81.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 2.9 tpp -51.3 -44.78 62.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 219' ' ' ALA . 26.3 mt -38.65 -56.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -44.38 -57.71 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 27.0 m -74.66 -34.62 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.2 t -42.58 159.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.11 84.04 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 102.64 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 m -85.8 -53.28 5.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 11.8 t -54.94 91.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.7 m -124.54 94.32 4.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 110.869 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.1 t -142.93 127.37 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.94 -120.34 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -59.36 106.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 110.874 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.5 m -137.29 116.3 12.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 171.27 146.46 5.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 138.56 38.18 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.711 2.274 . . . . 0.0 112.316 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.474 HG12 ' HD3' ' A' ' 153' ' ' PRO . 61.3 t -63.01 88.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.152 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.5 m -109.61 83.24 2.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.631 0.729 . . . . 0.0 110.889 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.474 ' HD3' HG12 ' A' ' 151' ' ' VAL . 53.5 Cg_endo -69.8 -18.4 36.82 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -118.24 123.41 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -43.66 159.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.5 t -166.56 134.46 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -52.1 145.37 10.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.1 p -90.96 129.58 36.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -107.54 85.08 2.1 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.736 . . . . 0.0 110.905 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 -44.75 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.412 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.455 HG21 ' HD3' ' A' ' 214' ' ' LYS . 64.9 t -48.31 -37.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -86.84 -16.44 61.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.66 -51.76 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.044 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.429 HD13 HD23 ' A' ' 222' ' ' LEU . 15.5 tp -46.03 -42.54 13.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.653 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.0 tp60 -51.83 -34.95 42.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -69.68 -41.19 75.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.23 -59.22 3.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 169' ' ' VAL . 12.9 m -41.11 -51.42 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 165' ' ' GLN . 88.2 t -54.12 -41.77 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -64.52 -45.43 87.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -75.19 -21.52 58.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.62 43.5 4.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.497 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -116.19 172.35 7.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.745 0.307 . . . . 0.0 110.922 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 175' ' ' LEU . 22.5 ptt-85 -101.55 164.22 11.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 174' ' ' ARG . 48.9 mt -36.4 142.34 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.573 0.701 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 146.8 61.1 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.631 2.221 . . . . 0.0 112.335 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.43 137.88 33.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.559 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 94.5 m-85 -127.83 122.15 31.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -149.28 139.6 22.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.148 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.1 t -76.33 126.64 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 67.2 p -94.04 -41.53 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -150.58 164.17 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.81 120.12 12.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.0 t -132.02 166.04 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 146.58 21.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.564 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.4 Cg_endo -69.77 -175.09 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.78 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.564 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.7 p-80 -61.44 -41.77 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -120.06 58.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -64.45 150.94 45.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.9 116.9 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -107.78 127.98 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 22.8 m -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.498 ' HB3' ' HB1' ' A' ' 213' ' ' ALA . 58.7 ttm -101.7 144.9 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 203' ' ' GLU . 18.0 m -122.65 139.06 54.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.7 t -96.67 120.54 37.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -102.51 119.56 39.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.2 t -115.51 157.44 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.492 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.2 mt-10 -33.82 -68.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -120.24 32.37 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 31.8 m-85 -146.43 152.05 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.0 mt -149.99 142.56 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 195' ' ' THR . 9.4 tm-20 -155.64 146.1 21.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.439 ' HA ' HG23 ' A' ' 195' ' ' THR . 53.5 mt -107.88 147.03 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -141.63 170.06 24.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.6 p -142.69 139.82 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.837 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.5 136.27 5.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 p -46.11 -23.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.9 m -142.74 148.75 37.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -42.42 -56.14 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -44.66 -44.26 8.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.3 mt -70.01 -60.84 2.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 194' ' ' MET . . . -35.21 -37.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.559 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 8.1 tttp -66.84 -53.94 27.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -64.56 -28.97 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -66.52 -49.03 67.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.08 -52.02 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -50.88 -44.49 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.5 -64.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -53.43 -33.32 53.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.569 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.6 OUTLIER -62.15 -36.94 83.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.429 HD23 HD13 ' A' ' 164' ' ' LEU . 67.9 mt -49.73 -38.03 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.5 -36.59 20.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -59.18 -50.2 74.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 221' ' ' MET . 28.8 m -69.12 -26.41 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.6 p -87.64 139.26 30.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -70.04 -88.97 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.33 53.8 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.7 2.267 . . . . 0.0 112.32 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.1 m -108.07 138.9 43.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 52.0 p -52.26 -58.39 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.3 m -60.24 149.35 33.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.854 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.3 t -90.04 91.64 8.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.45 112.33 1.16 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.4 p -74.69 163.88 27.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.877 0.37 . . . . 0.0 110.911 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.3 m -147.64 135.01 20.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 60.65 157.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 175.81 7.63 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 151' ' ' VAL . 30.2 m -120.13 113.79 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.9 t -95.99 142.96 25.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.623 0.725 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -39.37 6.72 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.709 2.273 . . . . 0.0 112.387 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 47.5 38.22 7.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -139.4 126.2 20.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 56.1 m -46.59 173.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.792 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.04 -33.28 21.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.94 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 67.2 m -109.74 120.78 43.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.429 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 13.1 t30 -147.25 140.47 14.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 0.0 110.849 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.6 Cg_endo -69.73 -48.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.331 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.6 t -49.29 -48.67 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -70.92 -9.57 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.68 -47.94 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.098 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.749 ' O ' HG22 ' A' ' 168' ' ' VAL . 17.8 tp -60.76 -26.55 67.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.478 ' OE1' HD21 ' A' ' 175' ' ' LEU . 1.2 tp60 -65.19 -31.5 72.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.12 -42.56 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -61.97 -54.04 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.0 m -45.21 -52.53 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.481 ' H ' HG23 ' A' ' 168' ' ' VAL . 69.4 t -52.06 -52.23 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -60.74 -29.4 69.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.531 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 27.1 mttm -85.63 -16.43 39.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.07 36.98 9.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.531 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 38.6 m0 -118.74 176.57 5.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.321 . . . . 0.0 110.88 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -109.05 164.11 12.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.478 HD21 ' OE1' ' A' ' 165' ' ' GLN . 21.4 mt -38.05 142.48 0.45 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.576 0.703 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.625 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.5 Cg_endo -69.75 149.71 67.3 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.357 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.19 139.8 30.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.569 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.4 m-85 -133.43 112.51 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.419 ' C ' ' HG3' ' A' ' 194' ' ' MET . 5.1 m -139.14 128.45 24.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.77 119.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.519 HG21 ' OG1' ' A' ' 195' ' ' THR . 1.5 t -96.32 -32.06 12.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -141.59 149.89 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.9 106.98 6.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.4 t -136.13 171.28 14.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.58 148.38 12.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.413 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.571 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.8 -173.1 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.33 -44.66 51.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.571 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.8 p-80 -61.17 -41.1 96.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -129.81 88.63 2.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -80.6 130.8 35.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -112.39 120.28 41.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -112.33 116.31 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 m -100.34 98.54 9.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.419 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.8 ttp -102.91 143.68 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.519 ' OG1' HG21 ' A' ' 181' ' ' THR . 2.4 m -109.67 140.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 36.1 t -101.61 119.76 39.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -101.08 103.95 15.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.6 t -96.17 159.45 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 50.6 mm-40 -32.96 -69.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -120.44 32.88 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 32.8 m-85 -146.23 154.19 41.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.6 mt -149.82 136.01 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.562 ' OE2' ' HB1' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -151.0 153.08 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 36.8 mt -109.31 130.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -116.76 176.66 16.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.8 p -149.23 144.77 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.64 141.54 7.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.503 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.9 p -54.08 -16.03 1.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 210' ' ' LYS . 3.1 m -149.7 143.84 25.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' SER . 76.0 mttt -37.5 -58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -41.81 -47.11 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 215' ' ' ARG . 35.7 mt -69.65 -59.05 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.25 -35.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.569 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -67.0 -48.68 67.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.6 ptt180 -65.4 -44.5 87.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 215' ' ' ARG . 22.2 t-20 -56.21 -42.67 77.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.562 ' HB1' ' OE2' ' A' ' 203' ' ' GLU . . . -68.83 -48.61 63.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.453 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -58.61 -46.43 87.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.56 -64.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -52.38 -43.88 64.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 222' ' ' LEU . 8.0 tpp -50.95 -47.03 61.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.844 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.503 HD23 HD13 ' A' ' 164' ' ' LEU . 46.6 mt -36.76 -51.59 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.951 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.13 -43.91 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -45.54 -56.72 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.549 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m -68.95 -37.95 77.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.6 t -63.77 134.48 55.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.13 -158.71 7.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.529 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -18.64 36.69 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.725 2.283 . . . . 0.0 112.342 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 p 71.85 29.38 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 44.5 t -77.07 -177.45 4.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.3 m 42.66 41.38 2.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.4 m -64.13 -55.32 22.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.864 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.06 161.37 10.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 96.7 p -138.19 112.44 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.861 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 149' ' ' GLY . 39.6 m -77.89 96.97 5.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.814 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 148' ' ' SER . . . 36.93 82.64 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.482 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 178.36 4.61 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.745 2.296 . . . . 0.0 112.346 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.9 m -73.39 129.43 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.139 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.5 p -117.89 143.14 32.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.701 0.762 . . . . 0.0 110.835 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 150.56 68.6 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.731 2.287 . . . . 0.0 112.317 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -80.66 107.39 13.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -71.15 83.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 62.0 p -50.04 -44.99 51.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -130.71 118.18 20.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.9 t -75.61 138.04 41.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -153.63 139.18 11.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -50.33 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.9 t -45.49 -41.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.141 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.08 -23.82 54.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.42 -58.42 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 111.1 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.43 -40.37 12.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.484 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 6.6 tp60 -56.47 -35.37 67.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.23 -37.06 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -66.44 -49.97 64.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 7.2 m -46.72 -36.18 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.52 -37.68 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -71.72 -40.58 69.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -78.59 -27.95 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.936 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.73 46.36 4.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 30.5 m0 -115.92 175.52 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 175' ' ' LEU . 55.0 mtt180 -100.57 155.13 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 174' ' ' ARG . 30.2 mt -34.39 141.55 0.25 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 152.91 69.35 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.716 2.278 . . . . 0.0 112.336 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -97.16 130.93 44.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.585 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 62.0 m-85 -123.04 109.77 14.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 m -144.54 148.57 34.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.5 t -87.27 122.46 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.0 t -96.62 -28.47 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.432 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 44.2 mt-30 -146.59 163.19 36.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.565 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 41.0 mt-10 -151.88 105.87 3.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.8 t -119.11 172.37 7.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.25 145.08 14.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.577 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.75 -175.33 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.577 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -71.5 -40.77 69.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -117.36 83.97 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -83.31 137.44 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -137.47 126.08 23.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.565 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 4.4 m-85 -117.01 128.5 55.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.2 m -94.39 105.33 17.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 40.5 ttm -105.74 141.79 36.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 203' ' ' GLU . 7.5 m -118.91 134.71 55.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -92.63 108.25 19.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -92.07 102.51 15.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 38.9 t -97.26 157.72 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.486 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 59.6 mm-40 -33.71 -73.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -114.2 30.34 7.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 36.1 m-85 -145.66 153.74 41.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 57.6 mt -149.78 135.49 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 195' ' ' THR . 4.2 tp10 -146.24 143.24 29.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 65.3 mt -108.39 136.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.87 -179.33 16.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.487 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 73.8 p -149.6 144.23 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.832 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -160.61 143.91 9.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.2 p -48.54 -29.38 4.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -141.69 148.37 38.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' LYS . 70.3 mttt -40.55 -67.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.438 ' H ' ' CD ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -35.35 -43.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.93 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.8 mt -72.52 -55.16 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.84 -39.05 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.585 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 5.4 ttmt -57.61 -55.48 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 216' ' ' ASN . 5.0 ptm180 -60.77 -37.39 81.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.448 ' N ' ' HG2' ' A' ' 215' ' ' ARG . 6.3 m-80 -56.91 -49.55 75.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.96 -46.75 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.118 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -49.83 -56.24 11.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -39.47 80.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.938 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 4.9 tpp -55.73 -45.73 77.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 54.4 mt -38.35 -51.73 1.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.7 mt -72.69 -48.49 38.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 224' ' ' ARG . 12.1 mmp_? -39.19 -50.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.574 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m -76.03 -35.15 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.7 t -123.14 93.94 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -75.09 -158.09 6.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 126.07 12.87 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 85.5 p -67.42 165.48 16.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 18.2 t -54.62 -43.45 72.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.855 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.448 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.1 p -150.38 162.68 40.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.804 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -88.22 133.37 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.64 109.78 3.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.497 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.1 m -93.44 42.99 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 110.817 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 54.5 p -57.05 -44.34 82.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.65 86.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.461 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 122.18 8.86 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.674 2.249 . . . . 0.0 112.33 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.12 175.77 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.164 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.8 m -86.37 150.51 51.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.671 0.748 . . . . 0.0 110.87 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -41.02 4.59 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -163.89 141.99 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -111.97 47.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.6 m 41.28 39.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -144.64 168.38 20.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 26.6 p -88.52 125.85 34.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -162.81 144.82 8.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.598 0.713 . . . . 0.0 110.927 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -50.52 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.23 -38.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.7 -19.94 62.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.5 -54.85 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.67 HD13 HD23 ' A' ' 222' ' ' LEU . 15.4 tp -44.67 -42.95 7.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.588 ' O ' HG23 ' A' ' 169' ' ' VAL . 15.5 tp60 -49.99 -35.89 26.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -69.61 -44.47 70.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -60.74 -58.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 5.3 m -42.05 -41.84 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 165' ' ' GLN . 89.7 t -62.2 -37.44 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 167' ' ' LEU . 16.4 mm100 -72.49 -38.79 68.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -80.24 -20.05 45.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.57 44.26 6.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -115.49 178.22 4.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.744 0.307 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.409 ' CD ' ' O ' ' A' ' 175' ' ' LEU . 0.5 OUTLIER -107.3 166.67 10.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.409 ' O ' ' CD ' ' A' ' 174' ' ' ARG . 44.3 mt -45.52 136.16 5.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.581 0.705 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.509 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.7 Cg_endo -69.72 158.13 58.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 0.0 112.348 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -95.77 148.49 22.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.581 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 80.7 m-85 -135.37 112.48 10.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -144.76 143.82 30.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 91.7 t -78.76 127.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.9 p -101.65 -40.74 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -135.75 163.29 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.547 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 73.6 mt-10 -150.82 107.01 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.7 t -123.19 172.19 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.32 145.91 16.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.445 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 53.1 Cg_endo -69.84 -164.47 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.614 2.209 . . . . 0.0 112.326 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.07 -42.93 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.506 ' CD2' ' H ' ' A' ' 188' ' ' HIS . 9.9 p80 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -133.21 49.11 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.05 136.89 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.96 123.4 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.547 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 3.4 m-85 -116.58 129.71 56.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.1 m -94.79 97.8 10.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 47.1 ttm -98.88 136.21 39.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.507 HG23 ' HA ' ' A' ' 204' ' ' ILE . 19.1 m -112.29 134.66 53.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 5.7 t -93.63 117.59 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.4 128.29 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.7 t -122.58 157.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.471 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.6 mm-40 -33.87 -66.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.469 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 20.6 mmm180 -123.21 32.84 5.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.556 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 22.1 m-85 -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.6 mt -150.0 139.8 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 195' ' ' THR . 14.8 tp10 -152.29 137.69 17.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.507 ' HA ' HG23 ' A' ' 195' ' ' THR . 61.4 mt -97.68 137.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.57 174.78 18.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.512 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.8 p -149.76 138.58 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.37 134.12 3.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.514 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.0 p -40.31 -35.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.9 t -132.01 146.17 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -41.46 -57.56 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -43.4 -40.55 3.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.507 HD23 ' HD3' ' A' ' 215' ' ' ARG . 24.4 mt -75.09 -60.24 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.3 -41.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.581 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 79.0 tttt -58.35 -57.41 13.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.507 ' HD3' HD23 ' A' ' 212' ' ' LEU . 5.1 ptm180 -61.13 -32.62 72.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -64.35 -46.37 83.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.71 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.01 92.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.13 -63.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -52.5 -40.29 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.577 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.8 OUTLIER -57.25 -34.92 69.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.67 HD23 HD13 ' A' ' 164' ' ' LEU . 75.2 mt -47.88 -46.91 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.09 -44.89 36.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 -47.21 -56.59 6.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 221' ' ' MET . 29.6 m -68.27 -32.59 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 13.7 m -79.4 83.59 5.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -40.35 146.5 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 160.13 50.84 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.616 2.211 . . . . 0.0 112.36 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 75.2 m -159.58 129.22 5.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.1 t -83.49 106.67 15.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.874 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.8 t -138.53 138.89 38.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 m -38.35 125.26 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.819 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.16 -110.09 3.92 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.483 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.1 t -157.93 142.49 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.816 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.9 t -134.82 110.07 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -128.62 67.68 0.55 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -174.34 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 0.0 112.371 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.4 m -119.96 159.18 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 65.6 p -67.1 144.08 98.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.668 0.747 . . . . 0.0 110.842 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 166.17 28.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 0.0 112.331 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -94.42 136.87 34.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -103.95 141.6 35.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 17.7 m -92.62 -48.91 6.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -130.07 165.17 22.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 28.1 p -75.64 146.81 40.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -158.66 142.41 11.09 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 110.894 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -50.34 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.345 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -48.89 -40.31 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.56 61.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.88 -58.88 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.477 HD13 HD23 ' A' ' 222' ' ' LEU . 27.3 tp -41.32 -45.54 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -52.01 -39.4 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.27 -31.62 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -75.3 -62.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.8 m -39.08 -46.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.02 -37.37 77.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 167' ' ' LEU . 32.3 mt-30 -72.22 -35.18 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.586 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 24.0 mmmt -82.96 -22.36 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.83 36.49 7.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.586 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 32.7 m0 -106.78 177.98 4.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 175' ' ' LEU . 83.7 mtt180 -102.28 155.41 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 174' ' ' ARG . 64.9 mt -36.91 142.8 0.35 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.26 50.25 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.429 ' C ' ' OE1' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -94.57 128.81 41.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CE1' ' HG3' ' A' ' 214' ' ' LYS . 87.9 m-85 -118.39 123.99 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 88.4 m -143.89 142.87 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.581 HG11 ' CD ' ' A' ' 183' ' ' GLU . 57.4 t -85.01 119.02 33.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.3 p -90.05 -62.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.424 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 26.4 tp60 -116.65 154.18 30.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.581 ' CD ' HG11 ' A' ' 180' ' ' VAL . 28.3 mt-10 -150.61 108.36 3.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.94 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 t -134.49 172.08 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 111.0 146.14 10.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.578 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.77 177.69 5.34 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.97 99.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 24.4 p-80 -68.34 -41.21 81.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -120.67 78.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -78.02 141.82 38.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -138.05 122.13 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.461 ' CD2' ' HG3' ' A' ' 210' ' ' LYS . 8.7 m-85 -114.45 141.23 47.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 8.7 m -112.84 98.56 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 54.6 ttm -105.67 138.08 42.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 204' ' ' ILE . 9.1 m -114.1 135.14 54.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 10.7 t -93.39 117.5 30.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -98.66 126.42 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.509 HG23 ' SD ' ' A' ' 221' ' ' MET . 17.8 t -122.23 157.78 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 16.1 mm-40 -32.73 -67.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.89 32.02 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.403 ' CD2' HG12 ' A' ' 225' ' ' VAL . 45.3 m-85 -144.91 152.09 39.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.7 mt -149.84 139.7 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -151.04 134.46 16.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.588 ' HA ' HG23 ' A' ' 195' ' ' THR . 14.0 mt -94.9 132.98 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -128.34 168.67 20.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -149.83 170.43 18.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 176.94 171.87 40.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 52.6 p -71.94 -17.96 62.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.4 m -150.54 142.1 23.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.461 ' HG3' ' CD2' ' A' ' 192' ' ' PHE . 8.3 mtmp? -40.49 -50.5 2.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -48.26 -39.97 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.7 mt -74.25 -63.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -38.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' A' ' 178' ' ' TYR . 12.1 tttm -61.4 -54.07 48.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -34.35 76.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.33 -47.1 80.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.28 91.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.448 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -61.62 -48.98 78.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.36 -61.69 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.2 -40.74 71.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.603 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -57.14 -32.78 66.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.477 HD23 HD13 ' A' ' 164' ' ' LEU . 59.5 mt -52.04 -49.62 63.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.4 mt -73.04 -44.0 61.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.414 ' HB3' ' NH1' ' A' ' 224' ' ' ARG . 2.9 mmm180 -45.91 -53.13 10.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 221' ' ' MET . 18.3 m -74.63 -26.8 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.9 t -78.26 137.66 38.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -134.53 175.74 20.31 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.514 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 113.19 3.29 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.3 m -91.07 116.93 29.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.9 m -76.33 97.09 4.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.637 0.732 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -49.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.721 2.281 . . . . 0.0 112.333 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' HG2' ' A' ' 215' ' ' ARG . 85.3 t -47.03 -36.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.22 -18.76 62.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.64 -53.67 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.717 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.3 tp -50.61 -28.86 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.422 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -70.05 -30.07 67.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -81.8 -43.09 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -62.52 -54.06 45.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.8 m -41.97 -54.23 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.55 ' H ' HG23 ' A' ' 168' ' ' VAL . 60.0 t -52.62 -36.86 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -72.81 -31.48 64.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.584 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 40.7 mttm -85.83 -20.69 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.47 36.27 7.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.584 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 43.9 m0 -114.31 172.82 6.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -101.47 162.53 12.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 24.9 mt -41.21 144.86 0.64 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.428 ' HG3' HD23 ' A' ' 164' ' ' LEU . 54.4 Cg_endo -69.71 152.52 69.56 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.718 2.278 . . . . 0.0 112.383 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -97.81 127.84 44.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 214' ' ' LYS . 40.8 m-85 -113.65 117.38 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.951 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.2 m -145.37 135.77 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.143 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.7 t -77.53 122.24 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.0 p -92.58 -60.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.415 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 18.4 tt0 -119.08 160.41 22.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.415 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 3.7 mp0 -144.57 114.04 7.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -134.61 167.74 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.46 149.26 9.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.593 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.1 Cg_endo -69.72 -169.22 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.6 16.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.593 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 15.6 p-80 -59.94 -35.15 74.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -134.47 91.79 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -87.12 146.69 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -138.7 123.92 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -108.29 135.34 49.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 37.7 m -99.24 97.83 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.0 ttm -100.2 138.93 36.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 204' ' ' ILE . 17.6 m -116.2 136.88 52.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 53.2 t -93.2 115.22 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.841 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -98.53 102.7 14.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 32.4 t -95.78 157.31 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -34.38 -65.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 5.9 ptm180 -122.92 31.06 6.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.559 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 23.6 m-85 -146.74 155.49 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.4 mt -150.01 141.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -153.17 122.8 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.575 ' HA ' HG23 ' A' ' 195' ' ' THR . 59.8 mt -84.99 140.29 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.183 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -140.01 165.59 25.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 62.4 m -143.38 150.86 39.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.52 140.5 6.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 76.3 p -38.07 -44.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.823 0.344 . . . . 0.0 111.216 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.9 m -120.24 164.81 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -61.04 -50.8 71.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -52.1 -45.03 64.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 30.9 mt -65.93 -51.93 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.4 -57.51 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.561 ' HG3' ' CE1' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -40.28 -50.31 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.452 ' HG2' HG23 ' A' ' 161' ' ' VAL . 64.7 mtt180 -62.8 -48.52 78.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -48.72 -41.66 32.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.55 -52.7 11.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.27 -59.65 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.42 -59.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -52.31 -43.95 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 14.3 tpp -53.68 -43.05 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -40.41 -58.26 1.59 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.64 -47.52 75.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -45.79 -55.17 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.559 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 30.1 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.614 0.721 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -50.75 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 80.2 t -47.26 -45.42 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.95 -12.84 84.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.527 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.23 -50.25 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 168' ' ' VAL . 20.0 tp -57.45 -38.06 73.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.474 HE22 HD23 ' A' ' 175' ' ' LEU . 6.2 tp60 -58.8 -27.95 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.83 -46.98 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -58.67 -54.02 51.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 164' ' ' LEU . 5.1 m -40.36 -51.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.465 ' N ' HG23 ' A' ' 168' ' ' VAL . 73.9 t -57.4 -34.08 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.119 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 167' ' ' LEU . 51.6 mt-30 -76.07 -33.43 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.567 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 15.3 mtpp -84.65 -15.14 46.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.21 41.91 7.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.488 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.567 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.9 m0 -118.74 174.3 6.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -102.21 163.64 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.474 HD23 HE22 ' A' ' 165' ' ' GLN . 38.9 mt -37.77 143.21 0.4 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 143.44 51.15 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.308 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -97.04 134.51 40.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.561 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.5 m-85 -132.32 115.21 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 194' ' ' MET . 9.7 m -139.69 131.3 27.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.444 HG11 ' OE2' ' A' ' 183' ' ' GLU . 72.6 t -63.54 112.86 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.531 HG21 ' OG1' ' A' ' 195' ' ' THR . 1.6 t -89.27 -33.63 16.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -150.89 156.74 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.463 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 75.5 mt-10 -140.35 110.99 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.6 t -126.74 171.05 11.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.69 162.75 12.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.53 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.3 Cg_endo -69.78 -179.34 2.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.0 112.39 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.89 28.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.53 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 18.5 p-80 -57.79 -41.34 81.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -127.49 88.87 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -83.47 125.05 31.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 129.63 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.463 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 10.6 m-85 -110.41 118.16 35.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.0 m -93.04 104.11 16.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.408 ' HG3' ' C ' ' A' ' 179' ' ' THR . 5.1 ttp -106.49 141.26 38.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.531 ' OG1' HG21 ' A' ' 181' ' ' THR . 3.4 m -108.33 135.41 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.147 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . 0.429 ' SG ' ' CE1' ' A' ' 178' ' ' TYR . 46.6 t -93.58 109.98 21.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -93.85 108.89 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -103.79 157.39 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 43.7 mm-40 -34.01 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.474 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 61.7 mtt180 -118.64 32.23 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.593 ' CD2' HG12 ' A' ' 225' ' ' VAL . 21.3 m-85 -147.64 154.66 40.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.43 ' C ' ' HE1' ' A' ' 221' ' ' MET . 97.6 mt -149.96 136.53 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -146.35 147.45 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 46.4 mt -104.83 126.65 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.32 168.27 18.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.2 m -143.52 160.15 41.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.909 0.385 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -178.3 140.6 4.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -42.42 -43.65 3.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 111.148 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 210' ' ' LYS . 55.8 p -125.64 140.85 52.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 209' ' ' SER . 85.9 mttt -36.54 -46.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -50.75 -51.76 47.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.38 -47.16 71.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -42.6 -46.5 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.2 OUTLIER -54.1 -46.28 72.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.81 -48.8 80.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -55.13 -44.33 74.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -66.9 -52.68 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.078 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.84 -64.06 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -38.18 -63.36 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -46.26 -47.61 18.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.43 ' HE1' ' C ' ' A' ' 202' ' ' ILE . 6.2 tpp -54.34 -43.15 71.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.473 HD23 HD13 ' A' ' 164' ' ' LEU . 64.7 mt -45.26 -60.0 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.09 -44.14 87.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -54.67 -62.76 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 201' ' ' PHE . 19.0 m . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -50.53 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.35 -41.29 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -78.67 -11.97 84.71 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.504 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.69 -48.52 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.087 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.658 ' O ' HG22 ' A' ' 168' ' ' VAL . 17.1 tp -52.35 -33.87 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.435 ' OE1' HD21 ' A' ' 175' ' ' LEU . 15.0 tp60 -60.45 -31.26 70.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.79 -42.37 34.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -64.08 -60.42 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 164' ' ' LEU . 5.4 m -36.34 -49.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.44 ' N ' HG23 ' A' ' 168' ' ' VAL . 48.0 t -59.76 -42.53 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 167' ' ' LEU . 78.2 mt-30 -64.87 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.549 ' HD2' ' CH2' ' A' ' 173' ' ' TRP . 40.1 mttm -99.96 -13.09 19.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.57 40.83 9.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.549 ' CH2' ' HD2' ' A' ' 171' ' ' LYS . 48.5 m0 -115.83 173.7 6.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.766 0.317 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -101.01 173.17 6.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.435 HD21 ' OE1' ' A' ' 165' ' ' GLN . 61.3 mt -49.36 143.58 9.68 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.903 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.39 69.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.37 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -98.7 131.04 45.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.565 ' CD2' ' HE3' ' A' ' 214' ' ' LYS . 70.3 m-85 -121.36 112.86 19.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.7 m -147.04 144.57 29.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 91.7 t -79.62 130.07 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.02 -40.87 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.427 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 31.3 tp60 -140.94 159.52 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.477 ' OE1' ' CE2' ' A' ' 192' ' ' PHE . 25.6 mt-10 -149.61 109.02 3.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.7 t -118.32 172.15 7.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.68 145.9 18.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.498 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.73 -168.42 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.88 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 2.3 p-80 -64.77 -41.53 95.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -117.32 89.85 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -88.24 131.3 34.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -130.51 114.86 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.477 ' CE2' ' OE1' ' A' ' 183' ' ' GLU . 32.1 m-85 -103.91 124.92 49.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -97.71 98.29 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 52.8 ttm -100.67 140.81 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 203' ' ' GLU . 20.3 m -115.39 138.56 50.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 221' ' ' MET . 7.0 t -95.28 117.22 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -98.95 122.92 42.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.2 t -119.65 157.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.489 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 75.2 mm-40 -34.05 -68.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 199' ' ' GLU . 13.4 mmp_? -120.76 32.33 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.579 ' CD2' HG12 ' A' ' 225' ' ' VAL . 28.6 m-85 -146.59 150.44 35.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -150.03 139.05 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 195' ' ' THR . 0.3 OUTLIER -153.64 142.6 21.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.485 ' HA ' HG23 ' A' ' 195' ' ' THR . 74.7 mt -100.87 141.11 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -130.15 173.12 20.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 60.6 p -142.95 146.62 34.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.408 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 208' ' ' THR . . . -168.46 126.62 1.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 207' ' ' GLY . 43.7 p -36.02 -44.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.1 t -118.18 144.53 45.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -44.26 -47.72 9.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -52.85 -46.6 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.2 -46.33 74.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -47.82 -44.46 28.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.565 ' HE3' ' CD2' ' A' ' 178' ' ' TYR . 51.8 tttt -55.49 -44.71 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -69.85 -41.22 75.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -61.83 -42.14 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.512 ' HB1' ' OE2' ' A' ' 203' ' ' GLU . . . -67.12 -54.92 16.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.65 -50.39 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.59 -62.11 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.084 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -51.99 -44.82 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.477 ' CE ' HG23 ' A' ' 198' ' ' VAL . 1.3 ttt -49.93 -40.69 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 71.5 mt -43.4 -52.35 6.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.3 mt -72.28 -48.74 40.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -45.49 -44.13 12.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.579 HG12 ' CD2' ' A' ' 201' ' ' PHE . 10.6 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.432 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 11.8 t30 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.638 0.733 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.74 -47.41 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 0.0 112.349 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.443 HG23 ' HG2' ' A' ' 215' ' ' ARG . 61.6 t -50.28 -37.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.81 -11.81 78.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.451 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.91 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.794 ' O ' HG22 ' A' ' 168' ' ' VAL . 15.2 tp -55.29 -34.48 64.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.536 ' OE1' HD21 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -60.81 -34.13 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -77.37 -49.85 14.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -55.72 -58.41 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.6 m -37.84 -46.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 165' ' ' GLN . 79.8 t -53.56 -46.48 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.17 -37.95 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.543 ' HD2' ' CH2' ' A' ' 173' ' ' TRP . 22.7 mtmm -74.39 -23.59 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.05 35.42 6.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.479 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.543 ' CH2' ' HD2' ' A' ' 171' ' ' LYS . 39.6 m0 -118.44 171.49 8.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -101.85 172.9 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.536 HD21 ' OE1' ' A' ' 165' ' ' GLN . 25.1 mt -43.54 144.08 1.4 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 0.0 110.944 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 155.35 66.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.331 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -93.54 135.5 34.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.572 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 42.7 m-85 -129.24 112.03 13.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.4 m -145.55 142.58 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.421 HG11 ' CG ' ' A' ' 183' ' ' GLU . 99.2 t -77.89 121.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 20.1 p -89.82 -45.8 9.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.419 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 28.4 tt0 -135.86 162.28 33.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.421 ' CG ' HG11 ' A' ' 180' ' ' VAL . 31.8 mt-10 -151.19 113.5 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -136.34 171.65 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.05 146.21 20.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.635 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.75 -164.24 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.705 2.27 . . . . 0.0 112.358 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.21 -38.96 55.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.635 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 44.3 p-80 -75.26 -21.85 58.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.448 ' HG3' ' CD2' ' A' ' 188' ' ' HIS . 22.6 mtp180 -131.81 58.18 1.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -68.44 134.95 50.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -137.69 114.68 10.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -107.77 131.66 54.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.0 m -104.05 97.72 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.9 ttm -101.38 135.29 43.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.546 HG23 ' HA ' ' A' ' 204' ' ' ILE . 33.4 m -114.42 136.7 52.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . 0.44 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 5.1 t -92.56 113.98 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -96.83 104.78 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.4 t -99.99 157.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.4 mm-40 -34.01 -72.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.0 29.8 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.486 ' CG ' HG12 ' A' ' 225' ' ' VAL . 38.8 m-85 -144.92 151.18 38.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 69.4 mt -149.98 137.27 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 195' ' ' THR . 18.2 tp10 -151.27 133.68 15.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.546 ' HA ' HG23 ' A' ' 195' ' ' THR . 57.9 mt -93.57 136.31 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.56 175.29 16.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 51.7 p -152.44 139.0 18.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.881 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -163.18 143.41 8.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.4 p -42.51 -39.45 2.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 111.155 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.8 m -129.67 148.47 51.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.4 ' HD3' HG21 ' A' ' 180' ' ' VAL . 43.5 mtmt -47.51 -40.1 17.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -56.18 -48.02 77.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.6 mt -70.57 -47.01 62.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -44.88 -52.7 8.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.141 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.572 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 12.9 ttmt -44.89 -46.99 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.443 ' HG2' HG23 ' A' ' 161' ' ' VAL . 46.1 mtt85 -62.17 -47.75 83.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -52.38 -46.14 66.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -68.8 -50.71 47.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -60.85 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 222' ' ' LEU . . . -45.67 -55.79 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -49.79 -41.27 44.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.604 ' O ' HG22 ' A' ' 225' ' ' VAL . 5.2 tpp -61.99 -45.21 94.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 219' ' ' ALA . 73.8 mt -37.07 -47.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.1 mt -77.9 -47.0 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -46.75 -57.36 4.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 221' ' ' MET . 16.8 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.084 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.63 0.729 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -50.74 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 94.7 t -49.37 -32.31 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -88.49 -22.69 39.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.42 -54.08 6.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.7 tp -49.1 -38.43 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.7 ' NE2' HD23 ' A' ' 175' ' ' LEU . 4.9 tp-100 -60.88 -31.51 70.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -77.3 -35.85 54.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -71.11 -55.89 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 164' ' ' LEU . 7.0 m -41.44 -52.57 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.51 ' H ' HG23 ' A' ' 168' ' ' VAL . 55.7 t -54.27 -36.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -75.32 -37.25 60.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.581 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 27.5 mttt -78.79 -14.87 59.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 39.03 7.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.581 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 36.4 m0 -120.69 171.58 8.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.773 0.321 . . . . 0.0 110.945 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -101.71 168.5 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.7 HD23 ' NE2' ' A' ' 165' ' ' GLN . 26.1 mt -43.65 142.88 1.74 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.56 68.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.329 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.87 127.1 48.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.542 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 75.5 m-85 -122.32 114.72 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.1 m -136.51 130.76 32.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.612 HG21 ' HE2' ' A' ' 210' ' ' LYS . 57.5 t -65.68 111.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.176 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -86.03 -59.09 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -117.18 158.07 24.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -145.62 113.37 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.3 t -133.03 169.89 16.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.86 145.47 19.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.59 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.74 -174.77 0.96 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.704 2.269 . . . . 0.0 112.36 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.06 85.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.59 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 19.2 p-80 -67.34 -39.89 85.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -113.34 51.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -58.28 129.49 42.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.908 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -133.66 116.64 16.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -107.05 128.23 54.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 m -101.96 100.72 11.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.073 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 4.9 ttp -106.37 139.56 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.665 HG23 ' HA ' ' A' ' 204' ' ' ILE . 5.8 m -110.43 140.13 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.56 117.73 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 16.5 ttp85 -99.97 101.58 12.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 37.3 t -96.05 157.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.491 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 11.0 mm-40 -33.75 -69.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.456 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 6.0 ptm180 -119.55 31.87 6.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.608 ' CD2' HG12 ' A' ' 225' ' ' VAL . 22.3 m-85 -147.41 151.91 37.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.0 mt -149.98 135.89 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.43 ' N ' ' HE1' ' A' ' 221' ' ' MET . 6.9 tp10 -150.85 134.92 16.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.665 ' HA ' HG23 ' A' ' 195' ' ' THR . 56.5 mt -86.63 135.82 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.769 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -123.34 169.23 15.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 78.4 p -144.21 143.47 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.87 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.66 132.32 2.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.9 p -38.34 -40.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.153 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 57.9 m -126.15 145.79 50.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.612 ' HE2' HG21 ' A' ' 180' ' ' VAL . 86.5 mttt -39.37 -45.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -56.05 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 22.6 mt -58.92 -43.71 91.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -53.54 -49.16 68.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.542 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 52.5 tttt -50.08 -37.95 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 216' ' ' ASN . 2.4 mtp-105 -68.83 -66.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 215' ' ' ARG . 0.7 OUTLIER -37.12 -50.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.769 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -61.53 -49.19 77.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.38 -55.82 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.453 ' HA ' HD12 ' A' ' 222' ' ' LEU . . . -45.72 -62.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -46.14 -45.99 16.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.43 ' HE1' ' N ' ' A' ' 203' ' ' GLU . 4.7 tpp -52.73 -43.58 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 219' ' ' ALA . 31.9 mt -43.31 -55.79 3.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.06 -39.03 92.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -55.45 -63.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.608 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.9 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.429 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 3.9 t30 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.624 0.726 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.1 Cg_endo -69.71 -50.41 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.689 2.259 . . . . 0.0 112.374 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.11 -35.16 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.51 -19.51 60.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.74 -55.99 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 168' ' ' VAL . 20.2 tp -49.09 -28.52 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -67.74 -32.38 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -78.88 -38.16 38.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.06 -50.25 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 164' ' ' LEU . 12.5 m -49.38 -44.1 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.402 ' N ' HG23 ' A' ' 168' ' ' VAL . 55.6 t -62.05 -32.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -80.1 -32.29 39.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.572 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 16.2 mtpp -82.95 -17.54 43.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.06 42.37 7.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.572 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.4 m0 -119.43 175.3 5.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.783 0.325 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -103.68 162.72 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.2 mt -38.77 143.29 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.625 0.726 . . . . 0.0 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 155.18 66.47 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.656 2.237 . . . . 0.0 112.382 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.91 141.34 30.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.568 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 65.9 m-85 -134.2 113.33 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 m -148.82 137.44 21.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.17 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.512 HG21 ' HE2' ' A' ' 210' ' ' LYS . 69.0 t -75.54 129.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.412 HG21 ' OG1' ' A' ' 195' ' ' THR . 0.1 OUTLIER -105.47 -35.55 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.444 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 2.9 tp-100 -137.33 154.39 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 2.2 mp0 -143.12 106.64 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -127.63 170.27 12.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 113.26 150.09 10.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.541 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.78 -165.55 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.17 -47.33 14.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.5 p-80 -58.19 -37.88 75.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -135.04 96.76 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -87.12 125.03 33.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.93 130.23 53.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -119.7 128.67 54.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 64.0 m -103.57 101.12 10.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 50.3 ttm -100.78 141.24 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 204' ' ' ILE . 1.6 m -113.53 141.99 46.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 7.1 t -102.39 112.23 24.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -95.46 108.67 20.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -100.93 158.19 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.6 mm-40 -33.2 -64.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 3.4 ptm180 -126.67 33.29 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 21.4 m-85 -147.93 158.09 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.0 mt -150.03 139.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.46 128.69 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.564 ' HA ' HG23 ' A' ' 195' ' ' THR . 38.0 mt -87.21 135.45 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -135.3 166.11 24.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 29.9 t -146.93 166.75 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.879 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 178.12 142.73 4.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.7 p -46.07 -32.66 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 111.126 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.7 m -130.86 154.98 47.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.512 ' HE2' HG21 ' A' ' 180' ' ' VAL . 70.6 mttt -50.82 -54.85 20.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -46.23 -38.37 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 213' ' ' ALA . 64.0 mt -72.78 -65.16 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.8 -39.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.568 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 74.8 tttt -61.22 -56.61 18.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -62.11 -28.02 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 -46.37 70.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -65.94 -42.48 89.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.23 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.77 -56.08 13.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -59.14 -35.22 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.42 ' HE2' HG23 ' A' ' 198' ' ' VAL . 5.0 tpp -59.58 -41.42 90.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.452 HD23 HD13 ' A' ' 164' ' ' LEU . 37.4 mt -43.98 -42.55 6.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.59 -43.62 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.959 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -49.48 -54.44 17.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 13.4 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.423 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 14.2 t30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.73 -43.02 2.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.672 2.248 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -51.12 -51.97 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.9 -10.57 80.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.62 -47.15 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 111.079 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 168' ' ' VAL . 29.8 tp -57.55 -26.41 61.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.688 ' NE2' HD23 ' A' ' 175' ' ' LEU . 5.7 tp-100 -69.75 -25.25 63.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.07 -29.74 34.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -75.89 -55.91 5.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.5 m -42.36 -50.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 168' ' ' VAL . 51.2 t -57.36 -38.45 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -72.19 -34.53 68.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.577 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 34.1 mttt -82.38 -18.21 42.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.61 40.12 6.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.577 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 42.6 m0 -118.78 176.96 5.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -103.46 173.07 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.839 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.688 HD23 ' NE2' ' A' ' 165' ' ' GLN . 32.3 mt -51.07 143.39 16.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.934 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.15 68.03 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.92 122.26 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.509 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 93.8 m-85 -113.76 114.98 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.416 ' C ' ' HG3' ' A' ' 194' ' ' MET . 4.4 m -140.17 132.05 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.53 119.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.467 HG21 ' OG1' ' A' ' 195' ' ' THR . 2.1 t -97.49 -37.51 9.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 10.8 tp60 -138.3 154.86 49.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.448 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 4.7 mp0 -144.25 108.98 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -125.02 172.13 9.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.26 145.15 16.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.521 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.8 -169.32 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.678 2.252 . . . . 0.0 112.356 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.84 -48.58 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.1 p-80 -59.55 -41.75 90.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -122.62 80.74 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -76.96 140.56 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.22 118.05 15.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -110.63 124.5 52.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 205' ' ' GLY . 88.0 m -102.61 104.63 15.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.416 ' HG3' ' C ' ' A' ' 179' ' ' THR . 4.0 ttp -103.09 145.78 29.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.467 ' OG1' HG21 ' A' ' 181' ' ' THR . 18.2 m -115.46 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.173 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -95.68 116.58 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -96.63 105.73 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 44.8 t -96.71 157.44 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 78.8 mm-40 -33.88 -69.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 78.8 mtt180 -119.32 30.94 6.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 21.7 m-85 -147.3 155.47 42.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.1 mt -149.84 139.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 195' ' ' THR . 45.6 mm-40 -151.58 140.73 21.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.8 mt -103.87 134.02 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 193' ' ' THR . . . -126.3 168.52 18.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.7 p -133.87 151.31 51.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -172.21 136.77 3.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.5 p -45.61 -42.07 10.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 212' ' ' LEU . 1.9 t -125.99 141.23 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -38.73 -48.91 1.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.82 -41.87 45.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 209' ' ' SER . 25.3 mt -75.33 -50.64 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.75 -41.32 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.509 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.1 ttpm? -54.33 -56.82 14.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -57.03 -40.11 76.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -45.33 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.29 -51.51 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -47.29 -63.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -39.44 -66.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -41.97 -47.38 4.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.4 ' HE2' HG23 ' A' ' 198' ' ' VAL . 16.7 tpp -56.69 -43.39 80.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 84.6 mt -44.89 -59.16 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.63 -46.81 87.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -48.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.402 HG12 ' CD2' ' A' ' 201' ' ' PHE . 27.9 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.448 ' ND2' ' HD2' ' A' ' 160' ' ' PRO . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.645 0.736 . . . . 0.0 110.852 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.448 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.75 -50.23 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.683 2.255 . . . . 0.0 112.338 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.14 -41.2 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.59 86.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -96.4 -55.29 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.793 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.7 tp -50.1 -30.06 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.524 ' OE1' HD21 ' A' ' 175' ' ' LEU . 2.8 tp60 -64.78 -34.7 78.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -77.57 -46.11 23.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.0 mt -58.87 -57.43 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.7 m -40.21 -42.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.26 -40.98 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 44.4 mt-30 -70.69 -31.2 68.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.594 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 28.2 mttp -85.02 -15.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.83 8.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.594 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 39.2 m0 -120.85 172.61 7.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -100.5 172.24 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.524 HD21 ' OE1' ' A' ' 165' ' ' GLN . 27.7 mt -46.95 142.6 4.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.527 ' HG3' HD23 ' A' ' 164' ' ' LEU . 54.0 Cg_endo -69.72 145.87 58.69 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.19 146.24 24.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 91.1 m-85 -138.0 117.94 13.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.979 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.1 m -140.25 128.42 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.158 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.92 113.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.5 p -88.51 -56.2 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.43 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 8.7 tp60 -119.88 154.72 33.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.43 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 2.7 mp0 -144.58 114.47 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.1 t -136.51 170.72 15.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.43 145.92 11.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.79 -173.13 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.71 62.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.451 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.0 p-80 -62.57 -38.71 91.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -123.28 83.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -82.19 126.46 32.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.21 124.39 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.18 132.31 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.4 m -107.19 102.71 12.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 8.6 ttp -107.49 139.67 41.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 203' ' ' GLU . 31.1 m -108.04 136.79 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.5 t -93.38 115.1 27.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -94.67 105.5 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.464 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.2 t -97.04 156.59 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.464 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 12.0 mm-40 -34.15 -70.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -117.27 29.93 7.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 30.1 m-85 -145.99 155.65 42.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.832 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -149.23 137.76 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 195' ' ' THR . 4.5 tp10 -150.43 145.44 26.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.18 131.33 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.31 173.75 17.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.7 t -152.14 155.34 37.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.845 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.92 144.09 8.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.1 p -49.38 -26.26 3.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 81.8 p -140.03 145.29 37.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -42.61 -54.42 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -44.82 -39.45 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 215' ' ' ARG . 75.2 mt -76.99 -58.11 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.24 -37.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.411 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 36.7 tttt -64.48 -49.28 72.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 212' ' ' LEU . 12.0 ptt180 -68.9 -30.55 69.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -45.77 84.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.52 81.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.078 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.22 66.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.54 -61.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -48.87 -43.26 38.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.497 ' O ' HG22 ' A' ' 225' ' ' VAL . 8.1 tpp -55.2 -43.8 74.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 80.4 mt -38.43 -53.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 24.9 mt -72.89 -38.95 66.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -52.07 -56.62 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.581 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 11.1 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.411 ' HA ' HD11 ' A' ' 222' ' ' LEU . 53.6 Cg_endo -69.79 -44.74 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.96 -48.85 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.99 -11.98 78.99 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.58 -55.38 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.55 HD23 ' HG3' ' A' ' 176' ' ' PRO . 17.1 tp -39.81 -35.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 6.6 tp-100 -55.81 -46.77 77.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.722 ' CG ' HD23 ' A' ' 167' ' ' LEU . 3.9 pt-20 -55.33 -33.99 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.722 HD23 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -70.27 -68.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.9 m -40.1 -45.54 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.1 t -52.31 -53.88 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -64.51 -38.95 92.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -71.25 -24.14 62.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.27 26.85 22.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.463 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -103.09 174.15 5.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 175' ' ' LEU . 35.7 ptt180 -103.58 159.78 15.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 174' ' ' ARG . 21.1 mt -34.25 142.05 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.562 0.696 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.55 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.4 Cg_endo -69.72 156.99 62.0 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -97.42 130.34 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.533 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 54.1 m-85 -124.07 112.79 17.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.3 m -145.34 150.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -82.96 133.04 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 -42.62 5.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 3.3 tp-100 -140.12 150.2 43.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 1.9 mp0 -137.27 107.05 6.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 t -124.33 169.91 11.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.92 144.41 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.77 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.34 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.05 -48.13 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -59.66 -37.47 78.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -125.46 81.69 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -81.44 136.33 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -136.89 114.47 11.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -110.25 130.11 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.3 m -99.79 106.64 18.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 36.2 ttm -108.46 138.87 44.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 203' ' ' GLU . 28.8 m -115.97 137.62 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 52.6 t -94.13 118.04 30.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -101.31 103.16 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.9 t -99.74 158.29 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.51 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 7.6 mm-40 -34.14 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 56.2 mtp180 -113.65 31.67 6.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.476 ' CG ' HG12 ' A' ' 225' ' ' VAL . 23.3 m-85 -146.98 148.92 32.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.6 mt -150.02 139.39 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 195' ' ' THR . 15.7 tt0 -155.77 139.69 16.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.514 ' HA ' HG23 ' A' ' 195' ' ' THR . 21.7 mt -98.33 142.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.16 179.07 18.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' A' ' 216' ' ' ASN . 1.9 m -150.98 161.74 42.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.87 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -175.54 139.59 4.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.7 p -41.78 -40.37 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 31.3 m -126.73 144.02 51.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.847 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -39.91 -49.83 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -52.53 -53.49 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 32.3 mt -57.19 -45.67 83.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 214' ' ' LYS . . . -49.24 -57.91 5.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.533 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.4 ttpm? -35.94 -46.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -68.15 -56.57 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 206' ' ' SER . 16.8 m-80 -38.09 -45.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.12 -46.73 49.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.05 -60.02 4.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.27 -55.0 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -57.56 -42.67 83.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.465 ' HE2' HG23 ' A' ' 198' ' ' VAL . 1.7 tpp -53.2 -45.47 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 160' ' ' PRO . 35.6 mt -42.13 -42.79 3.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.7 mt -78.46 -36.66 45.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -57.67 -60.5 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.476 HG12 ' CG ' ' A' ' 201' ' ' PHE . 30.6 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.597 0.713 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.19 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.64 2.226 . . . . 0.0 112.392 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -45.96 -40.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.55 71.34 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.458 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.04 -50.78 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -49.8 -38.39 34.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.428 ' O ' HG23 ' A' ' 169' ' ' VAL . 5.9 tp60 -52.43 -27.77 17.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.16 -43.66 41.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -62.17 -48.2 81.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 169' ' ' VAL . 17.4 m -60.91 -50.14 81.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.54 ' N ' HG23 ' A' ' 168' ' ' VAL . 26.0 t -56.32 -54.35 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 13.5 pt20 -62.02 -43.19 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.574 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 21.6 mmmt -67.47 -28.38 67.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.96 47.07 3.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.454 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.574 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 41.6 m0 -120.17 178.16 4.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 175' ' ' LEU . 12.3 ptt180 -99.29 148.87 23.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 174' ' ' ARG . 39.7 mt -34.03 142.35 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.596 0.712 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 143.18 49.91 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 0.0 112.349 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -104.11 128.82 51.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.414 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 89.8 m-85 -122.25 115.71 22.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 99.3 m -131.29 131.13 43.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.475 ' CG1' ' HG3' ' A' ' 183' ' ' GLU . 87.3 t -67.88 107.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.7 p -81.95 -59.07 2.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -115.26 151.74 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.475 ' HG3' ' CG1' ' A' ' 180' ' ' VAL . 3.6 mp0 -143.87 113.98 7.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.5 t -133.49 172.34 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.27 145.32 18.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.3 Cg_endo -69.79 -164.76 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.667 2.245 . . . . 0.0 112.325 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.75 -30.5 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 4.8 p-80 -80.61 -24.37 39.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -130.37 52.82 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -55.27 126.24 24.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.64 114.63 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.884 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.08 131.79 54.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.3 m -105.74 102.65 12.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.129 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 8.0 ttp -105.85 139.61 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 203' ' ' GLU . 29.2 m -112.16 138.63 48.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.31 122.79 38.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -104.9 103.6 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 17.7 t -96.97 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.532 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.9 mm-40 -33.51 -68.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -121.47 33.03 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -146.85 152.07 38.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 98.8 mt -149.23 141.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 195' ' ' THR . 13.2 mm-40 -156.48 139.06 15.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.56 134.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -124.3 165.01 17.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.5 p -134.91 138.24 43.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 0.0 110.828 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -158.46 134.64 3.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 208' ' ' THR . 12.2 p -43.13 -34.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 0.0 111.144 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 210' ' ' LYS . 28.6 t -132.43 141.84 49.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.426 ' HG2' HG21 ' A' ' 180' ' ' VAL . 22.9 mtmt -37.6 -57.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -46.01 -42.22 12.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 215' ' ' ARG . 54.1 mt -73.14 -57.03 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -39.71 -31.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.414 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 44.5 tttt -66.1 -45.25 81.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.2 ptt85 -66.39 -40.55 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.15 -50.91 71.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.428 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -59.64 -50.04 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -49.81 64.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.57 -62.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -50.52 -49.02 56.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.465 ' O ' HG22 ' A' ' 225' ' ' VAL . 2.4 tpp -48.62 -46.26 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.1 mt -38.74 -57.69 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.2 mt -63.68 -48.35 77.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -47.74 -63.26 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 221' ' ' MET . 31.1 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.621 0.724 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.362 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.0 t -49.26 -40.04 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.63 -15.51 81.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.51 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.85 -56.85 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.846 ' O ' HG22 ' A' ' 168' ' ' VAL . 36.3 tp -49.75 -30.21 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.5 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -63.39 -33.84 76.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -76.71 -41.56 44.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -64.6 -61.31 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.3 m -37.19 -53.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 165' ' ' GLN . 76.3 t -54.96 -44.1 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -64.81 -34.52 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.561 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 17.7 mtpp -83.34 -12.53 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.17 11.16 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.437 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.561 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 48.8 m0 -116.06 174.38 6.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.753 0.311 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -106.04 164.63 11.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.6 mt -42.52 142.27 1.35 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 110.884 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.83 143.57 50.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.5 128.77 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.556 ' OH ' ' HB2' ' A' ' 218' ' ' ALA . 90.9 m-85 -118.73 115.9 25.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 98.9 m -138.52 128.63 25.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.451 HG12 ' OE2' ' A' ' 183' ' ' GLU . 88.0 t -64.24 115.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.7 p -89.08 -58.9 2.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.438 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 9.0 tp60 -117.7 154.11 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.451 ' OE2' HG12 ' A' ' 180' ' ' VAL . 3.4 mp0 -144.85 114.74 7.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.5 t -136.03 172.42 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.67 144.75 13.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.575 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.75 -174.13 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 0.0 112.352 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.69 -42.69 73.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -66.78 -37.91 85.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -123.83 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -83.29 133.8 34.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -136.37 114.55 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -105.34 140.08 39.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 35.5 m -114.07 98.65 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 6.5 ttp -100.59 141.12 33.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.494 HG23 ' HA ' ' A' ' 204' ' ' ILE . 3.0 m -110.43 133.91 52.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 8.5 t -91.65 114.35 26.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -95.94 109.5 21.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.544 HG23 ' HE2' ' A' ' 221' ' ' MET . 36.9 t -102.17 156.69 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.473 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -33.54 -67.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 45.0 mtp180 -122.47 31.32 6.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 25.7 m-85 -147.34 156.34 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.8 mt -150.0 139.41 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.162 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.475 ' CG ' ' HG3' ' A' ' 224' ' ' ARG . 5.8 mm-40 -150.64 133.73 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.494 ' HA ' HG23 ' A' ' 195' ' ' THR . 35.0 mt -90.68 136.99 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -126.65 155.5 19.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.497 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 p -137.52 145.71 43.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.97 159.81 33.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.8 p -65.94 -12.61 56.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 111.129 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 64.8 p -150.92 154.9 38.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.813 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -49.57 -58.17 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -42.85 -44.66 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 214' ' ' LYS . 44.3 mt -67.57 -65.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.99 -31.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.525 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 73.0 tttt -67.33 -52.59 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.917 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -65.11 -39.21 92.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -57.68 -50.25 73.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.486 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -62.76 -49.55 74.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.081 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.556 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -55.55 -51.0 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.85 -62.19 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -51.97 -39.87 59.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.544 ' HE2' HG23 ' A' ' 198' ' ' VAL . 7.7 tpp -55.05 -41.98 72.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 18.7 mt -44.06 -62.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.7 -42.32 92.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.475 ' HG3' ' CG ' ' A' ' 203' ' ' GLU . 12.4 mmt180 -51.78 -56.12 15.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 21.5 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.615 0.721 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -50.36 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.667 2.245 . . . . 0.0 112.359 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.42 -42.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.74 -18.77 78.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.39 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.5 tp -47.91 -39.02 17.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -57.6 -31.06 65.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.956 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -80.39 -46.45 15.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -57.72 -46.94 83.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 164' ' ' LEU . 15.3 m -56.38 -52.48 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.545 ' N ' HG23 ' A' ' 168' ' ' VAL . 43.1 t -54.54 -58.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 15.2 pt20 -54.3 -44.9 72.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 12.1 mtpp -69.5 -25.94 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.4 48.97 3.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.461 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.576 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 45.7 m0 -123.13 178.13 5.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.893 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -99.83 157.21 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.7 mt -39.7 143.99 0.53 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 146.76 61.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.99 141.3 30.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.558 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 69.5 m-85 -133.77 118.43 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 98.5 m -147.72 135.16 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.467 HG11 ' CG ' ' A' ' 183' ' ' GLU . 87.9 t -75.47 118.11 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 57.4 p -88.34 -43.96 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.429 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 12.9 tm0? -135.33 161.3 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.467 ' CG ' HG11 ' A' ' 180' ' ' VAL . 29.1 mt-10 -151.72 113.85 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.1 t -134.39 172.1 13.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.44 145.68 11.67 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.598 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.76 -172.23 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.391 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.4 63.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.5 p-80 -80.55 -31.62 36.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -127.01 83.54 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -83.2 135.72 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -140.44 119.13 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -109.82 134.88 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 10.1 m -99.52 96.52 7.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 45.3 ttm -100.01 134.52 42.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 203' ' ' GLU . 30.6 m -111.63 137.41 49.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.5 t -93.34 119.02 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -103.11 100.01 9.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.9 t -97.0 159.84 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.538 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 29.8 mm-40 -34.3 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.473 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 14.5 mmt85 -113.34 33.07 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.473 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 20.0 m-85 -147.34 147.12 30.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.421 ' O ' ' CD ' ' A' ' 203' ' ' GLU . 77.5 mt -149.99 135.51 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 195' ' ' THR . 6.6 mp0 -153.94 146.54 24.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.445 ' HA ' HG23 ' A' ' 195' ' ' THR . 32.3 mt -101.31 136.61 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.43 -179.37 15.75 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 87.9 p -152.11 144.12 23.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -161.23 134.5 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 22.4 p -40.72 -39.54 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.121 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 45.6 m -128.78 141.9 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.823 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -38.55 -53.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -48.96 -45.12 41.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.9 mt -66.31 -51.65 55.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.62 -56.75 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.558 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 3.2 ttpm? -41.77 -47.13 4.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -67.85 -43.1 80.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.58 -48.31 79.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.86 -50.64 65.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.28 -56.24 23.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.42 -57.04 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -54.92 -42.87 72.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.595 ' O ' HG22 ' A' ' 225' ' ' VAL . 51.3 tpp -53.6 -40.95 66.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 32.0 mt -48.13 -47.72 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.71 -43.39 76.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -56.95 -58.38 8.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 221' ' ' MET . 27.3 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.426 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 8.8 t30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.73 -49.92 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.327 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.8 t -45.91 -32.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.163 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -93.57 -16.03 47.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.47 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.39 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.418 ' O ' HG22 ' A' ' 168' ' ' VAL . 13.7 tp -56.21 -40.21 73.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 4.9 tp-100 -57.26 -24.88 57.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.76 -42.19 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.89 -57.57 6.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 169' ' ' VAL . 16.0 m -39.42 -45.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.45 ' N ' HG23 ' A' ' 168' ' ' VAL . 20.2 t -57.44 -40.86 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 9.6 mm100 -76.41 -36.85 57.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.573 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.98 -23.89 58.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.6 39.42 5.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.573 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 12.1 m0 -121.33 168.37 11.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.91 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -98.92 170.41 8.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 37.1 mt -41.22 141.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 148.48 65.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -101.35 131.83 47.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.505 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 88.2 m-85 -123.97 120.01 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.932 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 48.6 m -140.14 129.93 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.26 113.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 68.4 p -82.09 -51.44 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.56 158.73 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -137.58 109.82 7.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.0 t -118.78 170.7 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 100.03 143.69 14.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.465 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.76 -168.18 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.63 2.22 . . . . 0.0 112.347 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.91 43.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -58.61 -41.2 85.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 189' ' ' ARG . 14.3 mtp-105 -120.92 91.73 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.9 137.97 31.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -138.57 119.27 14.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.54 126.2 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.8 m -99.41 97.28 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.9 ttp -101.72 139.32 37.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.868 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 203' ' ' GLU . 31.4 m -111.88 138.18 48.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.21 118.75 30.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.7 ttp85 -100.46 101.57 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 24.9 t -98.48 157.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 61.9 mm-40 -34.1 -72.56 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.21 31.52 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 29.4 m-85 -146.92 150.3 34.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.6 mt -149.68 138.29 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.121 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 195' ' ' THR . 4.5 tm-20 -153.14 146.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.1 136.48 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.64 171.25 17.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 77.8 p -144.22 142.25 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.23 134.6 3.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 30.9 p -40.84 -34.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.18 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.1 m -134.61 150.17 50.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -42.71 -55.75 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -44.05 -37.08 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.4 mt -78.87 -63.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.55 -34.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 43.5 tttt -66.31 -51.96 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.73 -50.77 65.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.9 86.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.15 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -48.29 -56.54 7.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -56.11 -46.5 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.416 ' HE3' ' HB ' ' A' ' 198' ' ' VAL . 7.9 tpp -51.08 -41.26 59.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.42 -53.33 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.88 -37.07 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -54.74 -45.49 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 18.4 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -50.67 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.378 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.6 t -45.56 -43.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -80.84 -17.35 72.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.544 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.56 6.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.061 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.51 HD23 ' HG3' ' A' ' 176' ' ' PRO . 16.4 tp -45.28 -43.42 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.858 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -50.62 -36.83 37.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -67.71 -44.54 77.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -60.09 -60.29 4.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.1 m -43.9 -39.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 165' ' ' GLN . 92.2 t -59.06 -38.39 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -77.96 -39.3 43.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.566 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.3 mmpt? -72.55 -25.51 61.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.81 43.63 5.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.501 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.566 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 11.0 m0 -121.58 175.35 6.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.32 . . . . 0.0 110.886 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -102.1 164.36 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 mt -38.35 143.28 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.51 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.78 151.55 68.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.645 2.23 . . . . 0.0 112.363 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -92.07 120.18 32.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.583 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 37.6 m-85 -112.25 113.29 25.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.5 m -149.71 146.15 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.557 HG12 ' OE2' ' A' ' 183' ' ' GLU . 62.0 t -81.82 132.67 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.07 -39.25 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -132.32 149.86 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.557 ' OE2' HG12 ' A' ' 180' ' ' VAL . 4.3 mp0 -143.22 111.68 6.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.5 t -128.24 172.25 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.23 145.64 15.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.52 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.76 -168.83 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.724 2.282 . . . . 0.0 112.345 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.33 -52.11 15.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.52 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 30.2 p-80 -57.47 -32.48 67.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -133.68 92.44 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -86.52 135.67 33.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -125.99 114.73 18.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -106.99 139.44 41.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 205' ' ' GLY . 20.1 m -116.85 102.79 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -102.26 148.25 25.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 204' ' ' ILE . 6.8 m -121.75 144.87 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 6.6 t -101.55 110.61 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -96.93 100.05 11.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 31.1 t -95.73 159.19 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 21.7 mm-40 -33.33 -66.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.465 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 66.9 mtt85 -123.92 33.6 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 23.9 m-85 -148.04 154.16 39.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -150.12 139.8 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -150.48 124.48 9.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.485 ' HA ' HG23 ' A' ' 195' ' ' THR . 58.2 mt -90.38 137.28 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 193' ' ' THR . . . -128.26 174.46 18.81 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 158.63 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 179.36 152.93 11.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.1 p -65.51 -23.19 66.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 0.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 150.33 50.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -49.15 -57.02 7.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.58 -40.36 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 213' ' ' ALA . 35.9 mt -70.85 -61.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.17 -44.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.583 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -58.23 -61.66 2.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.2 -26.43 60.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.31 -42.51 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.34 63.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.077 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.473 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -66.8 -53.8 29.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -42.14 -58.4 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -58.46 -44.9 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 13.0 tpp -50.45 -37.2 36.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 47.4 mt -48.63 -58.21 5.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.37 -44.15 97.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -48.22 -54.74 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.414 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.664 0.745 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -50.77 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.269 . . . . 0.0 112.392 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.9 t -47.45 -37.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.53 -19.83 61.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.39 -52.11 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.101 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.5 HD23 ' HG3' ' A' ' 176' ' ' PRO . 34.9 tp -47.99 -28.24 2.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 7.3 tp-100 -61.01 -56.17 24.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.707 ' CG ' HD23 ' A' ' 167' ' ' LEU . 5.0 pt-20 -48.58 -32.86 8.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.707 HD23 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -68.81 -68.37 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 3.3 m -40.21 -38.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -57.96 -47.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -71.9 -39.28 69.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.0 mmpt? -70.4 -27.13 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.12 45.06 4.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.492 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.576 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 10.6 m0 -123.89 174.7 7.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.758 0.313 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.72 166.4 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.53 140.65 0.98 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.608 0.718 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.5 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.74 159.31 53.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.329 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -95.53 138.42 33.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.516 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 70.6 m-85 -130.34 107.93 9.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.6 m -144.7 150.7 37.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.52 HG11 ' HG3' ' A' ' 183' ' ' GLU . 25.3 t -85.87 122.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 1.5 t -96.65 -32.35 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.152 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.43 145.67 50.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.52 ' HG3' HG11 ' A' ' 180' ' ' VAL . 1.9 mp0 -144.86 107.02 4.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -135.45 166.1 23.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.12 142.69 10.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.473 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.8 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.256 . . . . 0.0 112.308 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.13 -33.58 65.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.8 p-80 -77.8 -28.9 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -131.04 80.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.74 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -138.62 114.45 9.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -105.83 142.38 35.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -114.55 101.12 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.2 ttm -103.03 143.76 32.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.801 HG23 ' O ' ' A' ' 203' ' ' GLU . 89.1 m -124.05 136.01 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 11.0 t -91.38 111.88 23.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -96.09 110.13 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.0 t -103.64 159.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.53 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.3 mm-40 -34.17 -72.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.11 32.06 6.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -146.63 153.01 39.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.4 mt -150.04 137.23 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.109 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.801 ' O ' HG23 ' A' ' 195' ' ' THR . 29.0 tp10 -148.94 138.0 21.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.417 ' HA ' HG23 ' A' ' 195' ' ' THR . 46.1 mt -99.46 142.29 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -133.87 -179.27 16.24 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 65.7 p -151.52 153.57 34.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.401 . . . . 0.0 110.834 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -171.71 150.46 13.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.5 p -59.5 -34.2 72.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 6.1 m -131.59 144.91 51.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -41.63 -56.67 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -38.1 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.0 mt -75.37 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -39.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.516 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 11.0 tttm -61.14 -55.09 36.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.3 ptt85 -63.17 -30.64 71.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.68 -47.21 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.38 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.22 69.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 222' ' ' LEU . . . -44.83 -58.91 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -56.47 -44.97 81.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 2.9 tpp -51.3 -44.78 62.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 219' ' ' ALA . 26.3 mt -38.65 -56.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -44.38 -57.71 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 59.3 t30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.647 0.736 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 -44.75 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.412 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.455 HG21 ' HD3' ' A' ' 214' ' ' LYS . 64.9 t -48.31 -37.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -86.84 -16.44 61.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.66 -51.76 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.044 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.429 HD13 HD23 ' A' ' 222' ' ' LEU . 15.5 tp -46.03 -42.54 13.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.653 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.0 tp60 -51.83 -34.95 42.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -69.68 -41.19 75.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.23 -59.22 3.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 169' ' ' VAL . 12.9 m -41.11 -51.42 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 165' ' ' GLN . 88.2 t -54.12 -41.77 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -64.52 -45.43 87.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -75.19 -21.52 58.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.62 43.5 4.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.497 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -116.19 172.35 7.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.745 0.307 . . . . 0.0 110.922 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 175' ' ' LEU . 22.5 ptt-85 -101.55 164.22 11.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 174' ' ' ARG . 48.9 mt -36.4 142.34 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.573 0.701 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 146.8 61.1 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.631 2.221 . . . . 0.0 112.335 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.43 137.88 33.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.559 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 94.5 m-85 -127.83 122.15 31.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -149.28 139.6 22.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.148 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.1 t -76.33 126.64 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 67.2 p -94.04 -41.53 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -150.58 164.17 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.81 120.12 12.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.0 t -132.02 166.04 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 146.58 21.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.564 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.4 Cg_endo -69.77 -175.09 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.78 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.564 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.7 p-80 -61.44 -41.77 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -120.06 58.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -64.45 150.94 45.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.9 116.9 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -107.78 127.98 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 22.8 m -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.498 ' HB3' ' HB1' ' A' ' 213' ' ' ALA . 58.7 ttm -101.7 144.9 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 203' ' ' GLU . 18.0 m -122.65 139.06 54.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.7 t -96.67 120.54 37.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -102.51 119.56 39.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.2 t -115.51 157.44 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.492 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.2 mt-10 -33.82 -68.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -120.24 32.37 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 31.8 m-85 -146.43 152.05 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.0 mt -149.99 142.56 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 195' ' ' THR . 9.4 tm-20 -155.64 146.1 21.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.439 ' HA ' HG23 ' A' ' 195' ' ' THR . 53.5 mt -107.88 147.03 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -141.63 170.06 24.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.6 p -142.69 139.82 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.837 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.5 136.27 5.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 p -46.11 -23.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.9 m -142.74 148.75 37.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -42.42 -56.14 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -44.66 -44.26 8.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.3 mt -70.01 -60.84 2.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 194' ' ' MET . . . -35.21 -37.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.559 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 8.1 tttp -66.84 -53.94 27.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -64.56 -28.97 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -66.52 -49.03 67.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.08 -52.02 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -50.88 -44.49 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.5 -64.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -53.43 -33.32 53.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.569 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.6 OUTLIER -62.15 -36.94 83.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.429 HD23 HD13 ' A' ' 164' ' ' LEU . 67.9 mt -49.73 -38.03 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.5 -36.59 20.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -59.18 -50.2 74.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 221' ' ' MET . 28.8 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.429 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 13.1 t30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.654 0.74 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.6 Cg_endo -69.73 -48.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.331 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.6 t -49.29 -48.67 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -70.92 -9.57 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.68 -47.94 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.098 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.749 ' O ' HG22 ' A' ' 168' ' ' VAL . 17.8 tp -60.76 -26.55 67.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.478 ' OE1' HD21 ' A' ' 175' ' ' LEU . 1.2 tp60 -65.19 -31.5 72.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.12 -42.56 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -61.97 -54.04 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.0 m -45.21 -52.53 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.481 ' H ' HG23 ' A' ' 168' ' ' VAL . 69.4 t -52.06 -52.23 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -60.74 -29.4 69.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.531 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 27.1 mttm -85.63 -16.43 39.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.07 36.98 9.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.531 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 38.6 m0 -118.74 176.57 5.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.321 . . . . 0.0 110.88 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -109.05 164.11 12.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.478 HD21 ' OE1' ' A' ' 165' ' ' GLN . 21.4 mt -38.05 142.48 0.45 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.576 0.703 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.625 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.5 Cg_endo -69.75 149.71 67.3 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.357 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.19 139.8 30.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.569 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.4 m-85 -133.43 112.51 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.419 ' C ' ' HG3' ' A' ' 194' ' ' MET . 5.1 m -139.14 128.45 24.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.77 119.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.519 HG21 ' OG1' ' A' ' 195' ' ' THR . 1.5 t -96.32 -32.06 12.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -141.59 149.89 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.9 106.98 6.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.4 t -136.13 171.28 14.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.58 148.38 12.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.413 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.571 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.8 -173.1 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.33 -44.66 51.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.571 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.8 p-80 -61.17 -41.1 96.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -129.81 88.63 2.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -80.6 130.8 35.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -112.39 120.28 41.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -112.33 116.31 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 m -100.34 98.54 9.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.419 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.8 ttp -102.91 143.68 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.519 ' OG1' HG21 ' A' ' 181' ' ' THR . 2.4 m -109.67 140.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 36.1 t -101.61 119.76 39.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -101.08 103.95 15.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.6 t -96.17 159.45 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 50.6 mm-40 -32.96 -69.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -120.44 32.88 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 32.8 m-85 -146.23 154.19 41.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.6 mt -149.82 136.01 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.562 ' OE2' ' HB1' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -151.0 153.08 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 36.8 mt -109.31 130.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -116.76 176.66 16.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.8 p -149.23 144.77 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.64 141.54 7.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.503 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.9 p -54.08 -16.03 1.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 210' ' ' LYS . 3.1 m -149.7 143.84 25.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' SER . 76.0 mttt -37.5 -58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -41.81 -47.11 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 215' ' ' ARG . 35.7 mt -69.65 -59.05 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.25 -35.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.569 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -67.0 -48.68 67.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.6 ptt180 -65.4 -44.5 87.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 215' ' ' ARG . 22.2 t-20 -56.21 -42.67 77.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.562 ' HB1' ' OE2' ' A' ' 203' ' ' GLU . . . -68.83 -48.61 63.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.453 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -58.61 -46.43 87.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.56 -64.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -52.38 -43.88 64.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 222' ' ' LEU . 8.0 tpp -50.95 -47.03 61.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.844 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.503 HD23 HD13 ' A' ' 164' ' ' LEU . 46.6 mt -36.76 -51.59 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.951 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.13 -43.91 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -45.54 -56.72 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.549 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.452 ' ND2' ' HD2' ' A' ' 160' ' ' PRO . 1.3 t30 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.452 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.76 -50.33 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.9 t -45.49 -41.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.141 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.08 -23.82 54.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.42 -58.42 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 111.1 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.43 -40.37 12.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.484 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 6.6 tp60 -56.47 -35.37 67.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.23 -37.06 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -66.44 -49.97 64.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 7.2 m -46.72 -36.18 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.52 -37.68 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -71.72 -40.58 69.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -78.59 -27.95 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.936 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.73 46.36 4.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 30.5 m0 -115.92 175.52 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 175' ' ' LEU . 55.0 mtt180 -100.57 155.13 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 174' ' ' ARG . 30.2 mt -34.39 141.55 0.25 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 152.91 69.35 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.716 2.278 . . . . 0.0 112.336 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -97.16 130.93 44.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.585 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 62.0 m-85 -123.04 109.77 14.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 m -144.54 148.57 34.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.5 t -87.27 122.46 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.0 t -96.62 -28.47 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.432 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 44.2 mt-30 -146.59 163.19 36.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.565 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 41.0 mt-10 -151.88 105.87 3.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.8 t -119.11 172.37 7.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.25 145.08 14.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.577 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.75 -175.33 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.577 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -71.5 -40.77 69.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -117.36 83.97 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -83.31 137.44 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -137.47 126.08 23.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.565 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 4.4 m-85 -117.01 128.5 55.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.2 m -94.39 105.33 17.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 40.5 ttm -105.74 141.79 36.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 203' ' ' GLU . 7.5 m -118.91 134.71 55.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -92.63 108.25 19.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -92.07 102.51 15.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 38.9 t -97.26 157.72 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.486 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 59.6 mm-40 -33.71 -73.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -114.2 30.34 7.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 36.1 m-85 -145.66 153.74 41.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 57.6 mt -149.78 135.49 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 195' ' ' THR . 4.2 tp10 -146.24 143.24 29.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 65.3 mt -108.39 136.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.87 -179.33 16.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.487 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 73.8 p -149.6 144.23 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.832 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -160.61 143.91 9.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.2 p -48.54 -29.38 4.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -141.69 148.37 38.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' LYS . 70.3 mttt -40.55 -67.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.438 ' CD ' ' H ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -35.35 -43.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.93 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.8 mt -72.52 -55.16 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.84 -39.05 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.585 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 5.4 ttmt -57.61 -55.48 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 216' ' ' ASN . 5.0 ptm180 -60.77 -37.39 81.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.448 ' N ' ' HG2' ' A' ' 215' ' ' ARG . 5.1 m120 -56.91 -49.55 75.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.96 -46.75 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.118 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -49.83 -56.24 11.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -39.47 80.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.938 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 4.9 tpp -55.73 -45.73 77.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 54.4 mt -38.35 -51.73 1.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.7 mt -72.69 -48.49 38.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 224' ' ' ARG . 12.1 mmp_? -39.19 -50.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.574 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.598 0.713 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -50.52 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.23 -38.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.7 -19.94 62.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.5 -54.85 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.67 HD13 HD23 ' A' ' 222' ' ' LEU . 15.4 tp -44.67 -42.95 7.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.588 ' O ' HG23 ' A' ' 169' ' ' VAL . 15.5 tp60 -49.99 -35.89 26.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -69.61 -44.47 70.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -60.74 -58.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 5.3 m -42.05 -41.84 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 165' ' ' GLN . 89.7 t -62.2 -37.44 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 167' ' ' LEU . 16.4 mm100 -72.49 -38.79 68.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -80.24 -20.05 45.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.57 44.26 6.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -115.49 178.22 4.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.744 0.307 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.409 ' CD ' ' O ' ' A' ' 175' ' ' LEU . 0.5 OUTLIER -107.3 166.67 10.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.409 ' O ' ' CD ' ' A' ' 174' ' ' ARG . 44.3 mt -45.52 136.16 5.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.581 0.705 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.509 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.7 Cg_endo -69.72 158.13 58.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 0.0 112.348 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -95.77 148.49 22.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.581 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 80.7 m-85 -135.37 112.48 10.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -144.76 143.82 30.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 91.7 t -78.76 127.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.9 p -101.65 -40.74 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -135.75 163.29 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.547 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 73.6 mt-10 -150.82 107.01 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.7 t -123.19 172.19 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.32 145.91 16.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.644 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 53.1 Cg_endo -69.84 -164.47 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.614 2.209 . . . . 0.0 112.326 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.07 -42.93 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.644 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 46.0 p-80 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.571 ' HG3' ' CD2' ' A' ' 188' ' ' HIS . 34.3 mtm180 -133.21 49.11 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.05 136.89 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.96 123.4 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.547 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 3.4 m-85 -116.58 129.71 56.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.1 m -94.79 97.8 10.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 47.1 ttm -98.88 136.21 39.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.507 HG23 ' HA ' ' A' ' 204' ' ' ILE . 19.1 m -112.29 134.66 53.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 5.7 t -93.63 117.59 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.4 128.29 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.7 t -122.58 157.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.471 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.6 mm-40 -33.87 -66.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.469 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 20.6 mmm180 -123.21 32.84 5.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.556 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 22.1 m-85 -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.6 mt -150.0 139.8 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 195' ' ' THR . 14.8 tp10 -152.29 137.69 17.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.507 ' HA ' HG23 ' A' ' 195' ' ' THR . 61.4 mt -97.68 137.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.57 174.78 18.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.512 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.8 p -149.76 138.58 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.37 134.12 3.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.514 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.0 p -40.31 -35.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.9 t -132.01 146.17 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -41.46 -57.56 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -43.4 -40.55 3.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.507 HD23 ' HD3' ' A' ' 215' ' ' ARG . 24.4 mt -75.09 -60.24 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.3 -41.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.581 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 79.0 tttt -58.35 -57.41 13.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.507 ' HD3' HD23 ' A' ' 212' ' ' LEU . 5.1 ptm180 -61.13 -32.62 72.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -64.35 -46.37 83.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.71 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.01 92.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.13 -63.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -52.5 -40.29 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.577 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.8 OUTLIER -57.25 -34.92 69.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.67 HD23 HD13 ' A' ' 164' ' ' LEU . 75.2 mt -47.88 -46.91 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.09 -44.89 36.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 -47.21 -56.59 6.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 221' ' ' MET . 29.6 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.624 0.726 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -50.34 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.345 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -48.89 -40.31 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.56 61.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.88 -58.88 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.477 HD13 HD23 ' A' ' 222' ' ' LEU . 27.3 tp -41.32 -45.54 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -52.01 -39.4 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.27 -31.62 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -75.3 -62.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.8 m -39.08 -46.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.02 -37.37 77.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 167' ' ' LEU . 32.3 mt-30 -72.22 -35.18 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.586 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 24.0 mmmt -82.96 -22.36 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.83 36.49 7.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.586 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 32.7 m0 -106.78 177.98 4.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 175' ' ' LEU . 83.7 mtt180 -102.28 155.41 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 174' ' ' ARG . 64.9 mt -36.91 142.8 0.35 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.26 50.25 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.429 ' C ' ' OE1' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -94.57 128.81 41.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CE1' ' HG3' ' A' ' 214' ' ' LYS . 87.9 m-85 -118.39 123.99 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 88.4 m -143.89 142.87 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.581 HG11 ' CD ' ' A' ' 183' ' ' GLU . 57.4 t -85.01 119.02 33.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.3 p -90.05 -62.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.424 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 26.4 tp60 -116.65 154.18 30.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.581 ' CD ' HG11 ' A' ' 180' ' ' VAL . 28.3 mt-10 -150.61 108.36 3.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.94 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 t -134.49 172.08 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 111.0 146.14 10.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.578 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.77 177.69 5.34 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.97 99.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 24.4 p-80 -68.34 -41.21 81.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -120.67 78.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -78.02 141.82 38.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -138.05 122.13 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.461 ' CD2' ' HG3' ' A' ' 210' ' ' LYS . 8.7 m-85 -114.45 141.23 47.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 8.7 m -112.84 98.56 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 54.6 ttm -105.67 138.08 42.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 204' ' ' ILE . 9.1 m -114.1 135.14 54.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 10.7 t -93.39 117.5 30.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -98.66 126.42 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.509 HG23 ' SD ' ' A' ' 221' ' ' MET . 17.8 t -122.23 157.78 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 16.1 mm-40 -32.73 -67.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.89 32.02 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.403 ' CD2' HG12 ' A' ' 225' ' ' VAL . 45.3 m-85 -144.91 152.09 39.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.7 mt -149.84 139.7 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -151.04 134.46 16.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.588 ' HA ' HG23 ' A' ' 195' ' ' THR . 14.0 mt -94.9 132.98 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -128.34 168.67 20.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -149.83 170.43 18.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 176.94 171.87 40.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 52.6 p -71.94 -17.96 62.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.4 m -150.54 142.1 23.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.461 ' HG3' ' CD2' ' A' ' 192' ' ' PHE . 8.3 mtmp? -40.49 -50.5 2.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -48.26 -39.97 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.7 mt -74.25 -63.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -38.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' A' ' 178' ' ' TYR . 12.1 tttm -61.4 -54.07 48.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -34.35 76.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -47.1 80.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.28 91.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.448 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -61.62 -48.98 78.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.36 -61.69 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.2 -40.74 71.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' MET . . . . . 0.603 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -57.14 -32.78 66.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.477 HD23 HD13 ' A' ' 164' ' ' LEU . 59.5 mt -52.04 -49.62 63.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.4 mt -73.04 -44.0 61.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 224' ' ' ARG . 2.9 mmm180 -45.91 -53.13 10.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 221' ' ' MET . 18.3 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.9 m -162.54 153.73 17.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.842 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.4 m -134.41 142.84 47.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.66 133.21 8.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t -166.94 131.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 110.886 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.7 t -99.91 -48.31 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.86 149.61 24.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.474 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 111.77 2.91 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.658 2.239 . . . . 0.0 112.307 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.58 130.24 74.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -54.65 144.12 46.09 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.684 0.754 . . . . 0.0 110.855 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 103.26 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.261 . . . . 0.0 112.368 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -72.54 106.41 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -68.87 109.48 3.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 66.8 m -142.13 148.11 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -42.18 161.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 10.1 m -91.33 136.1 33.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -161.59 144.01 8.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.637 0.732 . . . . 0.0 110.83 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -49.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.721 2.281 . . . . 0.0 112.333 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' HG2' ' A' ' 215' ' ' ARG . 85.3 t -47.03 -36.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.22 -18.76 62.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.64 -53.67 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.717 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.3 tp -50.61 -28.86 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.422 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -70.05 -30.07 67.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -81.8 -43.09 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -62.52 -54.06 45.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.8 m -41.97 -54.23 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.55 ' H ' HG23 ' A' ' 168' ' ' VAL . 60.0 t -52.62 -36.86 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -72.81 -31.48 64.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.584 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 40.7 mttm -85.83 -20.69 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.47 36.27 7.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.584 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 43.9 m0 -114.31 172.82 6.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -101.47 162.53 12.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 24.9 mt -41.21 144.86 0.64 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.428 ' HG3' HD23 ' A' ' 164' ' ' LEU . 54.4 Cg_endo -69.71 152.52 69.56 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.718 2.278 . . . . 0.0 112.383 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -97.81 127.84 44.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 214' ' ' LYS . 40.8 m-85 -113.65 117.38 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.951 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.2 m -145.37 135.77 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.143 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.7 t -77.53 122.24 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.0 p -92.58 -60.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.415 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 18.4 tt0 -119.08 160.41 22.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.415 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 3.7 mp0 -144.57 114.04 7.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -134.61 167.74 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.46 149.26 9.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.593 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.1 Cg_endo -69.72 -169.22 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.6 16.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.593 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 15.6 p-80 -59.94 -35.15 74.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -134.47 91.79 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -87.12 146.69 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -138.7 123.92 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -108.29 135.34 49.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 37.7 m -99.24 97.83 8.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.0 ttm -100.2 138.93 36.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 204' ' ' ILE . 17.6 m -116.2 136.88 52.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 53.2 t -93.2 115.22 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.841 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -98.53 102.7 14.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 32.4 t -95.78 157.31 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -34.38 -65.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 5.9 ptm180 -122.92 31.06 6.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.559 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 23.6 m-85 -146.74 155.49 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.4 mt -150.01 141.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -153.17 122.8 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.575 ' HA ' HG23 ' A' ' 195' ' ' THR . 59.8 mt -84.99 140.29 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.183 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -140.01 165.59 25.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 62.4 m -143.38 150.86 39.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.52 140.5 6.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 76.3 p -38.07 -44.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.823 0.344 . . . . 0.0 111.216 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.9 m -120.24 164.81 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -61.04 -50.8 71.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -52.1 -45.03 64.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 30.9 mt -65.93 -51.93 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.4 -57.51 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.561 ' HG3' ' CE1' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -40.28 -50.31 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.452 ' HG2' HG23 ' A' ' 161' ' ' VAL . 64.7 mtt180 -62.8 -48.52 78.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -48.72 -41.66 32.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.55 -52.7 11.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.27 -59.65 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.42 -59.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -52.31 -43.95 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 14.3 tpp -53.68 -43.05 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.842 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -40.41 -58.26 1.59 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.64 -47.52 75.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -45.79 -55.17 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.559 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 30.1 m -72.51 -34.99 49.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.3 t -54.08 -65.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 173.24 -80.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 134.21 27.5 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.745 2.297 . . . . 0.0 112.38 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.4 t -119.08 96.73 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.7 t -78.08 108.81 11.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.885 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.1 t -163.44 129.1 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.864 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.5 t -160.47 150.38 17.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.803 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 105.22 138.53 9.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 t -160.1 146.91 16.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.859 0.362 . . . . 0.0 110.862 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 21.4 m -76.46 122.35 24.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.844 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -157.86 68.06 0.28 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 136.2 32.47 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.669 2.246 . . . . 0.0 112.384 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.74 HG12 ' HD3' ' A' ' 153' ' ' PRO . 87.5 t -56.18 117.99 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.129 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.1 t -115.45 80.07 7.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.663 0.744 . . . . 0.0 110.859 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.74 ' HD3' HG12 ' A' ' 151' ' ' VAL . 53.5 Cg_endo -69.78 157.32 60.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.693 2.262 . . . . 0.0 112.323 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -167.68 145.56 4.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -121.11 169.67 10.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 46.2 p -112.43 40.47 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -83.17 -57.57 3.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 69.4 m -54.1 137.28 40.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.34 143.72 0.79 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 110.912 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -50.75 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 80.2 t -47.26 -45.42 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.95 -12.84 84.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.527 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.23 -50.25 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 168' ' ' VAL . 20.0 tp -57.45 -38.06 73.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.474 HE22 HD23 ' A' ' 175' ' ' LEU . 6.2 tp60 -58.8 -27.95 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.83 -46.98 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -58.67 -54.02 51.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 164' ' ' LEU . 5.1 m -40.36 -51.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.465 ' N ' HG23 ' A' ' 168' ' ' VAL . 73.9 t -57.4 -34.08 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.119 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 167' ' ' LEU . 51.6 mt-30 -76.07 -33.43 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.567 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 15.3 mtpp -84.65 -15.14 46.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.21 41.91 7.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.488 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.567 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.9 m0 -118.74 174.3 6.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -102.21 163.64 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.474 HD23 HE22 ' A' ' 165' ' ' GLN . 38.9 mt -37.77 143.21 0.4 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 143.44 51.15 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.308 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -97.04 134.51 40.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.561 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.5 m-85 -132.32 115.21 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 194' ' ' MET . 9.7 m -139.69 131.3 27.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.444 HG11 ' OE2' ' A' ' 183' ' ' GLU . 72.6 t -63.54 112.86 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.531 HG21 ' OG1' ' A' ' 195' ' ' THR . 1.6 t -89.27 -33.63 16.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -150.89 156.74 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.463 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 75.5 mt-10 -140.35 110.99 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.6 t -126.74 171.05 11.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.69 162.75 12.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.53 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.3 Cg_endo -69.78 -179.34 2.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 0.0 112.39 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.89 28.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.53 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 18.5 p-80 -57.79 -41.34 81.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -127.49 88.87 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -83.47 125.05 31.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 129.63 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.463 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 10.6 m-85 -110.41 118.16 35.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.0 m -93.04 104.11 16.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.408 ' HG3' ' C ' ' A' ' 179' ' ' THR . 5.1 ttp -106.49 141.26 38.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.531 ' OG1' HG21 ' A' ' 181' ' ' THR . 3.4 m -108.33 135.41 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.147 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . 0.429 ' SG ' ' CE1' ' A' ' 178' ' ' TYR . 46.6 t -93.58 109.98 21.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -93.85 108.89 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -103.79 157.39 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 43.7 mm-40 -34.01 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.474 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 61.7 mtt180 -118.64 32.23 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.593 ' CD2' HG12 ' A' ' 225' ' ' VAL . 21.3 m-85 -147.64 154.66 40.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.43 ' C ' ' HE1' ' A' ' 221' ' ' MET . 97.6 mt -149.96 136.53 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -146.35 147.45 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 46.4 mt -104.83 126.65 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.32 168.27 18.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 56.2 m -143.52 160.15 41.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.909 0.385 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -178.3 140.6 4.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -42.42 -43.65 3.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 111.148 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 210' ' ' LYS . 55.8 p -125.64 140.85 52.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 209' ' ' SER . 85.9 mttt -36.54 -46.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -50.75 -51.76 47.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.38 -47.16 71.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -42.6 -46.5 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.2 OUTLIER -54.1 -46.28 72.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.81 -48.8 80.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -55.13 -44.33 74.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -66.9 -52.68 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.078 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.84 -64.06 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -38.18 -63.36 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -46.26 -47.61 18.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.43 ' HE1' ' C ' ' A' ' 202' ' ' ILE . 6.2 tpp -54.34 -43.15 71.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.473 HD23 HD13 ' A' ' 164' ' ' LEU . 64.7 mt -45.26 -60.0 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.09 -44.14 87.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -54.67 -62.76 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 201' ' ' PHE . 19.0 m -61.57 -37.42 77.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -75.92 165.79 24.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -58.78 151.73 32.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -25.05 29.19 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.66 2.24 . . . . 0.0 112.34 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 m -51.29 121.43 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 68.5 p -108.83 157.75 18.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.861 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.459 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 91.5 p -111.58 -45.99 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.1 t 49.4 42.84 22.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.836 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.73 138.28 12.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.6 m -136.22 166.26 23.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.8 m -150.61 159.63 44.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -173.69 146.25 8.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 141.16 44.37 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 p -134.73 141.34 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.123 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.4 p -138.95 144.21 40.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.669 0.747 . . . . 0.0 110.817 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 158.88 55.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.654 2.236 . . . . 0.0 112.345 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -86.24 -55.43 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -74.98 145.32 42.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 57.4 m -101.32 105.17 16.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -161.83 160.82 28.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.9 t -107.81 138.38 44.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.92 144.05 1.75 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -50.53 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.35 -41.29 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -78.67 -11.97 84.71 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.504 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.69 -48.52 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.087 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.658 ' O ' HG22 ' A' ' 168' ' ' VAL . 17.1 tp -52.35 -33.87 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.435 ' OE1' HD21 ' A' ' 175' ' ' LEU . 15.0 tp60 -60.45 -31.26 70.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.79 -42.37 34.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -64.08 -60.42 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 164' ' ' LEU . 5.4 m -36.34 -49.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.44 ' N ' HG23 ' A' ' 168' ' ' VAL . 48.0 t -59.76 -42.53 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 167' ' ' LEU . 78.2 mt-30 -64.87 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.549 ' HD2' ' CH2' ' A' ' 173' ' ' TRP . 40.1 mttm -99.96 -13.09 19.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.57 40.83 9.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.549 ' CH2' ' HD2' ' A' ' 171' ' ' LYS . 48.5 m0 -115.83 173.7 6.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.766 0.317 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -101.01 173.17 6.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.435 HD21 ' OE1' ' A' ' 165' ' ' GLN . 61.3 mt -49.36 143.58 9.68 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.903 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.39 69.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.37 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -98.7 131.04 45.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.565 ' CD2' ' HE3' ' A' ' 214' ' ' LYS . 70.3 m-85 -121.36 112.86 19.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.7 m -147.04 144.57 29.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 91.7 t -79.62 130.07 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.02 -40.87 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.427 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 31.3 tp60 -140.94 159.52 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.477 ' OE1' ' CE2' ' A' ' 192' ' ' PHE . 25.6 mt-10 -149.61 109.02 3.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.7 t -118.32 172.15 7.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.68 145.9 18.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.498 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.73 -168.42 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.88 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 2.3 p-80 -64.77 -41.53 95.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -117.32 89.85 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -88.24 131.3 34.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -130.51 114.86 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.477 ' CE2' ' OE1' ' A' ' 183' ' ' GLU . 32.1 m-85 -103.91 124.92 49.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -97.71 98.29 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 52.8 ttm -100.67 140.81 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 203' ' ' GLU . 20.3 m -115.39 138.56 50.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 221' ' ' MET . 7.0 t -95.28 117.22 29.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -98.95 122.92 42.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.2 t -119.65 157.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.489 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 75.2 mm-40 -34.05 -68.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 199' ' ' GLU . 13.4 mmp_? -120.76 32.33 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.579 ' CD2' HG12 ' A' ' 225' ' ' VAL . 28.6 m-85 -146.59 150.44 35.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -150.03 139.05 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 195' ' ' THR . 0.3 OUTLIER -153.64 142.6 21.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.485 ' HA ' HG23 ' A' ' 195' ' ' THR . 74.7 mt -100.87 141.11 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -130.15 173.12 20.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 60.6 p -142.95 146.62 34.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.408 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 208' ' ' THR . . . -168.46 126.62 1.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 207' ' ' GLY . 43.7 p -36.02 -44.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.1 t -118.18 144.53 45.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -44.26 -47.72 9.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -52.85 -46.6 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.2 -46.33 74.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -47.82 -44.46 28.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.565 ' HE3' ' CD2' ' A' ' 178' ' ' TYR . 51.8 tttt -55.49 -44.71 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -69.85 -41.22 75.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -61.83 -42.14 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.512 ' HB1' ' OE2' ' A' ' 203' ' ' GLU . . . -67.12 -54.92 16.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.65 -50.39 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.59 -62.11 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.084 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -51.99 -44.82 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.477 ' CE ' HG23 ' A' ' 198' ' ' VAL . 1.3 ttt -49.93 -40.69 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 71.5 mt -43.4 -52.35 6.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.3 mt -72.28 -48.74 40.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -45.49 -44.13 12.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.579 HG12 ' CD2' ' A' ' 201' ' ' PHE . 10.6 m -82.87 -34.6 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 20.1 t -69.38 111.33 5.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.65 157.21 45.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 141.52 45.32 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.323 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.4 t -98.22 -61.46 1.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.7 m -113.84 -61.3 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.542 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.0 p -67.14 136.51 55.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 110.877 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.9 t -142.85 139.22 30.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.16 -50.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.552 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 52.2 p -61.94 -47.88 82.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.0 110.864 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.9 m -72.48 103.1 3.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.95 156.55 15.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.62 12.3 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.664 2.243 . . . . 0.0 112.34 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 151' ' ' VAL . 13.8 p -161.99 124.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 61.5 p -122.04 144.12 40.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.907 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 135.8 31.42 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -83.6 151.62 25.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 156' ' ' SER . 38.0 mt-30 -127.77 108.44 10.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 155' ' ' GLN . 6.2 m -35.44 -40.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.07 100.54 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.915 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 32.0 p -70.99 143.16 50.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.432 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 11.8 t30 -171.25 141.2 1.33 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.638 0.733 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.74 -47.41 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 0.0 112.349 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.443 HG23 ' HG2' ' A' ' 215' ' ' ARG . 61.6 t -50.28 -37.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.81 -11.81 78.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.451 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.91 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.794 ' O ' HG22 ' A' ' 168' ' ' VAL . 15.2 tp -55.29 -34.48 64.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.536 ' OE1' HD21 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -60.81 -34.13 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -77.37 -49.85 14.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -55.72 -58.41 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.6 m -37.84 -46.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 165' ' ' GLN . 79.8 t -53.56 -46.48 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.17 -37.95 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.543 ' HD2' ' CH2' ' A' ' 173' ' ' TRP . 22.7 mtmm -74.39 -23.59 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.05 35.42 6.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.479 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.543 ' CH2' ' HD2' ' A' ' 171' ' ' LYS . 39.6 m0 -118.44 171.49 8.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -101.85 172.9 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.536 HD21 ' OE1' ' A' ' 165' ' ' GLN . 25.1 mt -43.54 144.08 1.4 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 0.0 110.944 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 155.35 66.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.331 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -93.54 135.5 34.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.572 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 42.7 m-85 -129.24 112.03 13.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.4 m -145.55 142.58 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.421 HG11 ' CG ' ' A' ' 183' ' ' GLU . 99.2 t -77.89 121.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 20.1 p -89.82 -45.8 9.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.419 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 28.4 tt0 -135.86 162.28 33.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.421 ' CG ' HG11 ' A' ' 180' ' ' VAL . 31.8 mt-10 -151.19 113.5 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -136.34 171.65 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.05 146.21 20.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.635 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.75 -164.24 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.705 2.27 . . . . 0.0 112.358 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.21 -38.96 55.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.635 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 44.3 p-80 -75.26 -21.85 58.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.448 ' HG3' ' CD2' ' A' ' 188' ' ' HIS . 22.6 mtp180 -131.81 58.18 1.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -68.44 134.95 50.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -137.69 114.68 10.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -107.77 131.66 54.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.0 m -104.05 97.72 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.9 ttm -101.38 135.29 43.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.546 HG23 ' HA ' ' A' ' 204' ' ' ILE . 33.4 m -114.42 136.7 52.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . 0.44 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 5.1 t -92.56 113.98 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -96.83 104.78 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.4 t -99.99 157.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.4 mm-40 -34.01 -72.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.0 29.8 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.486 ' CG ' HG12 ' A' ' 225' ' ' VAL . 38.8 m-85 -144.92 151.18 38.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 69.4 mt -149.98 137.27 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 195' ' ' THR . 18.2 tp10 -151.27 133.68 15.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.546 ' HA ' HG23 ' A' ' 195' ' ' THR . 57.9 mt -93.57 136.31 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.56 175.29 16.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 51.7 p -152.44 139.0 18.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.881 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -163.18 143.41 8.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.4 p -42.51 -39.45 2.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 111.155 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.8 m -129.67 148.47 51.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.4 ' HD3' HG21 ' A' ' 180' ' ' VAL . 43.5 mtmt -47.51 -40.1 17.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -56.18 -48.02 77.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.6 mt -70.57 -47.01 62.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -44.88 -52.7 8.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.141 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.572 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 12.9 ttmt -44.89 -46.99 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.443 ' HG2' HG23 ' A' ' 161' ' ' VAL . 46.1 mtt85 -62.17 -47.75 83.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -52.38 -46.14 66.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -68.8 -50.71 47.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -60.85 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 222' ' ' LEU . . . -45.67 -55.79 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -49.79 -41.27 44.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.604 ' O ' HG22 ' A' ' 225' ' ' VAL . 5.2 tpp -61.99 -45.21 94.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 219' ' ' ALA . 73.8 mt -37.07 -47.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.1 mt -77.9 -47.0 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -46.75 -57.36 4.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 221' ' ' MET . 16.8 m -67.47 -25.77 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.084 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 m -85.26 89.5 7.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -51.52 -94.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 123.06 9.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.3 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 140.16 47.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 54.6 m -90.87 54.93 2.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.435 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.0 t -145.14 139.39 27.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.815 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.6 p -92.41 41.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.84 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.17 127.71 0.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 t -94.37 143.39 26.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.826 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 t -125.4 108.72 11.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.99 146.22 16.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.55 14.32 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.338 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 151' ' ' VAL . 21.1 m -91.85 124.64 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.8 m -67.38 144.09 97.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.896 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 128.98 16.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.671 2.247 . . . . 0.0 112.373 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -124.08 89.05 3.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -108.9 144.5 36.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.9 p -108.23 47.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -95.79 -53.38 3.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 25.0 p -51.54 154.92 1.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -67.66 142.98 96.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.63 0.729 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -50.74 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 94.7 t -49.37 -32.31 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -88.49 -22.69 39.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.42 -54.08 6.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.7 tp -49.1 -38.43 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.7 ' NE2' HD23 ' A' ' 175' ' ' LEU . 4.9 tp-100 -60.88 -31.51 70.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -77.3 -35.85 54.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -71.11 -55.89 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 164' ' ' LEU . 7.0 m -41.44 -52.57 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.51 ' H ' HG23 ' A' ' 168' ' ' VAL . 55.7 t -54.27 -36.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -75.32 -37.25 60.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.581 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 27.5 mttt -78.79 -14.87 59.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 39.03 7.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.581 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 36.4 m0 -120.69 171.58 8.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.773 0.321 . . . . 0.0 110.945 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -101.71 168.5 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.7 HD23 ' NE2' ' A' ' 165' ' ' GLN . 26.1 mt -43.65 142.88 1.74 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.56 68.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.329 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.87 127.1 48.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.542 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 75.5 m-85 -122.32 114.72 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.1 m -136.51 130.76 32.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.612 HG21 ' HE2' ' A' ' 210' ' ' LYS . 57.5 t -65.68 111.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.176 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -86.03 -59.09 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -117.18 158.07 24.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -145.62 113.37 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.3 t -133.03 169.89 16.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.86 145.47 19.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.59 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.74 -174.77 0.96 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.704 2.269 . . . . 0.0 112.36 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.06 85.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.59 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 19.2 p-80 -67.34 -39.89 85.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -113.34 51.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -58.28 129.49 42.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.908 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -133.66 116.64 16.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -107.05 128.23 54.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 m -101.96 100.72 11.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.073 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 4.9 ttp -106.37 139.56 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.665 HG23 ' HA ' ' A' ' 204' ' ' ILE . 5.8 m -110.43 140.13 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.56 117.73 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 16.5 ttp85 -99.97 101.58 12.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 37.3 t -96.05 157.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.491 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 11.0 mm-40 -33.75 -69.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.456 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 6.0 ptm180 -119.55 31.87 6.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.608 ' CD2' HG12 ' A' ' 225' ' ' VAL . 22.3 m-85 -147.41 151.91 37.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.0 mt -149.98 135.89 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.43 ' N ' ' HE1' ' A' ' 221' ' ' MET . 6.9 tp10 -150.85 134.92 16.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.665 ' HA ' HG23 ' A' ' 195' ' ' THR . 56.5 mt -86.63 135.82 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.769 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -123.34 169.23 15.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 78.4 p -144.21 143.47 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.87 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.66 132.32 2.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.9 p -38.34 -40.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.153 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 57.9 m -126.15 145.79 50.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.612 ' HE2' HG21 ' A' ' 180' ' ' VAL . 86.5 mttt -39.37 -45.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -56.05 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 22.6 mt -58.92 -43.71 91.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -53.54 -49.16 68.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.542 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 52.5 tttt -50.08 -37.95 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 216' ' ' ASN . 2.4 mtp-105 -68.83 -66.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 215' ' ' ARG . 0.7 OUTLIER -37.12 -50.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.769 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -61.53 -49.19 77.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.38 -55.82 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.453 ' HA ' HD12 ' A' ' 222' ' ' LEU . . . -45.72 -62.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -46.14 -45.99 16.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.43 ' HE1' ' N ' ' A' ' 203' ' ' GLU . 4.7 tpp -52.73 -43.58 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 219' ' ' ALA . 31.9 mt -43.31 -55.79 3.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.06 -39.03 92.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -55.45 -63.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.608 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.9 m -66.3 -32.37 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t -49.87 165.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -151.08 83.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.496 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -4.21 13.61 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 97.3 p -49.74 126.68 14.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.8 m -105.74 154.47 20.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.5 t -113.04 85.32 2.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 0.0 110.879 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t 67.34 47.45 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.52 111.05 0.45 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -57.25 134.81 56.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 149' ' ' GLY . 15.4 m 57.44 43.35 23.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 148' ' ' SER . . . 34.0 -96.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.53 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.431 ' N ' ' O ' ' A' ' 148' ' ' SER . 53.7 Cg_endo -69.74 108.57 2.1 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.665 2.243 . . . . 0.0 112.382 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.32 156.55 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.0 m -50.58 144.54 12.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.675 0.75 . . . . 0.0 110.855 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -22.55 31.79 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.318 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -56.9 126.8 28.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 156' ' ' SER . 19.4 mt-30 -134.26 137.2 44.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 155' ' ' GLN . 1.1 t -34.7 -58.54 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.816 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -148.56 154.04 39.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -89.73 136.33 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.429 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 3.9 t30 -162.64 141.19 6.7 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.624 0.726 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.1 Cg_endo -69.71 -50.41 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.689 2.259 . . . . 0.0 112.374 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.11 -35.16 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.51 -19.51 60.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.74 -55.99 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 168' ' ' VAL . 20.2 tp -49.09 -28.52 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -67.74 -32.38 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -78.88 -38.16 38.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.06 -50.25 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 164' ' ' LEU . 12.5 m -49.38 -44.1 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.402 ' N ' HG23 ' A' ' 168' ' ' VAL . 55.6 t -62.05 -32.79 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -80.1 -32.29 39.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.572 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 16.2 mtpp -82.95 -17.54 43.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.06 42.37 7.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.572 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 50.4 m0 -119.43 175.3 5.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.783 0.325 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -103.68 162.72 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.2 mt -38.77 143.29 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.625 0.726 . . . . 0.0 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 155.18 66.47 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.656 2.237 . . . . 0.0 112.382 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.91 141.34 30.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.568 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 65.9 m-85 -134.2 113.33 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 m -148.82 137.44 21.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.17 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.512 HG21 ' HE2' ' A' ' 210' ' ' LYS . 69.0 t -75.54 129.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.412 HG21 ' OG1' ' A' ' 195' ' ' THR . 0.1 OUTLIER -105.47 -35.55 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.444 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 2.9 tp-100 -137.33 154.39 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 2.2 mp0 -143.12 106.64 4.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -127.63 170.27 12.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 113.26 150.09 10.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.541 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 54.0 Cg_endo -69.78 -165.55 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.17 -47.33 14.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.5 p-80 -58.19 -37.88 75.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -135.04 96.76 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -87.12 125.03 33.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.93 130.23 53.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -119.7 128.67 54.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 64.0 m -103.57 101.12 10.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 50.3 ttm -100.78 141.24 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 204' ' ' ILE . 1.6 m -113.53 141.99 46.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 7.1 t -102.39 112.23 24.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -95.46 108.67 20.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 20.1 t -100.93 158.19 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.6 mm-40 -33.2 -64.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 3.4 ptm180 -126.67 33.29 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 21.4 m-85 -147.93 158.09 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.0 mt -150.03 139.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.46 128.69 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.564 ' HA ' HG23 ' A' ' 195' ' ' THR . 38.0 mt -87.21 135.45 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -135.3 166.11 24.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 29.9 t -146.93 166.75 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.879 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 178.12 142.73 4.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.7 p -46.07 -32.66 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 111.126 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.7 m -130.86 154.98 47.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.512 ' HE2' HG21 ' A' ' 180' ' ' VAL . 70.6 mttt -50.82 -54.85 20.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -46.23 -38.37 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 213' ' ' ALA . 64.0 mt -72.78 -65.16 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.8 -39.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.568 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 74.8 tttt -61.22 -56.61 18.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -62.11 -28.02 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 -46.37 70.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 196' ' ' CYS . . . -65.94 -42.48 89.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.23 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.77 -56.08 13.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -59.14 -35.22 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.42 ' HE2' HG23 ' A' ' 198' ' ' VAL . 5.0 tpp -59.58 -41.42 90.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.452 HD23 HD13 ' A' ' 164' ' ' LEU . 37.4 mt -43.98 -42.55 6.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.59 -43.62 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.959 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -49.48 -54.44 17.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 13.4 m -64.47 -35.4 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.6 p -72.9 121.91 20.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.23 84.35 0.77 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.465 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 154.34 67.88 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.73 2.287 . . . . 0.0 112.344 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 27.7 m -54.32 -51.25 65.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.822 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.1 t -129.38 -62.3 0.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 25.4 p -128.95 -49.88 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.1 p -55.72 105.9 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.892 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.07 114.19 3.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 t -99.36 101.94 13.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 110.837 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.2 p -113.46 154.5 26.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -137.02 66.1 0.55 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 174.95 8.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.56 122.73 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -156.97 149.06 17.58 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.656 0.741 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 106.7 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.348 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -101.58 117.63 35.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 53.43 46.91 25.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.6 m -91.23 -44.2 9.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -58.51 -51.68 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 20.7 p -62.24 144.77 55.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.423 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 14.2 t30 -70.14 140.34 88.12 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.73 -43.02 2.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.672 2.248 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -51.12 -51.97 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.9 -10.57 80.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.62 -47.15 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 111.079 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 168' ' ' VAL . 29.8 tp -57.55 -26.41 61.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.688 ' NE2' HD23 ' A' ' 175' ' ' LEU . 5.7 tp-100 -69.75 -25.25 63.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.07 -29.74 34.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -75.89 -55.91 5.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.5 m -42.36 -50.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.126 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 168' ' ' VAL . 51.2 t -57.36 -38.45 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -72.19 -34.53 68.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.577 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 34.1 mttt -82.38 -18.21 42.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.61 40.12 6.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.577 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 42.6 m0 -118.78 176.96 5.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -103.46 173.07 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.839 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.688 HD23 ' NE2' ' A' ' 165' ' ' GLN . 32.3 mt -51.07 143.39 16.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.934 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.15 68.03 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 0.0 112.354 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.92 122.26 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.509 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 93.8 m-85 -113.76 114.98 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.416 ' C ' ' HG3' ' A' ' 194' ' ' MET . 4.4 m -140.17 132.05 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.53 119.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.467 HG21 ' OG1' ' A' ' 195' ' ' THR . 2.1 t -97.49 -37.51 9.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 10.8 tp60 -138.3 154.86 49.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.448 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 4.7 mp0 -144.25 108.98 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -125.02 172.13 9.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.26 145.15 16.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.521 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.8 -169.32 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.678 2.252 . . . . 0.0 112.356 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.84 -48.58 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 5.1 p-80 -59.55 -41.75 90.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -122.62 80.74 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -76.96 140.56 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.22 118.05 15.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -110.63 124.5 52.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 205' ' ' GLY . 88.0 m -102.61 104.63 15.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.416 ' HG3' ' C ' ' A' ' 179' ' ' THR . 4.0 ttp -103.09 145.78 29.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.467 ' OG1' HG21 ' A' ' 181' ' ' THR . 18.2 m -115.46 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.173 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -95.68 116.58 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -96.63 105.73 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 44.8 t -96.71 157.44 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 78.8 mm-40 -33.88 -69.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 78.8 mtt180 -119.32 30.94 6.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 21.7 m-85 -147.3 155.47 42.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.1 mt -149.84 139.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 195' ' ' THR . 45.6 mm-40 -151.58 140.73 21.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.8 mt -103.87 134.02 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 193' ' ' THR . . . -126.3 168.52 18.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.7 p -133.87 151.31 51.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -172.21 136.77 3.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.5 p -45.61 -42.07 10.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 212' ' ' LEU . 1.9 t -125.99 141.23 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -38.73 -48.91 1.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.82 -41.87 45.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 209' ' ' SER . 25.3 mt -75.33 -50.64 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.75 -41.32 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.509 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.1 ttpm? -54.33 -56.82 14.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -57.03 -40.11 76.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -45.33 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.29 -51.51 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -47.29 -63.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -39.44 -66.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -41.97 -47.38 4.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.4 ' HE2' HG23 ' A' ' 198' ' ' VAL . 16.7 tpp -56.69 -43.39 80.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.459 ' O ' ' CB ' ' A' ' 226' ' ' SER . 84.6 mt -44.89 -59.16 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.63 -46.81 87.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -48.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.402 HG12 ' CD2' ' A' ' 201' ' ' PHE . 27.9 m -65.75 -31.49 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 222' ' ' LEU . 21.3 t -81.86 103.99 11.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.59 75.67 0.42 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.475 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -25.44 28.49 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.642 2.228 . . . . 0.0 112.344 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.1 t -114.09 152.35 31.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 66.4 m -87.96 176.28 7.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.2 p -124.13 141.35 52.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.0 m -148.39 148.0 29.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.77 -178.29 46.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.8 m -64.67 84.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.858 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.6 m -173.55 170.22 4.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 175.48 146.55 5.89 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 161.81 44.49 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.692 2.262 . . . . 0.0 112.347 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -166.51 132.71 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.159 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.2 p -110.88 145.0 31.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.658 0.742 . . . . 0.0 110.876 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 143.87 52.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -104.62 145.61 30.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.09 -67.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 69.5 m -80.97 136.1 35.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -48.44 -43.03 34.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.4 m -68.07 121.19 15.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.448 ' ND2' ' HD2' ' A' ' 160' ' ' PRO . 1.0 OUTLIER -171.05 139.85 1.27 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.645 0.736 . . . . 0.0 110.852 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.448 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.75 -50.23 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.683 2.255 . . . . 0.0 112.338 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.14 -41.2 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.59 86.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -96.4 -55.29 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.793 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.7 tp -50.1 -30.06 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.524 ' OE1' HD21 ' A' ' 175' ' ' LEU . 2.8 tp60 -64.78 -34.7 78.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -77.57 -46.11 23.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.0 mt -58.87 -57.43 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.7 m -40.21 -42.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.26 -40.98 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 44.4 mt-30 -70.69 -31.2 68.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.594 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 28.2 mttp -85.02 -15.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.83 8.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.594 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 39.2 m0 -120.85 172.61 7.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -100.5 172.24 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.524 HD21 ' OE1' ' A' ' 165' ' ' GLN . 27.7 mt -46.95 142.6 4.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.527 ' HG3' HD23 ' A' ' 164' ' ' LEU . 54.0 Cg_endo -69.72 145.87 58.69 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.19 146.24 24.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 91.1 m-85 -138.0 117.94 13.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.979 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.1 m -140.25 128.42 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.158 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.92 113.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.5 p -88.51 -56.2 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.43 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 8.7 tp60 -119.88 154.72 33.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.43 ' OE2' ' C ' ' A' ' 182' ' ' GLN . 2.7 mp0 -144.58 114.47 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.1 t -136.51 170.72 15.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.43 145.92 11.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.79 -173.13 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.71 62.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.451 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.0 p-80 -62.57 -38.71 91.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -123.28 83.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -82.19 126.46 32.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.21 124.39 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.18 132.31 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.4 m -107.19 102.71 12.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 8.6 ttp -107.49 139.67 41.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 203' ' ' GLU . 31.1 m -108.04 136.79 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.5 t -93.38 115.1 27.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -94.67 105.5 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.464 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.2 t -97.04 156.59 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.464 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 12.0 mm-40 -34.15 -70.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -117.27 29.93 7.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 30.1 m-85 -145.99 155.65 42.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.832 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -149.23 137.76 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 195' ' ' THR . 4.5 tp10 -150.43 145.44 26.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.18 131.33 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.31 173.75 17.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.7 t -152.14 155.34 37.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.845 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -168.92 144.09 8.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.1 p -49.38 -26.26 3.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 81.8 p -140.03 145.29 37.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -42.61 -54.42 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -44.82 -39.45 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 215' ' ' ARG . 75.2 mt -76.99 -58.11 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.24 -37.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.411 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 36.7 tttt -64.48 -49.28 72.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 212' ' ' LEU . 12.0 ptt180 -68.9 -30.55 69.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -45.77 84.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.52 81.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.078 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.22 66.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.54 -61.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -48.87 -43.26 38.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.497 ' O ' HG22 ' A' ' 225' ' ' VAL . 8.1 tpp -55.2 -43.8 74.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 80.4 mt -38.43 -53.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 24.9 mt -72.89 -38.95 66.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -52.07 -56.62 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.581 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 11.1 m -71.34 -31.32 43.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 26.1 t -71.75 154.45 41.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.823 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -102.44 -78.86 1.34 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.508 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 124.36 11.02 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.697 2.265 . . . . 0.0 112.332 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 59.9 p -151.05 123.54 8.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 88.4 p -115.53 170.36 8.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.5 p -39.91 127.9 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -157.45 118.66 3.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -139.43 -157.3 7.24 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.526 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 79.7 p -103.44 125.41 50.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.2 p -104.19 -0.66 28.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.64 83.87 1.76 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 170.68 16.03 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.372 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 78.9 t -124.31 128.08 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.133 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.3 t -168.54 142.44 2.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.651 0.739 . . . . 0.0 110.851 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.47 34.39 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.708 2.272 . . . . 0.0 112.346 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -60.78 -48.53 81.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -85.13 110.74 19.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 t -75.88 82.09 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.846 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -39.3 -50.81 2.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.832 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 19.3 t -60.44 123.57 17.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.841 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -40.09 155.21 0.18 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.411 ' HA ' HD11 ' A' ' 222' ' ' LEU . 53.6 Cg_endo -69.79 -44.74 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.96 -48.85 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.99 -11.98 78.99 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.58 -55.38 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.55 HD23 ' HG3' ' A' ' 176' ' ' PRO . 17.1 tp -39.81 -35.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 6.6 tp-100 -55.81 -46.77 77.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.722 ' CG ' HD23 ' A' ' 167' ' ' LEU . 3.9 pt-20 -55.33 -33.99 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.722 HD23 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -70.27 -68.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.9 m -40.1 -45.54 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.1 t -52.31 -53.88 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -64.51 -38.95 92.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -71.25 -24.14 62.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.27 26.85 22.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.463 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -103.09 174.15 5.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 175' ' ' LEU . 35.7 ptt180 -103.58 159.78 15.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 174' ' ' ARG . 21.1 mt -34.25 142.05 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.562 0.696 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.55 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.4 Cg_endo -69.72 156.99 62.0 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -97.42 130.34 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.533 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 54.1 m-85 -124.07 112.79 17.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.3 m -145.34 150.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -82.96 133.04 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 -42.62 5.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 183' ' ' GLU . 3.3 tp-100 -140.12 150.2 43.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' A' ' 182' ' ' GLN . 1.9 mp0 -137.27 107.05 6.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 t -124.33 169.91 11.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.92 144.41 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.77 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.34 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.05 -48.13 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -59.66 -37.47 78.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -125.46 81.69 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -81.44 136.33 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -136.89 114.47 11.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -110.25 130.11 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.3 m -99.79 106.64 18.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 36.2 ttm -108.46 138.87 44.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 203' ' ' GLU . 28.8 m -115.97 137.62 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 52.6 t -94.13 118.04 30.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -101.31 103.16 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.9 t -99.74 158.29 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.51 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 7.6 mm-40 -34.14 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 56.2 mtp180 -113.65 31.67 6.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.476 ' CG ' HG12 ' A' ' 225' ' ' VAL . 23.3 m-85 -146.98 148.92 32.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.6 mt -150.02 139.39 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 195' ' ' THR . 15.7 tt0 -155.77 139.69 16.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.514 ' HA ' HG23 ' A' ' 195' ' ' THR . 21.7 mt -98.33 142.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.16 179.07 18.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' A' ' 216' ' ' ASN . 1.9 m -150.98 161.74 42.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.87 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -175.54 139.59 4.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.7 p -41.78 -40.37 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 111.153 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 31.3 m -126.73 144.02 51.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.847 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -39.91 -49.83 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -52.53 -53.49 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 32.3 mt -57.19 -45.67 83.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 214' ' ' LYS . . . -49.24 -57.91 5.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.533 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 3.4 ttpm? -35.94 -46.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -68.15 -56.57 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 206' ' ' SER . 16.8 m-80 -38.09 -45.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.12 -46.73 49.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.05 -60.02 4.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -40.27 -55.0 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -57.56 -42.67 83.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.465 ' HE2' HG23 ' A' ' 198' ' ' VAL . 1.7 tpp -53.2 -45.47 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 160' ' ' PRO . 35.6 mt -42.13 -42.79 3.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.7 mt -78.46 -36.66 45.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -57.67 -60.5 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.476 HG12 ' CG ' ' A' ' 201' ' ' PHE . 30.6 m -72.35 -37.61 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.402 ' O ' ' HD3' ' A' ' 228' ' ' PRO . 2.0 t -126.14 96.64 4.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.63 83.81 0.36 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 226' ' ' SER . 53.8 Cg_endo -69.79 114.87 3.85 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.353 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 10.5 t -139.54 146.67 40.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.826 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.5 m -81.54 93.83 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.843 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.4 p -134.59 145.62 48.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.904 0.383 . . . . 0.0 110.837 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -56.48 147.57 21.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.2 65.86 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.7 t -153.4 176.85 11.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.85 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.0 p -79.87 2.87 21.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 138.98 145.49 4.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 100.82 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.335 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 151' ' ' VAL . 7.4 p -38.65 117.97 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.8 m -107.5 81.5 1.1 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.605 0.717 . . . . 0.0 110.837 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.443 ' HD3' HG22 ' A' ' 151' ' ' VAL . 53.8 Cg_endo -69.8 120.16 6.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.624 2.216 . . . . 0.0 112.369 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -115.93 132.59 56.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -85.93 141.33 29.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.3 m -132.47 -55.03 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.08 -36.07 67.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 46.8 t -59.4 133.62 56.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.83 143.01 8.66 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 0.0 110.93 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.19 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.64 2.226 . . . . 0.0 112.392 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -45.96 -40.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.55 71.34 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.458 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.04 -50.78 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -49.8 -38.39 34.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.428 ' O ' HG23 ' A' ' 169' ' ' VAL . 5.9 tp60 -52.43 -27.77 17.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.16 -43.66 41.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -62.17 -48.2 81.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 169' ' ' VAL . 17.4 m -60.91 -50.14 81.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.54 ' N ' HG23 ' A' ' 168' ' ' VAL . 26.0 t -56.32 -54.35 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 13.5 pt20 -62.02 -43.19 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.574 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 21.6 mmmt -67.47 -28.38 67.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 92.96 47.07 3.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.454 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.574 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 41.6 m0 -120.17 178.16 4.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 175' ' ' LEU . 12.3 ptt180 -99.29 148.87 23.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 174' ' ' ARG . 39.7 mt -34.03 142.35 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.596 0.712 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 143.18 49.91 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 0.0 112.349 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -104.11 128.82 51.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.414 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 89.8 m-85 -122.25 115.71 22.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 99.3 m -131.29 131.13 43.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.475 ' CG1' ' HG3' ' A' ' 183' ' ' GLU . 87.3 t -67.88 107.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.7 p -81.95 -59.07 2.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -115.26 151.74 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.475 ' HG3' ' CG1' ' A' ' 180' ' ' VAL . 3.6 mp0 -143.87 113.98 7.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.5 t -133.49 172.34 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.27 145.32 18.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.3 Cg_endo -69.79 -164.76 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.667 2.245 . . . . 0.0 112.325 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.75 -30.5 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 4.8 p-80 -80.61 -24.37 39.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -130.37 52.82 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -55.27 126.24 24.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.64 114.63 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.884 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.08 131.79 54.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.3 m -105.74 102.65 12.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.129 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 8.0 ttp -105.85 139.61 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 203' ' ' GLU . 29.2 m -112.16 138.63 48.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.31 122.79 38.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -104.9 103.6 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 17.7 t -96.97 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.532 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.9 mm-40 -33.51 -68.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -121.47 33.03 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -146.85 152.07 38.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 98.8 mt -149.23 141.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 195' ' ' THR . 13.2 mm-40 -156.48 139.06 15.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.56 134.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -124.3 165.01 17.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.5 p -134.91 138.24 43.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 0.0 110.828 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -158.46 134.64 3.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 208' ' ' THR . 12.2 p -43.13 -34.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 0.0 111.144 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 210' ' ' LYS . 28.6 t -132.43 141.84 49.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.832 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.426 ' HG2' HG21 ' A' ' 180' ' ' VAL . 22.9 mtmt -37.6 -57.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -46.01 -42.22 12.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 215' ' ' ARG . 54.1 mt -73.14 -57.03 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -39.71 -31.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.414 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 44.5 tttt -66.1 -45.25 81.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.2 ptt85 -66.39 -40.55 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.15 -50.91 71.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.428 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -59.64 -50.04 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -52.58 -49.81 64.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.57 -62.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -50.52 -49.02 56.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.465 ' O ' HG22 ' A' ' 225' ' ' VAL . 2.4 tpp -48.62 -46.26 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.1 mt -38.74 -57.69 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 19.2 mt -63.68 -48.35 77.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -47.74 -63.26 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 221' ' ' MET . 31.1 m -63.63 -27.83 43.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.3 t -42.75 126.87 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -124.89 -160.19 10.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -174.69 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.669 2.246 . . . . 0.0 112.375 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.2 t -62.05 103.53 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.0 m 53.42 44.4 30.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.528 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.2 p -109.31 -43.54 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.872 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.3 t -117.28 137.28 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.83 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.45 -156.21 15.76 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.534 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -122.07 -59.36 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 53.8 m -115.04 142.03 47.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.823 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -151.07 -91.8 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.468 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 136.25 32.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.672 2.248 . . . . 0.0 112.342 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.67 141.09 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.112 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.3 m -142.92 143.77 26.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.697 0.76 . . . . 0.0 110.878 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 138.74 38.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.368 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -60.26 144.1 51.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -105.07 170.61 7.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 t -82.32 -57.0 3.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.82 141.67 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 60.6 m -103.44 136.82 42.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -133.48 144.2 51.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.362 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.0 t -49.26 -40.04 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.63 -15.51 81.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.51 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.85 -56.85 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.846 ' O ' HG22 ' A' ' 168' ' ' VAL . 36.3 tp -49.75 -30.21 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.5 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -63.39 -33.84 76.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -76.71 -41.56 44.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -64.6 -61.31 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.3 m -37.19 -53.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 165' ' ' GLN . 76.3 t -54.96 -44.1 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -64.81 -34.52 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.561 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 17.7 mtpp -83.34 -12.53 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.17 11.16 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.437 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.561 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 48.8 m0 -116.06 174.38 6.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.753 0.311 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -106.04 164.63 11.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.6 mt -42.52 142.27 1.35 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.63 0.728 . . . . 0.0 110.884 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.83 143.57 50.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.5 128.77 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.556 ' OH ' ' HB2' ' A' ' 218' ' ' ALA . 90.9 m-85 -118.73 115.9 25.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 98.9 m -138.52 128.63 25.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.451 HG12 ' OE2' ' A' ' 183' ' ' GLU . 88.0 t -64.24 115.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.7 p -89.08 -58.9 2.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.438 ' C ' ' OE2' ' A' ' 183' ' ' GLU . 9.0 tp60 -117.7 154.11 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.451 ' OE2' HG12 ' A' ' 180' ' ' VAL . 3.4 mp0 -144.85 114.74 7.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.5 t -136.03 172.42 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.67 144.75 13.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.575 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.75 -174.13 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 0.0 112.352 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.69 -42.69 73.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -66.78 -37.91 85.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -123.83 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -83.29 133.8 34.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -136.37 114.55 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -105.34 140.08 39.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 35.5 m -114.07 98.65 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 6.5 ttp -100.59 141.12 33.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.494 HG23 ' HA ' ' A' ' 204' ' ' ILE . 3.0 m -110.43 133.91 52.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 8.5 t -91.65 114.35 26.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -95.94 109.5 21.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.544 HG23 ' HE2' ' A' ' 221' ' ' MET . 36.9 t -102.17 156.69 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.473 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.1 mm-40 -33.54 -67.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 45.0 mtp180 -122.47 31.32 6.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 25.7 m-85 -147.34 156.34 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.8 mt -150.0 139.41 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.162 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.475 ' CG ' ' HG3' ' A' ' 224' ' ' ARG . 5.8 mm-40 -150.64 133.73 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.494 ' HA ' HG23 ' A' ' 195' ' ' THR . 35.0 mt -90.68 136.99 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -126.65 155.5 19.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.497 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 p -137.52 145.71 43.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.97 159.81 33.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.8 p -65.94 -12.61 56.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 111.129 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 64.8 p -150.92 154.9 38.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.813 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -49.57 -58.17 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -42.85 -44.66 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 214' ' ' LYS . 44.3 mt -67.57 -65.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.99 -31.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.525 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 73.0 tttt -67.33 -52.59 38.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.917 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -65.11 -39.21 92.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -57.68 -50.25 73.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.486 ' HB2' ' HA3' ' A' ' 205' ' ' GLY . . . -62.76 -49.55 74.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.081 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.556 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -55.55 -51.0 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.85 -62.19 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -51.97 -39.87 59.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.544 ' HE2' HG23 ' A' ' 198' ' ' VAL . 7.7 tpp -55.05 -41.98 72.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 18.7 mt -44.06 -62.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.7 -42.32 92.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.475 ' HG3' ' CG ' ' A' ' 203' ' ' GLU . 12.4 mmt180 -51.78 -56.12 15.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 21.5 m -69.55 -36.31 70.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 7.4 p -60.81 172.48 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.97 -94.94 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -25.99 27.99 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.343 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 31.9 t -50.71 134.99 24.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.806 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.5 m -48.37 155.27 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.877 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.499 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.4 t -48.34 145.16 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.837 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 m -77.36 155.87 31.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.856 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -95.93 71.05 0.92 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.504 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 146' ' ' GLY . 35.5 p 34.69 44.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 95.1 p -137.87 108.95 6.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -125.42 145.88 15.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.48 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 115.06 3.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.683 2.256 . . . . 0.0 112.373 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 86.1 t -95.44 121.89 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.5 p -71.92 148.2 91.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 122.54 9.21 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.346 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -59.0 -42.8 90.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -145.01 111.38 5.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 t -88.25 97.72 11.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -82.07 45.78 0.96 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.2 p -104.03 172.77 6.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -91.83 144.81 29.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.615 0.721 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -50.36 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.667 2.245 . . . . 0.0 112.359 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.42 -42.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.74 -18.77 78.61 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.39 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 168' ' ' VAL . 14.5 tp -47.91 -39.02 17.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -57.6 -31.06 65.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.956 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -80.39 -46.45 15.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -57.72 -46.94 83.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 164' ' ' LEU . 15.3 m -56.38 -52.48 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.545 ' N ' HG23 ' A' ' 168' ' ' VAL . 43.1 t -54.54 -58.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 171' ' ' LYS . 15.2 pt20 -54.3 -44.9 72.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HD3' ' CZ3' ' A' ' 173' ' ' TRP . 12.1 mtpp -69.5 -25.94 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.4 48.97 3.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.461 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.576 ' CZ3' ' HD3' ' A' ' 171' ' ' LYS . 45.7 m0 -123.13 178.13 5.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.893 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -99.83 157.21 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 25.7 mt -39.7 143.99 0.53 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 146.76 61.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.99 141.3 30.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.558 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 69.5 m-85 -133.77 118.43 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 98.5 m -147.72 135.16 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.467 HG11 ' CG ' ' A' ' 183' ' ' GLU . 87.9 t -75.47 118.11 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 57.4 p -88.34 -43.96 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.429 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 12.9 tm0? -135.33 161.3 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.467 ' CG ' HG11 ' A' ' 180' ' ' VAL . 29.1 mt-10 -151.72 113.85 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.1 t -134.39 172.1 13.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.44 145.68 11.67 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.598 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.76 -172.23 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.391 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.4 63.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.5 p-80 -80.55 -31.62 36.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -127.01 83.54 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -83.2 135.72 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -140.44 119.13 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -109.82 134.88 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 10.1 m -99.52 96.52 7.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 45.3 ttm -100.01 134.52 42.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.826 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 203' ' ' GLU . 30.6 m -111.63 137.41 49.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 40.5 t -93.34 119.02 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -103.11 100.01 9.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.9 t -97.0 159.84 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.538 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 29.8 mm-40 -34.3 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.473 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 14.5 mmt85 -113.34 33.07 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.473 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 20.0 m-85 -147.34 147.12 30.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.421 ' O ' ' CD ' ' A' ' 203' ' ' GLU . 77.5 mt -149.99 135.51 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 195' ' ' THR . 6.6 mp0 -153.94 146.54 24.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.445 ' HA ' HG23 ' A' ' 195' ' ' THR . 32.3 mt -101.31 136.61 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.43 -179.37 15.75 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 87.9 p -152.11 144.12 23.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -161.23 134.5 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 22.4 p -40.72 -39.54 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.121 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 45.6 m -128.78 141.9 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.823 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -38.55 -53.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -48.96 -45.12 41.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.9 mt -66.31 -51.65 55.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.62 -56.75 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.558 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 3.2 ttpm? -41.77 -47.13 4.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -67.85 -43.1 80.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.58 -48.31 79.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.86 -50.64 65.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.28 -56.24 23.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -43.42 -57.04 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -54.92 -42.87 72.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.595 ' O ' HG22 ' A' ' 225' ' ' VAL . 51.3 tpp -53.6 -40.95 66.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 32.0 mt -48.13 -47.72 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.71 -43.39 76.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -56.95 -58.38 8.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 221' ' ' MET . 27.3 m -62.98 -29.07 46.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 95.4 p -157.06 117.65 3.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 171.63 -93.37 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 90.21 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.727 2.285 . . . . 0.0 112.316 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 21.6 t -113.16 -61.27 1.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 28.8 t -130.98 96.63 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.875 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.461 180.0 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 21.2 t -54.57 151.09 8.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.867 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 p -132.81 -55.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.888 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.58 -163.56 12.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.427 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.0 p -161.23 139.23 9.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.827 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.4 t -153.23 157.29 40.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.75 145.74 23.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.465 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 105.07 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 0.0 112.336 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.6 p -90.87 122.44 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.141 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.9 p -71.18 144.05 89.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.681 0.753 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 154' ' ' GLN . 53.3 Cg_endo -69.77 -1.04 7.8 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 0.0 112.315 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 153' ' ' PRO . 77.9 mm-40 -35.38 108.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.401 ' C ' ' OE1' ' A' ' 155' ' ' GLN . 2.5 tm0? -165.79 140.82 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.6 p -171.05 148.56 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 50.22 32.69 6.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 2.8 t -101.68 148.26 25.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.426 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 8.8 t30 -68.73 140.42 91.82 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.8 Cg_endo -69.73 -49.92 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.327 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.8 t -45.91 -32.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.163 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -93.57 -16.03 47.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.47 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.39 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.418 ' O ' HG22 ' A' ' 168' ' ' VAL . 13.7 tp -56.21 -40.21 73.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 4.9 tp-100 -57.26 -24.88 57.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.76 -42.19 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.89 -57.57 6.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 169' ' ' VAL . 16.0 m -39.42 -45.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.45 ' N ' HG23 ' A' ' 168' ' ' VAL . 20.2 t -57.44 -40.86 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' LEU . 9.6 mm100 -76.41 -36.85 57.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.573 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.98 -23.89 58.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.6 39.42 5.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.573 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 12.1 m0 -121.33 168.37 11.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.91 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -98.92 170.41 8.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 37.1 mt -41.22 141.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 148.48 65.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -101.35 131.83 47.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.505 ' CG ' ' HG3' ' A' ' 214' ' ' LYS . 88.2 m-85 -123.97 120.01 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.932 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.41 ' C ' ' HG3' ' A' ' 194' ' ' MET . 48.6 m -140.14 129.93 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.26 113.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 68.4 p -82.09 -51.44 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.56 158.73 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -137.58 109.82 7.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.0 t -118.78 170.7 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 100.03 143.69 14.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.465 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.76 -168.18 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.63 2.22 . . . . 0.0 112.347 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.91 43.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 3.4 p-80 -58.61 -41.2 85.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 189' ' ' ARG . 14.3 mtp-105 -120.92 91.73 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.9 137.97 31.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -138.57 119.27 14.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.54 126.2 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.8 m -99.41 97.28 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.9 ttp -101.72 139.32 37.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.868 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 203' ' ' GLU . 31.4 m -111.88 138.18 48.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.21 118.75 30.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.7 ttp85 -100.46 101.57 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 24.9 t -98.48 157.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 61.9 mm-40 -34.1 -72.56 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.21 31.52 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 29.4 m-85 -146.92 150.3 34.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.6 mt -149.68 138.29 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.121 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 195' ' ' THR . 4.5 tm-20 -153.14 146.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.1 136.48 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.64 171.25 17.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 77.8 p -144.22 142.25 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -165.23 134.6 3.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 30.9 p -40.84 -34.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.18 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.1 m -134.61 150.17 50.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -42.71 -55.75 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -44.05 -37.08 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.4 mt -78.87 -63.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.55 -34.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 178' ' ' TYR . 43.5 tttt -66.31 -51.96 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.73 -50.77 65.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.9 86.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.15 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -48.29 -56.54 7.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -56.11 -46.5 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.416 ' HE3' ' HB ' ' A' ' 198' ' ' VAL . 7.9 tpp -51.08 -41.26 59.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.42 -53.33 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.88 -37.07 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -54.74 -45.49 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 18.4 m -80.25 -34.36 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.4 m -89.1 80.45 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 76.59 164.4 18.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 155.9 64.8 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 44.9 t -43.09 -49.7 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 50.6 m -93.62 133.36 37.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.844 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.465 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.7 t 61.51 44.43 9.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.2 t -79.75 -43.83 21.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.52 86.67 0.25 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.522 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -88.87 -55.95 3.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 110.883 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.5 t 55.07 25.04 6.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -120.45 -79.91 0.59 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 126.05 12.85 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.36 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.8 t -118.2 138.58 48.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 m -136.55 144.04 45.64 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.644 0.735 . . . . 0.0 110.877 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 133.76 26.49 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 0.0 112.322 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.28 166.27 18.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.936 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -118.5 -17.92 9.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.4 m -79.01 152.94 30.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.69 157.02 28.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.87 132.81 33.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -65.98 140.56 97.15 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -50.67 0.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.378 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.6 t -45.56 -43.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -80.84 -17.35 72.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.544 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.56 6.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.061 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.51 HD23 ' HG3' ' A' ' 176' ' ' PRO . 16.4 tp -45.28 -43.42 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.858 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -50.62 -36.83 37.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -67.71 -44.54 77.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -60.09 -60.29 4.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.1 m -43.9 -39.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 165' ' ' GLN . 92.2 t -59.06 -38.39 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -77.96 -39.3 43.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.566 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.3 mmpt? -72.55 -25.51 61.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.81 43.63 5.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.501 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.566 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 11.0 m0 -121.58 175.35 6.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.32 . . . . 0.0 110.886 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -102.1 164.36 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 mt -38.35 143.28 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.51 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.78 151.55 68.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.645 2.23 . . . . 0.0 112.363 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -92.07 120.18 32.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.583 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 37.6 m-85 -112.25 113.29 25.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.5 m -149.71 146.15 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.557 HG12 ' OE2' ' A' ' 183' ' ' GLU . 62.0 t -81.82 132.67 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.07 -39.25 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -132.32 149.86 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.557 ' OE2' HG12 ' A' ' 180' ' ' VAL . 4.3 mp0 -143.22 111.68 6.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.5 t -128.24 172.25 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.23 145.64 15.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.52 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 53.6 Cg_endo -69.76 -168.83 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.724 2.282 . . . . 0.0 112.345 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.33 -52.11 15.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.52 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 30.2 p-80 -57.47 -32.48 67.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -133.68 92.44 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -86.52 135.67 33.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -125.99 114.73 18.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -106.99 139.44 41.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 205' ' ' GLY . 20.1 m -116.85 102.79 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -102.26 148.25 25.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 204' ' ' ILE . 6.8 m -121.75 144.87 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 6.6 t -101.55 110.61 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -96.93 100.05 11.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 31.1 t -95.73 159.19 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 21.7 mm-40 -33.33 -66.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.465 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 66.9 mtt85 -123.92 33.6 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 200' ' ' ARG . 23.9 m-85 -148.04 154.16 39.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -150.12 139.8 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -150.48 124.48 9.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.485 ' HA ' HG23 ' A' ' 195' ' ' THR . 58.2 mt -90.38 137.28 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 193' ' ' THR . . . -128.26 174.46 18.81 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 158.63 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.924 0.392 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 179.36 152.93 11.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.1 p -65.51 -23.19 66.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 0.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 150.33 50.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -49.15 -57.02 7.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.58 -40.36 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 213' ' ' ALA . 35.9 mt -70.85 -61.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.17 -44.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.583 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -58.23 -61.66 2.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.2 -26.43 60.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.31 -42.51 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.34 63.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.077 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.473 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -66.8 -53.8 29.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -42.14 -58.4 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -58.46 -44.9 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 13.0 tpp -50.45 -37.2 36.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 47.4 mt -48.63 -58.21 5.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.37 -44.15 97.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -48.22 -54.74 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.414 HG12 ' CD2' ' A' ' 201' ' ' PHE . 33.1 m -74.78 -34.01 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.3 t -42.23 -57.22 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 168.74 162.32 20.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.503 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 229' ' ' SER . 53.5 Cg_endo -69.76 -22.58 31.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.696 2.264 . . . . 0.0 112.309 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 228' ' ' PRO . 98.8 p -37.62 -59.57 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.7 m -52.3 -61.53 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.482 179.996 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.9 t -118.76 131.22 56.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.37 . . . . 0.0 110.874 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.1 t -64.17 83.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.87 40.49 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.455 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.0 m -143.83 173.98 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 0.0 110.842 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 89.0 p -170.04 163.2 9.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.836 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 131.95 146.23 5.68 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 -176.38 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.713 2.275 . . . . 0.0 112.365 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.6 p -173.81 144.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.8 m -164.42 144.17 6.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 137.46 35.47 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.691 2.261 . . . . 0.0 112.353 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -94.79 81.51 3.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -160.79 140.1 10.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 19.1 m -63.25 -63.17 1.27 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.33 151.19 5.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 63.9 m -58.5 161.5 4.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.37 143.05 47.67 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.664 0.745 . . . . 0.0 110.894 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -50.77 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.269 . . . . 0.0 112.392 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.9 t -47.45 -37.35 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.53 -19.83 61.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.39 -52.11 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.101 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.5 HD23 ' HG3' ' A' ' 176' ' ' PRO . 34.9 tp -47.99 -28.24 2.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 7.3 tp-100 -61.01 -56.17 24.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.707 ' CG ' HD23 ' A' ' 167' ' ' LEU . 5.0 pt-20 -48.58 -32.86 8.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.707 HD23 ' CG ' ' A' ' 166' ' ' GLU . 4.8 mt -68.81 -68.37 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 3.3 m -40.21 -38.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -57.96 -47.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -71.9 -39.28 69.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HD3' ' CH2' ' A' ' 173' ' ' TRP . 2.0 mmpt? -70.4 -27.13 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.12 45.06 4.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.492 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.576 ' CH2' ' HD3' ' A' ' 171' ' ' LYS . 10.6 m0 -123.89 174.7 7.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.758 0.313 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.72 166.4 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.53 140.65 0.98 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.608 0.718 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.5 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.8 Cg_endo -69.74 159.31 53.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.329 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -95.53 138.42 33.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.516 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 70.6 m-85 -130.34 107.93 9.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.6 m -144.7 150.7 37.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.52 HG11 ' HG3' ' A' ' 183' ' ' GLU . 25.3 t -85.87 122.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 1.5 t -96.65 -32.35 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.152 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.43 145.67 50.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.52 ' HG3' HG11 ' A' ' 180' ' ' VAL . 1.9 mp0 -144.86 107.02 4.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -135.45 166.1 23.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.12 142.69 10.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.508 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.473 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.5 Cg_endo -69.8 -169.92 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.256 . . . . 0.0 112.308 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.13 -33.58 65.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.8 p-80 -77.8 -28.9 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -131.04 80.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.74 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -138.62 114.45 9.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -105.83 142.38 35.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -114.55 101.12 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.2 ttm -103.03 143.76 32.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.801 HG23 ' O ' ' A' ' 203' ' ' GLU . 89.1 m -124.05 136.01 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 11.0 t -91.38 111.88 23.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -96.09 110.13 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.0 t -103.64 159.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.53 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 6.3 mm-40 -34.17 -72.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.11 32.06 6.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -146.63 153.01 39.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.4 mt -150.04 137.23 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.109 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.801 ' O ' HG23 ' A' ' 195' ' ' THR . 29.0 tp10 -148.94 138.0 21.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.417 ' HA ' HG23 ' A' ' 195' ' ' THR . 46.1 mt -99.46 142.29 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -133.87 -179.27 16.24 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 65.7 p -151.52 153.57 34.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.401 . . . . 0.0 110.834 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -171.71 150.46 13.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.5 p -59.5 -34.2 72.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 6.1 m -131.59 144.91 51.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -41.63 -56.67 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -38.1 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.0 mt -75.37 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -39.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.516 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 11.0 tttm -61.14 -55.09 36.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.3 ptt85 -63.17 -30.64 71.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.68 -47.21 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.38 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.22 69.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 222' ' ' LEU . . . -44.83 -58.91 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -56.47 -44.97 81.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 2.9 tpp -51.3 -44.78 62.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 219' ' ' ALA . 26.3 mt -38.65 -56.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -44.38 -57.71 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 27.0 m -74.66 -34.62 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.2 t -42.58 159.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.11 84.04 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 102.64 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 m -85.8 -53.28 5.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 11.8 t -54.94 91.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.7 m -124.54 94.32 4.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 110.869 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.1 t -142.93 127.37 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.94 -120.34 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -59.36 106.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 110.874 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.5 m -137.29 116.3 12.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 171.27 146.46 5.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 138.56 38.18 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.711 2.274 . . . . 0.0 112.316 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.474 HG12 ' HD3' ' A' ' 153' ' ' PRO . 61.3 t -63.01 88.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.152 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.5 m -109.61 83.24 2.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.631 0.729 . . . . 0.0 110.889 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.474 ' HD3' HG12 ' A' ' 151' ' ' VAL . 53.5 Cg_endo -69.8 -18.4 36.82 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -118.24 123.41 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -43.66 159.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.5 t -166.56 134.46 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -52.1 145.37 10.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.1 p -90.96 129.58 36.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -107.54 85.08 2.1 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.736 . . . . 0.0 110.905 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 -44.75 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.412 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.455 HG21 ' HD3' ' A' ' 214' ' ' LYS . 64.9 t -48.31 -37.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -86.84 -16.44 61.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.66 -51.76 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.044 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.429 HD13 HD23 ' A' ' 222' ' ' LEU . 15.5 tp -46.03 -42.54 13.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.653 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.0 tp60 -51.83 -34.95 42.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -69.68 -41.19 75.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -67.23 -59.22 3.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 169' ' ' VAL . 12.9 m -41.11 -51.42 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 165' ' ' GLN . 88.2 t -54.12 -41.77 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -64.52 -45.43 87.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -75.19 -21.52 58.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.62 43.5 4.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.497 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -116.19 172.35 7.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.745 0.307 . . . . 0.0 110.922 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 175' ' ' LEU . 22.5 ptt-85 -101.55 164.22 11.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 174' ' ' ARG . 48.9 mt -36.4 142.34 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.573 0.701 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 146.8 61.1 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.631 2.221 . . . . 0.0 112.335 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.43 137.88 33.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.559 ' CE2' ' HE3' ' A' ' 214' ' ' LYS . 94.5 m-85 -127.83 122.15 31.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -149.28 139.6 22.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.148 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.1 t -76.33 126.64 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 67.2 p -94.04 -41.53 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -150.58 164.17 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.81 120.12 12.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.0 t -132.02 166.04 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 146.58 21.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.564 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.4 Cg_endo -69.77 -175.09 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.78 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.564 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.7 p-80 -61.44 -41.77 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -120.06 58.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -64.45 150.94 45.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.9 116.9 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -107.78 127.98 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 22.8 m -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.498 ' HB3' ' HB1' ' A' ' 213' ' ' ALA . 58.7 ttm -101.7 144.9 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 203' ' ' GLU . 18.0 m -122.65 139.06 54.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 7.7 t -96.67 120.54 37.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -102.51 119.56 39.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 21.2 t -115.51 157.44 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.492 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 15.2 mt-10 -33.82 -68.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -120.24 32.37 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 31.8 m-85 -146.43 152.05 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.0 mt -149.99 142.56 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 195' ' ' THR . 9.4 tm-20 -155.64 146.1 21.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.439 ' HA ' HG23 ' A' ' 195' ' ' THR . 53.5 mt -107.88 147.03 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -141.63 170.06 24.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.6 p -142.69 139.82 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.837 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.5 136.27 5.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 p -46.11 -23.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.9 m -142.74 148.75 37.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -42.42 -56.14 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -44.66 -44.26 8.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 77.3 mt -70.01 -60.84 2.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 194' ' ' MET . . . -35.21 -37.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.559 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 8.1 tttp -66.84 -53.94 27.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -64.56 -28.97 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -66.52 -49.03 67.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.08 -52.02 58.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -50.88 -44.49 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.5 -64.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -53.43 -33.32 53.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.569 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.6 OUTLIER -62.15 -36.94 83.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.429 HD23 HD13 ' A' ' 164' ' ' LEU . 67.9 mt -49.73 -38.03 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.5 -36.59 20.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -59.18 -50.2 74.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 221' ' ' MET . 28.8 m -69.12 -26.41 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.6 p -87.64 139.26 30.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -70.04 -88.97 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.33 53.8 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.7 2.267 . . . . 0.0 112.32 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.1 m -108.07 138.9 43.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 52.0 p -52.26 -58.39 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.3 m -60.24 149.35 33.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.854 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.3 t -90.04 91.64 8.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.45 112.33 1.16 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.4 p -74.69 163.88 27.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.877 0.37 . . . . 0.0 110.911 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.3 m -147.64 135.01 20.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 60.65 157.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 175.81 7.63 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 151' ' ' VAL . 30.2 m -120.13 113.79 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.9 t -95.99 142.96 25.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.623 0.725 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -39.37 6.72 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.709 2.273 . . . . 0.0 112.387 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 47.5 38.22 7.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -139.4 126.2 20.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 56.1 m -46.59 173.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.792 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.04 -33.28 21.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.94 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 67.2 m -109.74 120.78 43.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.429 ' CG ' ' HD2' ' A' ' 160' ' ' PRO . 13.1 t30 -147.25 140.47 14.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 0.0 110.849 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 159' ' ' ASN . 53.6 Cg_endo -69.73 -48.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.331 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.6 t -49.29 -48.67 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -70.92 -9.57 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.68 -47.94 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.098 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.749 ' O ' HG22 ' A' ' 168' ' ' VAL . 17.8 tp -60.76 -26.55 67.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.478 ' OE1' HD21 ' A' ' 175' ' ' LEU . 1.2 tp60 -65.19 -31.5 72.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.12 -42.56 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -61.97 -54.04 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 164' ' ' LEU . 3.0 m -45.21 -52.53 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.481 ' H ' HG23 ' A' ' 168' ' ' VAL . 69.4 t -52.06 -52.23 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -60.74 -29.4 69.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.531 ' HD2' ' CZ3' ' A' ' 173' ' ' TRP . 27.1 mttm -85.63 -16.43 39.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.07 36.98 9.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.531 ' CZ3' ' HD2' ' A' ' 171' ' ' LYS . 38.6 m0 -118.74 176.57 5.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.321 . . . . 0.0 110.88 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -109.05 164.11 12.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.478 HD21 ' OE1' ' A' ' 165' ' ' GLN . 21.4 mt -38.05 142.48 0.45 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.576 0.703 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.625 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.5 Cg_endo -69.75 149.71 67.3 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.357 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.19 139.8 30.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.569 ' CD2' ' HG3' ' A' ' 214' ' ' LYS . 77.4 m-85 -133.43 112.51 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.419 ' C ' ' HG3' ' A' ' 194' ' ' MET . 5.1 m -139.14 128.45 24.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.77 119.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.519 HG21 ' OG1' ' A' ' 195' ' ' THR . 1.5 t -96.32 -32.06 12.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -141.59 149.89 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.9 106.98 6.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.4 t -136.13 171.28 14.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.58 148.38 12.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.413 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.571 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.8 -173.1 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.33 -44.66 51.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.571 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 8.8 p-80 -61.17 -41.1 96.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -129.81 88.63 2.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -80.6 130.8 35.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -112.39 120.28 41.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -112.33 116.31 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 m -100.34 98.54 9.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.419 ' HG3' ' C ' ' A' ' 179' ' ' THR . 3.8 ttp -102.91 143.68 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.519 ' OG1' HG21 ' A' ' 181' ' ' THR . 2.4 m -109.67 140.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 36.1 t -101.61 119.76 39.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -101.08 103.95 15.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 19.6 t -96.17 159.45 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 50.6 mm-40 -32.96 -69.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -120.44 32.88 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 32.8 m-85 -146.23 154.19 41.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.6 mt -149.82 136.01 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.562 ' OE2' ' HB1' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -151.0 153.08 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 36.8 mt -109.31 130.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -116.76 176.66 16.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.8 p -149.23 144.77 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -164.64 141.54 7.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.503 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.9 p -54.08 -16.03 1.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 210' ' ' LYS . 3.1 m -149.7 143.84 25.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' SER . 76.0 mttt -37.5 -58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -41.81 -47.11 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 215' ' ' ARG . 35.7 mt -69.65 -59.05 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.25 -35.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.569 ' HG3' ' CD2' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -67.0 -48.68 67.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 212' ' ' LEU . 9.6 ptt180 -65.4 -44.5 87.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 215' ' ' ARG . 22.2 t-20 -56.21 -42.67 77.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.562 ' HB1' ' OE2' ' A' ' 203' ' ' GLU . . . -68.83 -48.61 63.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.453 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -58.61 -46.43 87.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -45.56 -64.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -52.38 -43.88 64.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 222' ' ' LEU . 8.0 tpp -50.95 -47.03 61.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.844 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.503 HD23 HD13 ' A' ' 164' ' ' LEU . 46.6 mt -36.76 -51.59 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.951 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.13 -43.91 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -45.54 -56.72 4.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.549 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m -68.95 -37.95 77.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.6 t -63.77 134.48 55.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.13 -158.71 7.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.529 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -18.64 36.69 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.725 2.283 . . . . 0.0 112.342 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 p 71.85 29.38 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 44.5 t -77.07 -177.45 4.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.3 m 42.66 41.38 2.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.4 m -64.13 -55.32 22.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.864 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.06 161.37 10.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 96.7 p -138.19 112.44 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.861 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 149' ' ' GLY . 39.6 m -77.89 96.97 5.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.814 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 148' ' ' SER . . . 36.93 82.64 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.482 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 178.36 4.61 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.745 2.296 . . . . 0.0 112.346 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.9 m -73.39 129.43 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.139 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.5 p -117.89 143.14 32.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.701 0.762 . . . . 0.0 110.835 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 150.56 68.6 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.731 2.287 . . . . 0.0 112.317 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -80.66 107.39 13.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -71.15 83.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 62.0 p -50.04 -44.99 51.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -130.71 118.18 20.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.9 t -75.61 138.04 41.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.452 ' ND2' ' HD2' ' A' ' 160' ' ' PRO . 1.3 t30 -153.63 139.18 11.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.452 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 54.0 Cg_endo -69.76 -50.33 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.9 t -45.49 -41.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.141 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.08 -23.82 54.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.42 -58.42 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 111.1 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.43 -40.37 12.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.484 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 6.6 tp60 -56.47 -35.37 67.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.23 -37.06 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -66.44 -49.97 64.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 7.2 m -46.72 -36.18 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.52 -37.68 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -71.72 -40.58 69.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -78.59 -27.95 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.936 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.73 46.36 4.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 30.5 m0 -115.92 175.52 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 175' ' ' LEU . 55.0 mtt180 -100.57 155.13 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 174' ' ' ARG . 30.2 mt -34.39 141.55 0.25 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.624 0.726 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 152.91 69.35 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.716 2.278 . . . . 0.0 112.336 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -97.16 130.93 44.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.585 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 62.0 m-85 -123.04 109.77 14.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 m -144.54 148.57 34.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.5 t -87.27 122.46 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.0 t -96.62 -28.47 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.432 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 44.2 mt-30 -146.59 163.19 36.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.565 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 41.0 mt-10 -151.88 105.87 3.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.8 t -119.11 172.37 7.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.25 145.08 14.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.577 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.8 Cg_endo -69.75 -175.33 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.577 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 6.6 p-80 -71.5 -40.77 69.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -117.36 83.97 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -83.31 137.44 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -137.47 126.08 23.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.565 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 4.4 m-85 -117.01 128.5 55.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.2 m -94.39 105.33 17.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 40.5 ttm -105.74 141.79 36.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 203' ' ' GLU . 7.5 m -118.91 134.71 55.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 41.2 t -92.63 108.25 19.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -92.07 102.51 15.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 38.9 t -97.26 157.72 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.486 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 59.6 mm-40 -33.71 -73.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -114.2 30.34 7.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 36.1 m-85 -145.66 153.74 41.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 57.6 mt -149.78 135.49 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 195' ' ' THR . 4.2 tp10 -146.24 143.24 29.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 65.3 mt -108.39 136.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.87 -179.33 16.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.487 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 73.8 p -149.6 144.23 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.832 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -160.61 143.91 9.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.2 p -48.54 -29.38 4.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -141.69 148.37 38.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' LYS . 70.3 mttt -40.55 -67.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.438 ' CD ' ' H ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -35.35 -43.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.93 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.8 mt -72.52 -55.16 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -41.84 -39.05 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.585 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 5.4 ttmt -57.61 -55.48 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 216' ' ' ASN . 5.0 ptm180 -60.77 -37.39 81.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.448 ' N ' ' HG2' ' A' ' 215' ' ' ARG . 5.1 m120 -56.91 -49.55 75.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.96 -46.75 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.118 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -49.83 -56.24 11.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -39.47 80.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.938 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . . . . . . . . . 4.9 tpp -55.73 -45.73 77.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 54.4 mt -38.35 -51.73 1.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 14.7 mt -72.69 -48.49 38.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 224' ' ' ARG . 12.1 mmp_? -39.19 -50.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.574 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 27.3 m -76.03 -35.15 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.7 t -123.14 93.94 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -75.09 -158.09 6.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 126.07 12.87 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 85.5 p -67.42 165.48 16.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 18.2 t -54.62 -43.45 72.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.855 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.448 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.1 p -150.38 162.68 40.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.804 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -88.22 133.37 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.64 109.78 3.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.497 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.1 m -93.44 42.99 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 110.817 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 54.5 p -57.05 -44.34 82.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.65 86.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.461 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 122.18 8.86 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.674 2.249 . . . . 0.0 112.33 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.12 175.77 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.164 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.8 m -86.37 150.51 51.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.671 0.748 . . . . 0.0 110.87 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -41.02 4.59 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -163.89 141.99 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -111.97 47.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.6 m 41.28 39.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -144.64 168.38 20.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 26.6 p -88.52 125.85 34.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -162.81 144.82 8.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.598 0.713 . . . . 0.0 110.927 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -50.52 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.23 -38.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.7 -19.94 62.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.5 -54.85 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.67 HD13 HD23 ' A' ' 222' ' ' LEU . 15.4 tp -44.67 -42.95 7.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.588 ' O ' HG23 ' A' ' 169' ' ' VAL . 15.5 tp60 -49.99 -35.89 26.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -69.61 -44.47 70.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.6 mt -60.74 -58.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 165' ' ' GLN . 5.3 m -42.05 -41.84 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 165' ' ' GLN . 89.7 t -62.2 -37.44 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 167' ' ' LEU . 16.4 mm100 -72.49 -38.79 68.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -80.24 -20.05 45.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.57 44.26 6.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -115.49 178.22 4.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.744 0.307 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.409 ' CD ' ' O ' ' A' ' 175' ' ' LEU . 0.5 OUTLIER -107.3 166.67 10.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.409 ' O ' ' CD ' ' A' ' 174' ' ' ARG . 44.3 mt -45.52 136.16 5.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.581 0.705 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.509 ' HG3' HD23 ' A' ' 164' ' ' LEU . 53.7 Cg_endo -69.72 158.13 58.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 0.0 112.348 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -95.77 148.49 22.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.581 ' CD1' ' HG3' ' A' ' 214' ' ' LYS . 80.7 m-85 -135.37 112.48 10.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -144.76 143.82 30.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 91.7 t -78.76 127.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.9 p -101.65 -40.74 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -135.75 163.29 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.547 ' HG2' ' CD2' ' A' ' 192' ' ' PHE . 73.6 mt-10 -150.82 107.01 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.7 t -123.19 172.19 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.32 145.91 16.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.644 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 53.1 Cg_endo -69.84 -164.47 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.614 2.209 . . . . 0.0 112.326 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.07 -42.93 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.644 ' CE1' ' CG ' ' A' ' 186' ' ' PRO . 46.0 p-80 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.571 ' HG3' ' CD2' ' A' ' 188' ' ' HIS . 34.3 mtm180 -133.21 49.11 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.05 136.89 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.96 123.4 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.547 ' CD2' ' HG2' ' A' ' 183' ' ' GLU . 3.4 m-85 -116.58 129.71 56.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.1 m -94.79 97.8 10.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 47.1 ttm -98.88 136.21 39.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.507 HG23 ' HA ' ' A' ' 204' ' ' ILE . 19.1 m -112.29 134.66 53.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 5.7 t -93.63 117.59 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.4 128.29 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 199' ' ' GLU . 42.7 t -122.58 157.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.471 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.6 mm-40 -33.87 -66.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.469 ' O ' ' CD1' ' A' ' 201' ' ' PHE . 20.6 mmm180 -123.21 32.84 5.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.556 ' CE2' ' HA ' ' A' ' 225' ' ' VAL . 22.1 m-85 -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.6 mt -150.0 139.8 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 195' ' ' THR . 14.8 tp10 -152.29 137.69 17.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.507 ' HA ' HG23 ' A' ' 195' ' ' THR . 61.4 mt -97.68 137.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.57 174.78 18.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.512 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.8 p -149.76 138.58 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.37 134.12 3.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.514 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.0 p -40.31 -35.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.9 t -132.01 146.17 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -41.46 -57.56 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -43.4 -40.55 3.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.507 HD23 ' HD3' ' A' ' 215' ' ' ARG . 24.4 mt -75.09 -60.24 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -36.3 -41.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.581 ' HG3' ' CD1' ' A' ' 178' ' ' TYR . 79.0 tttt -58.35 -57.41 13.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.507 ' HD3' HD23 ' A' ' 212' ' ' LEU . 5.1 ptm180 -61.13 -32.62 72.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -64.35 -46.37 83.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.71 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.01 92.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -50.13 -63.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -52.5 -40.29 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.577 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.8 OUTLIER -57.25 -34.92 69.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.67 HD23 HD13 ' A' ' 164' ' ' LEU . 75.2 mt -47.88 -46.91 32.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.09 -44.89 36.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 -47.21 -56.59 6.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 221' ' ' MET . 29.6 m -68.27 -32.59 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 13.7 m -79.4 83.59 5.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -40.35 146.5 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 160.13 50.84 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.616 2.211 . . . . 0.0 112.36 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 75.2 m -159.58 129.22 5.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.1 t -83.49 106.67 15.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.874 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.8 t -138.53 138.89 38.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 m -38.35 125.26 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.819 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.16 -110.09 3.92 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.483 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.1 t -157.93 142.49 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.816 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.9 t -134.82 110.07 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -128.62 67.68 0.55 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -174.34 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 0.0 112.371 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.4 m -119.96 159.18 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 65.6 p -67.1 144.08 98.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.668 0.747 . . . . 0.0 110.842 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 166.17 28.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 0.0 112.331 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -94.42 136.87 34.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -103.95 141.6 35.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 17.7 m -92.62 -48.91 6.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -130.07 165.17 22.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 28.1 p -75.64 146.81 40.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -158.66 142.41 11.09 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 110.894 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -50.34 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.345 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -48.89 -40.31 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.56 61.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.88 -58.88 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.477 HD13 HD23 ' A' ' 222' ' ' LEU . 27.3 tp -41.32 -45.54 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -52.01 -39.4 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.27 -31.62 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 167' ' ' LEU . 4.5 mt -75.3 -62.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.8 m -39.08 -46.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.132 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.02 -37.37 77.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 167' ' ' LEU . 32.3 mt-30 -72.22 -35.18 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.586 ' HE3' ' CZ2' ' A' ' 173' ' ' TRP . 24.0 mmmt -82.96 -22.36 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.83 36.49 7.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.586 ' CZ2' ' HE3' ' A' ' 171' ' ' LYS . 32.7 m0 -106.78 177.98 4.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 175' ' ' LEU . 83.7 mtt180 -102.28 155.41 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 174' ' ' ARG . 64.9 mt -36.91 142.8 0.35 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.26 50.25 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.429 ' C ' ' OE1' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -94.57 128.81 41.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CE1' ' HG3' ' A' ' 214' ' ' LYS . 87.9 m-85 -118.39 123.99 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 88.4 m -143.89 142.87 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.581 HG11 ' CD ' ' A' ' 183' ' ' GLU . 57.4 t -85.01 119.02 33.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.3 p -90.05 -62.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.424 ' C ' ' HG3' ' A' ' 183' ' ' GLU . 26.4 tp60 -116.65 154.18 30.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.581 ' CD ' HG11 ' A' ' 180' ' ' VAL . 28.3 mt-10 -150.61 108.36 3.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.94 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 t -134.49 172.08 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 111.0 146.14 10.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.578 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 53.9 Cg_endo -69.77 177.69 5.34 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.97 99.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HB2' ' A' ' 186' ' ' PRO . 24.4 p-80 -68.34 -41.21 81.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -120.67 78.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -78.02 141.82 38.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -138.05 122.13 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.461 ' CD2' ' HG3' ' A' ' 210' ' ' LYS . 8.7 m-85 -114.45 141.23 47.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 8.7 m -112.84 98.56 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 54.6 ttm -105.67 138.08 42.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 204' ' ' ILE . 9.1 m -114.1 135.14 54.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' CYS . . . . . . . . . . . . . 10.7 t -93.39 117.5 30.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -98.66 126.42 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.509 HG23 ' SD ' ' A' ' 221' ' ' MET . 17.8 t -122.23 157.78 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 16.1 mm-40 -32.73 -67.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.89 32.02 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.403 ' CD2' HG12 ' A' ' 225' ' ' VAL . 45.3 m-85 -144.91 152.09 39.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.7 mt -149.84 139.7 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -151.04 134.46 16.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.588 ' HA ' HG23 ' A' ' 195' ' ' THR . 14.0 mt -94.9 132.98 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -128.34 168.67 20.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -149.83 170.43 18.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 176.94 171.87 40.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 52.6 p -71.94 -17.96 62.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.4 m -150.54 142.1 23.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.461 ' HG3' ' CD2' ' A' ' 192' ' ' PHE . 8.3 mtmp? -40.49 -50.5 2.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -48.26 -39.97 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 213' ' ' ALA . 38.7 mt -74.25 -63.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 212' ' ' LEU . . . -35.72 -38.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' A' ' 178' ' ' TYR . 12.1 tttm -61.4 -54.07 48.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -34.35 76.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -47.1 80.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.28 91.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.448 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . . . -61.62 -48.98 78.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -47.36 -61.69 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.2 -40.74 71.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.603 ' O ' HG22 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -57.14 -32.78 66.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.477 HD23 HD13 ' A' ' 164' ' ' LEU . 59.5 mt -52.04 -49.62 63.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.4 mt -73.04 -44.0 61.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 224' ' ' ARG . 2.9 mmm180 -45.91 -53.13 10.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 221' ' ' MET . 18.3 m -74.63 -26.8 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.149 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.9 t -78.26 137.66 38.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -134.53 175.74 20.31 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.514 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 113.19 3.29 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.3 m -91.07 116.93 29.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.9 m -76.33 97.09 4.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 -179.996 . . . . . . . . 0 0 . 1 stop_ save_